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Abstract 
 
This thesis is divided into three sections. 
 
Section one is a review of transannular pericyclic reactions. It covers the four main 
types of pericyclic reaction and major contributions in the field to date. Recent 
applications of these reactions to natural product synthesis are also included. 
 
Section two discusses the results of research efforts into transannular Claisen 
rearrangements of α-sulfonyl lactones. The background to the project is discussed 
along with initial investigations into the transannular Claisen and decarboxylative 
Claisen rearrangements (dCr) of the 7-membered α-tosyl lactone to form vinyl 
cyclopropanes. Stereoselectivity from within the pericyclic array, by substitution at the 
lactone C7 position is examined. Efforts towards stereoinduction from outside of the 
pericyclic array are also detailed, along with aryl substitution at the lactone C5 position 
to form highly substituted vinyl cyclopropanes. Extension of this methodology to the 
unprecedented transannular Claisen rearrangement and dCr reaction of 8-membered α-
tosyl lactones to give vinyl cyclobutanes is reported. Finally, efforts towards a novel 
synthetic route to (±)-grandisol utilising the transannular Claisen rearrangement 
chemistry is described. 
 
Section three details the experimental procedures and spectroscopic data for the 
compounds described in section two. 
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Stereochemical Notation 
 
It should be noted that the Maehr convention for indicating relative and absolute 
stereochemistry has been used throughout this report.1 Therefore, solid and broken 
lines are used to denote racemates, and solid and broken wedges denote absolute 
configuration. Narrowing of the wedges implies increasing distance from the reader in 
the latter case. 
 
 
 
It should also be noted that in the case of the cyclopropanes with a sulfoximine 
appendage, the stereochemistry at the carbon centre is implied by the dashed bond to 
COOH or H. The bond to the sulfoximine is kept as a single line, allowing the 
stereochemistry at the sulfur centre to remain unchanged to save confusion. 
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1.1 Introduction 
 
Pericyclic reactions are concerted, single-step processes with no intermediates. The 
transition state is always cyclic, and as such the stereochemistry of the product is 
highly predictable. They are highly versatile and some of the most efficient known 
reactions in terms of atom economy.2 Pericyclic reactions can broadly be divided into 
four major categories (Figure 1):  
• Cycloadditions: the formation of two new σ-bonds between the termini of two 
conjugated π systems to form a ring 1 → 2.  
• Electrocyclic reactions: the formation of one new σ bond, often the cyclisation 
of a linear conjugated system 3 → 4.  
• Sigmatropic rearrangements: the simultaneous formation and breaking of a σ 
bond 5 → 6. These are further classified by the distance migrated by each end 
of the σ bond along the conjugated system.  
• Group transfer reactions: the cleavage and formation of unequal numbers of σ 
bonds to form an acyclic product, for example, the ene reaction 7 → 8. 
 
 
Figure 1: Major classes of pericyclic reaction 
 
Transannular reactions occur across a ring, presenting both an enthalpic and entropic 
advantage due to the proximity of the reacting sites. Sterically congested systems 
which are inert to inter- and intra-molecular strategies may also react. Conformational 
restrictions lead to marked chemo-, regio- and diastereoselectivities. When these 
attributes are combined with those of pericyclic reactions, the rapid establishment of 
high levels of cyclic complexity and enhanced stereocontrol are predicted. 
Transannular reactions can also be divided into the four major classes of pericyclic 
reaction (Figure 2):  
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• Transannular cycloaddition: the formation of a tricycle from an alkene-
containing macrocycle with establishment of four new contiguous stereocentres 
9 → 10. 
• Transannular electrocyclic reactions: the formation of a bicycle containing two 
new stereogenic centres in the forward sense 11 → 12. The reverse, ring-
opening reaction is also transannular 12 → 11. 
• Transannular sigmatropic rearrangements: the ring contraction of a macrocycle 
with formation of two new stereocentres 13 → 14. 
• Transannular ene reaction: the pericyclic transfer of a proton across a ring, 
frequently forming a bicyclic system 15 → 16. 
 
 
Figure 2: Examples of transannular pericyclic reactions 
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1.2 Transannular Cycloadditions 
 
1.2.1 Transannular Diels–Alder Reaction 
 
The transannular Diels–Alder (TADA) reaction has been the subject of extensive 
research due to its ability to construct functionalised tricyclic compounds with four 
contiguous stereocentres from macrocyclic trienes.3 Alkyne and unactivated tetracyclic 
dienophiles, along with terminally substituted dienes prove problematic in inter- and 
intramolecular Diels–Alder reactions.4 These coupling partners are well-tolerated in 
the TADA process due to enthalpic and entropic activation of the macrocycle.5,6,7 
Furthermore, conformational restrictions of the macrocycle allow high levels of 
stereocontrol. Trienes 17 of the type [m+n+6] undergo the TADA reaction to form an 
A.B.C tricycle [m.6.n] 18 (Scheme 1). 
 
 
Scheme 1: Transannular Diels–Alder reaction 
 
The geometry of the macrocyclic trienes participating in the TADA reaction is 
described in terms of C (cis) or T (trans) in the order depicted. The highest priority 
alkene of the diene is first and the dienophile last; consequently macrocycle 19 is 
defined as TTC. The stereochemistry of the newly-formed bonds of the product 
tricycle are then expressed in terms of C (cis), T (trans), S (syn) and A (anti), also in 
the order illustrated. In the case of tricycle 20, R1 and R3 are trans to each other, R3 
and R4 are syn to one another, and R4 and R2 are trans to each other, hence tricycle 20 
is defined as TST (Scheme 2). 
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Scheme 2: Geometric description of the TADA reaction 
 
There are eight possible geometric isomers of the Diels–Alder precursor, for which the 
relative stereochemistry of the resulting tricycles may be predicted. For the TADA 
reaction of each 14-membered macrocycle, two possible stereochemical configurations 
of the A.B.C.[6.6.6] tricycle are theoretically possible. Due to the stereoelectronic 
requirement for the Diels–Alder to go through a boat-like transition state, some of 
these outcomes may be discounted (Table 1).8 
 
 
Tricycle Stereochemistry Triene Geometry Tricycle Stereochemistry 
TAT 
 
CTT 
 
CAC 
TAT 
 
TCT 
 
CAC 
TAC 
 
CCT 
 
CAT 
TAC 
 
TTT 
 
CAT 
TSC 
 
CTC 
 
CST 
TSC 
 
TCC 
 
CST 
TST 
 
CCC 
 
CSC 
TST 
 
TTC 
 
CSC 
 
Table 1: Predicted stereochemical outcomes for the TADA 
 
Experimentally, Deslongchamps and co-workers have shown the stereochemical 
outcome for the [6.6.6] tricyclic products to be in good agreement with the 
predictions.9 The results of their studies are summarised (Table 2). Generally the 
Diels–Alder reaction required elevated temperature of 300–350 °C. The exception are 
the TT dienes which underwent transannular Diels–Alder reaction under the 
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macrocyclisation conditions (80 °C). In these cases, the macrocyclic triene could not 
be isolated. 
 
Macrocyclic 
Geometry 
Diels–Alder 
conditions 
Tricycle Stereochemistry Ratio Yield 
CTT 300 °C, 2 h 33 (CAC) – 91% 
TCT 350 °C, 1 h 33  (CAC) + 36 + unknown 2:3:1 >90% 
CCT 300 °C, 3 h 42 + 33 (CAC) + (36+unknown) 6.4:1.4:1.7 >90% 
TTT 80 °C 51 (CAT) + 52 (TAC) 1:2 65% 
CTC 300 °C, 2.75 h 27 (CST) – 89% 
TCC 300 °C, 2 h 28 (TSC) – 100% 
CCC 300 °C, 30 min 27 (CST) + 28 (TSC) 1:1 95% 
TTC 80 °C 47 (TST) – 53% 
 
Table 2: Experimental outcome for the TADA reactions 
 
The CT dienes underwent high-yielding, efficient reactions in contrast to their inter- 
and intramolecular equivalents. As predicted, the CTC and TCC macrocycles 23 and 
24 gave the expected CST and TSC tricycles 27 and 28 respectively. Both compounds 
are sterically unhindered in the expected chair-boat-chair transition state 25 and 26, 
hence formed the predicted tricycles in excellent yield (Scheme 3). 
 
E
E
E
E
R
H
H
E
E
E
E
R
H
H
E
E
E
E
R
R'
H
H
R'R'
23 (CTC) R = Me, R' = H 27 (CST) R = Me, R' = H
24 (TCC) R = H, R' = Me 28 (TSC) R = H, R' = Me
25 R = Me, R' = H
26 R = H, R' = Me
E = COOMe
 
Scheme 3: TADA reaction of CTC and TCC macrocycles 
 
The CTT macrocycle 30 produced CAC tricycle 33 via transition state 32 when heated 
to 300 °C. The same CAC tricycle 33 was also obtained from TCT macrocycle 29 at 
350 °C. Two additional products, 36 and an unidentified compound were obtained in a 
2:3:1 ratio. In the chair-boat-chair transition state 31, additional steric hindrance is 
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created by the methyl group when compared to transition state 32. Consequently, the 
transannular ene reaction of 29 can now viably compete with the TADA reaction to 
produce CTT macrocycle 35. This can then undergo an unhindered Diels–Alder 
reaction to produce CAC tricycle 36 containing a tri-substituted alkene (Scheme 4). 
 
 
Scheme 4: TADA reactions of TCT and CTT macrocycles 
 
Although the CC dienes are not generally compatible with Diels–Alder reactions,10 the 
CCC macrocycle 37 is predicted to form a CSC tricycle 39. Consideration of the chair-
boat-chair transition state 38 reveals steric interaction between the two chair-like rings. 
Experimentally, CCC macrocycle 37 is thought to undergo two consecutive 1,5-H 
shifts via macrocycle 40 to form a mixture of the CTC and TCC macrocycles 23 and 
24. These then undergo the TADA reaction to give a 1:1 mixture of macrocycles 27 
and 28 (Scheme 5).  
 
Transannular Pericyclic Reactions 
 18 
  
Scheme 5: TADA reaction of CCC macrocycle 
 
It was predicted that the CCT macrocycle 41 could not adopt the conformation 
necessary for the TADA reaction to occur. Heating of triene 41 to 350 °C produced the 
ten-membered bicycle 42 in 64% yield, confirming this hypothesis. Additionally, a 
mixture of 33 and 36 was also observed, suggesting interconversion to the TCT and 
CTT macrocycles (Scheme 6). 
 
 
Scheme 6: Attempted TADA of CCT macrocycle 
 
Since the TT dienes are set up in the necessary cisoid geometry, they are extremely 
reactive and undergo the TADA reaction under macrocyclisation conditions. Both the 
TTT and TTC macrocycles are predicted to form a mixture of stereoisomers. The TTC 
macrocycles are predicted to react via conformation 43a or 43b to give a mixture of 
CSC and TST trienes 46 and 47. Experimentally, only TST triene 47 is produced. 
Transition state 44, leading to the CSC product, suffers from two 1,3-diaxial 
interactions between the olefin and axial ester functionality, hence is disfavoured. No 
such interactions exist in transition state 45, and hence complete conversion to the TST 
tricycle 47 is observed (Scheme 7). 
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Scheme 7: TADA reaction of TTC macrocycle 
 
Using the predicted chair-boat-chair transition state model, TTT macrocycle 48 may 
react in either conformation a or b to form tricycles CAT 51 and TAC 52. Both 
transition states 49 and 50, which vary only by the position of the methyl group, 
exhibit 1,3-diaxial interaction between the olefin and ester group. This is thought to be 
slightly greater in transition state 50. However, this prediction was not borne out, since 
a ratio of 1:2 in favour of the TAC tricycle 52 was obtained (Scheme 8).  
 
 
Scheme 8: TADA reaction of TTT macrocycles 
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It has further been predicted that this transformation may also occur through 
competing boat-boat-chair transition states 53 and 54, again leading to the same CAT 
and TAC tricycles 51 and 52. In this case, transition state 53 has the methyl group in 
the boat-like conformation creating additional steric hindrance, whereas 54 is in the 
chair-like conformation, hence suffering from less steric hindrance. The predicted 
lower energy of the transformation of 54 → 52 compared to 53 → 51, favouring the 
TAC product 52, supports the ratio observed (Scheme 9).  
 
 
Scheme 9: TADA reaction of TTT macrocycles via chair-boat-boat transition states 
 
These experimental results were in close agreement with the predictions, with six of 
the possible eight stereochemical outcomes for the tricyclic products observed (Table 
1). Careful examination of the transition states accounts for the anomalous results in 
the TCT, CCC and TTC macrocycles. The significant level of stereochemical control 
exhibited demonstrates the potential of the transannular Diels–Alder approach to 
tricyclic systems. 
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1.2.2 The TADA Reaction as a General Approach to the Synthesis of 
Steroids 
 
Given the ability to control the stereochemical outcome of the TADA reaction, there is 
potential to synthesise polycyclic natural products via this method. The majority of 
diterpenes, triterpenes and steroids could potentially be derived from TADA 
precursors. For example, retrosynthetic analysis of triterpene 55, an 
A.B.C.D.E.[6.6.6.6.5] pentacycle, leads back to the three tricyclic systems 56, 57 and 
58. These, in turn, can be derived from the 13- and 14-membered macrocyclic trienes 
59, 60 and 61 (Scheme 10).  
HO
Me Me
MeA B
D
E
MeMe
E
E
E'
E' Me
Me
E'
E'
E
E Me
E'
E'
E
E
A B B
D
D
E
C
Me
Me
E
E
E'
E' Me
Me
E'
E'
E
E Me
E'
E'
E
E
55 A.B.C.D.E.[6.6.6.6.5]
56 A.B.C.[6.6.6] 57 B.C.D.[6.6.6] 58 C.D.E.[6.6.5]
59 6160
E = COOMe
 
Scheme 10: General strategy for the synthesis of steroids 
 
It has been estimated that there are more than 4000 polycyclic natural products which 
could be synthesised from just 20 key tricyclic intermediates.3a The TADA could 
therefore provide a general route to a large number of natural products of this type. 
Deslongchamps and co-workers have carried out investigations into the TADA 
reaction of macrocycles 59, 60 and 61.3 For B.C.D[6.6.6] macrocycle 60, incorporating 
an unactivated tetra-substituted dienophile, four macrocycles were investigated, each 
Transannular Pericyclic Reactions 
 22 
producing a single stereoisomer: CTT→CAC, TTT→CAT, TTC→TST and 
CTC→CST. This demonstrates the efficient synthesis of tricycles, such as 57, with 
two adjacent stereo-controlled quaternary centres. 
 
The synthesis of 5β-steroids has been demonstrated by Takahashi and co-workers.11 Of 
the four possible tetracyclic products, only the CATAT isomer 63 was obtained from 
the TADA reaction of TTT macrocycle 62 (Scheme 11).  
 
 
Scheme 11: Stereoselective synthesis of 5β-steroids 
 
This selectivity can be explained by examination of the transition states where the two 
Z groups depicted are a carbonyl (Scheme 12). In this example transition states 65 and 
68 are disfavoured as they take the chair-boat-boat conformation, and transition state 
66 is disfavoured due to a 1,3-diaxial interactions between the methyl and diene. Given 
the sp2 conformation of the carbonyl, the axial interaction of the Z group indicated in 
transition states 67 and 68 are negligible, resulting in complete selectivity for the 
CATAT tetracycle 71. Further work on these substrates has been carried out by 
Deslongchamps and co-workers to investigate the role of the substituents on the 
outcome of the TADA reaction.12 By replacing the carbonyl at C3 with two bulky Z 
groups, the ratio of the tetracycles produced is dramatically altered. Steric interactions 
between the diene and axial Z group in transition state 67 raise the energy of this 
conformation, allowing chair-boat-boat transition state 65 to compete. In the case 
where the Z substituents are the bulky SO2Ph, only the TACAT tetracycle 69 and 
TACST tetracycle 70 are obtained in a 2:1 ratio. With smaller Z substituents such as 
CO2Me and CN, the CATAT tetracycle 71 can start to compete, but in each case a 
mixture of isomers is obtained, in contrast to carbonyl example. Chair-boat-boat 
transition state 68 can not be accessed due to the presence of two diaxial interactions. 
Given these results it is clear that the substituents play a fundamental role in the 
preferred orientation of the TADA transition states (Scheme 12). 
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Scheme 12: Substituent effects in the TADA reaction 
 
Synthetic studies towards the synthesis of TSC [6.6.5] tricycles13 have been applied to 
the synthesis of the B.C.D. rings of 14β-hydroxysteroids.14 The stereochemistry of the 
TSC [6.6.5] tricycles was found to be controlled by the substituent at the C17 position. 
In the TCC macrocyclic triene 73, steric repulsion in the transition state 74 is 
minimised by the bulky OTBDMS group being positioned exo, leading to TSC tricycle 
75 (Scheme 13).  
 
OTBDMS
OTBDMS
E
E
OR E
E
E
OR
E
OR
H
E
E
H
OTBDMS
E
PhMe, BSA
230 °C
94%
73 (TCC) 74 75 (TSC)
17
 
Scheme 13: Synthetic approach to 14β-hydroxysteroids 
 
The 5α-steroid aldosterone 81 exemplifies the TAT ring geometry commonly found in 
naturally occurring diterpenes and steroids. This is the only geometry not directly 
accessible via the TADA reaction, and as such, must be accessed by epimerisation. 
This methodology has been utilised in the synthesis of the TATAT analogue 80. 
Heating of the TCC macrocycle 76 gave tetracycle 78 with the expected TSCAT 
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geometry, controlled by the trans geometry of the cyclopentanone. Subjection of 
tetracycle 78 to PTSA allowed epimerisation at the C9 position to give tetracycle 79 
with the desired TATAT geometry, which was further manipulated to provide 
polycycle 80. This approach may in principle allow access to a large number of 
steroidal natural products (Scheme 14). 
 
 
Scheme 14: Synthetic approach to 5α-steroids containing the TAT geometry 
 
In addition to the terpene and steroidal natural products accessible via the TADA 
reaction, a number of other natural products have also been synthesised using this 
methodology,15 including the alkaloid cassain A 82,16 polyketide (+)-FR182877 8317 
and its enantiomer,18 macrolide (+)-superstolide A 84,19 polyketide (–)-spinosyn A 
8520 stemodane diterpene (+)-maritimol 86,21 and quinine-based longithorone A 87.22 
The ability to both predict and influence the stereochemical outcome of the 
transannular Diels–Alder reaction make this an extremely valuable tool in target-
oriented synthesis (Figure 3). 
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Figure 3: Natural products synthesised via the TADA reaction 
 
1.2.3 An Example of the TADA Reaction in Total Synthesis; (±)-
Strychnine 
 
Given the complex cyclic nature of strychnine (–)-88 with its six stereocentres, it is not 
surprising that this synthetic challenge has also been approached using the transannular 
Diels–Alder reaction. Pentacyclic amine 89 is an intermediate in a previous synthesis 
of strychnine incorporating the required ABCEG rings.23 This intermediate could be 
assembled by the transannular Diels–Alder reaction of cyclophane 90 which would 
simultaneously form the C, E and G rings of strychnine (Scheme 15). 
 
N
O
O
N
H
H
H
N
O
NR
H
N
N
N
NR
88 ( )-strychnine 89 90
R = COOMe
A
B
E D
F
G
C
 
Scheme 15: Retrosynthetic TADA approach to strychnine 
 
On heating aza-cyclophane 90, pentacyclic amine 93 was obtained as a single 
diastereoisomer via a quantitative transannular inverse-electron Diels–Alder reaction. 
Of the eight possible transition state conformations, the favoured one has an exo-chair-
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boat-chair conformation 91 leading to the TAC ring junctions of the forming bonds, in 
agreement with the observations of Deslongchamps and co-workers. Extrusion of N2 
from intermediate 92 led to the desired pentacyclic amine 93 with the desired relative 
stereochemistry at the two newly formed quaternary centres (Scheme 16).24 
 
H
N
N
N
NR
N
R
N
N
N
H N
R
N
H
N N
N
NR
N,N-diethylaniline
, 1 h
100% -N2
90 (TTT) 91 92 (TAC) 93
R = COOMe
 
Scheme 16: Inverse-electron TADA approach to (±)-strychnine 
 
1.2.4 Asymmetric Catalysis of the TADA Reaction 
 
As demonstrated in the synthesis of steroids (vide supra), the absolute stereochemistry 
of the transannular Diels–Alder reaction can be controlled by the presence of 
macrocyclic stereocentres. Balskus and Jacobsen have recently published the first 
example of a catalytic, asymmetric TADA reaction to give tricyclic products with high 
levels of enantiomeric control.25 The chiral triflimide-activated oxazaborolidine Lewis 
acid catalysts have been used to good effect in enantioselective inter- and 
intramolecular Diels–Alder reactions.26 By varying the boron substituent of the 
oxazaborolidine catalyst, the yield and stereoselectivity are affected. The best results 
were obtained using the 2-fluorophenyl derivative 96. The o-tolyl-substituted 
oxazaborolidine, optimised for inter- and intramolecular Diels–Alder reactions, gave 
both a low yield and enantioselectivity for the transannular substrates. The additional 
steric congestion of a macrocyclic system is likely to be the cause of this effect. TTT 
macrocyclic triene 94 was subjected to oxazaborolidine catalyst 96 and at room 
temperature gave the [5.6.8] CAT tricycle 95 in 69% yield and 90% ee (Scheme 17). 
Using this chemistry the [5.6.7], [6.6.7], [6.6.8] and [7.6.7] fused ring systems were all 
accessed with good enantioselectivity (85–92% ee). Currently this catalytic 
asymmetric methodology is limited to the TT dienes, although this may be attributed to 
the elevated temperatures required for the TADA reaction of the alternative diene 
geometries.  
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Scheme 17: Asymmetric catalysis of the TADA reaction 
 
This catalytic asymmetric system has been shown to affect the stereoselectivity of 
unselective reactions. Macrocycle 97 contains a 1,3-anti dimethyl substitution, so that 
both possible endo transition states 98a and 98b are destabilised by an axial methyl 
substituent. The resulting CAT tricycles 99a and 99b are obtained as a 1:1 mixture 
under standard TADA conditions. Subjection of the macrocycle to catalyst 96 
drastically alters the selectivity to favour tricycle 99b by 97.2:2.8 in excellent yield. 
Conversely, exposure of the macrocycle to the catalytic enantiomer ent-96 leads to 
selective formation of tricycle 99a (Scheme 18). 
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Scheme 18: Catalyst effect on a poorly selective TADA reaction 
 
The authors have applied their methodology to the synthesis of the sesquiterpene 
natural product 11,12-diacetoxydrimane 103. In this synthesis, silicon-containing 
macrocyclic ketone 100 is subjected to oxazaborolidine catalyst 96 to give complete 
conversion to the desired tricyclic product 101 in 20:1 dr. Oxidation, followed by 
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oxidative cleavage gave [6.6.5] tricyclic lactone 102 in 83% ee. Further reduction and 
acetylation gave the desired bicyclic target 11,12-diacetoxydrimane 103 (Scheme 19). 
 
 
Scheme 19: Enantioselective synthesis of 11,12-diacetoxydrimane 
 
1.2.5 Alternative Transannular Cycloadditions 
 
Far less research has been carried out on non-Diels–Alder transannular cycloadditions. 
However, a novel cycloaddition–cycloreversion27 synthesis of tricyclopentanoids has 
been developed by Mehta and co-workers.28 In three steps the CSC tricyclopentanoidal 
frame 108 is established, allowing development of a general approach to sesquiterpene 
natural products such as hirustene29 and the antibiotic ikarugamycin.30 Diels–Alder 
adduct 106 is obtained by subjection of cyclopentadiene 104 and 2,5-dimethyl-p-
benzoquinone 105 to thermal conditions. A transannular [2+2] photocycloaddition 
gave pentacyclic dione 107, which subsequently underwent thermal cycloreversion to 
yield the tricyclicpentanoid 108 (Scheme 20). 
 
 
Scheme 20: General approach to tricyclopentanoids 
 
This transannular photoaddition–cycloreversion strategy was utilised by White and co-
workers in their synthesis of byssochlamic acid.31 In this case the [2+2] 
photocycloaddition gave a 1:1 mixture of products resulting from the syn and anti 
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isomers of tricyclic diene 109. The exo,exo product 110a with both alkyl chains 
directed away from the sterically congested cage, and the exo,endo adduct 110b, with 
the ethyl directed towards the centre of the structure and the propyl away, resulted 
from the anti and syn isomers of 109 respectively. Cycloreversion under thermal 
conditions furnished tricyclic diene 111a and 111b. Lactone hydrolysis and oxidation 
to the tetra-carboxylic acid 112a and 112b was followed by acidic dehydration 
accompanied by epimerisation of the propyl substituent of 112b to give (+)-
byssochlamic acid 113 (Scheme 21). 
 
 
Scheme 21: Transannular photoaddition-cycloreversion approach to (+)-byssochlamic acid 
 
Transannular cycloadditions of increased ring size have also been investigated. 
Griesbaum and co-workers have demonstrated ozonide formation by the transannular 
[3+2] cycloaddition of a carbonyl oxide and carbonyl group.32 Ozonolysis of the 
alkene-bridged bicycle 114 on polyethylene gave the expected intermediate 115. 
Tricyclic ozonide 116 was isolated in 14% yield from the transannular [3+2] 
cycloaddition of carbonyl oxide intermediate 115 (Scheme 22). 
 
 
Scheme 22: Ozonide formation by transannular [3+2] cycloaddition 
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A transannular nitrone [3+2] cycloaddition reaction has been utilised in the stereo-
controlled synthesis of the spirocyclic core of pinnaic acid.33 Stereochemical control of 
this reaction is dependent on the size of the reactant macrocycle. This must be 
sufficiently large to allow the reacting olefin unconstrained approach to the nitrone, but 
not so large as to allow the nitrone to pass through the ring. In this case the single 
stereocentre controls the face of nitrone attack, and hence the three new stereocentres 
established in this transformation. Subjection of macrocyclic lactone 117 to thermal 
conditions resulted in a single tetracyclic diastereomer 118. Methanolysis and 
reductive cleavage of the isoxalidine revealed the azaspirocyclic core 119 of pinnaic 
acid (Scheme 23). 
 
 
Scheme 23: Transannular nitrone [3+2] cycloaddition 
 
Gung and co-workers demonstrated the first transannular [4+3] cycloaddition of a 
furan and allene in their approach to the ABCD rings of cortistatins.34 Treatment of 
furanoallene macrocycle 120 with palladium (II) acetate produced the desired 
tetracycle 121 in 37% yield. The proposed mechanism involves palladium activation of 
the allene 122 to form a π-allyl system 123. Nucleophilic attack by the furan gives the 
[4+3] cycloaddition product 125, which deprotonates to form the desired tetracyclic 
product 121. Stereocontrol of the product is in agreement with the endo-tethered 
transition state 124 (Scheme 24). 
 
 
Scheme 24: Proposed mechanism for the furan-allene [4+3] cycloaddition 
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A biomimetic pathway between two natural products, (–)-bipinnatin J 126 and (+)-
intricarene 129, involving singlet oxygen-mediated ring expansion, dehydration and a 
[5+2] transannular cycloaddition has been proposed by Pattenden and co-workers.35 
Bipinnatin J 126 underwent oxidative furanyl ring expansion and acylation leading to 
acetoxypyranone 127. When heated under reflux in the presence of DBU, formation of 
the oxidopyrilium ion 128 allowed the transannular [5+2] cycloaddition to occur 
leading directly to (+)-inticarene 129 (Scheme 25). 
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Scheme 25: Biomimetic interconversion of (–)-bipinnatin J to (+)-intricarene 
 
The research into transannular cycloaddition reactions presented here demonstrates the 
synthetic value of this transformation. The level of complexity and stereocontrol 
obtained in a single step makes this family of reactions extremely attractive in natural 
product synthesis. 
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1.3 Transannular Electrocyclic Reactions 
 
Electrocyclic reactions, in which a ring is always formed or broken, are prevalent in 
nature and have been proposed in a number of biosyntheses to polycyclic natural 
products.36 All annulenes are able to undergo electrocyclisation reactions under both 
thermal and photochemical conditions following the Woodward–Hoffmann rules.37 
For example, [16]annulene 130 is conformationally mobile and readily equilibrates 
with 131. Two electrocyclisations occur, each involving 6π electrons, to give 
cyclooctadienes 132 and 133. Under thermal conditions the electrocyclisation is 
disrotatory for the 4n+2 π electron system 131 → 132, whilst under photochemical 
conditions it is conrotatory 131 → 133 (Scheme 26).38 
 
 
Scheme 26: Electrocyclisations of annulenes 
 
An extensively studied transannular system is the equilibrium between the 
cycloheptatrienes 134 and their bicyclic isomer, norcaradienes 135.39 The position of 
the equilibrium depends on the energy difference between the release of ring strain and 
the formation of a σ bond at the expense of a π bond. The unsubstituted compound, 
where R = H, exists entirely in the monocyclic cycloheptatriene form 134, whereas for 
the dicyano compound, where R = CN, only the bicyclic compound 135 is detected. 
This equilibrium can also be shifted towards the norcaradiene isomer 135 by 
incorporation of a benzyl group or bridging of the cyclopropane with a five-membered 
ring (Scheme 27).  
 
 
Scheme 27: Electrocyclic equilibrium between cycloheptatriene and norcaradiene 
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The oxy-equivalent of the cycloheptatriene–norcaradiene electrocyclisation has also 
been proposed in the biosynthesis of the aranotin family. Under thermal conditions the 
transannular electrocyclic ring opening of arene oxide 136 is thought to form oxepine 
137, which is further oxygenated to give aranotin 138 (Scheme 28).40  
 
 
Scheme 28: Proposed biosynthesis of aranotin 
 
1.3.1 The Endiandric Acid Cascade 
 
An extremely elegant use of the transannular electrocyclisation reaction is Nicolaou’s 
biomimetic synthesis of endiandric acid.41 This family of natural products occur as 
racemates, despite containing eight stereocentres. This observation led to the 
hypothesis that a series of non-enzymatic electrocyclisations from achiral precursors 
could be the natural biogenesis of these compounds.42 Endiandric acid A–D 153, 154, 
155 and 149 are found in nature, whereas endiandric acids E 150, F 151 and G 152 are 
proposed to be intermediate precursors to the tetracyclic endiandric acids A 153, B 154 
and C 155 respectively. Synthetically, Nicolaou demonstrated that hydrogenation of 
acetylenes 139 and 140 initiated a spontaneous electrocyclisation cascade. The 
undetected polyenes 141, 142, 143 and 144 experience conrotatory 8π electron 
electrocyclisation to give cyclooctatrienes 145, 146, 147 and 148. This is followed by 
the transannular disrotatory 6π electron electrocyclisation to give the bicyclic 
endiandric acids D 149, E 150, F 151 and G 152. A non-reversible intramolecular 
Diels–Alder reaction of endiandric acids E 150, F 151 and G 152 affords tetracyclic 
endiandric acids A 153, B 154 and C 155 respectively. This explains the lack of 
endiandric acids E 150, F 151 and G 152 in nature. Due to its geometry, endiandric 
acid D 149 is not able to undergo a Diels–Alder reaction, hence is the only bicyclic 
product of the electrocyclisations to be found in nature. This biomimetic cascade 
Transannular Pericyclic Reactions 
 34 
allows synthesis of an entire family of natural products in one-pot with formation of 
eight new stereocentres demonstrating the power of pericyclic reactions (Scheme 29). 
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Scheme 29: The endiandric acid cascade 
 
Since the synthesis of the endiandric acids, a number of other bicyclo[4.2.0]octadiene 
natural products have been isolated and synthesised using this 8π-6π electrocyclisation 
cascade. The optically active polyketides SNF4435C and SNF4435D are found as a 
3:1 mixture in nature and biosynthetically can be traced back to a common tetraene 
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precursor via an 8π-6π electrocyclisation cascade. A number of groups have completed 
the synthesis of SNF4435C and SNF4435D using this approach.43 Baldwin and co-
workers have demonstrated the tetraene natural product spectinabilin 156 to be a 
synthetic precursor to the SNF4435C 161 and D 162. By subjection of the 
spectinabilin 156 to thermal conditions, isomerisation of the (E,E,E,E) polyene to the 
requisite (E,Z,Z,Z) is achieved. The intramolecular 8π conrotatory electrocyclisation, 
followed directly by the endo-selective 6π disrotatory electrocyclisation led to 
SNF4435C 161 and SNF4435D 162. Conrotatory 8π electrocyclisations are thought to 
exhibit a helical transition state geometry, as illustrated in transition states 157 and 
158. 1,3-Diaxial interaction at the furanyl stereocentre drives a preference for 
formation of 159 over 160. The disrotatory 6π electrocyclisation is shown to be 
entirely endo-selective to give a ratio of SNF4435C 161 and SNF4435D 162 of 3.6:1, 
similar to the ratio found in nature. This ratio is based entirely on the selectivity of the 
8π electrocyclisation step (Scheme 30). 
 
Scheme 30: Biosynthetic synthesis of SNF4435C and D from spectinabilin 
 
Transannular Pericyclic Reactions 
 36 
Interestingly when the same tetraene 156 was subjected to palladium (II) catalysis 
conditions, additional isomerisation was thought to occur, leading to formation of two 
unexpected diastereoisomers. These isomeric products are consistent with the 8π-6π 
electrocyclisation cascade of the (Z,Z,Z,Z)- and (E,Z,Z,E)-isomers of tetraene 156. 
Furthermore, the related tetraene 163 incorporating an electron-withdrawing group 
undergoes a different reaction under thermal conditions.44 In this case isomerisation of 
the tetraene 163 to the (E,E,Z,E) geometry 164 followed by 6π disrotatory 
electrocyclisation to give intermediate 165 and an intramolecular Diels–Alder reaction 
gives the tricyclic structure 166. Under photochemical conditions tetraene 163 is 
isomerised to the (E,E,Z,Z) geometry 168 which undergoes 6π conrotatory 
electrocyclisation to intermediate 169 followed by σ2a + π2a electrocyclisation to give 
bicycle 170. Interestingly this is the structural core of a related family of natural 
products known as the crispatanes. This structural motif has also seen a biomimetic 
synthesis by Baldwin and co-workers.45 In this case tetraene 163 is subjected to 
palladium catalysis (PdCl2(MeCN)2) to promote the desired 8π-6π electrocyclisation 
cascade and form the bicyclo[4.2.0]octadiene core 167 (Scheme 31). 
 
 
Scheme 31: Electrocyclisation pathways of tetraenic ester 163 
 
Electrocyclisations occur regularly in nature, and as such hold great appeal in 
biomimetic syntheses. Their ability to occur spontaneously and generate polycyclic 
complexity with a highly predictable steric outcome substantiates their value in 
synthetic chemistry. 
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1.4 Transannular Sigmatropic Rearrangements 
 
Sigmatropic rearrangements are defined by the migration of a σ bond, and can be 
classified by the distance travelled by each end of the bond. The most common class 
are the [3,3]-sigmatropic rearrangements, dominated by two named reactions; the Cope 
rearrangement46 and the Claisen rearrangement.47 The Cope rearrangement involves 
only carbon atoms in the pericyclic ring 5 → 6, whereas the Claisen rearrangement 
includes an oxygen atom 171 → 172 (Figure 4). 
 
 
Figure 4: Common sigmatropic rearrangerments 
 
1.4.1 Transannular Cope Rearrangements 
 
In its simplest form the Cope rearrangement involves no structural change; as in the 
transannular Cope rearrangement of 3,4-homotropilidene 173 to its mirror image 173'. 
This represents a fully reversible and symmetrical Cope rearrangement. In non-
symmetrical rearrangements, this characteristic is frequently masked by an inherent 
thermodynamic bias for one of the conjugate pairs.48 Variable temperature NMR 
experiments suggest that 3,4-homotropilidene undergoes Cope rearrangement around 
one thousand times per second at 180 °C, and about once per second at –50 °C. At low 
temperatures this compound has seven different identifiable protons by NMR, whereas 
at high temperatures it has only four (Scheme 32).49 
 
 
Scheme 32: Cope rearrangement of 3,4-homotropilidene 
 
It was proposed that by addition of a third bridge between the two methylene positions 
of 3,4-homotropilidene 173, this Cope rearrangement could proceed even more rapidly 
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as a consequence of the compound being locked into its higher-energy boat-like 
conformation. This structure, bullvalene 174, can undergo three reversible Cope 
rearrangements to give identical products, 174a, 174b, 174c, due to its three-fold axis 
of symmetry. In fact, all its isomers can be transformed into one another. With a 
molecular formula of C10H10, there are more than 1.2 million combinations that form 
bullvalene. Each carbon atom is equally bonded and non-bonded to every other carbon, 
so that they move statistically around the surface of a sphere, known as a ‘fluxional 
structure’ (Scheme 33).48,49,50 
 
 
Scheme 33: Reversible Cope rearrangements of bullvalene 
 
Shortly after its hypothesis, bullvalene 174 was synthesised by Schröder via photolysis 
of the dimer of cyclooctatetraene 175 with extrusion of benzene 176. As predicted, at 
high temperatures it exhibited a single sharp peak at 4.2 ppm in the 1H NMR. At –25 
°C, two peaks are present, one at 5.7 ppm, corresponding to six protons and the other 
at 2.1 ppm, corresponding to four protons (Scheme 34).51 
 
 
Scheme 34: Synthesis of bullvalene 
 
The transannular Cope rearrangement has recently been utilised in the synthesis of (–)-
kainic acid (–)-179 and its enantiomer.52 Amide 177 exhibits planar chirality and its 
isomers do not interconvert at room temperature. Both enantiomers (S)-177 and (R)-
177 can be obtained by resolution of the racemate 177. This planar chirality is 
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transferred in the transannular Cope rearrangement to diene 178 under palladium-
catalysed conditions as the key step in this approach to both enantiomers of kainic acid 
179 (Scheme 35). 
 
 
Scheme 35: Transannular Cope rearrangement in the synthesis of (–)-kainic acid 
 
1.4.2 Transannular Claisen Rearrangements 
 
The reversible nature of the Cope rearrangement frequently makes its use unfeasible in 
organic synthesis. A more established sigmatropic rearrangement is the Claisen 
rearrangement, which benefits from the driving force of carbonyl formation. Both the 
groups of Knight53 and Funk54 have investigated the transannular ring contraction of 
macrocyclic lactones to form carbocyclic carboxylic acids. Using standard Ireland–
Claisen conditions, lactones 180 were converted to silyl ketene acetals 181 which 
undergo spontaneous rearrangement to the corresponding silyl esters 182, followed by 
hydrolysis to the carboxylic acids 183. In the case of lactone 180a rearrangement 
occurred at –60 °C, whereas the large ring lactones 180d and 180e required heating to 
110 °C and 80 °C respectively (Scheme 36). 
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Scheme 36: The transannular Claisen rearrangement of macrocyclic lactones 
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Products 183a-d were found to have syn relationship between the forming vinyl and 
carboxylic acid groups which can be explained by the reaction going through a boat-
like transition state 185. The alternative chair-like transition state 184 is highly 
strained in comparison. This chair-like transition state 184 only becomes accessible 
when the bridging methylene chain is sufficiently long to release the strain. In this case 
when n = 7, product 183e is formed as a 76:24 mixture of the cis:trans 
diastereoisomers (Figure 5). 
 
 
Figure 5: Transannular Claisen rearrangement transition states 
 
Lactone 186, containing a trans double bond, was also subjected to the transannular 
Claisen rearrangement conditions. Conservation of the enolate geometry led to the 
trans product 187 via boat-like transition state 188. This was found to be marginally 
favoured over the cis product 183c, obtained through the chair-like transition state 189 
(Scheme 37).54 
 
 
Scheme 37: Effect of a trans alkene on the transannular Claisen rearrangement 
 
Funk and co-workers demonstrated 1,2-relative asymmetric induction in the 
transannular Claisen rearrangement in their approach to (±)-dihydronepetalactone 192. 
Lactone 190 underwent the Claisen rearrangement to give the single diastereoisomer 
191. Stereoselective hydroboration followed by oxidative workup gave a 93:7 mixture 
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of two terpenes; (±)-dihydronepetalactone 192 and (±)-isodihydronepetalactone 193 
(Scheme 38).54b 
 
 
Scheme 38: Synthesis of (±)-dihydronepetalactone 
 
The stereochemical outcome for the Claisen rearrangement of lactone 190 can be 
justified by inspection of the possible transition states for the reaction. Transition state 
194 is preferred and gives rise to the observed cis,trans product 191. Each of the other 
transition states 195, 196 and 197 suffer from 1,3-diaxial interactions, making them 
energetically disfavoured (Figure 6). 
 
 
Figure 6: Possible transition states for the Claisen rearrngement of 190 
 
Additionally, both the groups of Knight and Funk have applied this chemistry to the 
stereoselective synthesis of cis-chrysanthemic acid 200.55 This demonstrates the 
transannular Claisen contraction of the 7-membered lactone 198 under the standard 
conditions used for the larger systems. The cyclopropyl natural product (±)-
chrysanthemic acid 200 is formed as a single diastereoisomer due to the requirement 
for the boat-like transition state 199 (Scheme 39). 
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Scheme 39: Synthesis of (±)-chrysanthemic acid via the transannular Claisen rearrangement 
 
More recently it has been shown that replacement of the silyl group in the ketene acetal 
with a trialkyl phosphinyl group enhances the rate of these rearrangements.56 Funk and 
co-workers demonstrated a decrease in half life from 58 min to 10 min at 65 °C for the 
rearrangement of lactone 198 to cis-chrysanthemic acid 200 via the phosphinyl ketene 
acetal. Additionally, substitution of the silyl ketene acetal for the phosphinyl ketene 
acetal has been shown to affect the diastereoselectivity of the rearrangement. 
Rearrangement of lactone 201 can occur through the chair-like transition state 202a or 
through the boat-like transition state 202b. The silyl ketene acetal of lactone 201 
underwent rearrangement at 100 °C over 10 h to give a 72:28 ratio of bicycles 
204:203, favouring the boat-like transition state 202b. However, rearrangement of the 
phosphonate enol occurred at room temperature with enhanced stereoselectivity. 
Furthermore, bis(trichloroethyl)phosphinyl ketene acetal rearranged with even greater 
stereoselectivity, again favouring the boat-like transition state 202b to give the trans 
bicycle 204 with 94:6 selectivity. Given the boat-like transition state 202b is assumed 
to be more sterically crowded than the analogous chair-like transition state 202a, this 
effect is thought to be electronic rather than steric (Scheme 40). 
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Scheme 40: Effect of phosphinyl ketene acetal on diastereoselectivity 
 
The synthesis of heterocycles was shown to be viable utilising transannular Claisen 
rearrangement chemistry by substitution of a carbon atom for a heteroatom. Funk and 
co-workers demonstrated the simultaneous construction of a piperidine ring and 
establishment of the cis stereochemistry of the vinyl and carboxylic acid substituents in 
their approach to N-benzoylmeroquinene methyl ester 208, a key intermediate in 
several syntheses of cinchona alkaloid.57 Azalactone 205 was subjected to the standard 
conditions to give the desired rearrangement product 207 via ketene acetal 206 
(Scheme 41). 
 
 
Scheme 41: Heterocyclic transannular Claisen rearrangement approach to N-benzoylmeroquinene 
 
The transannular Claisen rearrangement has featured in a number of total syntheses. 
For example, Stork and co-workers employed this reaction as the key step in the first 
synthetic approach to the main skeleton 210 of gelsemine 211. Tricyclic lactone 209 
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was subjected to standard Claisen conditions to obtain the key intermediate 210 in 
excellent yield (Scheme 42).58 
 
 
Scheme 42: Transannular Claisen rearrangement as an approach to gelsemine 
 
The transannular Claisen rearrangement has also been utilised as an alternative ring 
contraction route to large ring carbocycles which are difficult to synthesise. For 
example, in their approach to the indacene ring-containing family of natural products, 
Roush and co-workers synthesised the more easily accessible 16-membered lactone 
212 as a facile approach to the 12-membered carbocycle 213. This intermediate is not 
isolated and spontaneously undergoes a transannular Diels–Alder reaction to tricycle 
214. Macrocycle 213 has a cis relationship of the vinyl and carboxyl substituents, both 
of which are of pseudoequatorial geometry in the lowest energy transition state, 
leading to the favoured product 214. This methodology could be utilised in the 
synthesis of indacene ring-containing natural products such as (+)-ikarugamycin 215 
and (–)-lepicidin A 216 (Scheme 43). 
 
 
Scheme 43: Transannular Claisen approach to the indacene ring 
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Transannular sigmatropic rearrangements represent an alternative method for the 
introduction of asymmetric centres concomitant with ring formation. In particular, the 
ability of the Claisen rearrangement to form carbocycles with cis selectivity of the 
substituents, from the more easily obtained lactones is an invaluable addition to 
synthesis. The generality of the strategy to varying ring size and incorporation of 
heteroatoms makes it potentially applicable to a wide variety of systems. 
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1.5 Transannular Ene Reactions 
 
The transannular ene reaction has already been discussed as a competing reaction 
during the transannular Diels–Alder reaction of TCT and CCT macrocyclic trienes 
(vide supra). More commonly the enophile is a carbonyl, which is particularly 
favoured due to its inherent electrophilicity. A number of groups have used the 
transannular ene reaction in the synthesis of trans-decalins such as (±)-calameon 223.59 
In this synthetic approach methyl cyclobutenecarboxylate 217 and piperitone 218 are 
combined in a [2+2] photocycloaddition to give tricyclic ester 219. Thermal retro 
cycloaddition gives macrocyclic diene 220, which adopts the boat-chair conformation 
221 and is ideally suited for the transannular ene reaction to give bicycle 222. In this 
transformation the ring junction bond and stereochemistry are simultaneously 
established through the geometrically-controlled ene reaction. Further functional group 
manipulation led to the natural product (±)-calameon 223 (Scheme 44). Wender and 
co-workers further reported the success of the transannular ene reaction for these 
compounds, where the carbonyl is replaced with the methylene derivatives CH2, 
CHOMe and CHCO2Me leading to alternative functional group substitution at the ring 
junction.60 
 
 
Scheme 44: The transannular ene approach to trans-decalins 
 
1.5.1 The Tandem Oxy-Cope–Transannular Ene Reaction 
 
More recently Paquette and co-workers demonstrated a tandem oxy-Cope–
methylation–transannular ene reaction to form the interesting tricyclic diterpene 
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jatrophatrione 229.61 The anionic inter-molecular oxy-Cope rearrangement between 
bicyclic ketone 224 and diene 225 gave the tricyclic intermediate 226 which was 
methylated to give intermediate 227. This immediately undergoes transannular ene 
reaction to furnish the desired tetracycle 228. This transformation is facilitated by the 
close transannular proximity between the carbonyl and allylic proton. Oxidative ring 
opening and further elaborations gave access to the tricyclic core of jatrophatrione 229 
(Scheme 45). 
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Scheme 45: Tandem oxy-Cope–methylation–transannular ene reaction 
 
In recent years the greatest contributor to the field of transannular-ene reactions has 
been Barriault and co-workers.62 They have described a number of ene-containing 
tandem pericyclic reactions, starting with the oxy-Cope–transannular ene reaction.63 
1,2-Divinylcyclohexanols 230 in toluene were heated in a sealed tube at 220 °C to give 
the oxy-Cope–ene product as a single diastereoisomer. The addition of DBU to the 
reaction mixture was found to be essential in suppressing the retro-ene reaction. The 
stereoselectivity can be explained by examination of the transition states. The initial 
oxy-Cope reaction is assumed to go through a chair-like transition state for the 
transformation of diol 230 to enol 231. Rapid tautomerisation to the keto form 232 
allows access to two possible pathways. The first is a transannular ene reaction to give 
bicyclic alcohol 236 via the chair-like transition state 234. The second pathway is a 
ring flip to intermediate 233 which then undergoes a transannular ene reaction to give 
237 via the chair-like transition state 235 (Scheme 46). 
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Scheme 46: Proposed mechanism for the tandem oxy-Cope–ene reaction 
 
The product ratio is dependent on the energy difference between transition states 234 
and 235 assuming a rapid equilibrium between conformers 232 and 233. Therefore, the 
substitution pattern of the divinylcyclohexanol 230 will determine the diastereomeric 
outcome of this reaction. For example, methyl substituted divinylcyclohexanol 238 
gives bicycle 239 as the exclusive product. Transition state 234 experiences 1,3-diaxial 
strain as a result of the axial methyl group, whereas transition state 235 has the methyl 
group equatorial, favouring product 239. Conversely, the cyclic allylic alcohol 240 
experiences diaxial strain in transition state 235, therefore favouring transition state 
234 leading to the tricycle 241 as the single diastereoisomer (Scheme 47). 
 
 
Scheme 47: Examples of tandem oxy-Cope–ene reactions 
 
Barriault than applied the tandem oxy-Cope–transannular ene reaction to the synthesis 
of (+)-arteannuin M.64 Using (+)-limonene 242 as the starting material, 
divinylcyclohexanol 243 was obtained in two steps. The key pericyclic transformation 
allowed rapid access to the bicyclic 244 containing hydroxyl functionality at the ring 
junction. Further functional group manipulation led to (+)-arteannuin M 245 (Scheme 
48). Erosion of enantiopurity was observed in the key transformation and found to be 
catalysed by the presence of DBU in the reaction. Further investigations revealed the 
electronic nature of the vinyl substituent to affect the enantioselectivity. Replacement 
of the –OTBDPS side chain with a more electron-withdrawing group e.g. CF3 showed 
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greater erosion of the enantioselectivity, whereas electron-donating or neutral 
substituents showed less, demonstrating the reaction is under Curtin–Hammett control. 
 
 
Scheme 48: Synthesis of (+)-arteannuin M 
 
1.5.2 The Oxy-Cope–Ene–Claisen Cascade 
 
The inability to establish an all-carbon substituted quaternary centre is a limitation of 
the oxy-Cope–ene cascade. Incorporation of an allyloxy ether fragment to the 
isopropenyl unit will allow addition of a Claisen rearrangement to the pericyclic 
sequence, and access to a product containing one or more all-carbon quaternary 
centres. Following the oxy-Cope rearrangement and tautomerisation of 
divinylcyclohexanol 246, two potential transition states are feasible for the ene 
reaction. Transition state 248 has the allyloxy group positioned over the bicyclic core, 
hence is less favoured than transition state 247, leading to intermediate 249. The 
Claisen rearrangement proceeds anti to the bridgehead alcohol to afford tricycle 251 as 
the single isomer (Scheme 49).65  
 
 
Scheme 49: Proposed mechanism for the tandem oxy-Cope–ene–Claisen 
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This combination of pericyclic reactions represents an efficient strategy for the 
stereoselective synthesis of multiple carbon–carbon bonds. As such this methodology 
allows access to structurally complex dipterpenes such as tetrodecamycin 253 and 
dihydroxychiolide 254. The key pericyclic cascade towards the former has been 
reported.66 Retrosynthetically tetrodecamycin can be divided into a tetronic acid 
residue 255 and the decalin core 256, which has been synthesised by tandem oxy-
Cope–ene–Claisen reaction of dieneyne 258 to give the key decalin intermediate 257 
containing the requisite quaternary carbon centres. In a further ten steps decalin 256 
was obtained. The final addition of tetronic acid derivative 255 to decalin 256 is yet to 
be reported (Scheme 50).   
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Scheme 50: Synthesis of tetrodecamycin via the tandem oxy-Cope–ene–Claisen reaction 
 
1.5.3 The Oxy-Cope–Claisen–Ene Cascade 
 
A number of decalin structures, such as LL-S491β 259, myrocin C 260 and teucrolivin 
A 261 contain an all-carbon quaternary centre adjacent to a tertiary alcohol. These 
compounds could be derived from common decalin core 265 formed by a thermal oxy-
Cope–Claisen–ene cascade.67 Allylic ether 262 undergoes an oxy-Cope rearrangement 
to give macrocyclic allylic ether 263. Claisen rearrangement of 263 allows formation 
of ketone 264 followed by a transannular ene reaction to furnish the desired bicyclic 
alcohol 265 (Scheme 51). 
Transannular Pericyclic Reactions 
 51 
 
Scheme 51: The tandem oxy-Cope–Claisen–ene reaction 
 
The excellent stereoselectivity observed in this reaction is a result of the conformation 
of intermediates 263 and 264. The mechanism proposed shows the oxy-Cope 
rearrangement of allylic ether 266 proceeding via a chair-like transition state to give 
the macrocycle 267. This can then undergo a Claisen rearrangement to form ketone 
269 or ring flip to the alternate conformation 268. The rate of ring inversion is thought 
to be slow in comparison to the Claisen rearrangement; hence macrocycle 269 is the 
sole product. Consequently diastereomers 275 and 276 are never observed under 
thermal reaction conditions. From intermediate ketone 269 conformational inversion to 
270 followed by ene reaction leads to bicycle 273. Alternatively, direct transannular 
ene reaction gives diastereomer 274. The ratio of these two diastereomeric outcomes 
again depends on the rate of ring inversion compared to the ene reaction. In this case a 
fast rate is observed; hence the ratio of 273:274 is governed by the Curtin–Hammett 
principle. The favoured diastereomer is therefore generally determined by the least 
sterically demanding transition state, dependent on the substituents (Scheme 52).  
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Scheme 52: Proposed mechanism for the tandem oxy-Cope–Claisen–ene reaction 
 
These pericyclic cascades are efficient and reliable methods for the rapid construction 
of complex carbocycles with excellent control of stereoselectivity. The mechanistic 
studies outlined allow facile prediction of the favoured diastereomeric outcome by 
careful interpretation of the transition states. A large number of decalin cores can 
potentially be accessed using this chemistry. 
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1.6 Conclusion 
 
As a synthetic family, transannular pericyclic reactions enable the formation of new 
stereocentres with concomitant ring formation. Steric restrictions often allow excellent 
control over these newly formed stereocentres. The range of transformations outlined 
here demonstrates surprising versatility, and are key to the synthesis of a wide variety 
of cyclic natural products. The enthalpic and entropic advantage presented by these 
systems, frequently coupled with the need for only heat or light activation make 
transannular pericyclic reactions excellent candidates for biomimetic syntheses. Some 
areas, such as the transannular Diels–Alder reaction, have seen extensive research, and 
the stereoselectivity of the process is well understood. Other areas, such as the 
transannular Cope rearrangement have seen surprisingly little attention from the 
synthetic community. Recent interest in biomimetic and cascade syntheses utilising 
this class of reaction suggest continued activity in the field of transannular pericyclic 
reactions. 
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2.1 Background 
2.1.1 Historical Background 
 
Since its discovery in 1912,47 the Claisen rearrangement has been extensively 
employed in organic synthesis.68 In this transformation an allylic vinyl ether 280 
undergoes a concerted [3,3]-sigmatropic rearrangement to give a γ,δ-unsaturated 
carbonyl 282 or 284. This process forms new carbon–carbon bonds in a regiospecific 
manner from simple precursors. The reaction is compatible with a wide range of 
functional groups, can exhibit high levels of stereoselectivity, and thus is a useful tool 
in total synthesis. Under normal circumstances the Claisen rearrangement goes through 
a chair-like transition state 281, to give an anti relationship of R1 and R2 for the diene 
shown, 282. In a small number of cases, such as when the substrate is cyclic, the 
reaction is forced to go through a boat-like transition state 283. This leads to the 
opposite stereochemical outcome of R1 with respect to R2, as seen in 284 (Scheme 53). 
 
Scheme 53: The Claisen rearrangement 
 
Several variations on the original Claisen procedure have been developed, one of 
which, the Ireland–Claisen, uses a silyl ketene acetal as the active species in the key 
C–C bond formation.69 Silyl ketene acetal 286 is readily formed from the 
corresponding ester 285 using a silylating agent. This substrate undergoes facile 
rearrangement to give the carboxylic acid 287 on hydrolysis, often at or below ambient 
temperature (Scheme 54). 
 
 
Scheme 54: The Ireland-Claisen rearrangement 
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A [3,3]-sigmatropic rearrangement requires the simultaneous breaking and forming of 
a σ bond. The mechanism for both the chair- 288 and boat-like 289 transformations is 
pericyclic. In order for this reaction to be thermally allowed by the Woodward–
Hoffmann rules, the number of suprafacial 4q+2 components in the reaction must be 
odd.37 The Claisen rearrangement involves two π2 components and one σ2 component. 
The forming bonds are illustrated by dotted bonds, and both the chair- 288 and boat-
like 289 transition states show three suprafacial interactions, confirming that the 
reaction is thermally allowed for both conformations (Figure 7). 
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Figure 7: Orbital description of the Claisen rearrangement 
 
Under certain circumstances the Claisen rearrangement will go through the less-
favoured boat-like transition state. Ireland and co-workers demonstrated examples of 
cyclic substrates whereby a destabilising steric interaction in the chair-like transition 
state led to a preference for the boat-like transition state.70 In this example, 
conformational constraints of the furan 290 require the highlighted bonds to point in 
the same direction in the transition state. The steric bulk of the silyl group results in the 
chair-like conformation being disfavoured, forcing the transition state via the boat to 
give furan 291 as the major product (Figure 8).  
 
 
Figure 8: Conformation constraints in the Ireland–Claisen 
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Katsuki and co-workers also demonstrated that substitution of the silyl ketene acetal 
for a more bulky enolate will increase the steric interaction and force the Claisen 
rearrangement via the boat-like transition state.71 In this example the cis/trans diene 
292 undergoes a Claisen rearrangement with a silyl reagent. The chair-like transition 
state is favoured yielding primarily the syn product 293. Use of a bulky hafnium 
cyclopentadienyl reagent forces the transition state to be boat-like to reduce the steric 
interactions and reverse the syn:anti ratio to favour the anti product 294 (Scheme 55).   
 
 
Scheme 55: Influence of steric constraints in the Ireland–Claisen 
 
2.1.2 Transannular Claisen Rearrangements 
 
As an extension of the Ireland–Claisen rearrangement, the analogous transannular 
reaction utilises macrocycles (see section 1.4.2). Ring contraction of macrocyclic 
lactones 295 via transannular Claisen rearrangement was previously developed by 
Knight53 and Funk.54 When Funk and co-workers heated silyl ketene acetals 294 in 
toluene, 3-, 5-, 6-, 7-, 8- and 11-membered carbocycles 297 were synthesised. In each 
case, syn relative stereochemistry of the carboxylic acid and vinyl moiety was 
observed. Interestingly, synthesis of the cyclobutane carbocycles via this method was 
never reported (Scheme 56).54b 
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Scheme 56: Transannular Claisen rearrangement 
 
In agreement with the cyclic substrate analysis made by Ireland and co-workers 
(Figure 8), Funk proposed a boat-like transition state for the rearrangement of the silyl 
ketene acetal to explain the relative stereochemistry of the products. For example, in 
the following transformation to form cyclopentane 191, the syn stereochemistry would 
be achieved via transition state B. Transition state A is extremely strained, making the 
chair conformer disfavoured (Figure 9). In a later review, molecular modelling 
techniques showed that the boat transition state is indeed lower in energy.54b 
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Figure 9: Transannular Claisen rearrangement transition states 
 
This chemistry was applied to the synthesis of the natural product (±)-cis-
chrysanthemic acid 200. Lactone 198 was subjected to LDA and TBDMSCl to form 
the silyl ketene acetal, which goes through a boat-like transition state 199. Ring 
contraction via a transannular Ireland–Claisen rearrangement to give the cyclopropane 
is the key step in the synthesis (Scheme 57).55 
 
 
Scheme 57: Key step in the synthesis of (±)-cis-chrysanthemic acid 
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2.1.3 The Decarboxylative Claisen Rearrangement 
 
Within the Craig group a novel variant of the Ireland–Claisen rearrangement has 
recently been developed. In the decarboxylative Claisen rearrangement (dCr), α-tosyl 
esters 298 are silylated to form α-tosyl silyl ketene acetals 299. [3,3]-Sigmatropic 
rearrangement of 299 gives intermediate 300, followed by simultaneous desilylation–
decarboxylation and protonation to form homoallylic sulfones 301.72 Two sets of 
reagents have been developed for the dCr reaction, the first being N,O-
bis(trimethysilyl)acetamide (BSA) (0.1 equiv) and KOAc (0.1 equiv), and the second 
TBDMSOTf (2.1 equiv) and DBU (2.1 equiv). The reaction is effected by either 
overnight reflux in toluene, or subjection to microwave irradiation at 150 °C for 3 min 
(Scheme 58). 
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Scheme 58: The decarboxylative Claisen rearrangement 
 
The silylating agent most commonly used for the dCr reaction is BSA 302 along with 
potassium acetate 303 as the nucleophilic base. It was found that a wide variety of 
homoallylic sulfones 301 could be generated in high yields when allylic tosyl acetates 
298 were exposed to substoichiometric quantities of BSA and KOAc, and either heated 
at reflux in toluene for 15 hours, or subjected to microwave irradiation. Following 
extensive studies within the Craig group a catalytic cycle has been proposed for the 
dCr reaction (Scheme 59).73 It is thought that Me3SiOAc 305 and N-
trimethylsilylacetamide 304 are reversibly formed on combination of KOAc 303 and 
BSA 302, and it is the conjugate base of BSA 304 that effects enolate formation, and 
Me3SiOAc 305 that acts as the silyl transfer agent on acetate 298 to form silyl ketene 
acetal 299. [3,3]-Sigmatropic rearrangement of silyl ketene acetal 299 affords silyl 
ester 300. The nucleophilic acetate anion 303 abstracts the silyl group with loss of 
carbon dioxide. Abstraction of a proton by the resulting α-sulfonyl anion from N-
trimethylsilylacetamide 306 allows regeneration of the active species 304 and 305 and 
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formation of the homoallylic sulfone product 301. Evidence in support of this proposal 
was heating the ester in the absence of KOAc yields the carboxylic acid, product of the 
sigmatropic rearrangement, but does not lead to decarboxylation. In this case, the ester 
undergoes direct proton–silyl exchange with BSA 302. 
 
 
Scheme 59: Proposed catalytic cycle 
 
Subsequent research into the dCr reaction has demonstrated the versatility and scope of 
this process. This includes extension to heteroaromatic systems;74 dCr reaction of 
allylic tosylmalonate esters to give homo allylic tosyl esters;75 regioselective dCr 
reaction of bis(allyl) 2-tosylmalonates;76 double dCr reaction of bis(allyl) 2-
tosylmalonates and consequent conversion of the diene product to substituted 
pyridines.77 
 
2.1.4 Prior Transannular Claisen Rearrangement Work within the Craig 
Group 
 
Based on the work of Funk and Knight we wished to extend our dCr methodology to a 
transannular process. Initial focus was the synthesis of substituted cyclopropanes 307 
via the transannular dCr reaction of 7-membered α-tosyl lactone 308 (Scheme 60).78  
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Scheme 60: Proposed dCr cascade of cyclic malonate 
 
Previous work in the Craig group focused on the synthesis of 7-membered α-tosyl 
lactone 316, which was successfully developed via lactonisation of a hydroxy acid. In 
this synthesis, cis-butene diol 309 was protected using a two-step MOM-protection–
reduction to give allylic alcohol 311, which following mesylation gave mesylate 312. 
Coupling of 312 with tosyl acetate 313 and concomitant deprotection–saponification 
led to hydroxy acid 315. Facile lactonisation of 315 under standard esterification 
conditions yielded the desired lactone 316 (Scheme 61). 
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Scheme 61: Synthesis of 7-membered lactone 316 
 
The dCr reaction of lactone 316, under mild rt conditions was investigated. 
Interestingly, vinyl cyclopropane carboxylic acid 317, product of the Ireland–Claisen 
rearrangement was observed, however spontaneous decarboxylation via the dCr 
reaction was not achieved (Scheme 62). 
 
 
Scheme 62: Attempted dCr of 7-membered lactone 
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2.1.5 Focus of the Current Work 
 
The construction of cyclopropanes is an attractive synthetic challenge given the large 
number of natural products containing this moiety.79 Vinyl cyclopropanes have proved 
valuable in a number of synthetic transformations including isomerisation to 
cyclopentenes,80 polymerisation,81 cycloadditions,82 cycloheptadiene formation83 and 
regioselective ring opening.84 There are a wide variety of methods available for the 
synthesis of cyclopropanes,85 but all have some limitation on the scope of functionality 
that may be incorporated. 
 
The possibility for extending the current methodology to the novel transannular dCr 
reaction is the initial focus of this thesis (Scheme 63). Using this chemistry, vinyl 
cyclopropane 318 could be prepared from α-tosyl lactone 319 with control of 
diastereoselectivity. The conditions necessary for this reaction were investigated. The 
scope of this transformation to incorporate additional substitution, R1, on the 
cyclopropane ring was evaluated. Additionally, the susceptibility of the dCr reaction to 
enantioselectivity by induction from within, (R2) as well as from outside (SR3) of the 
pericyclic array were explored.  
 
 
Scheme 63: Proposed transannular decarboxylative Claisen rearrangement 
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2.2 The Transannular Claisen Rearrangement 
 
Repetition of the previous work78 to synthesise α-tosyl lactone 316 (Scheme 61) gave 
comparable yields in each step. This allowed for optimisation of the conditions 
necessary to effect a Claisen rearrangement to give vinyl cyclopropane carboxylic acid 
317 (Table 3). All reactions were run overnight at room temperature and any 
conversion rates measured by 1H NMR. 
 
 
Run BSA (equiv used) KOAc (equiv used) Outcome 
1 1.0 0.1 Quantitative yield of 317a 
2 1.0 0.0 95 % yield of 317a 
3 0.5 0.1 93 % yield of 317a 
4 0.1 0.1 Reaction did not go to completion 
5 0.1 0.0 Reaction did not go to completion 
6 0.5 0.0 37 % conversion to 317b 
7 0.25 0.1 19 % conversion to 317b 
a isolated yield; b conversion measured by 1H NMR 
 
Table 3: Results of Claisen rearrangement conditions 
 
Quantitative conversion to cyclopropane 317 was achieved in runs 1–3, but the 
reaction did not go to completion in runs 4–7. This illustrated that KOAc is not a 
necessary reagent when 1.0 equiv of BSA is used, but is necessary with 0.5 equiv of 
BSA. With less than 0.5 equiv of BSA, the reaction did not go to completion 
regardless of the addition of KOAc. In this case the Claisen rearrangement could not 
be shown to be catalytic in TMS, but given these cyclopropanes do not decarboxylate 
spontaneously under the conditions studied it is hypothesised that the TMS is retained 
until acidic work-up. These results demonstrate a vastly improved yield over those 
previously reported.78 
 
Given the propensity of α-tosyl lactone 316 to transannular Claisen rearrangement 
using BSA/KOAc at rt, the decarboxylation of acid 317 was attempted in a separate 
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step. Previously, Krapcho-like conditions were utilised resulting in 34% yield of 
decarboxylated product 320.78 Subsequently, microwave conditions were attempted 
and the desired product 320 was produced in a much improved 80% yield (Scheme 
64). 
 
 
Scheme 64: Decarboxylation of cyclopropane 
 
2.2.1 The Transannular Decarboxylative Claisen Rearrangement 
 
Based on the decarboxylation result it was envisaged that the dCr reaction of lactone 
316 might be possible using more the forcing microwave conditions. It was found that 
by subjecting lactone 316 to microwave irradiation at 160 °C for 10 min, using 1.0 
equivalent of BSA and 0.1 equivalents of KOAc in DMF, a high yield of vinyl 
cyclopropane 320 was achieved. This is the first example of a transannular dCr 
reaction (Scheme 65).  
 
 
Scheme 65: Single step dCr reaction of lactone 316 
 
Based on NMR analysis, the decarboxylated cyclopropane was produced as a single 
diastereoisomer. Mechanistically, following the [3,3]-sigmatropic rearrangement of 
lactone 316, cyclopropane ester 321 undergoes desilylation–decarboxylation to give α-
tosyl carbanion 322. Protonation can occur from either face of the cyclopropane to 
give diastereoisomers 320 and 323 (Scheme 66). Experimentally, protonation occurs 
only from the re-face to give vinyl cyclopropane 320. The rationale for the preference 
of the single diastereomeric product is that an anti relationship between the vinyl and 
tosyl groups is less sterically hindered. 
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Scheme 66: Proposed transition state for transannular dCr reaction 
 
2.2.2 Alternative Lactonisation Strategies 
 
Previously a route to form the 7–membered α-tosyl lactone 308 via ring-closing 
metathesis (RCM) from diene 324 was attempted.78 This approach utilised 
benzylidene[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene] 
dichloro(tricyclohexylphosphine)ruthenium (Grubbs II) but did not prove successful, 
presumably due to the coordinating effects of the ester group on the metal (Scheme 
67). 
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Scheme 67: Unsuccessful RCM approach to unsaturated lactone 
 
Recent research from the Fürstner group has shown that the successful ring-closing 
metathesis (RCM) of ester-containing dienes is possible when a metal additive is used 
to bind the ester, thus freeing up the catalyst for the metathesis reaction.86 It was 
thought that diene 325 would be particularly disposed to this type of chelation due to 
the presence of the sulfone (Scheme 68). 
 
 
Scheme 68: Metal-mediated RCM 
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Synthesis of tosylated dienes 327 as the precursors for metathesis, is well established 
within the group using dCr chemistry.77 This procedure would also open up a 
straightforward route to substituted cyclopropanes 329 allowing investigation into the 
stereochemical effects of substitution (Scheme 69). 
 
 
Scheme 69: Proposed route to substituted cyclopropanes 
 
Synthesis of metathesis precursor 334 was easily achieved in a two-step procedure by 
coupling tosylacetic acid 330 with allyl alcohol 331 to give ester 332, followed by 
alkylation with allyl bromide 333 (Scheme 70). 
 
Scheme 70: Synthesis of RCM precursor 
 
Synthesis of phenyl substituted RCM precursor 341, was slightly more involved, but 
also had precedent within the group.77 Reaction of Meldrum’s acid 336 with allyl 
alcohol 331 produced malonic acid allyl ester 337. Coupling with cinnamyl alcohol 
338 gave malonate 339. This synthetic route would potentially allow a variety of R 
groups to be incorporated into the lactone. The tosylation step requires two equivalents 
of malonate 339 with respect to TsF, but excess starting material is readily recovered 
from this reaction.77 The resulting tosyl malonate 340 is a precursor for the dCr 
reaction, and rapidly gave the desired product 341 in greater than 80% yield using 
TBDMSOTf (2.1 equiv) and DBU (2.1 equiv) (Scheme 71).75 
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Scheme 71: Synthesis of substituted RCM precursor 
 
Several different Lewis acids were investigated along with Grubbs II in CH2Cl2 for 
both dienes 334 and 341 in an attempt to achieve the RCM reaction to form lactone 
308. In every case, no reaction was observed, and heating at reflux resulted in 
decomposition of the starting material (Table 4). Given the success of the work done 
by Fürstner and co-workers,86 it was surprising that our dienes did not give any of the 
desired lactone. 
 
 
Run Lewis acid Conditions Result 
1 None rt 16 h No reaction 
2 None reflux 16 h Decomposition 
3 LiCl rt 16 h No reaction 
4 NaI rt 16 h No reaction 
5 AlCl3 rt 16 h No reaction 
6 ZnCl2 rt 16 h No reaction 
7 Ti(OiPr)4 rt 16 h No reaction 
 
Table 4: Results of Lewis acid-mediated RCM 
 
In order to overcome this problem and effect an RCM, we planned to form the enolate 
of diene ester 334 and trap with a silyl group to give silyl ketene acetal 342. Metathesis 
could then take place to give lactone 343 and may allow spontaneous rearrangement to 
the cyclopropane 317 (Scheme 72).  
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Scheme 72: Formation of a formal enolate 
 
The first step of this reaction, formation of the silyl ketene acetal 342, was investigated 
using a number of different bases and conditions, producing some interesting results 
(Table 5). 
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Run Base TBDMSOTf LiOTf Result 
1 NEt3 1.1 equiv 1.0 equiv 1.0 equiv No reaction 
2 NEt3 1.1 equiv 1.0 equiv None No reaction 
3 DBU 1.1 equiv 1.0 equiv 1.0 equiv Decomposition 
4 NaH 1.1 equiv 1.0 equiv 1.0 equiv No reaction 
5 NEt3 neat 1.0 equiv 1.0 equiv No reaction 
6 NEt3 neat 5.0 equiv 1.0 equiv Product 344 
7 NEt3 neat 5.0 equiv None Product 344 
8 DBU 1.1 equiv 5.0 equiv 1.0 equiv Decomposition 
9 NaH 1.1 equiv TBDMSCl 1.0 equiv None No reaction 
 
Table 5: Results for silyl ketene acetal formation 
 
Surprisingly, only neat NEt3 and 5.0 equivalents of TBDMSOTf gave any product, but 
not the one expected. Product 344 was obtained very cleanly, and its identity verified 
by NMR and mass spectrometry (Scheme 73). Ester 334 appears to have undergone an 
Ireland–Claisen rearrangement under the conditions attempted. This was not the 
desired product, but it does show that the silyl ketene acetal 342 has been formed. This 
reaction was performed several times in order to establish the time-frame in which the 
conversion occurs. Within 30 min diene 344 was formed completely with no evidence 
for the presence of the silyl ketene acetal 334. The same study was performed without 
lithium triflate present, and interestingly, the reaction was notably slower under these 
conditions. In 30 min strong NMR evidence for the presence of ketene acetal 342 and 
some acid 344 were observed. No clear explanation for this difference in rate can be 
given at present. It was envisaged that in slowing down this reaction it might be 
possible to intercept the ketene acetal and perform the ring closing metathesis on this 
Results and Discussion 
 
 69 
compound. Addition of Grubbs II in CH2Cl2 to the reaction mixture, however, resulted 
in no reaction. Under these conditions it is unlikely that the metathesis reaction can 
viably compete with the Claisen rearrangement. 
 
 
Scheme 73: Attempted silyl ketene acetal formation 
 
Since this work was undertaken, Nguyen and co-workers have published a Lewis acid 
substrate encapsulation strategy for the RCM synthesis of unsaturated ε-lactones.87 
They report the coordination of the α,ω-dienyl ester precursor 345 to the bulky Lewis 
acid aluminium tris(2,6-diphenylphenoxide) (ATPH) 347 thus forcing the ester into the 
E-conformation and favouring intramolecular RCM to give the desired 7-membered 
lactone 346 (Scheme 74). 
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Scheme 74: Substrate encapsulated RCM 
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2.3 Stereoinduction from Within the Pericyclic Array 
2.3.1 Background 
 
Stereoinduction from within the pericyclic array is well established in Claisen 
chemistry.88 Ireland showed that the alkene geometry of the silyl ketene acetal is 
affected by the choice of solvent system, leading to the reverse stereoselectivity for the 
Ireland–Claisen rearrangement (Scheme 75).89 In acyclic systems, erosion of the dr is 
attributed to lack of discrimination between the chair- and boat-like transition states. 
For our cyclic substrates, in which the rearrangement occurs via a boat-like transition 
state, interconversion to the chair-like transition state is not possible due to the large 
energy difference between these conformations. Therefore, erosion of stereochemistry 
by transition state interconversion is unlikely for cyclic substrates. 
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Scheme 75: Solvent-dependence of Ireland–Claisen stereoselectivity 
 
It has also been shown that induction from a stereocentre α- to the ester is possible. 
Nakai and co-workers investigated the effect of varying both the triflate silylating 
agent and the amine base. Use of tBuMe2OTf and (o-Hex)2NMe gave a maximum ee 
of 86% for acid 353, measured by derivatisation with N-(S)-α-phenylethyl amine 
(Scheme 76).90 
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Scheme 76: Literature precedent for stereoinduction 
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2.3.2 Model Racemic C-7 Substituted Lactone 
 
Based on this precedent we decided to investigate the effect of a stereocentre on the 
transannular dCr reaction by introduction of a methyl group at the C-7 position of 
lactone 354. We believed that Claisen rearrangement of this compound would lead to a 
di-substituted alkene, which can exist as the trans or cis alkene (S)-355 and (R)-356 
depending on the conformation of the transition state (TS1 and TS2 respectively). In 
the opposite enantiomeric series, both the trans and cis alkene (R)-355 and (S)-356 are 
also viable, but from the opposite transition state conformers, TS2* and TS1* 
respectively (Figure 10). 
 
 
Figure 10: Geometry of methyl substitution 
 
Initially this chemistry was developed on a racemic 7-membered lactone. Synthesis of 
methyl-substituted lactone 354 commenced by protection of propargyl alcohol 357 
followed by addition of acetaldehyde 359 to give alkyne 360. Carbonate protection of 
360 and removal of the THP-protecting group gave alcohol 362. Hydrogenation of 
alkyne 362 to cis-alkene 363 proved slightly problematic, where addition of quinoline 
to 25% wt. Lindlar’s catalyst in THF gave a mixture of the desired product, starting 
material and the over-reduced product. Elimination of quinoline from the reaction and 
reduction of catalyst loading to 5% wt. allowed clean reduction, which was easily 
followed by TLC, to give alkene 363 on a multigram scale. Conversion of alcohol 363 
to mesylate 364 was achieved under standard mesylation conditions (Scheme 77). 
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Scheme 77: Synthesis of methyl-substituted alkene 
 
To continue the synthesis of lactone 354 alkylation of the anion of tosyl ester 365 with 
mesylate 364 gave protected hydroxy ester 367. Single step deprotection–
saponification of carbonate 367 was followed by conversion of the resultant hydroxy 
acid 368 to lactone 354 using EDCI to give a yield of 35% over the four steps. The 
moderate yield in this route is primarily due to the alkylation step. Purification at the 
intermediate stages is hindered by unreacted tosyl ester 365, which proved difficult to 
separate from the desired products. Both the rt Claisen and microwave dCr reaction 
were carried out on lactone 354 to give cyclopropanes 355 and 369 respectively in 
excellent yields. It is notable that only the trans alkene product was observed in both 
reactions, indicating a lack of ring inversion between the transition state TS1 and TS2 
(Scheme 78). This phenomenon has been previously observed in acyclic substrates.89 
 
 
Scheme 78: Synthesis of C-7 substituted cyclopropane 
Results and Discussion 
 
 73 
 
2.3.3 Enantiomerically Pure System 
 
Based on the successful racemic model system, the corresponding enantiomerically 
pure substrate was synthesised, using the chiral pool reagent (S)-methyl lactate 370. 
Silylation of (S)-methyl lactate 370 gave TBDPS-protected ester 371. Reduction to 
aldehyde 372 was achieved at –78 °C in a 59% yield along with 26% of the fully 
reduced alcohol 373. This alcohol could be re-oxidised back to aldehyde 372 using 
IBX in 81% yield. The key step in this synthesis is the cis-selective Wittig reaction 
utilising conditions described by Ando, where the phosphonate 374 is the modified 
Horner–Wadsworth–Emmons reagent.91 A yield of 80% with a 92:8 cis:trans 
selectivity was obtained for the desired Z-unsaturated ester 375, where the isomers 
were separable by column chromatography. Reduction using DIBAL-H gave alcohol 
376 (Scheme 79). 
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Scheme 79: Synthesis of enantiomerically pure alcohol 376 
 
Alcohol 376 was mesylated to 377 and used to alkylate methyl p-toluenesulfonyl 
acetate 365 to give ester 378 in 80% yield over two steps. Removal of the protecting 
group and saponification gave the desired hydroxy acid (S)-368, which was then 
lactonised to give lactone (S)-354 as a single enantiomer (Scheme 80). 
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Scheme 80: Synthesis of enantiomerically pure lactone 
 
During saponification of ester 379 under standard conditions a mixture of products 
were isolated. The major product was a diastereomeric mixture of undesired γ-lactone 
380 (Scheme 81). A similar competing cyclisation reaction was previously observed in 
the attempted non-aqueous acidic deprotection of unsubstituted substrate 315.78 
Careful control of the pH during work-up allowed isolation of the desired hydroxy acid 
(S)-368, as the major product. 
 
 
Scheme 81: Formation of undesired γ-lactone 
 
Both the rearrangement of lactone (S)-354 under the rt Claisen conditions and the dCr 
gave the desired vinyl cyclopropanes (S)-355 and (S)-369 exclusively as the trans 
isomer (Scheme 82).  
 
 
Scheme 82: Rearrangement of enantiomerically pure lactone 
 
In order to establish the degree of stereoinduction in the transannular Claisen 
rearrangement the carboxylic acid (S)-355 was reduced to the alcohol 383 with 
LiAlH4. The alcohol was coupled to Mosher’s acid chloride 384 to form the Mosher’s 
ester 385 (Scheme 83).  
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Scheme 83: Determination of cyclopropane ee 
 
Analysis of ester 385 by 19F NMR revealed a single peak, demonstrating formation of 
only a single enantiomer of the cyclopropane and indicating complete stereoinduction 
from the C-7 position (Figure 11). 
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Figure 11: 19F NMR of Mösher's ester 
 
This result is not surprising given the total preference for the trans alkene geometry in 
the racemate which demonstrates minimal ring inversion in the transition state (vide 
supra). In this stereo-controlled series, the inverted transition state TS2 leads to the 
geometric isomer of the product – the cis alkene (R)-356. The product enantiomer (R)-
355 can come only from the lactone with the opposite stereochemistry at the C-7 
position (R)-354 (Figure 12). 
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Figure 12: Transition state of enantiomeric series 
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2.4 Stereoinduction from Outside of the Pericyclic Array 
2.4.1 Background 
 
As demonstrated in section 2.3 asymmetric induction from within the pericyclic array 
was shown to be essentially complete in our substrates. The ability to control the 
stereoselectivity from outside the pericyclic array, using a chiral auxiliary, was an 
attractive proposition. Previous work within the Craig group has employed a variety of 
N-arylsulfonyl sulfoximine groups in place of tosyl, to effect a diastereoselective form 
of the dCr reaction.92 Enantiomerically pure sulfoximines are readily produced from 
the racemate and are ideal as a chiral replacement for tolylsulfonyl. They benefit from 
chemical similarity to tolylsulfonyl, with the versatility to adapt both the steric bulk 
and electron-withdrawing effect of the substituent.93 A number of different nitrogen 
substituents of the sulfoximine esters 386 were investigated and the diastereomeric 
ratios of their dCr reaction products 387 and 388 recorded (Scheme 84). 
 
 
Scheme 84: dCr reaction of racemic sulfoximine-substituted esters92 
 
Of the examples investigated, it was found that the best diastereomeric ratio of 82:18 
was achieved when R = N-(2,4,6-triisopropylphenylsulfonyl)-S-phenyl sulfoximine 
(Tris) 389 (Scheme 85). 
 
 
Scheme 85: Claisen rearrangement of a Tris-sulfoximine 
 
The effects of substitution on the alkenyl chain were also investigated for the 
triisopropylphenylsulfonyl sulfoximine 391. Slight improvements to the diastereomeric 
ratio to 87:13 were observed when R3=nPr and R1=R2=R4=H (Scheme 86). All other 
examples investigated resulted in a decrease in the dr. 
Results and Discussion 
 
 78 
 
 
Scheme 86: Effect of alkenyl substitution on dr 
 
A transition-state model based on a pseudochair conformation has been proposed to 
rationalise the observed stereochemical outcome. When the bulky ArSO2 group of the 
sulfoximine is positioned antiperiplanar to the ketene-acetal double bond in TS1, the 
more stable conformation is achieved. This allows syn approach of the allylic portion 
to the ketene acetal with regard to the sulfoximine oxygen, whilst being anti to the 
bulky phenyl, explaining why selectivity is enhanced by the larger aryl groups such as 
2,4,6-triisopropylphenyl (Scheme 87). 
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Scheme 87: Proposed transition-state model92 
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2.4.2 Sulfoximine Approach 
 
It was envisaged that application of this sulfoximine approach to our cyclic system 
could lead to even greater diastereoselectivity given the flexibility constraints of the 
cyclic substrate. The synthesis used previously was repeated to produce the N-
tosylsulfonylsulfoximine acetic acid 403.92 Methyl anisole 397 was reacted with 
Chloramine-T to give sulfilimine 398. Oxidation using a biphasic RuO4 system gave 
sulfoximine 399. Removal of the tosyl group revealed the free –NH 400 which was 
resolved using (–)-CSA to give 401 as a single enantiomer. Re-attachment of the tosyl 
group and CO2-mediated carboxylation gave N-tosylsulfonylsulfoximine acetic acid 
403 (Scheme 88). 
 
 
Scheme 88: Synthesis of sulfoximine precursor 
 
The sulfoximine acetic acid 403 was esterified with a tert-butyl group and coupled to 
mesylate 312. It was thought that the sulfoximine might have a destabilising effect on 
the molecule and hence might be susceptible to decarboxylation under the rather harsh 
double deprotection step used for the tosyl equivalent. It was therefore surprising to 
find that the sulfoximine 405 was more stable to the acidic conditions and that only the 
–MOM group was removed, leaving the tBu moiety intact to form 406 rather than the 
desired hydroxy acid 407 (Scheme 89). 
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Scheme 89: Novel sulfoximine synthesis 
 
Subjection of esters 405 and 406 to TFA (1%, 20% and 50%) in CH2Cl2 at rt showed 
no reaction by TLC analysis, but on work up only unidentified decomposition product 
was isolated. In order to overcome this issue, the tert-butyl group was replaced with 
methyl, which is more easily removed under mild conditions. Synthesis of the methyl 
derivative showed significant advantages compared to the analogous tert-butyl 
synthesis: addition of the –COOMe to form 408 was achieved in one step at 78% yield, 
rather than the two-step carboxylation–protection chemistry which yielded 404 in only 
25% yield overall. The alkylation of sulfoximine 408 to form ester 409 was also 
noticeably higher yielding in this case (Scheme 90). 
 
 
Scheme 90: Synthesis of methyl-protected sulfoximine 
 
It was thought that the deprotection–saponification of 409 could still be achieved in a 
single step. A TMSCl–NaI reaction mixture was unsuccessfully employed for this 
purpose, resulting in iodoalkane formation. Eventually a two-step strategy was 
employed, resulting in good yields for both steps (Scheme 91).  
 
 
Scheme 91: Deprotection of methyl sulfoximine 
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Cyclisation of hydroxy acid 407 to form the lactone 412 was attempted using the same 
procedure as for the tosyl compound with DIC as the coupling reagent. Although the 
reaction was successful, it proved extremely difficult to separate the product 412 from 
the urea by-product of the coupling reagent. Therefore EDCI, a water-soluble coupling 
reagent, was utilised allowing the by-products to be washed out. This yielded 84% of 
the desired product (Scheme 92). 
 
 
Scheme 92: Cyclisation of tosylsulfoximine 
 
Claisen rearrangement chemistry on lactone 412 was investigated. As with the sulfonyl 
equivalent, both the Ireland–Claisen reaction at rt and the dCr reaction under 
microwave conditions were realised in good yields (Scheme 93). The diastereomeric 
ratio was judged by 1H NMR to be approximately 3:2 for both products 413 and 414. 
 
 
Scheme 93: Claisen reaction of sulfoximine lactone 
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2.4.3 2,4,6-Triisopropylphenylsulfonyl Approach 
 
Previous research within the Craig group found the highest diastereomeric ratio was 
achieved using 2,4,6-triisopropylphenylsulfonyl (Tris) as a substituent of N-
sulfoximine. Subsequently, incorporation of this group into the sulfoximines was used 
in an attempt to increase the diastereomeric ratio of the Claisen rearrangement 
products. Again, the initial stage of the synthesis to form the acetic acid derivative has 
been reported.92 As in the previous synthesis, addition of TrisCl rather than TsCl to the 
resolved sulfoximine 401, followed by methyl carbonate gave ester 416 (Scheme 94). 
 
 
Scheme 94: Tris sulfoximine acetic acid synthesis 
 
Additionally the two NaH mediated alkylation steps were combined to good effect. 
The desired two-step product 417 was obtained in 47% yield along with 36% of the 
product of step 1, ester 416. Both the deprotection and saponification steps gave 
excellent yields as did the cyclisation to lactone 420, again using EDCI as the coupling 
agent. The room temperature Claisen rearrangement gave cyclopropane 421 and 
microwave-assisted dCr reaction afforded 422 in good yields (Scheme 95).  
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Scheme 95: Synthesis of Tris-cyclopropanes 
 
Unfortunately the diastereomeric ratio of cyclopropanes 421 and 422 was the same as 
for the tosyl sulfoximine at 3:2. It is surprising that the greatly increased steric bulk of 
the 2,4,6-triisopropylphenyl group over tolyl did not have any effect, especially given 
the precedent from the acyclic substrates. The major difference between the transition 
states assumed for this work compared to those proposed for the open-chain reactions 
is conformational. Whilst a pseudo-chair transition state is proposed for the acyclic 
substrates, the cyclic lactones are believed to have a boat-like transition state. The 
lactones also have an additional carbon atom, forming part of the cyclic system which 
potentially has an effect on the rotation of the sulfoximine, thereby influencing the 
diastereomeric ratio (Figure 13). 
 
 
Figure 13: Comparison of Transition States 
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2.5 Aryl-Substitution at the Lactone C-5 Position  
 
Given the lack of stereoselectivity induced through use of the chiral sulfoximine group, 
it was envisaged that introduction of an aryl group to the C-5 position of the lactone 
would lead to greater enhancement of the diastereoselectivity. Through examination of 
the Claisen rearrangement transition state, the proximity of the aryl substituent to the 
bulky sulfoximine group is notable. It was therefore anticipated that rotational freedom 
of the sulfoximine group would be reduced and that consequently the stereoselectivity 
might improve (Figure 14). 
 
 
Figure 14: Transition states for aryl-substituted lactones 
 
Retrosynthetically the aryl-substituted lactone 423 could come from the alkylation 
product of mesylate 426 and sulfoximine ester 416, used previously (Scheme 96). 
 
 
Scheme 96: Retrosynthesis of aryl-substituted lactone 
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2.5.1 Synthesis of the Aryl-Substituted Allylic Alcohol 
 
It was necessary to devise a synthesis to the tri-substituted alkene 426. Initial 
investigations focused on the stannylation of but-2-yn-1,4-diol 427 is stannylated and 
subsequently mono-protected to give 429.94 It was envisaged that the stannyl group 
could be readily substituted for phenyl to give allylic alcohol 430 using a method 
similar to that described in the literature.95 Mesylation of the alcohol would then lead 
to allylic mesylate 426. Given that a variety of groups could be introduced to the 
alkene in a reasonably convergent synthesis, this was an attractive route. The 
stannylation and protection steps using Parrain’s chemistry were successful, but 
unfortunately the palladium coupling reaction did not yield any product (Scheme 97). 
Replacement of the tributyl tin group with iodine in order to perform Suzuki coupling 
was also unsuccessful. 
 
 
Scheme 97: Stannyl approach 
 
Based on these results, an alternative strategy in which a starting material with the tri-
substituted double bond already in place was investigated. Retrosynthetically, allylic 
alcohol 431 is the product of palladium cross-coupling of bromo-substituted allylic 
alcohol 432. This comes from protection of diol 433, which in turn is the reduction 
product of bromofuranone 434. This is accessed in a single step from the commercially 
available tetronic acid 435 (Scheme 98). 
 
 
Scheme 98: Retrosynthetic route from tetronic acid 
 
Tetronic acid 435 was converted into bromofuranone 434 in good yields using oxalyl 
bromide and DMF. The LiAlH4-mediated ring opening gave diol 433 in 78% yield 
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using the Fieser work up.96 This method negates the need for an aqueous wash as diol 
433 is somewhat water-soluble. Reaction with trimethyl orthoformate was a little 
problematic as no reaction was observed on a small (0.5 mmol) scale. An increase in 
the scale (7.5 mmol) and concentration up to 1.0 M gave orthoester 436 in an 
acceptable yield of 55% (Scheme 99). 
 
 
Scheme 99: Synthesis of bromo-substituted orthoester 
 
It was expected that on reduction of the cyclic orthoester 436 both possible 
regioisomers 432 and 437 would be observed. It was therefore extremely surprising 
that reduction with DIBAL-H gave a single regioisomer 432 in excellent yield, and 
fortuitously, it was the required one (Scheme 100).  
 
 
 
Scheme 100: Ring-opening of bromo-orthoester 
 
This result was proved using NMR analysis, which shows coupling of the OH peak 
with the methylene β- to the bromine. By addition of a small amount of D2O to the 
sample, the doublet at 4.4 ppm was seen to change to a singlet, and the OH triplet at 
2.6 ppm disappeared, confirming the identity of these peaks as CBrCH2OH and OH 
respectively (Figure 15). 
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Figure 15: 1H NMR of allylic alcohol 432 and with addition of D2O 
 
Interestingly, previous reports into the ring opening of these substituted orthoesters 
observed the opposite selectivity when the substituent was an alkyl group (Scheme 
101).97 
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Scheme 101: Literature precedent for ring opening of substituted orthoesters 
 
It is evident from the contrasting results that the electronics of the system, rather than 
steric interaction, affect the selectivity of this reaction. In the case of the bromo-
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derivatives, the electron-withdrawing nature of the bromine atom removes electron 
density from the σ system. This means that when the aluminium of DIBAL-H attacks 
at the oxygen closer to the bromine 442 it is less destabilised than attack at the oxygen 
further from the bromine 441. This results in a preference for alcohol 432 as observed 
experimentally. In the case of the electron-donating alkyl substituents, they donate 
electron density into the σ system. This results in attack at the oxygen further from the 
alkyl group 443 being more stabilised than attack at the oxygen closer to the alkyl 
group 444. As observed experimentally, this results in a preference for alcohol 440 
(Figure 16). 
 
 
Figure 16: Regio-selectivity of orthoesters 
 
Initial attempts at the Suzuki cross-coupling reaction utilised literature conditions 
successfully developed for bromofuranone 434.98  This method employs Pd(PPh3)2Cl2 
as the catalyst and 2 M KF(aq) as the base. Under these conditions, the bromo allyl 
alcohol 432 was unreactive to a number of different aryl boronic acids (Scheme 102). 
 
 
Scheme 102: Attempted Suzuki reaction of bromo allyl alcohol 432 
 
A number of other sets of conditions were attempted for this cross-coupling, all of 
which proved unsuccessful and led to decomposition of the starting material: 
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• Pd(PPh3)4, K3PO4, dioxane, reflux, 6 h 
• Pd(OAc)2, PPh3, KOH, MeOH:THF 1:1, rt 
• PdCl2(PPh3)2, 2 M KF(aq), THF, m/w, 120 °C, 30 min 
• Pd(PPh3)4, 2 M Na2CO3(aq), PhMe, EtOH, 100 °C, 12 h, sealed tube 
• PdCl2(dppf), 2 M Na2CO3(aq), PhMe, EtOH, 100 °C, 12 h, sealed tube 
• Pd(OAc)2, PCy3, K3PO4, PhMe, H2O, 100 °C, 12 h, sealed tube 
 
In order to identify the reasons surrounding the failure of these Suzuki couplings a 
number of alternative methods were investigated. A Negishi reaction was attempted, in 
which bromobenzene 446 was treated with nBuLi and transmetallated with zinc to give 
the active species 447, hence presenting the reactive palladium species with an 
alternative metal.99 However, this also proved unsuccessful, resulting in starting 
material only (Scheme 103).  
 
 
Scheme 103: Attempted Negishi reaction 
 
A further attempt at this coupling used conditions presented by Miyaura.100 In this case 
allyl bromide 432 is first converted into boronate 449 then coupled to an aryl bromide. 
This approach avoids insertion of the palladium into the allylic alcohol, as the boronate 
is now the ‘attacking’ species in the catalytic cycle. Unfortunately, synthesis of the 
boronate 449 was not successful, with only boronic by-product being isolated (Scheme 
104). 
 
 
Scheme 104: Attempted Miyaura reaction of bromo allylic alcohol 432 
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To overcome the problems encountered in forming allylic alcohol 431, bromo-
substituted alkene 432 was taken through the established synthetic sequence to form 
lactone 455, with the intention of performing a Suzuki reaction in the latter stages of 
the synthesis. Interestingly, formation of the bromo-mesylate 450 resulted in 
scrambling of the regiochemistry. It is proposed that the electron-withdrawing 
properties of bromine make the mesylate sufficiently labile to allow attack of the 
OMOM on the methylene to form dihydrofuran 451. The mesylate anion is then able 
to attack at either methylene to form a mixture of regio-isomers 450 and 452 (Scheme 
105). 
 
 
Scheme 105: Regiochemical 'scrambling' of bromo mesylate 
 
Formation of the undesired mesylate regioisomer 452 was prevented by minimising 
the reaction time to 30 min and ensuring the temperature was not allowed to rise above 
0 °C. The bromo-substituted mesylate 450 was used to alkylate tosyl ester 313 to give 
ester 453. A single step MOM deprotection and saponification gave hydroxy acid 454, 
which was easily converted into lactone 455 using EDCI. Unexpectedly, under the 
standard rt Claisen conditions to give the highly substituted cyclopropane 456, no 
reaction was observed. Additionally the dCr reaction of lactone 455 did not lead to the 
desired vinyl cyclopropane 457 (Scheme 106). Attempts to perform a Suzuki reaction 
on ester 453 and lactone 455 leading to the corresponding phenyl compounds were 
also unsuccessful. 
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Scheme 106: Synthesis to bromo-substituted cyclopropane 
 
In order to overcome the instability of the allylic alcohols it was necessary to revert to 
the less convergent synthesis. The Suzuki reaction with phenyl boronic acid was 
performed on bromofuranone 434 following the literature precedent98 to give furanone 
458 in quantitative yield (Scheme 107). 
 
 
Scheme 107: Suzuki reaction of bromofuranone 434 
 
Repetition of the chemistry used to form bromo-substituted orthoester 436 successfully 
allowed synthesis of the corresponding phenyl orthoester 460 from furanone 458 
(Scheme 108). 
 
 
Scheme 108: Synthesis of phenyl-substituted orthoester 460 
 
It was disappointing to find that reduction of the phenyl-substituted orthoester 460 was 
not completely regioselective, as observed for the bromo counterpart. In this case a 
selectivity of 69:31 was detected by 1H NMR, where the major isomer was the desired 
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alcohol 431. These regioisomers were separable by column chromatography (Scheme 
109). 
 
 
Scheme 109: Ring-opening of phenyl-substituted orthoester 
 
Given subsequent results and the instability of aryl allyl alcohols such as 431, the 
inability to form 431 via direct Pd-catalysed coupling is most likely due to the 
instability of the products under the forcing reaction conditions. This proposal was 
confirmed by subjecting aryl allylic alcohol 431 to Suzuki conditions, resulting in 
decomposition of the starting material (Scheme 110). 
 
 
Scheme 110: Control Suzuki reaction 
 
Further work with these aryl allylic alcohols, such as 431, produced low yields and 
poor product quality leading to the assumption of instability of the phenyl alkenes. The 
electron-donating effect of the phenyl group into the double bond was thought to lead 
to elimination to give homo allylic alkene cations 462/463 (Figure 17).  
 
 
Figure 17: Phenyl electron donation into allyl alcohol 
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2.5.2 The Tosyl Series 
 
With allylic alcohol 431 successfully in hand, subjection to standard mesylation 
conditions gave mesylate 464. Using optimised conditions this phenyl-substituted 
mesylate experienced no scrambling of the regiochemistry as seen for the bromo 
mesylate 450. Alkylation of tosyl ester 313 with mesylate 464 gave ester 465 which 
was treated with aqueous acid to reveal hydroxy acid 466. EDCI-mediated 
lactonisation of 466 gave lactone 467 (Scheme 111). 
 
 
Scheme 111: Synthesis of phenyl-substituted lactone 
 
Implementation of the standard dCr reaction conditions on lactone 467 gave the 
desired product in good yield, but as a mixture of diastereomers. The quaternary α-
tosyl carbon centre underwent epimerisation to give a 2:3 ratio of diastereoisomers 
468:469 where the major isomer 469 has the phenyl group anti to the bulky tosyl. The 
Claisen rearrangement at rt was also attempted, but for this more sterically hindered 
phenyl-substituted lactone the reaction did not go to completion. A conversion to the 
vinyl cyclopropane carboxylic acid 470 of around 60% was observed by 1H NMR, 
although none of the product could be isolated (Scheme 112). 
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Scheme 112: Claisen and dCr reactions of phenyl-substituted lactone 
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Given the inherent instability of the phenyl derivatives, less electron-rich fluorinated 
aryl groups were also investigated, with the expectation that their lower electron 
density would reduce the electron donation into the allylic alcohol, increasing 
compound stability. Indeed, the 2,4- and 2,6-difluorophenyl analogues proved more 
stable and their synthesis initially higher-yielding than the corresponding phenyl 
compounds. Suzuki reaction of bromofuranone 434 with 2,4-difluorophenyl boronic 
acid and 2,6-difluorophenyl boronic acid gave the corresponding furanones 471. 
Reductive ring opening with DIBAL-H to diols 472 followed by the two-step –MOM 
protection gave allylic alcohols 445. Again, ring opening of orthoester 473 gave a 
regioisomeric mixture of around 2:1 for the required isomer 445:474 (Scheme 113). 
 
 
Scheme 113: Difluorophenyl-substituted allylic alcohol synthesis 
 
Aryl-substituted alkene 445a was subsequently mesylated to give 426a. Alkylation of 
tosyl acetate 313 gave ester 475a, followed by deprotection–saponification in a single 
step, yielded hydroxy acid 476a. Lactonisation of hydroxy acid 476a with EDCI gave 
difluorophenyl-substituted 7-membered lactone 477a (Scheme 114). 
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Scheme 114: Synthesis of 2,4-difluorophenyl-substituted lactone 
 
The 2,6-difluorophenyl-substituted lactone 477b was synthesised in the same manner, 
using the methyl ester 365 rather than the tbutyl ester 313. This required a two-step 
deprotection via hydroxy ester 478b (Scheme 115). 
 
 
Scheme 115: Synthesis of 2,6-difluorophenyl-substituted lactone 
 
Subjection of lactones 477 to the standard Claisen rearrangement and dCr reaction 
conditions produced comparable results to the phenyl-substituted lactone 467 for both 
the 2,4- and 2,6-difluorophenyl substrates 477a and 477b. The dCr reaction proceeded 
in good yields of 75% and 82% respectively to give vinyl cyclopropanes 479 and 480. 
Epimerisation at the α-tosyl carbon resulted in approximately a 2:3 ratio of 
diastereoisomers 479:480, where the favoured isomer 480 has the aryl group anti to the 
tosyl in order to limit steric interaction. This geometric relationship has been proven by 
NOESY NMR spectroscopy. The rate of the rt Claisen rearrangement was severely 
hindered by the additional steric bulk of the aryl group. Under standard conditions the 
reaction failed to go to completion. The best conversion to the cyclopropane 481 of 2:1 
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was observed after 72 h at rt for 2,4-difluorophenyl lactone 477a. Attempts to push this 
reaction to completion by increasing the temperature resulted in decarboxylation to 
give cyclopropanes 479 and 480. Addition of excess BSA at daily intervals and 
increased time, up to 2 weeks, also failed to push this reaction to completion (Scheme 
116). 
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Scheme 116: Claisen and dCr reaction of difluorophenyl-substituted lactone 
 
2.5.3 The Sulfoximine Series 
 
Similar chemistry was utilised to synthesise systems with the chiral sulfoximine group 
in place of tosyl, with the aim of investigating the effect of the aryl group on the 
diastereoselectivity of the resultant cyclopropanes. Alkylation of sulfoximine esters 
416 with mesylates 426a 426b and 464 gave esters 482. Deprotection and 
saponification of esters 482 to hydroxy acids 484 followed by subsequent lactonisation 
gave the desired aryl-substituted sulfoximine lactones 423 (Scheme 117).  
 
 
Scheme 117: Aryl-substituted sulfoximine lactone synthesis 
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The standard Claisen rearrangement of lactone 423 to give cyclopropanes 424 and 425 
was further hindered by the increased steric bulk of the sulfoximine. In this case it was 
not possible to force these reactions to completion. Analysis by 1H NMR of the 
incomplete reaction showed vinyl cyclopropane carboxylic acids 425:424 forming in a 
3:2 mixture of diastereoisomers with respect to the sulfoximine stereochemistry. The 
dCr reaction gave a diastereomeric mixture of vinyl cyclopropanes 485, 486, 487 and 
488 in good yields under the standard microwave conditions. The ratio of 
diastereoisomers was very similar for each of the three aryl groups investigated. As 
with the corresponding tosyl reaction, epimerisation at the carbon centre α- to the 
sulfur was observed. Diastereoisomers 486, 488 have the aryl and sulfoximine groups 
anti and are favoured in approximately a 3:2 ratio over 485, 487. Compounds 485 and 
486 are also favoured in around a 3:2 ratio over 487 and 488, demonstrating no 
improvement in this selectivity with the addition of the aryl group. These two factors 
result in a total ratio for the four diastereoisomers of approximately 9:6:6:4 for 
486:485:488:487 (Scheme 118).  
 
 
Scheme 118: Claisen and dCr reactions of aryl-substituted sulfoximine lactones 
 
Characteristic 1H NMR signals in the vinylogous region of the 2,4-difluorophenyl 
transformation allowed comparisons in the phenyl and 2,6-difluorophenyl analogues, 
confirming that the stereochemical trend is comparable in each case. These signals are 
highly diagnostic due to the extreme variation in their chemical shift. The crude NMR 
of cyclopropane 485/486/487/488c shows CH=CH2 double doublets between 5.6 and 
6.5 ppm, trans CH=CH2 doublets between 5.0 and 5.2 ppm, and cis CH=CH2 doublets 
between 4.4 and 4.8 ppm (Figure 18).  
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Figure 18: 1H NMR of vinylogous region for the diastereomeric mixture of vinyl cyclopropanes 
 
Analysis by NOESY for the three most abundant isomers 486, 485 and 488 where Ar = 
Ph and 2,4-difluorophenyl verifies the relationship between the three stereocentres. 
This confirms the hypothesis illustrated in Figure 14 in which TS1 leads to the major 
product, having an (RS,2S) relationship. Unequivocal stereochemical assignment of the 
3rd most abundant diastereoisomer 488a for the dCr reaction of the 2,4-difluorophenyl 
substituted lactone 423a, has been established by X-ray crystallography as (RS,1R,2R) 
in agreement with the stereoselectivity observed in the acyclic examples (Figure 19).92  
 
 
Figure 19: X-ray crystal structure of cyclopropane 488a 
 
Overall, aryl substitution of the lactones had no effect on the diastereoselectivity of the 
transannular dCr and Claisen rearrangements. This was surprising given the 
encouraging results shown by the acyclic examples. It is possible that the sulfoximine 
phenyl and NTris groups are not sufficiently different in size, or the bulk of the Tris 
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group is too far from the stereocentre to have a significant effect. It is proposed that the 
lowest energy conformation would place the sulfonyl of the sulfoximine group closest 
to the reaction centre and aryl group, as shown in transition state B. However, 
differentiation between the steric bulk of the phenyl and NTris groups may be limited, 
hence discrimination between transition states A and C would also be minimal, 
particularly at elevated microwave temperatures. This may explain the lack of 
selectivity observed in these transannular Claisen rearrangements (Figure 20). 
 
 
Figure 20: Rotation of sulfoximine group 
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2.6 Cyclobutane Synthesis 
 
Following the success of the transannular Claisen and dCr reactions of 7-membered α-
tosyl lactones, we wished to extend this chemistry to higher homologues. Claisen-
mediated ring contraction of macrocyclic lactones, from 9-membered rings and larger, 
were developed by Knight53 and Funk.54 The notable exception in these ring 
contractions is the 8-membered lactone, which would give a vinyl cyclobutane. At the 
outset, we propose that subjection of the 8-membered α-tosyl lactone 489 to the 
standard rt Claisen and microwave-assisted dCr conditions would lead to vinyl 
cyclobutanes 490 and 491 respectively (Scheme 119). 
 
 
Scheme 119: Proposed Claisen and dCr reactions of 8-membered lactone 489 
 
2.6.1  Synthesis of the 8-Membered Lactone 
 
Thus, synthesis of the required homo-allylic alcohol 497 was initiated from 3-butyn-1-
ol 492. Alcohol protection with a THP group followed by addition of 
paraformaldehyde to the acetylide gave alcohol 494. Protection of the alcohol 
functionality as a carbonate and removal of the THP group using PPTS to give alcohol 
496 were extremely efficient reactions. The hydrogenation of alkyne 496 to cis-alkene 
497 was a clean and high yielding reaction using 5% wt. Lindlar’s catalyst in THF 
(Scheme 120).  
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Scheme 120: Synthesis of homo-allylic alcohol 497 
 
Under standard mesylation conditions homo-allylic mesylate 498 was formed from 
alcohol 497. Attempts to form ester 500 by direct alkylation of methyl 2-tosylacetate 
365 with mesylate 498 proved unsuccessful. In order to increase the reactivity of 
homo-allylic mesylate 498 to alkylation, catalytic nBu4NI (10 mol%) was added and 
the reaction heated under reflux overnight to give the desired ester 500. However, 
formation and isolation of iodide 499 in a separate step prior to alkylation to give ester 
500 improved both the conversion and yield without the need for increased 
temperatures. Deprotection–saponification under basic conditions was possible in a 
single step to give hydroxy acid 502. However, unreacted methyl 2-tosylacetate 365 
persisted through the synthetic sequence and was not separable from acid 502. The 
solution was a two-step route whereby intermediate hydroxy ester 501 could be 
isolated from the tosyl ester 365 prior to saponification (Scheme 121). 
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Scheme 121: Synthesis of hydroxy acid 502 
 
Subjection of hydroxy acid 502 to the lactonisation conditions previously employed in 
formation of the 7-membered lactones led primarily to polymerised product, with only 
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0.4% of lactone 489 isolated. Clearly alternative lactonisation strategies needed to be 
employed; those attempted for the synthesis of lactone 489 are outlined (Table 6).  
 
 
Run Coupling 
Reagent 
Conditions Result 
1 EDCI 0 °C → rt, 16 h, 0.2 M 0.4% of 489a 
2 2-pyridine 
thiol 
NEt3, 0 °C, 30 min, 0.2 M Decomposition 
3 Aldrithiol PPh3, rt, 30 min, 0.2 M Decomposition 
4 MNBAb DMAP, NEt3, rt, 48 h, 0.02 M No Reaction 
5 MNBAb Sc(OTf)3, rt → reflux, 20 h, 0.1 M, 
addition of 502 via syringe pump 
No Reaction 
6 Yamaguchic NEt3, rt, 16 h, 0.1 M No Reaction 
7 Yamaguchic DMAP, NEt3, rt, 16 h, 0.1 M No Reaction 
8 EDCI rt, 10 h, 0.01 M 
addition of 502 via syringe pump 
30% conversiond 
9 DIC rt, 16 h, 0.01M 
addition of 502 via syringe pump 
20% conversiond 
10 HATU DIPEA, rt, 20 h, 0.02 M 
addition of 502 via syringe pump 
66% of 489a 
aIsolated yield; bMNBA = 2-methyl-6-nitrobenzoic acid; cYamaguchi’s reagent = 2,4,6-
trichlorobenzoylchloride; dconversion to lactone 489, measured by 1H NMR 
 
Table 6: Attempted lactonisation conditions for 8-membered lactone 
 
The alternative class of coupling reagents investigated, including 2-pyridine thiol 
derivatives, MNBA and Yamaguchi’s reagent, all failed to give any of the desired 
product. Returning to the diimide reagents, use of high dilution and syringe pump 
addition of the hydroxy acid 502 were employed. Both EDCI and DIC showed 
promising conversion to lactone 489, but increased reaction time and temperature 
failed to push the reaction to completion. Ultimately, addition of hydroxy acid 502 via 
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syringe pump to an excess of HATU and Hünig’s base gave complete conversion and 
66% isolated yield of the desired lactone 489 (Scheme 122). 
 
 
Scheme 122: Formation of 8-membered lactone 489 
 
2.6.2 Transannular Claisen Rearrangements of 8-Membered Lactones 
 
Subjection of the 8-membered lactone 489 to the standard rt Claisen and microwave 
dCr conditions gave the desired vinyl cyclobutanes 490 and 491 respectively in 
excellent yields. Thus, the first Claisen-mediated ring contraction of an 8-membered 
lactone to form vinyl cyclobutanes was realised (Scheme 123). 
 
 
Scheme 123: Claisen and dCr reactions of lactone 489 
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2.7 (±)-Grandisol 
 
2.7.1 Background 
 
Isolation, identification and synthesis of grandisol was first achieved by Gueldner and 
co-workers.101 (+)-Grandisol (+)-503 is the primary active component of the male boll 
weevil pheromone along with alcohol 504 and aldehydes 505 and 506. Although only 
(+)-grandisol is produced naturally, the racemate (±)-grandisol shows almost equal 
biological activity.102 Grandisol is a unique monoterpene incorporating a cyclobutane 
ring system with a quaternary carbon centre into its structure. These features pose a 
considerable challenge to the synthetic chemist, and consequently there are over 120 
papers published on the compound. In previous syntheses of grandisol 503, two 
primary routes for formation of the cyclobutane ring have been utilised; 2+2 
cycloaddition, often photochemically activated; and base-mediated cyclisation 
(Scheme 124).  
 
 
Scheme 124: Components of the boll weevil pheromone 
 
2.7.2 Gueldner’s Synthesis 
 
Gueldner and co-workers employed photocycloaddition of isoprene 507 and 3-buten-2-
one 508 to produce a number of products including cis- and trans-2-methyl-2-
vinylcyclobutyl methyl ketones 509 and 510.101 The photo cycloaddition yielded 1.2% 
of each of these cyclobutanes along with several other higher yielding by-products. 
Grignard addition to the mixture gave tertiary alcohols 511 and 512, which were 
subsequently separated. Hydroboration to give diols 513 and 514 followed by 
acetylation and reduction gave the desired product (±)-grandisol 503 and its trans 
isomer 515 (Scheme 125). 
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Scheme 125: First published synthesis of (±)-grandisol 503 
 
2.7.3 Siddall’s Synthesis 
 
Siddall and co-workers demonstrated the first selective synthesis of (±)-grandisol by 
photochemical cycloaddition of ethylene to 3-methylcyclohex-2-enone 516 to give the 
bicyclic species 517.103 Reduction to the α,β-unsaturated alcohol, followed by ring-
opening gave the cis-keto acid 518. Finally a Wittig reaction to form the vinyl group 
and esterification–reduction of the acid moiety led to (±)-grandisol 503 (Scheme 126). 
 
 
Scheme 126: Stereoselective photochemical cycloaddition 
 
2.7.4 Billups’ Synthesis 
 
Billups and co-workers developed an extremely rapid two-step synthesis of grandisol 
via dimerisation of isoprene 507.104 Ni(0) catalysis of 507 gave cis-cyclobutane 519 
which was converted into (±)-grandisol 503 by hydroboration and peroxide oxidation 
of the resulting organoborane (Scheme 127). 
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Scheme 127: Billups' two-step synthesis from isoprene 
 
2.7.5 Clark’s Synthesis 
 
Two published syntheses utilise the same final-stage strategy involving manipulation 
of the methyl and hydroxy substituents. In his synthesis, Clark demonstrated that 
organocuprate-mediated addition to methyl cyclobutenecarboxylate 520 gave a 
diastereomeric mixture of esters 521.105 Methylation of cyclobutane 521 results in an 
85:15 mixture of isomers which, following hydrolysis of the ester, were recrystallised 
to give pure acid 522. Diazoketone 524 was prepared using diazomethane substitution 
of the acid chloride of 522. Treatment of 524 with methanolic silver benzoate gave 
ester 525 and aluminate reduction of ester 525 gave access to (±)-grandisol 503 
(Scheme 128). 
 
 
Scheme 128: Clark's synthesis via intermediate 521 
 
2.7.6 Mori’s Synthesis 
 
The second synthesis utilising intermediate 521 is an enantioselective synthesis of (+)-
grandisol by Mori and Fukamatsu, starting from the monoterpene (–)-carvone 526.106 
Iodo ester 527 was synthesised in seven steps, and subsequent base-mediated 
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cyclisation gave cyclobutane (S)-521 as a diastereomeric mixture. As in Clark’s 
synthesis, methylation gave an 83:17 mixture of the esters (S)-528:(S)-529. An elegant 
iodolactonisation method converted only the cis-isomer (S)-528 to iodolactone 530 and 
upon zinc reduction, acid (S)-522 was recovered as a single enantiomer. Reduction of 
acid (S)-522 to the alcohol and subsequent tosylation gave tosylate 531, which was 
converted into (+)-grandisol (+)-503 via nitrile 532 (Scheme 129). 
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Scheme 129: Mori's grandisol strategy 
 
2.7.7 A Novel Approach 
 
Given the notable structural similarity of (±)-grandisol 503 to vinyl cyclobutane 490, 
(see section 2.6.2), a new route to this natural product was envisaged which 
incorporates the novel transannular Claisen rearrangement chemistry developed thus 
far. Retrosynthetically, manipulation of the methyl and hydroxy side chains of (±)-
grandisol 503 leads back to vinyl cyclobutane 533, product of the transannular Claisen 
rearrangement of methyl-substituted 8-membered lactone 534. This can be obtained 
from homo-allylic alcohol 535, which in turn could come from the Horner–
Wadsworth–Emmons reaction of aldehyde 536 with phosphonate 537 developed by 
Ando (Scheme 130). 
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Scheme 130: Novel retrosynthetic route to (±)-grandisol 503 
 
Given that previous syntheses of grandisol had relied upon 2+2 cycloaddition or base-
mediated cyclisation methods to form the cyclobutane ring, we believed that the 
proposed transannular Claisen rearrangement route to (±)-grandisol represents an 
interesting novel approach. The synthesis was initiated by mono-protection of 1,3-
propane diol 538 and subsequent oxidation to aldehyde 540 (Scheme 131). 
  
 
Scheme 131: Synthesis of aldehyde 540 
 
Methyl-substituted Ando-phosphonate 537 was synthesised by addition of 
iodomethane to Ando-phosphonate 375 in 63% yield.107 Horner–Wadsworth–Emmons 
reaction of aldehyde 540 with phosphonate 537 gave the cis alkene 541 with an 87:13 
selectivity of geometric isomers. Reduction of the ester 541 to allylic alcohol 542 
followed by carbonate protection and removal of the silyl protecting group under 
acidic conditions gave homo-allylic alcohol 544 (Scheme 132). 
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Scheme 132: Synthesis of homo-allylic alcohol 544 
 
Using chemistry identical to that developed previously, homo-allylic alcohol 544 was 
converted into iodide 546 via mesylate 545. Alkylation of the anion of tosyl 2-methyl 
acetate 365 with iodide 546 followed by deprotection of the carbonate, gave hydroxy 
ester 548 in 51% over the four steps. Saponification to hydroxy acid 549 followed by 
lactonisation under the optimised conditions utilised for 8-membered lactone 489, gave 
the desired lactone 534 in an exceptional 85% yield. The transannular Claisen 
rearrangement of lactone 534 gave an outstanding yield of the desired vinyl 
cyclobutane carboxylic acid 533 (Scheme 133).   
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Scheme 133: Formation of cyclobutane 533 
 
Esterification of carboxylic acid 533 using TMS diazomethane was achieved in high 
yield to give ester 550. Ideally, direct substitution of the tosyl group for a methyl, 
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leading to ester 528 could be achieved in a single step. Vinyl cyclobutane ester 528 is 
an intermediate in the syntheses of grandisol published by Clark and Mori.105,106 
Lithium naphthalide has previously been utilised within the Craig group for the 
cleavage of tosyl groups.108 Tosyl–methyl substitution to give ester 528 was however, 
unsuccessful (Scheme 134). 
 
 
Scheme 134: Attempted direct tosyl-methyl substitution 
 
Removal of the tosyl group from tosyl ester 550 was attempted using a number of 
reductive metals such as magnesium and sodium. The most reproducible results were 
observed using sodium amalgam in methanol at rt to yield ester 521, also a published 
intermediate in previous syntheses.105,106 Attempts to introduce methyl iodide directly 
into the reaction mixture did not lead to isolation of the desired methyl-substituted 
product 528. Although the product could be clearly identified by 1H NMR, significant 
problems were encountered with the volatility of the compound, thus no calculable 
yield or further analytical data could be collected (Scheme 135). 
 
 
Scheme 135: Sodium amalgam-mediated detosylation 
 
Additionally, lactone 534 underwent the transannular dCr reaction to give vinyl 
cyclobutane 551. This constitutes the second example of this reaction on an 8-
membered lactone (Scheme 136). 
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Scheme 136: Transannular dCr reaction of lactone 534 
 
2.7.8 Proposed Improvements to the Approach 
 
Given the issues surrounding the removal of the tosyl group, an alternative route is 
proposed whereby the methyl group at C1 is introduced at the beginning of the 
synthesis. Retrosynthetically (±)-grandisol 503 is again formed by homologation of 
acid 522. This acid comes directly from the transannular Claisen rearrangement of 
methyl-substituted lactone 552, which in turn is derived from hydroxy acid 553. 
Following the same chemistry utilised previously, ethyl ester 555 can be alkylated with 
iodide 554 (Scheme 137). Although work throughout this thesis has focused on the 
transannular Claisen rearrangement of α-tosyl lactones, the work published by 
Knight53 and Funk54 suggests replacement with a methyl in the proposed strategy will 
not adversely affect the success of the Claisen rearrangement. 
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Scheme 137: Proposed alternative route to (±)-grandisol 
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2.8 Conclusion 
 
Substantial advances within the field of transannular Claisen rearrangement chemistry 
have been made. Mild and efficient reaction conditions for the transannular Claisen 
rearrangement of 7-membered α-tosyl lactones were established and the first 
transannular dCr reaction under microwave conditions was achieved. Introduction of a 
stereocentre within the pericyclic array, at the C-7 position of lactone 354 
demonstrated total enantioselectivity for both the Claisen and dCr reaction. Attempts 
to affect the stereoselectivity of the Claisen rearrangement from outside of the 
pericyclic array, using the chiral sulfoximine group, were less successful. Increasing 
the steric bulk of the sulfoximine and introduction of an aryl group to the lactone C-5 
position 423 did not enhance the stereoselectivity. Incorporation of an aryl group 
produced vinyl cyclopropanes with a quaternary centre at the C-2 position and gave 
insight into the steric limit of the transannular Claisen rearrangement of these 7-
membered lactones. 
 
The chemistry developed for the 7-membered α-tosyl lactone systems was applied to 
the corresponding 8-membered lactone 489. Vinyl cyclobutanes 490 and 491 produced 
by the transannular Claisen rearrangement and dCr reactions of this α-tosyl lactone 
represent the first example of this chemistry. During these investigations, a novel 
method for the high yielding synthesis of 8-membered unsaturated α-tosyl lactones 
was established. This chemistry has been applied towards the synthesis of the vinyl 
cyclobutane natural product (±)-grandisol 503. Although the final product was not 
achieved, the key transannular Claisen rearrangement step was successful. An 
extremely promising alternative route has been devised whereby the problematic 
methyl substituent is in place from the start of the synthetic sequence. 
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3.1 General Laboratory Procedures 
 
All reactions were performed under nitrogen unless otherwise stated. Melting points 
were determined using Stuart Scientific SMP1 melting point apparatus and are 
uncorrected. Infrared spectra were recorded on Mattson 5000 FTIR and Perkin-Elmer 
Spectrum RX FT-IR System spectrometers. Proton nuclear magnetic resonance (1H 
NMR), carbon nuclear magnetic resonance (13C NMR) and fluorine nuclear magnetic 
resonance (19F NMR) spectra were recorded in CDCl3 unless otherwise stated on a Jeol 
GX-270, Brüker DRX-300, Brüker AV-400 or Brüker AV-500 spectrometer. Chemical 
shifts are in parts per million (ppm) and are referenced relative to the residual proton-
containing solvent (1H NMR: 7.26 ppm for CDCl3; 13C NMR: 77.0 ppm for CDCl3). 
Mass spectra (CI, EI and FAB) were recorded using Micromass AutoSpec-Q, 
Micromass Platform II or Micromass AutoSpec Premier instruments. Elemental 
analyses were performed at the microanalytical laboratories of the London 
Metropolitan University. Optical rotations were measured on an Optical Activity Ltd. 
instrument.  Analytical thin layer chromatography (TLC) was performed on pre-coated 
Aluminium-backed Merck Kieselgel 60 F254 plates. Visualisation was effected with 
ultraviolet light, potassium permanganate or vanillin as appropriate. Flash column 
chromatography was performed using BDH (40–63 µm) silica gel unless otherwise 
stated. Standard solvents were distilled under nitrogen prior to use; Et2O and THF 
from sodium-benzophenone ketyl, CH2Cl2 from CaH2 and toluene from sodium. All 
other solvents were reagent grade. Petrol refers to petroleum ether of the fraction bp 
40–60 °C. All liquid reagents were distilled prior to use. BSA was purchased from 
Alfa Aesar Lancaster and distilled prior to use. Potassium acetate was oven-dried at 
120 °C for several days prior to use. Microwave reactions were performed in a Biotage 
initiator.  
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3.2 General Synthetic Procedures 
 
General Procedure A, for the preparation of orthoesters 310, 436, 460, 473a and 
473b 
To a solution of the diol (1.0 equiv) in CH2Cl2 was added CSA (1 mol%) and 
trimethylorthoformate (2.0 equiv). The reaction mixture was stirred at rt for 1 h before 
addition of NEt3. The mixture was concentrated under reduced pressure and purified 
by column chromatography to give the desired orthoester. 
 
General Procedure B, for the preparation of allylic alcohols 311, 432, 431, 461, 
445a, 445b, 474a, 474b 
To a solution of the orthoester (1.0 equiv) in PhMe at –78 °C was added DIBAL-H 
(1.3 equiv) dropwise. The reaction mixture was allowed to warm to rt and stirred for 
16 h. The reaction mixture was again cooled to 0 °C, carefully quenched with sat. 
Na/K tartrate soln. and the mixture allowed to stir for a further 1 h. The aqueous layer 
was then extracted with EtOAc and the combined organic layers washed with sat. 
NaCl(aq) (×2) and H2O, dried (MgSO4) and concentrated under reduced pressure. 
Purification by column chromatography gave the desired alkene. 
 
General Procedure C, for the preparation of mesylates 312, 364, 377, 450, 464, 
426a, 426b, 498, 545 
To a solution of alcohol (1.0 equiv) in CH2Cl2 at 0 °C was added NEt3 (3.0 equiv). The 
reaction mixture was stirred at 0 °C for 15 min, and methane sulfonyl chloride (2.0 
equiv) was added dropwise. The reaction was stirred at 0 °C for 30 min, washed with 2 
M HCl(aq) (×2) and sat. NaHCO3(aq) (×2). The organic phase was dried (MgSO4) and 
concentrated under reduced pressure to give the desired methane sulfonate 
 
General Procedure D, for the preparation of esters 314, 367, 378, 405, 409, 453, 
465, 475a, 475b, 482c, 482a, 482b, 500, 547 
To a suspension of sodium hydride (60% dispersion in mineral oil, washed with 
hexane; 1.1 equiv) in THF or DMF at 0 °C, was added dropwise a solution of the ester 
(1.0 equiv) in THF or DMF. The reaction mixture was stirred at 0 °C for 30 min and a 
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solution of the methane sulfonate or iodide (1.0 equiv) in THF or DMF was added 
dropwise. The reaction mixture was stirred at 0 °C for a further 30 min, then at rt for 
16 h. The solution was concentrated under reduced pressure and the crude product 
suspended in EtOAc, washed with sat. NH4Cl(aq), H2O and sat. NH4Cl(aq). The organic 
phase was dried (MgSO4), concentrated under reduced pressure and purified by 
column chromatography to give the desired ester. 
 
General Procedure E, for the preparation of alcohols 315, 410, 418, 454, 466, 
476a, 478b, 483c, 483a, 483b 
To a solution of the ester (1.0 equiv) in MeCN was added 2 M HCl(aq). The reaction 
mixture was heated under reflux for 2 h, cooled, and partitioned between CH2Cl2 and 
H2O. The aqueous phase washed with CH2Cl2 (× 5). The combined organic washings 
were dried (MgSO4), concentrated under reduced pressure, and purified by column 
chromatography to give the desired alcohol. 
 
General Procedure F, for the preparation of acids 368, (S)-368, 411, 419, 476b, 
484c, 484a, 484b, 502, 549 
To a solution of the ester (1.0 equiv) in THF was added 2 M LiOH(aq) (5.0 equiv). The 
reaction was stirred at rt for 1 h, then partitioned between Et2O and H2O and the 
aqueous layer acidified to pH 1 with 2 M HCl(aq). The aqueous layer was then extracted 
with Et2O (×3) and the organic layers combined, dried (MgSO4) and concentrated 
under reduced pressure to give, without further purification, the desired acid. 
 
General Procedure G, for the preparation of lactones 316, 354, (S)-354, 412, 420, 
455, 467, 477a, 477b, 423c, 423a, 423b 
To a solution of the hydroxy acid (1.0 equiv) in CH2Cl2 at 0 °C was added EDCI (1.1 
equiv) portionwise. The reaction mixture was allowed to warm to rt and left to stir for 
16 h. The reaction mixture was partitioned between H2O and CH2Cl2, the organic layer 
washed with sat. NH4Cl(aq) and H2O, dried (MgSO4) and concentrated under reduced 
pressure. The product was purified by column chromatography to give the desired 
lactone. 
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General Procedure H, for the preparation of vinyl cyclopropane carboxylic acids 
317, 355, (S)-355, 413, 421 and vinyl cyclobutane carboxylic acids 490, 533 
To a solution of lactone (1.0 equiv) in CH2Cl2 was added KOAc (0.1 equiv) and BSA 
(1.0 equiv). The reaction mixture was stirred at rt for 16 h, then diluted with CH2Cl2, 
washed with 2 M HCl(aq) and H2O, dried (MgSO4) and concentrated under reduced 
pressure to give the desired carboxylic acid. 
 
General Procedure I, for the preparation of vinyl cyclopropanes 320, 369, (S)-369, 
414, 422, 468, 469, 479a, 480a, 479b, 480b, 485c, 486c, 487c, 488c, 485a, 486a, 
487a, 488a, 485b, 486b, 487b, 488b and vinyl cyclobutanes 491, 551 
A solution of lactone (1.0 equiv), BSA (1.0 equiv) and KOAc (0.1 equiv) in DMF was 
subjected to microwave irradiation at 160 °C for 10 min. The reaction mixture was 
diluted with EtOAc, washed with sat. NaCl(aq) (×3) and H2O, dried (MgSO4) and 
concentrated under reduced pressure to give the desired vinyl carbocycle. 
 
General Procedure J, for the preparation of diols 459, 472a, 472b 
To a solution of furan-2-one (1.0 equiv) in PhMe at −78 °C was added DIBAL-H (2.2 
equiv) dropwise. The reaction mixture was allowed to stir at –78 °C for 2 h, then 
warmed to rt and stirred for a further 2 h. The reaction mixture was again cooled to 0 
°C and carefully quenched with sat. Na/K tartrate soln. and the mixture stirred for a 
further 1 h. The aqueous layer was then extracted with EtOAc and the combined 
organic layers washed with sat. NaCl(aq) (×2) and H2O, dried (Na2SO4) and 
concentrated under reduced pressure. Purification by column chromatography gave the 
desired diol. 
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3.3 Individual Procedures 
 
3.3.1 Compounds Relevant to Section 2.2 
 
tert-Butyl 2-tosyl acetate 
 
To t-butanol (3.80 mL, 30.0 mmol, 1.0 equiv) and p-toluenesulfonylacetic acid 330 
(6.43 g, 30.0 mmol, 1.0 equiv) in CH2Cl2 (75 mL) at 0 °C was added dropwise N,N’-
diisopropylcarbodiimide (4.70 mL, 30.0 mmol, 1.0 equiv). The reaction mixture was 
stirred at 0 °C for 10 min then rt for 1 h, filtered, concentrated under reduced pressure 
and purified by column chromatography (35% EtOAc–petrol) to give tert-butyl 2-tosyl 
acetate 313 (7.99 g, 99%) as a colourless oil; Rf 0.35 (20% EtOAc–petrol); νmax (film) 
3649, 3566, 2981, 2938, 1728, 1597, 1475, 1455, 1394, 1371, 1326, 1294, 1259, 1147, 
1120, 1085, 910, 815, 713, 694, 646 cm-1; δH (270 MHz) 7.80 (2H, dd, J 7.0, 1.5 Hz, o-
SO2Ar), 7.35 (2H, dd, J 7.0, 1.5 Hz, m-SO2Ar), 3.99 (2H, s, SO2CH2), 2.44 (3H, s, 
ArCH3), 1.36 (9H, s, C(CH3)3); δC (67.5 MHz) 161.5 (C=O), 145.2, 136.0 (4o), 129.8, 
128.6 (3o), 83.6 (C(CH3)3), 62.3 (SCH2), 27.8 (C(CH3)3), 21.8 (ArCH3); data in 
accordance with those previously reported.109   
 
(Z)-2-Methoxy-4,7-dihydro-1,3-dioxepine 
 
According to general procedure A, cis-butene-1,4-diol 309 (12.0 mL, 146 mmol, 1.0 
equiv) in CH2Cl2 (146 mL) was treated with trimethyl orthoformate (32.0 mL, 292 
mmol, 2.0 equiv) and CSA (0.34 g, 1.46 mmol, 1.0 mol%). Distillation from the crude 
reaction mixture (80 °C at 15 mmHg) gave (Z)-2-methoxy-4,7-dihydro-1,3-dioxepine 
310 as a colourless oil, used in the following step without further purification; Rf 0.66 
(70% EtOAc–petrol); νmax (film) 3034, 2948, 2869, 1450, 1392, 1379, 1342, 1275, 
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1200, 1132, 1024, 952, 916, 788, 644 cm-1;  δH (270 MHz) 5.69 (2H, t, J 1.5 Hz, 
HC=CH), 5.37 (1H, s, OCH), [4.46, 4.12] (4H, 2 × d, J 15.5 Hz, CH2), 3.39 (3H, s, 
OCH3); δC (67.5 MHz) 129.3 (HC=CH), 113.8 (OCHO), 61.6 (OCH2), 53.6 (OCH3); 
data in accordance with those previously reported.110  
 
(Z)-4-(Methoxymethoxy)but-2-en-1-ol 
 
According to general procedure B, orthoester 310 (14.4 g, 111 mmol, 1.0 equiv) in 
PhMe (200 mL) was treated with DIBAL-H (1.5 M in PhMe; 95.9 mL, 144 mmol, 1.3 
equiv) Purification by column chromatography (40–60% EtOAc–petrol) gave (Z)-4-
(methoxymethoxy)but-2-en-1-ol, 311 (12.7 g, 69% over 2 steps) as a colourless oil; Rf 
0.28 (50% EtOAc–petrol); νmax (film) 3411, 3023, 2937, 2886, 2825, 2740, 1658, 
1465, 1450, 1401, 1211, 1151, 1105, 1043, 987, 943, 919 cm-1; δH (270 MHz) 5.91–
5.81 (1H, m, CHCH2OCH2), 5.74–5.64 (1H, m, CHCH2OH), 4.63 (2H, s, OCH2O), 
4.19 (2H, d, J 6.5 Hz, CH2OH), 4.14 (2H, d, J 6.5 Hz, CHCH2OCH2), 3.37 (3H, s, 
OCH3); δC (67.5 MHz) 132.7 (CHCH2OCH2), 128.0 (CHCH2OH), 95.4 (OCH2O), 62.5 
(CH2OH), 58.5 (CHCH2OCH2), 55.4 (OCH3); data in accordance with those 
previously reported.111 
 
(Z)-4-(Methoxymethoxy)but-2-enyl methanesulfonate 
 
According to general procedure C, alcohol 311 (1.72 g, 13.0 mmol, 1.0 equiv) in 
CH2Cl2 (65 mL) was reacted with NEt3 (5.44 mL, 39.0 mmol, 3.0 equiv) and methane 
sulfonyl chloride (2.01 mL, 26.0 mmol, 2.0 equiv) to give (Z)-4-
(methoxymethoxy)but-2-enyl methane sulfonate 312 as an orange oil used crude in the 
next step; Rf 0.17 (50% EtOAc–petrol); δH (270 MHz) [5.94–5.85, 5.82–5.71] (2H, 2 × 
m, CH=CH), 4.84 (2H, d, J 6.5 Hz, CHCH2OS), 4.62 (2H, s, OCH2O), 4.17 (2H, d, J 
6.5 Hz, CHCH2OMOM), 3.37 (3H, s, OCH3), 3.01 (3H, s, SCH3); δC (67.5 MHz) 
132.6 (CHCH2OMOM), 124.9 (CHCH2OMs), 95.8 (OCH2O), 65.3 (OCH2O), 62.7 
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(CH2OS), 55.5 (OCH3), 38.1 (SCH3); data in accordance with those previously 
reported.78 
 
(Z)-tert-Butyl 6-(methoxymethoxy)-2-tosylhex-4-enoate 
 
According to general procedure D, a suspension of sodium hydride (766 mg, 31.9 
mmol, 1.1 equiv) in THF (50 mL) was treated with a solution of ester 313 (7.84 g, 29.0 
mmol, 1.0 equiv) in THF (50 mL) followed by a solution of mesylate 312 (29.0 mmol, 
1.0 equiv) in THF (40 mL). Purification by column chromatography (20% EtOAc–
petrol) gave (Z)-tert-butyl 6-(methoxymethoxy)-2-tosylhex-4-enoate 314 (6.95 g, 57% 
over 2 steps) as a yellow oil; Rf 0.32 (35% EtOAc–petrol); νmax (film) 3517, 3451, 
2935, 2886, 2823, 1731, 1693, 1596, 1454, 1396, 1369, 1292, 1145, 1106, 1047, 993, 
948, 919, 836, 815 cm-1; δH (270 MHz) 7.75 (2H, d, J 8.0 Hz, o-SO2Ar), 7.35 (2H, d, J 
8.0 Hz, m-SO2Ar), [5.71–5.62, 5.47–5.37] (2H, m, CH=CH), 4.58 (2H, s, OCH2O), 
4.15–3.98 (2H, m, CHCH2O), 3.84 (1H, dd, J 10.0, 5.5 Hz, SCH), 3.33 (3H, s, OCH3), 
2.73 (2H, m, SCHCH2) 2.44 (3H, s, ArCH3) 1.33 (9H, s, C(CH3)3); δC (67.5 MHz) 
164.4 (C=O), 145.4, 134.4 (4°) 130.2, 129.7, 129.5, 126.3 (3°), 95.9 (OCH2O), 83.4 
(C(CH3)3), 70.7 (SCH) 62.8 (OCH2CH), 55.3 (OCH3), 27.7 (C(CH3)3), 25.4 
(SCHCH2), 21.8 (ArCH3); data in accordance with those previously reported. 78 
 
(Z)-6-Hydroxy-2-tosylhex-4-enoic acid 
 
According to general procedure E, ester 314 (6.50 g, 16.9 mmol, 1.0 equiv) was heated 
under reflux in MeCN (175 mL) and 2 M HCl(aq) (35 mL) to give (Z)-6-hydroxy-2-
tosylhex-4-enoic acid 315 (2.70 g, 56%) as a white crystalline solid; mp 124–126 °C; 
νmax (nujol) 3417, 2502, 1704, 1595, 1415, 1346, 1322, 1303, 1259, 1213, 1182, 1145, 
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1084, 1019, 978, 960, 937, 838, 813 cm-1; δH (270 MHz, DMSO-d6) 7.75 (2H, d, J 8.0 
Hz, o-SO2Ar), 7.47 (2H, d, J 8.0 Hz, m-SO2Ar), [5.60–5.51, 5.30–5.20] (2H, 2 × m, 
CH=CH), 4.19 (1H, dd, J 8.5, 6.5 Hz, SCH), 3.99–3.83 (2H, m, CH2OH), 2.50 (2H, m, 
SCHCH2), 2.42 (3H, s, ArCH3); δC (67.5 MHz, DMSO-d6) 166.9 (C=O), 145.6, 134.9 
(4°), 134.7, 130.3, 129.4, 124.0 (3°), 69.6 (SCH), 57.3 (HOCH2), 25.5 (SCHCH2), 21.7 
(ArCH3); data in accordance with those previously reported. 78  
 
(Z)-3-Tosyl-3,4-dihydrooxepin-2-(7H)-one 
 
According to general procedure G, hydroxy acid 315 (2.50 g, 8.80 mmol, 1.0 equiv) in 
CH2Cl2 (150 mL) was treated with N,N’diisopropylcarbodiimide (1.51 mL, 9.67 mmol, 
1.1 equiv). Purification by column chromatography (30% EtOAc–petrol) gave (Z)-3-
tosyl-3,4-dihydrooxepin-2-(7H)-one 316 (1.83 g, 78%) as a white powder; mp 144–
146 °C; Rf 0.56 (50% EtOAc–petrol); νmax (nujol) 1742, 1592, 1322, 1305, 1248, 1156, 
1083, 1072, 1051, 943, 816, 790, 769, 709, 657 cm-1; δH (270 MHz) 7.94 (2H, d, J 8.5 
Hz, o-SO2Ar), 7.35 (2H, d, J 8.5 Hz, m-SO2Ar), 5.92–5.77 (2H, m, CH=CH), [4.95–
4.86, 4.48–4.39] (2H, 2 × m, OCH2), 4.69 (1H, dd, J 13.0, 4.0 Hz, SCH), [3.17–3.07, 
2.69–2.56] (2H, 2 × m, SCHCH2), 2.43 (3H, s, ArCH3); δC (67.5 MHz) 166.6 (C=O), 
145.6, 133.6 (4°), 130.5, 129.6, 129.4, 124.3 (3°), 64.3 (SCH), 63.9 (OCH2), 27.0 
(SCHCH2), 21.7 (ArCH3); m/z (CI) 284 [M+NH4]+, 189, 174, 162, 145, 130, 52; data 
in accordance with those previously reported. 78 
 
1-Tosyl-2-vinylcyclopropane carboxylic acid 
 
According to procedure H lactone 316 (150 mg, 560 µmol, 1.0 equiv) in CH2Cl2 (6 
mL) was treated with KOAc (5.5 mg, 56.0 µmol, 0.1 equiv) and BSA (140 µl, 560 
µmol, 1.0 equiv) to give 1-tosyl-2-vinylcyclopropane carboxylic acid 317 (150 mg, 
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quantitative) as a colourless solid; mp 118–120 °C; νmax (nujol) 3339, 2717, 2590, 
1694, 1596, 1318, 1289, 1145, 1084, 929, 817, 726, 665 cm-1; δH (270 MHz) 7.78 (2H, 
d, J 8.0 Hz, o-SO2Ar), 7.33 (2H, d, J 8.0 Hz, m-SO2Ar), 5.58 (1H, ddd, J 17.0, 10.0, 
8.5 Hz, CH=CH2), 5.39 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis), 5.22 (1H, dd, J 10.0, 1.5 
Hz, CH=CH2 trans), 3.02 (1H, m, SCCH), 2.44 (3H, s, ArCH3), 2.16 (1H, dd, J 10.0, 
5.5 Hz, SCCH2), 1.96 (1H, dd, J 8.5, 5.5 Hz, SCCH2); δC (100 MHz) 168.0 (C=O), 
145.2, 136.0 (4°), 130.6, 129.8, 128.8 (3°), 121.2 (CH=CH2), 50.5 (SC), 33.0 (SCCH), 
21.7 (ArCH3), 20.3 (SCCH2); m/z (CI) 284 [M+NH4]+, 242, 240, 174, 162, 145, 102, 
85; data in accordance with those previously reported. 78 
 
1-Methyl-4-(2-vinylcyclopropylsulfonyl)benzene 
HTs
O
Ts
O
COOHTs
317 320 316
 
Method A: A solution of cyclopropane 317 (117 mg, 0.44 mmol, 1.0 equiv) and 
NaHCO3 (37.0 mg, 0.44 mmol, 1.0 equiv) in DMF (5 mL) was subjected to microwave 
irradiation at 160 °C for 10 min The reaction mixture was diluted with EtOAc, washed 
with sat. NaCl(aq) (×3) and H2O, dried (MgSO4) and concentrated under reduced 
pressure to give 1-methyl-4-(2-vinylcyclopropylsulfonyl)benzene 320 (78 mg, 80%) as 
a yellow oil. 
Method B: According to procedure I, lactone 316 (150 mg, 560 µmol, 1.0 equiv) in 
DMF (mL) was treated with BSA (140 µl, 560 µmol, 1.0 equiv) and KOAc (5.53 mg, 
56.0 µmol, 0.1 equiv) to give 1-methyl-4-(2-vinylcyclopropylsulfonyl)benzene 320 
(110 mg, 88%) as a yellow oil; Rf 0.59 (50% EtOAc–petrol); νmax (film) 3086, 3041, 
2925, 1639, 1598, 1495, 1444, 1402, 1343, 1313, 1147, 1089, 942, 914, 858, 816, 743, 
666, 646 cm-1; δH (400 MHz, DMSO-d6) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.44 (2H, d, 
J 8.0 Hz, m-SO2Ar), 5.38 (1H, ddd, J 17.0, 10.0, 8.5 Hz, CH=CH2), 5.22 (1H, d, J 17.0 
Hz, CH=CH2 cis), 4.97 (1H, d, J 10.0 Hz, CH=CH2 trans), 2.95 (1H, m, SCH), 2.40 
(3H, s, ArCH3), 2.24 (1H, m, SCHCH), [1.44, 1.17] (2H, 2 × m, SCHCH2); δC (100 
MHz, DMSO-d6) 144.0, 137.6 (4°), 136.1, 129.9, 127.1 (3°), 116.1 (CH=CH2), 38.7 
(SCH), 22.3 (SCHCH), 21.0 (ArCH3), 12.3 (SCHCH2); m/z (CI) 240 [M+NH4]+, 223, 
84, 67 (Found [M+NH4]+, 240.1067. C12H14O2S requires [M+NH4]+, 240.1058). 
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Allyl 2-tosylacetate 
 
To allyl alcohol 331 (2.04 mL, 30.0 mmol, 1.0 equiv) was added tosyl acetic acid 330 
(6.43 g, 30.0 mmol, 1.0 equiv) in CH2Cl2 (150 mL). The reaction mixture was cooled 
to 0 °C and N,N’-diisopropylcarbodiimide (4.67 mL, 30.0 mmol, 1.0 equiv) was added. 
The reaction mixture was stirred at 0 °C for 1 h, then at rt for 16 h. The reaction 
mixture was filtered, concentrated under reduced pressure and purified by column 
chromatography (35% EtOAc–petrol) to give allyl 2-tosylacetate 332 (7.47 g, 98%) as 
a colourless solid; mp 37–38 °C; Rf 0.69 (50% EtOAc–petrol);  νmax (film) 3466, 2945, 
1738, 1648, 1597, 1495, 1452, 1401, 1327, 1151, 1084, 1018, 988, 935, 814, 733, 646, 
605 cm-1; δH (270 MHz) 7.80 (2H, d, J 8.0 Hz, o-SO2Ar), 7.35 (2H, d, J 8.0 Hz, m-
SO2Ar), 5.79 (1H, ddt, J 17.0, 10.0, 6.0 Hz, CH=CH2), 5.27 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 5.22 (1H, d, J 10.0 Hz, CH=CH2 trans) 4.56 (2H, dt, J 6.0, 1.5 Hz, 
OCH2), 4.10 (2H, s, SCH2), 2.44 (3H, s, ArCH3); δC (67.5 MHz) 162.3 (C=O), 145.6, 
135.7 (4°), 130.9, 129.9, 128.7 (3°), 119.5 (CH=CH2), 66.8, (OCH2), 61.1 (SCH2), 
21.8 (ArCH3); m/z (CI) 272 [M+NH4]+, 188, 186, 52; data in accordance with those 
previously reported.76  
 
Allyl 2-tosylpent-4-enoate and Allyl 2-allyl-2-tosylpent-4-enoate 
 
To acetate 332 (7.27 g, 28.6 mmol, 1.0 equiv) and tetra-N-butylammonium iodide 
(10.57 g, 28.6 mmol, 1.0 equiv) in PhMe (35 mL) at rt was added DBU (8.56 mL, 57.2 
mmol, 2.0 equiv). The reaction mixture was stirred for 1 h, and then allyl bromide 333 
(2.49 mL, 28.6 mmol, 1.0 equiv) added dropwise. The reaction mixture was stirred for 
a further 1 h, then diluted with EtOAc, washed with 2 M HCl(aq) (× 3) and H2O, dried 
(MgSO4), concentrated under reduced pressure and purified by column 
chromatography to give allyl 2-tosylpent-4-enoate 334 (4.80 g, 57%) as a colourless 
oil; Rf 0.49 (30% EtOAc–petrol); νmax (film) 3083, 2927, 1738, 1642, 1597, 1493, 
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1440, 1346, 1327, 1238, 1147, 1084, 989, 930, 851, 815, 718, 666, 567 cm-1; δH (270 
MHz) 7.73 (2H, d, J 8.5 Hz, o-SO2Ar), 7.34 (2H, d, J 8.5 Hz, m-SO2Ar), 5.82–5.56 
(2H, m, CH=CH2), 5.28–5.05 (4H, m, CH=CH2), 4.52 (2H, d, J 6.0 Hz, OCH2), 3.99 
(1H, dd, J 11.0, 4.0 Hz, SCH), 2.82–2.59 (2H, m, SCHCH2), 2.43 (3H, s, ArCH3); δC 
(67.5 MHz) 165.3 (C=O), 145.6, 133.9 (4°), 131.7, 131.0, 129.8, 129.5 (3°), 119.3, 
119.2 (CH=CH2), 70.2 (SCH), 66.7 (OCH2), 31.1 (SCHCH2), 21.8 (ArCH3); m/z (CI) 
312 [M+NH4]+; data in accordance with those previously reported.112  
 
Plus the dialkylated product, allyl 2-allyl-2-tosylpent-4-enoate 335 (0.85 g, 9%) as a 
colourless oil; Rf 0.56 (30% EtOAc–petrol); νmax (film) 3080, 2982, 1732, 1639, 1597, 
1493, 1438, 1360, 1322, 1211, 1147, 1082, 994, 924, 817, 708, 666, 585 cm-1; δH (270 
MHz) 7.69 (2H, d, J 8.5 Hz, o-SO2Ar), 7.31 (2H, d, J 8.5 Hz, m-SO2Ar), 5.92–5.72 
(3H, m, CH=CH2), 5.32–5.12 (6H, m, CH=CH2), 4.51 (2H, dt, J 6.0, 1.0 Hz, OCH2), 
2.94–2.75 (4H, m, SCCH2), 2.44 (3H, s, ArCH3); m/z (CI) 352 [M+NH4]+; data in 
accordance with those previously reported.112  
 
3-(Allyloxy)-3-oxopropanoic acid 
 
A mixture of Meldrum’s acid 336 (4.32 g, 30.0 mmol, 1.0 equiv) and allyl alcohol 331 
(2.04 mL, 30.0 mmol, 1.0 equiv) was heated at gentle reflux for 16 h. The solution was 
then cooled to rt and the residual acetone removed under reduced pressure to give 3-
(allyloxy)-3-oxopropanoic acid 337 (3.89 g, 90%) as a yellow oil; νmax (film) 2951, 
1738, 1650, 1415, 1370, 1155, 993, 936 cm-1; δH (270 MHz) 5.98–5.82 (1H, m, 
CH=CH2), 5.38–5.22 (2H, m, CH=CH2), 4.65 (2H, d, J 6.5 Hz, OCH2), 3.47 (2H, s, 
COCH2CO); δC (67.5 MHz) 171.6 (COOH), 166.4 (COOCH2), 131.3 (CH=CH2), 
119.2 (CH=CH2), 66.5 (OCH2), 41.0 (COCH2CO); m/z (CI) 162 [M+NH4]+; data in 
accordance with those previously reported.112  
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Allyl cinnamyl malonate 
 
To a solution of the acid 337 (3.69 g, 25.6 mmol, 1.0 equiv) and cinnamyl alcohol 338 
(3.44 g, 25.6 mmol, 1.0 equiv) in CH2Cl2 (40 mL) at 0 °C, were added DMAP (0.31 g, 
2.56 mmol, 0.1 equiv) and DCC (5.81 g, 28.2 mmol, 1.1 equiv). The reaction was 
allowed to warm to rt and after stirring for 20 h, the precipitate was filtered over celite, 
washed with sat. NaCl(aq) (× 3), dried (MgSO4) and concentrated under reduced 
pressure. Purification by column chromatography (10% EtOAc–petrol) gave allyl 
cinnamyl malonate 339 (4.52 g, 68%) as a pale yellow liquid; Rf 0.62 (20% EtOAc–
petrol); νmax (film) 3083, 3027, 2948, 1732, 1649, 1495, 1449, 1412, 1380, 1365, 1330, 
1271, 1148, 992, 969, 938, 747, 694 cm-1; δH (270 MHz) 7.40–7.24 (5H, m, Ph), 6.66 
(1H, d, J 16.0 Hz, PhCH=CH), 6.26 (1H, dt, J 16.0, 6.5 Hz, PhCH=CH), 5.88 (1H, ddt, 
J 17.0, 10.5, 6.0 Hz, CH=CH2), 5.33 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis), 5.23 (1H, 
dd, J 10.5, 1.5 Hz, CH=CH2 trans), 4.80 (2H, d, J 6.5 Hz, OCH2CHCH), 4.64 (2H, d, J 
6.0 Hz, OCH2CHCH2), 3.45 (2H, s, COCH2CO); δC (67.5 MHz) 166.3, 166.2 (C=O), 
136.1 (4°), 134.8, 131.6, 128.7, 128.3, 126.7, 122.5 (3°), 118.8 (CH=CH2), 66.1 
(OCH2), 41.0 (COCH2CO); m/z (CI) 278 [M+NH4]+, 394, 233, 134, 117; data in 
accordance with those previously reported.76  
 
1-Allyl 3-cinnamyl 2-tosylmalonate 
 
To a solution of malonate 339 (3.70 g, 14.2 mmol, 2.0 equiv) in DMSO (8 mL) was 
added KOtBu (1.60 g, 14.2 mmol, 2.0 equiv) dropwise. The orange solution was stirred 
at rt for 15 min and tosyl fluoride (1.24 g, 7.1 mmol, 1.0 equiv) was added. After 
stirring at rt overnight, the orange solution was poured onto 2 M HCl(aq), extracted with 
Et2O (× 2) and washed with sat. NaCl(aq) (× 2). The organic fraction was dried 
(MgSO4), concentrated under reduced pressure and purified by column 
chromatography (10% EtOAc–petrol) to give starting material 339 (2.02 g, 55% with 
respect to the initial material used) as a pale yellow liquid, and the desired product 1-
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allyl 3-cinnamyl 2-tosylmalonate 340 (2.01 g, 68% with respect to TsF) as a viscous 
yellow oil; Rf 0.21 (20% EtOAc–petrol); νmax (film) 3468, 3028, 2949, 1744, 1649, 
1596, 1494, 1449, 1376, 1336, 1275, 1151, 1082, 969, 938, 913, 815, 734, 706, 693, 
673, 564 cm-1; δH (270 MHz) 7.84 (2H, d, J 8.5 Hz, o-SO2Ar), 7.37–7.25 (7H, m, m-
SO2Ar and Ph), 6.63 (1H, d, J 16.0 Hz, PhCH), 6.16 (1H, dt J 16.0, 6.5 Hz, PhCHCH), 
5.83 (1H, ddt, J 17.0, 10.5, 6.0 Hz, CH=CH2), 5.32 (1H, d, J 17.0 Hz, CH=CH2 cis), 
5.23 (1H, d, J 10.5 Hz, CH=CH2 trans), 5.02 (1H, s, SCH), 4.80 (2H, dt, J 6.5, 1.0 Hz, 
OCH2CHCH), 4.66 (2H, d, J 6.0 Hz, OCH2CHCH2), 2.37 (3H, s, ArCH3); δC (125 
MHz) 160.8, 160.7 (C=O), 146.1, 134.1 (4°), 135.8, 130.5, 130.3, 129.5, 128.7, 128.4, 
126.7, 121.3 (3°), 119.7 (CH=CH2), 74.6 (SCH), 67.5, 67.4 (CH2), 21.7 (ArCH3); m/z 
(CI) 432 [M+NH4]+, 356, 315, 272, 174, 134, 117; data in accordance with those 
previously reported. 76  
 
Allyl 3-phenyl-2-tosylpent-4-enoate 
 
To a solution of malonate 340 (1.25 g, 3.02 mmol, 1.0 equiv) in CH2Cl2 (12.5 mL) 
were added at rt TBDMSOTf (1.46 mL, 6.34 mmol, 2.1 equiv) and DBU (0.95 mL, 
6.34 mmol, 2.1 equiv) simultaneously and the reaction stirred at rt overnight. The 
solvent was removed under reduced pressure and the product purified by column 
chromatography (10% EtOAc–petrol) to give a diastereomeric mixture of allyl 3-
phenyl-2-tosylpent-4-enoate 341 (0.92 g, 82%) as a pale yellow liquid; Rf 0.62 (30% 
EtOAc–petrol); νmax (film) 3063, 3029, 2927, 1741, 1648, 1596, 1493, 1454, 1363, 
1326, 1279, 1205, 1145, 1083, 988, 928, 814, 701, 665 cm-1; δH (270 MHz) 7.79 (2H, 
d, J 8.0 Hz, o-SO2Ar), 7.37–7.07 (7H, m, m-SO2Ar and Ph), 6.22–6.08 (1H, m, 
PhCHCHCH2) 5.93–5.76 (1H, m, OCH2CHCH2) 5.41–4.91 (4H, m, 2 × CH=CH2), 
4.61–4.45 (2H, m, OCH2), 4.21–4.00 (2H, m, SCH and PhCH),  [2.44, 2.35] (3H, 2 × 
s, ArCH3); δC (125 MHz) 164.9 (C=O), 145.6, 144.7, 139.3, 137.9, 136.0, 134.9 (4°), 
136.8, 136.6, 131.1, 130.7, 129.8, 129.6, 129.4, 128.9, 128.7, 128.5, 128.0, 127.6, 
127.4 (3°), 119.5, 118.9, 118.1, 117.9 (CH=CH2), 75.5, 75.0 (PhCH), 66.9, 66.4 
(OCH2), 49.4, 49.3 (SCH), 21.8, 21.7 (ArCH3); m/z (CI) 388 [M+NH4]+; data in 
accordance with those previously reported. 76  
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3.3.2 Compounds Relevant to Section 2.3 
 
2-(Prop-2-ynyloxy)-tetrahydro-2H-pyran 
 
To a mixture of propargyl alcohol 357 (10 mL, 172 mmol, 1.0 equiv) and 
dihydropyran (15.7 mL, 172 mmol, 1.0 equiv) was added a few drops of 2 M HCl(aq) 
and the mixture allowed to stir for 3 h. Et2O was then added and the solution was 
shaken vigorously with 2 M NaOH(aq) to remove the acid, and the aqueous layer re-
extracted with Et2O. The organic layers were combined, dried (MgSO4), concentrated 
under reduced pressure and purified by vacuum distillation (10 mmHg, 61–63 °C) to 
give 2-(prop-2-ynyloxy)-tetrahydro-2H-pyran 358 (18.9 g, 78%) as a colourless oil; Rf 
0.58 (30% EtOAc–petrol); νmax (film) 3291, 2944, 2871, 2117, 1442, 1389, 1348, 
1265, 1202, 1183, 1121, 1079, 1058, 1030, 949, 902, 870, 815, 665 cm-1; δH (400 
MHz) 4.85 (1H, t, J 3.5 Hz, OCHO), 4.29 (2H, 2 × dd, J 15.5, 2.5 Hz, OCH2C), [3.86, 
3.56] (2H, 2 × m, OCH2CH2), 2.44 (1H, t, J 2.5 Hz, CCH), 1.91–1.52 (6H, m, 
OCH2CH2CH2CH2); δC (100 MHz) 96.8 (OCHO), 79.8 (CCH), 74.0 (CCH), 62.0 
(OCH2C), 54.0 (OCH2CH2), 30.2 (OCHCH2), 25.3 (OCH2CH2), 19.0 (OCH2CH2CH2); 
m/z (CI) 158 [M+NH4]+, 118, 102, 85, 52; data in accordance with the literature.113 
 
5-(Tetrahydro-2H-pyran-2-yloxy)pent-3-yn-2-ol 
 
To alkyne 358 (16.75 g, 119 mmol, 1.0 equiv) in THF (190 mL) was added nBuLi 
(2.61 M; 45.8 mL, 119 mmol, 1.0 equiv) dropwise at –78 °C. The mixture was then 
stirred at –78 °C for 10 min, then acetaldehyde 359 (8.07 mL, 143 mmol, 1.2 equiv) 
added dropwise. The mixture was stirred at –78 °C for a further 30 min before being 
quenched with sat. NH4Cl(aq). The reaction mixture was poured onto Et2O and the 
aqueous layer further extracted with Et2O (×2), dried (MgSO4), concentrated under 
reduced pressure and purified by column chromatography (30% EtOAc–petrol) to give 
5-(tetrahydro-2H-pyran-2-yloxy)pent-3-yn-2-ol 360 (21.97 g, 100%) as a colourless 
oil; Rf 0.43 (50% EtOAc–petrol); νmax (film) 3417, 2942, 2870, 1443, 1389, 1364, 
1266, 1202, 1183, 1150, 1119, 1078, 1025, 971, 945, 902, 871, 813 cm-1; δH (400 
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MHz) 4.83 (1H, t, J 3.5 Hz, OCHO), 4.59 (1H, m, CHOH), 4.31 (2H, 2 × dd, J 15.5, 
1.5 Hz, OCH2C), [3.86, 3.56] (2H, 2 × m, OCH2CH2), 2.11 (1H, d, J 5.0 Hz, OH), 
1.90–1.52 (6H, m, OCH2CH2CH2CH2); δC (100 MHz) 96.8 (OCHO), 87.9 (CCHOH), 
79.9 (CCH2OC), 62.0 (OCH2C), 58.4 (CHOH), 30.2 (OCHCH2), 25.3 (OCH2CH2), 
24.2 (CH3), 19.0 (OCH2CH2CH2); m/z (CI) 202 [M+NH4]+, 102, 85, 83; data in 
accordance with the literature.114 
 
Methyl 5-(tetrahydro-5H-pyran-2-yloxy)pent-3-yn-2-yl carbonate 
 
To alcohol 360 (22.0 g, 119 mmol, 1.0 equiv) and pyridine (38.3 mL, 476 mmol, 4.0 
equiv) in CH2Cl2 (240 mL) at 0 °C was added methyl chloroformate (12.0 mL, 155 
mmol, 1.3 equiv) dropwise and the reaction stirred at 0 °C for 1 h. The reaction 
mixture was then diluted with H2O, extracted with EtOAc and the organic layers 
washed with sat. NH4Cl(aq) and sat. NaCl(aq). The combined organic layers were dried 
(MgSO4), concentrated under reduced pressure and purified by column 
chromatography (30% EtOAc–petrol) to give methyl 5-(tetrahydro-5H-pyran-2-
yloxy)pent-3-yn-2-yl carbonate 361 (26.82 g, 93%) as a colourless oil; Rf 0.60 (50% 
EtOAc–petrol); νmax (film) 2944, 2871, 1752, 1443, 1344, 1314, 1265, 1120, 1054, 
1026, 989, 940, 903, 873, 791 cm-1; δH (400 MHz) 5.39 (1H, q, J 6.5 Hz, OCHCH3), 
4.81 (1H, t, J 3.0 Hz, OCHO), 4.31 (2H, 2 × dd, J 16.0, 1.5 Hz, OCH2C), [3.84, 3.54] 
(2H, 2 × m, OCH2CH2), 3.82 (3H, s, OCH3), 1.89–1.52 (6H, m, OCH2CH2CH2CH2), 
1.57 (3H, d, J 7.0 Hz, CHCH3); δC (100 MHz) 154.8 (C=O), 96.8 (OCHO), 83.5 
(CCHO), 81.8 (CCH2O), 64.4 (OCHCH3), 62.0 (OCH2C), 54.9 (OCH3) 54.1 
(OCH2CH2), 30.2 (OCHCH2), 25.3 (OCH2CH2), 21.4 (CHCH3), 19.0 (OCH2CH2CH2); 
m/z (CI) 260 [M+NH4]+, 176, 102, 85, 52 (Found [M+NH4]+, 260.1493. C12H18O5 
requires [M+NH4]+, 260.1498) (Found: C, 59.42; H, 7.43. C12H18O5 requires C, 59.59; 
H, 7.43). 
 
5-Hydroxypent-3-yn-2-yl methyl carbonate 
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To a solution of carbonate 361 (15.0 g, 61.9 mmol, 1.0 equiv) and pyridinium p-
toluenesulfonate (1.56 g, 6.19 mmol, 10 mol%) in EtOH (300 mL) was stirred at 55 °C 
for 2 h. The reaction mixture was allowed to cool, concentrated under reduced pressure 
and purified by column chromatography (40% EtOAc–petrol) to give 5-hydroxypent-
3-yn-2-yl methyl carbonate 362 as a colourless oil (9.72 g, 93%); Rf 0.43 (50% 
EtOAc–petrol); νmax (film) 3429, 2994, 2955, 2866, 1749, 1446, 1345, 1316, 1266, 
1164, 1114, 1056, 1024, 983, 938, 874, 791 cm-1; δH (400 MHz) 5.37 (1H, tt, J 6.5, 1.5 
Hz, CH), 4.32 (2H, dd, J 6.0, 1.5 Hz, CH2), 3.83 (3H, s, OCH3), 1.85 (1H, t, J 6.0 Hz, 
OH), 1.57 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 154.9 (C=O), 83.9 (CCHOH), 
83.4 (CCHCH3), 64.3 (CHCH3), 55.0 (OCH3), 51.0 (CH2), 21.2 (CHCH3); m/z (CI) 
176 [M+NH4]+, 141, 97 (Found [M+NH4]+, 176.0927. C7H10O4 requires [M+NH4]+, 
176.0923) (Found: C, 53.19; H, 6.28. C7H10O4 requires C, 53.16; H, 6.37). 
 
(Z)-5-Hydroxypent-3-en-2-yl methyl carbonate 
 
To carbonate 362 (5.06 g, 32.0 mmol, 1.0 equiv) in THF (200 mL) was added 
Lindlar’s catalyst (250 mg, 5% wt.). With vigorous stirring the reaction vessel was 
flushed with a balloon of H2(g) then allowed to stir for 1 h under a slight positive 
pressure of H2(g). The reaction mixture was then filtered through celite, concentrated 
under reduced pressure and purified by column chromatography (20–30% EtOAc–
petrol) to give (Z)-5-hydroxypent-3-en-2-yl methyl carbonate 363 as a colourless oil 
(3.89 g, 77%); Rf 0.36 (50% EtOAc–petrol); νmax (film) 3424, 2983, 2955, 2936, 2876, 
1745, 1444, 1378, 1336, 1268, 1135, 1031, 940, 898, 859, 793 cm-1; δH (400 MHz) 
5.84 (1H, ddd, J 11.0, 8.0, 6.0 Hz, CHCH2OH), 5.53 (2H, m, CHCH3 and CHCHCH3), 
[4.45, 4.09] (2H, 2 × m, CH2OH), 3.78 (3H, s, OCH3), 2.47 (1H, dd, J 8.0, 4.5 Hz, 
OH), 1.37 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 155.5 (C=O), 132.1, 130.7 
(CH=CH), 70.6 (CHCH3), 58.4 (CH2), 54.7 (OCH3), 20.5 (CHCH3); m/z (CI)  178 
[M+NH4]+, 52 (Found [M+NH4]+, 178.1081. C7H12O4 requires [M+NH4]+, 178.1079). 
 
(Z)-4-(Methoxycarbonyloxy)pent-2-enyl methane sulfonate 
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According to general procedure C, carbonate 363 (1.00 g, 6.24 mmol, 1.0 equiv) in 
CH2Cl2 (30 mL) was treated with NEt3 (2.61 mL, 18.7 mmol, 3.0 equiv) and MsCl 
(0.97 mL, 12.5 mmol, 2.0 equiv) to give (Z)-4-(methoxycarbonyloxy)pent-2-enyl 
methane sulfonate 364 as an orange oil, used crude in the next step; Rf 0.46 (50% 
EtOAc–petrol); νmax (film) 2985, 2968, 1746, 1444, 1353, 1271, 1174, 1050, 1019, 
973, 940, 845, 793 cm-1; δH (400 MHz) 5.73 (2H, m, CH=CH), 5.43 (1H, dq, J 13.0, 
6.5 Hz, CHCH3), 4.93 (2H, 2 × dd, J 12.5, 6.0 Hz, OCH2), 3.76 (3H, s, OCH3), 3.04 
(3H, s, SCH3), 1.39 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 155.0 (C=O), 134.7, 
125.1 (CH=CH), 70.2 (CHCH3), 65.3 (CH2), 54.8 (OCH3), 28.0 (SCH3), 20.4 
(CHCH3); m/z (CI) 256 [M+NH4]+, 143, 99 (Found [M+NH4]+, 256.0858. C8H14O6S 
requires [M+NH4]+, 256.0855). 
 
(Z)-Methyl 6-(methoxycarbonyloxy)-2-tosylhept-4-enoate 
 
According to general procedure D, sodium hydride (300 mg, 7.49 mmol, 1.2 equiv) in 
THF (10 mL) was treated with methyl 2-tosylacetate 365 (1.42 g, 6.24 mmol, 1.0 
equiv) in THF (7.5 mL) and (Z)-4-(methoxycarbonyloxy)pent-2-enyl methane 
sulfonate 364 (1.49 g, 6.24 mmol, 1.0 equiv) in THF (7.5 mL) to give (Z)-methyl 6-
(methoxycarbonyloxy)-2-tosylhept-4-enoate 367 as a colourless oil used crude in the 
next step; Rf 0.61 (50% EtOAc– petrol).  
 
(Z)-6-Hydroxy-2-tosylhept-4-enoic acid 
Ts
OMe
O
OMeO
O
Ts
OH
O
HO
367 368
 
According to general procedure F, ester 367 (2.16 g, 5.83 mmol, 1.0 equiv) in THF (15 
mL) was treated with 2 M LiOH(aq) (15 mL) to give (Z)-6-hydroxy-2-tosylhept-4-enoic 
acid 368 as a colourless oil, used crude in the next step. 
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(Z)-7-Methyl-3-tosyl-3,4-dihydrooxepin-2(7H)-one 
 
According to general procedure G, acid 368 (1.36 g, 4.56 mmol, 1.0 equiv) in CH2Cl2 
(11.4 mL) was treated with EDCI (961 mg, 5.00 mmol, 1.1 equiv). Purification by 
column chromatography (30–100% EtOAc–petrol) gave (Z)-7-methyl-3-tosyl-3,4-
dihydrooxepin-2(7H)-one 354 (35% over 3 steps) as a colourless solid; Rf 0.44 (50% 
EtOAc–petrol); mp 170–172 °C; νmax (film) 3052, 2983, 2935, 1731, 1658, 1595, 
1430, 1328, 1315, 1285, 1266, 1201, 1183, 1157, 1141, 1121, 1086, 1038, 916, 898, 
814, 739, 583 cm-1; δH (400 MHz) 7.95 (2H, d, J 8.0 Hz, o-SO2Ar), 7.36 (2H, d, J 8.0 
Hz, m-SO2Ar), 5.79 (1H, ddq, J 11.5, 5.0, 2.5 Hz, CHCHCH3), 5.59 (ddd, J 11.5, 5.5, 
2.5 Hz, CH2CHCH), 5.21 (1H, dqd, J 9.5, 6.5, 3.0 Hz, CHCH3), 4.74 (1H, dd, J 13.5, 
4.0 Hz, SCH), [3.13, 3.08] (1H, 2 × m, SCHCH2), 2.64 (1H, 2 × ddd, J 13.5, 5.5, 3.0 
Hz, SCHCH2), 2.45 (3H, s, ArCH3), 1.40 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 
166.2 (C=O), 145.6, 133.6 (4°), 130.5, 130.5, 129.6, 128.6 (3°), 71.2 (SCH), 64.5 
(OCH), 27.1 (CH2), 21.8 (CHCH3), 21.6 (ArCH3); m/z (CI) 298 [M+NH4]+, 174, 144, 
52 (Found [M+NH4]+, 298.1115. C14H16O4S requires [M+NH4]+, 298.1113) (Found: C, 
59.93; H, 5.67. C14H16O4S requires C, 59.98; H, 5.75).  
 
(E)-2-(Prop-1-enyl)-1-tosylcyclopropanecarboxylic acid 
 
According to general procedure H, lactone 354 (100 mg,  0.36 mmol, 1.0 equiv) in 
CH2Cl2 (1.8 mL) was treated with KOAc (3.5 mg, 0.036 mmol, 0.1 equiv) and N,O-
bis(trimethylsilyl)acetamide (176 µL, 0.72 mmol, 2.0 equiv) to give (E)-2-(prop-1-
enyl)-1-tosylcyclopropanecarboxylic acid 355 (99 mg, 99%) as a colourless solid 
without further purification; mp 96–98 °C; νmax (film) 3437, 3055, 1698, 1596, 1422, 
1304, 1265, 1140, 1085, 964, 815, 735, 664 cm-1; δH (400 MHz) 8.91 (1H, br. s, OH), 
7.79 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, d, J 8.0 Hz, m-SO2Ar), 5.86 (1H, dq, J 
13.0, 6.5 Hz, CHCH3), 5.23 (1H, ddd, J 15.5, 8.5, 1.5 Hz, CHCHCH3), 3.02 (1H, dd, J 
9.0, 9.0 Hz, SCCH), 2.45 (3H, s, ArCH3), 2.13 (1H, dd, J 10.0, 5.5 Hz, CH2), 1.92 (1H, 
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dd, J 8.5, 5.5 Hz, CH2), 1.67 (3H, dd, J 6.5, 1.0 Hz, CHCH3); δC (100 MHz) 169.0 
(C=O), 145.1, 136.2 (4°), 133.0, 129.8, 128.8, 123.1 (3°), 50.2 (SC), 33.2 (SCCH), 
21.7 (ArCH3), 20.6 (CH2), 18.1 (CHCH3); m/z (CI) 298 [M+NH4]+, 279, 254 (Found 
[M+NH4]+, 298.1114. C14H16O4S requires [M+NH4]+, 298.1113) (Found: C, 59.95; H, 
5.70. C14H16O4S requires C, 59.98; H, 5.75). 
 
(E)-1-Methyl-4-(2-(prop-1-enyl)cyclopropylsulfonyl)benzene 
 
According to general procedure I lactone 354 (100 mg, 0.36 mmol, 1.0 equiv) in DMF 
(1.8 mL) was treated with KOAc (3.5 mg, 0.036 mmol, 0.1 equiv) and BSA (88 µL, 
0.36 mmol, 1.0 equiv). Purification by column chromatography (20% EtOAc–petrol) 
gave (E)-1-methyl-4-(2-(prop-1-enyl) cyclopropylsulfonyl)benzene 369 (68 mg, 80%) 
as a colourless solid; Rf 0.65 (50% EtOAc–petrol); mp 80–82 °C; νmax (film) 3029, 
2930, 1593, 1299, 1182, 1145, 1088, 1050, 961, 840, 815, 728, 622 cm-1; δH (400 
MHz) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, d, J 8.0 Hz, m-SO2Ar), 5.61 (1H, dq, 
J 15.0, 6.5 Hz, CHCH3), 5.01 (1H, ddd, J 15.0, 7.5, 1.5 Hz, CHCHCH3), 2.44 (3H, s, 
ArCH3), 2.37–2.29 (2H, m, SCH and SCHCH), 1.62 (3H, dd, J 6.5, 1.5 Hz, CHCH3), 
1.57 (1H, ddd, J 14.5, 5.5, 5.5, CH2), 1.05 (1H, m, CH2); δC (100 MHz) 144.2, 137.9 
(4°), 129.9, 128.0, 127.8, 127.5 (3°), 39.9 (SCH), 22.0 (SCHCH), 21.6 (ArCH3), 17.7 
(CHCH3), 12.8 (CH2); m/z (CI) 254 [M+NH4]+, 490 (Found [M+NH4]+, 254.1210. 
C13H16O2S requires [M+NH4]+, 254.1215) (Found: C, 66.08; H, 6.77. C13H16O2S 
requires C, 66.07; H, 6.82). 
 
Ethyl 2-(diphenoxyphosphoryl)acetate 
 
To a solution of diphenyl phosphite (11.5 ml, 60.0 mmol, 1.0 equiv) in CH2Cl2 (100 
mL) at 0 °C was added ethyl bromoacetate (6.65 ml, 60.0 mmol, 1.0 equiv), followed 
by triethylamine (9.20 ml, 66.0 mmol, 1.1 equiv) dropwise. The resulting suspension 
was stirred at 0 °C for 15 min, warmed to rt and stirred for a further 2 h. The reaction 
was quenched with H2O (100 mL) and extracted with EtOAc (3 × 100 mL). The 
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combined organic extracts were washed with sat. NaCl(aq) (50 mL), dried (MgSO4) and 
concentrated under reduced pressure. Purification by column chromatography (10–
50% EtOAc–petrol) gave ethyl 2-(diphenyoxyphosphoryl)acetate 374 as a colourless 
oil (9.01 g, 47%); Rf 0.48 (50% EtOAc–petrol); νmax (film) 3069, 2984, 1739, 1591, 
1488, 1399, 1367, 1286, 1187, 1116, 1071, 1025, 943, 766, 689 cm–1; δH (400 MHz) 
7.37 (4H, m, m-Ph), 7.25 (6H, m, o-/p-Ph), 4.26 (2H, q, J 7.0 Hz, OCH2), 3.30 (2H, d, 
J 21.5 Hz, PCH2), 1.30 (3H, t, J 7.0 Hz, CH3); δC (100 MHz) 164.9 (C=O), 150.0 (4°), 
129.9, 125.6, 120.7 (3°), 62.0 (OCH2), 34.8, 33.4 (PCH2), 14.1 (CH3); m/z (CI) 338 
[M+NH4]+, 321; data in accordance with the literature.91a 
 
(S)-Methyl 2-(tert-butyldiphenylsilyloxy)propanoate 
 
To a solution of (S)-methyl lactate 370 (9.20 mL, 96.0 mmol, 1.0 equiv) in THF (100 
mL) was added tBuPh2SiCl (32.5 mL, 125 mmol, 1.3 equiv), DMAP (1.17 g, 10.0 
mmol, 10 mol%) and triethylamine (33.4 mL, 240 mmol, 2.5 equiv) and the reaction 
stirred at rt overnight. The reaction mixture was concentrated under reduced pressure 
and the residue triturated in Et2O (250 mL). The solids were removed by filtration and 
the filtrate washed with acetic acid (15% v/v in H2O), H2O, sat. NaHCO3(aq) and H2O. 
The organic layer was dried (MgSO4) and purified by column chromatography (50% 
CH2Cl2–petrol) to give (S)-methyl 2-(tert-butyldiphenylsilyloxy)propanoate 371 
(24.70 g, 75%) as a colourless oil; Rf 0.63 (50% CH2Cl2–petrol); [α]D20 –38.02 (c. 
0.102 gdm–3, CHCl3); νmax (film) 2933, 2858, 1758, 1473, 1428, 1205, 1138, 1112, 
1062, 998, 822, 739, 702 cm–1; δH (400 MHz) 7.70 (4H, m, m-Ph), 7.43 (6H, m, o-/p-
Ph), 4.31 (1H, q, J 6.5 Hz, OCH), 3.59 (3H, s, OCH3), 1.40 (3H, d, J 6.5 Hz, CHCH3), 
1.13 (9H, s, C(CH3)3); δC (100 MHz) 174.2 (C=O), 133.6, 133.2 (4°), 135.9, 135.8, 
129.8, 127.6, 127.6 (3°), 68.9 (OCH3), 51.6 (OCH), 26.8 (C(CH3)3), 21.3 (CHCH3), 
19.3 (C(CH3)3); m/z (CI) 360 [M+NH4]+, 265; data in accordance with the literature.115 
 
(S)-2-(tert-butyldiphenylsiloxy)propan-1-ol 
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To a stirred solution of ester 371 (2.00 g, 5.84 mmol, 1.0 equiv) in PhMe (5.6 mL) at –
78 °C was added DIBAL-H (1.2 M in PhMe; 6.08 mL, 7.30 mmol, 1.25 equiv) over a 
period of 15 min The mixture was stirred at –78 °C for 1 h, then 0 °C for 1 h. The 
reaction was quenched with Na/K tartrate at 0 °C and allowed to stir at rt for 1 h. The 
aqueous layer was then extracted with EtOAc and the combined organic layers washed 
with sat. NaCl(aq) (×2) and H2O, dried (MgSO4) and concentrated under reduced 
pressure. Purification by column chromatography (50% CH2Cl–petrol) gave (S)-2-
(tert-butyldiphenylsiloxy)propan-1-ol 373 (1.28 g, 70%) as a colourless oil; Rf 0.24 
(50% CH2Cl2–petrol); νmax (film) 3420, 3071, 2931, 2858, 1472, 1428, 1111, 1047, 
821, 738, 702, 611 cm–1; δH (400 MHz) 7.72 (4H, m, m-Ph), 7.43 (6H, m, o-/p-Ph), 
3.99 (1H, qdd, J 6.0, 6.0, 1.0 Hz, CHCH3), 3.54 (1H, dd, J 11.0, 3.5 Hz, CH2), 3.46 
(1H, dd, J 11.0, 5.5 Hz, CH2), 1.11 (9H, s, C(CH3)3), 1.08 (3H, d, J 6.0 Hz, CHCH3); 
δC (100 MHz) 134.1, 133.8 (4°), 135.9, 135.7, 134.8, 129.8, 129.8, 129.7, 127.8, 127.6 
(3°), 70.2 (CH2OH), 68.3 (CHCH3), 27.0 (C(CH3)3), 19.7 (CHCH3), 19.3 (C(CH3)3); 
m/z (CI) 332 [M+NH4]+, 237, 216, 196; data in accordance with the literature.116 
 
(S)-2-(tert-Butyldiphenylsilyloxy)propanal 
 
To a stirred solution of ester 371 (10.28 g, 30.0 mmol, 1.0 equiv) in PhMe (30 mL) at 
–78 °C was added DIBAL-H (1.2 M in PhMe; 30.0 mL, 36.0 mmol, 1.20 equiv) over a 
period of 15 min The mixture was stirred at –78 °C for 1 h, then quenched with Na/K 
tartrate at 0 °C and allowed to stir at rt for 1 h. The aqueous layer was then extracted 
with EtOAc and the combined organic layers washed with sat. NaCl(aq) (×2) and H2O, 
dried (MgSO4) and concentrated under reduced pressure. Purification by column 
chromatography (50% CH2Cl–petrol) gave (S)-2-(tert-butyldiphenylsilyloxy)propanal 
372 (5.37 g, 57%) as a colourless oil; Rf 0.43 (50% CH2Cl2–petrol); [α]D20 –64.0 (c. 
0.506 gdm–3, CHCl3); νmax (film) 2932, 1738, 1472, 1428, 1373, 1242, 1112, 1068, 
822, 741, 703, 611, 507 cm–1; δH (400 MHz) 9.65 (1H, d, J 1.0 Hz, CHO), 7.67 (4H, 
m, m-Ph), 7.40 (6H, m, o-/p-Ph), 4.11 (1H, qd, J 7.0, 1.0 Hz, CHCH3), 1.23 (3H, d, J 
7.0 Hz, CHCH3), 1.21 (9H, s, C(CH3)3); δC (100 MHz) 204.0 (C=O), 134.8 (4°), 135.8, 
127.9, 127.8 (3°), 74.5 (OCHCH3), 26.9 (C(CH3)3), 19.3 (C(CH3)3), 18.4 (CHCH3); 
m/z (CI) 330 [M+NH4]+, 274, 266, 196; data in accordance with the literature.115 
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(S,Z)-Ethyl 4-(tert-butyldiphenylsilyloxy)pent-2-enoate 
 
To a solution of phosphate 374 (2.71 g, 8.47 mmol, 1.0 equiv), in THF (85 mL) was 
added sodium iodide (1.52 g, 10.2 mmol, 1.2 equiv) and DBU (1.39 mL, 9.32 mmol, 
1.1 equiv) at 0 °C and stirred for 10 min The mixture was cooled to –78 °C and 
aldehyde 372 (2.65 g, 8.47 mmol, 1.0 equiv) added. After a further 10 min the solution 
was warmed to 0 °C over 2 hours. The reaction was quenched with sat. NH4Cl(aq), 
extracted with EtOAc and the combined organic fractions washed with H2O and sat. 
NH4Cl(aq), dried (MgSO4) and concentrated under reduced pressure. Purification by 
column chromatography (10% CH2Cl2–petrol) gave (S,Z)-ethyl 4-(tert-
butyldiphenylsilyloxy)pent-2-enoate 375 (3.09 g, 92%; 92:8 cis:trans; separable by 
column chromatography) as a colourless oil; Cis isomer: Rf 0.63 (20% CH2Cl2–petrol); 
[α]D20 –31.18 (c. 0.1004 gdm–3, CHCl3); νmax (film) 3071, 2960, 2932, 2858, 1720, 
1649, 1472, 1428, 1389, 1364, 1193, 1112, 1074, 1031, 997, 822, 740, 702, 613 cm–1; 
δH (400 MHz) 7.64 (4H, m, m-Ph), 7.36 (6H, m, o-/p-Ph), 6.23 (1H, dd, J 11.5, 8.0 Hz, 
OCHCH), 5.50 (1H, dd, J 11.5, 1.5 Hz, COCH), 5.41 (1H, qd, J 7.5, 6.5 Hz, CHCH3), 
3.98 (2H, q, J 7.0 Hz, OCH2), 1.25 (3H, d, J 6.5 Hz, CHCH3), 1.14 (3H, t, J 7.0 Hz, 
CH2CH3), 1.07 (9H, s, C(CH3)3); δC (100 MHz) 165.5 (C=O), 153.6 (OCHCH), 134.2 
(4°), 135.8, 135.7, 129.5, 127.5, 127.4 (3°), 117.0 (COCH), 66.8 (CHCH3), 59.9 
(OCH2), 27.0 (C(CH3)3), 23.3 (CHCH3), 19.2 (C(CH3)3), 14.1 (CH2CH3); m/z (CI) 383 
[M+H]+, 325, 305, 127 (Found [M+H]+, 383.2057. C23H30O3Si requires [M+H]+, 
383.2042) (Found: C, 72.18; H, 8.03. C23H30O3Si  requires C, 72.21; H, 7.90). 
 
(S,Z)-4-(tert-Butyldiphenylsilyloxy)pent-2-en-1-ol 
 
To a solution of ester 375 (763 mg, 1.99 mmol, 1.0 equiv) in PhMe (5.5 mL) at –78 °C 
was added DIBAL-H (1.2 M in PhMe; 3.66 ml, 4.39 mmol, 2.2 equiv) dropwise. The 
solution was allowed to warm to rt and stirred for a further 2 h. The reaction mixture 
was quenched dropwise with sat. Na/K tartrate solution and left to stir vigorously 
overnight. The layers were then separated and the aqueous layer further extracted with 
EtOAc. The combined organic layers were washed with sat. NaCl(aq) (× 2) and H2O, 
Experimental 
 
 136 
dried (MgSO4) and concentrated under reduced pressure. Purification by column 
chromatography (20–50% CH2Cl2–petrol) gave (S,Z)-4-(tert-
butyldiphenylsilyloxy)pent-2-en-1-ol 376 as a colourless oil (476 mg, 70%); Rf 0.52 
(50% CH2Cl2–petrol); [α]D20 +20.9 (c. 0.114 gdm–3, CHCl3); νmax (film) 3349, 2963, 
2931, 2858, 1472, 1427, 1390, 1367, 1111, 1082, 1030, 822, 739, 702, 613 cm–1; δH 
(400 MHz) 7.68 (4H, m, m-Ph), 7.41 (6H, m, o-/p-Ph), 5.57 (1H, dd, J 11.0, 8.5 Hz, 
OCHCH), 5.33 (1H, m, CH2CH), 4.54 (1H, qd, J 8.0, 6.5 Hz, CHCH3), 3.70 (2H,  m, 
OCH2), 1.21 (3H, d, J 6.5 Hz, CHCH3), 1.05 (9H, s, C(CH3)3); δC (100 MHz) 134.2 
(4°), 136.0, 135.9, 129.7, 129.7, 127.6, 127.5, 127.0 (3°), 65.7 (CHCH3), 58.5 (OCH2), 
26.9 (C(CH3)3), 24.7 (CHCH3), 19.2 (C(CH3)3), 14.1 (CH2CH3); m/z (CI) 341 [M+H]+, 
358, 280, 274, 263, 216, 196 (Found [M+H]+, 341.1939. C21H28O2Si requires [M+H]+, 
341.1937) (Found: C, 73.98; H, 8.21. C21H28O2Si requires C, 74.07; H, 8.29). 
 
(S,Z)-4-(tert-Butyldiphenylsilyloxy)pent-2-enyl methanesulfonate 
 
According to general procedure C, alcohol 376 (376 mg, 1.10 mmol, 1.0 equiv) in 
CH2Cl2 (5.5 mL) was treated with NEt3 (462 µL, 3.31 mmol, 3.0 equiv) and MsCl (171 
µL, 2.21 mmol, 2.0 equiv) to give (S,Z)-4-(tert-butyldiphenylsilyloxy)pent-2-enyl 
methanesulfonate 377 as a colourless gum, used without further purification; Rf 0.71 
(50% EtOAc–petrol); νmax (film) 3071, 2932, 2858, 1472, 1428, 1356, 1176, 1111, 
1086, 971, 928, 822, 742, 704, 613 cm–1; δH (400 MHz) 7.65 (4H, m, m-Ph), 7.40 (6H, 
m, o-/p-Ph), 5.80 (1H, ddt, J 11.0, 8.5, 1.5 Hz, OCHCH), 5.37 (1H, dtd, J 11.0, 7.0, 1.0 
Hz, CH2CH), 4.54 (1H, dqd, J 8.5, 6.5, 1.0 Hz, CHCH3), 4.30 (2H,  m, OCH2), 2.83 
(3H, s, SCH3), 1.22 (3H, d, J 6.5 Hz, CHCH3), 1.05 (9H, s, C(CH3)3); δC (100 MHz) 
133.9, 133.8 (4°), 140.8, 135.8, 135.8, 129.8, 129.8, 127.7, 127.6, 120.1 (3°), 65.8 
(CHCH3), 65.3 (CH2), 37.8 (SO2CH3), 26.9 (C(CH3)3), 24.3 (CHCH3), 19.1 (C(CH3)3); 
m/z (CI) 436 [M+NH4]+, 274, 196, 142, 102 (Found [M+NH4]+, 436.1983. 
C22H30O4SSi requires [M+H]+, 436.1978). 
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(6S,Z)-Methyl 6-(tert-butyldiphenylsilyloxy)-2-tosylhept-4-enoate 
 
According to general procedure D, sodium hydride (53 mg, 1.32 mmol, 1.2 equiv) 
suspended in DMF (1.5 mL) was treated with methyl p-toluenesulfonyl acetate 365 
(250 mg, 1.10 mmol, 1.0 equiv) in DMF (2.0 mL) and mesylate 377 (460 mg, 1.10 
mmol, 1.0 equiv) in DMF (2.0 mL). Purification by column chromatography (20% 
EtOAc–petrol) gave (6S,Z)-methyl 6-(tert-butyldiphenylsilyloxy)-2-tosylhept-4-enoate 
378 (350 mg, 70% over 2 steps) as a mixture of diastereomers; Rf 0.71 (50% EtOAc–
petrol); νmax (film) 2958, 2931, 2857, 1744, 1597, 1428, 1330, 1194, 1148, 1110, 1084, 
821, 740, 704 cm–1; δH (400 MHz) 7.64 (6H, m, m-Ph and o-SO2Ar), 7.41 (8H, m, o-
/p-Ph and m-SO2Ar), 5.62 (1H, m, OCHCH), [5.05, 4.97] (1H, 2 × dt, J 10.5, 7.0 Hz, 
CH2CH), 4.48 (1H, m, CHCH3), [3.69, 3.66] (1H,  2 × dd, J 11.0, 4.5 Hz, SCH), [3.63, 
3.61] (3H, 2 × s, OCH3), [2.47, 2.46] (3H, 2 × s, ArCH3), [2.35, 2.28] (2H, 2 × m, 
CH2), [1.12, 1.10] (3H, 2 × d, J 6.0 Hz, CHCH3), 1.05 (9H, s, C(CH3)3); δC (100 MHz) 
165.9 (C=O), 145.4, 138.8, 138.7, 134.1, 133.8 (4°), 135.9, 135.8, 129.7, 129.7, 129.3, 
127.6, 127.5, 120.9, 120.8 (3°), 70.4, 69.8 (SCH), 65.7, 65.4 (CHCH3), 53.0, 52.9 
(OCH3), 26.9 (C(CH3)3), 25.2, 25.1 (CH2), 24.4, 24.3 (CHCH3), 21.8 (ArCH3), 19.1 
(C(CH3)3); m/z (CI) 568 [M+NH4]+, 410, 312, 295, 218, 190, 142, 130 (Found 
[M+NH4]+, 568.2571. C31H38O5SSi requires [M+NH4]+, 568.2553) (Found: C, 67.68; 
H, 7.01. C31H38O5SSi requires C, 67.60; H, 6.95). 
 
(6S,Z)-Methyl 6-hydroxy-2-tosylhept-4-enoate 
 
To a stirred solution of 378 (279 mg, 051 mmol, 1.0 equiv) in MeOH (1.7 mL) at rt 
was added conc. HCl (34 µL). The mixture was stirred for 16 h, then NaHCO3(s) was 
added until effervescence had ceased. The solids were then removed by filtration and 
the reaction mixture concentrated under reduced pressure and purified by column 
chromatography (30–50% EtOAc–petrol) to give a diastereomeric mixture of (6S,Z)-
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methyl 6-hydroxy-2-tosylhept-4-enoate 379 as a colourless oil (115 mg, 72%); Rf 0.17 
(50% EtOAc–petrol); νmax (film) 3523, 2968, 2927, 1742, 1597, 1437, 1324, 1195, 
1148, 1084, 1057, 816, 729, 666 cm–1; δH (400 MHz) 7.74 (2H, d, J 8.0 Hz, o-SO2Ar), 
7.37 (2H, dd, J 8.0, 3.0 Hz, m-SO2Ar), 5.54 (1H, 2 × d, J 10.0 Hz, OCHCH), 5.23 (1H, 
2 × dd, J 10.5, 6.5 Hz, CH2CH), 4.58 (1H, 2 × t, J 6.5 Hz, CHCH3), 4.00 (1H, dd, J 
10.5, 4.5 Hz, SCH), 3.97 (1H, dd, J 11.0, 3.5 Hz, SCH),  [3.64, 3.63] (3H, 2 × s, 
OCH3), 2.97–2.65 (2H, m, CH2), [2.46, 2.45] (3H, 2 × s, ArCH3), 2.14 (1H, br s, OH), 
1.19 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 166.5, 166.1 (C=O), 145.7, 145.7, 
134.0, 134.0 (4°), 138.6, 138.0, 129.9, 129.8, 129.2, 129.2, 123.4, 123.0 (3°), 70.2, 
70.1 (SCH), 63.4, 63.0 (CHCH3), 53.2, 53.0 (OCH3), 25.3, 25.1 (CH2), 23.4, 22.9 
(CHCH3), 21.7 (ArCH3), 19.1 (C(CH3)3); m/z (CI) 330 [M+NH4]+, 312, 295 (Found 
[M+NH4]+, 330.1371. C15H20O5S requires [M+NH4]+, 330.1375) (Found: C, 57.70; H, 
6.49. C15H20O5S requires C, 57.67; H, 6.45). 
 
(6S,Z)-6-Hydroxy-2-tosylhept-4-enoic acid  
 
According to general procedure F, ester 379 (909 mg, 2.91 mmol, 1.0 equiv) in THF 
(7.28 mL) was treated with 2 M LiOH(aq) (7.28 mL) to give a diastereomeric mixture 
of (6S,Z)-6-hydroxy-2-tosylhept-4-enoic acid (S)-368 (719 mg, 83%) as a colourless 
foam, used without further purification; νmax (film) 3443, 1773, 1597, 1449, 1323, 
1305, 1182, 1148, 967, 936, 815, 735, 707, 648 cm–1; δH (400 MHz; MeOD) 7.82 (2H, 
2 × d, J 8.5 Hz, o-SO2Ar), 7.45 (2H, d, J 8.0 Hz, m-SO2Ar), 5.88 (1H, m, OCHCH), 
5.50 (1H, m, CH2CH), 5.01 (1H, q, J 8.0 Hz, CHCH3), 4.87 (2H, br s, CHCH3 and 
OH), 4.73 (1H, dd, J 10.0, 10.0 Hz, SCH), 4.52 (1H, dd, J 10.0, 3.5 Hz, SCH), 2.93 
(1H, dd, J 7.0, 3.5 Hz, CH2), 2.76 (1H, dd, J 9.5, 7.0 Hz, CH2), 2.46 (3H, s, ArCH3), 
1.72 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz; MeOD) 168.5, 168.3 (C=O), 146.1, 
145.9, 134.4, 134.2 (4°), 132.2, 132.0, 129.7, 129.6, 129.2, 129.0, 128.0, 127.9 (3°), 
80.7, 79.0 (SCH), 64.8, 64.0 (CHCH3), 30.2, 30.1 (CH2), 20.4 (ArCH3), 16.6 
(CHCH3); m/z (CI) 316 [M+NH4]+, 298, 272, 237, 174, 144 (Found [M+NH4]+, 
316.1224. C14H18O5S requires [M+NH4]+, 316.1219) (Found: C, 56.36; H, 6.08. 
C14H18O5S requires C, 56.48; H, 6.06). 
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(7S,Z)-7-Methyl-3-tosyl-3,4-dihydrooxepin-2(7H)-one 
 
According to general procedure G, acid (S)-368 (100 mg, 0.34mmol, 1.0 equiv) in 
CH2Cl2 (1.7 mL) was treated with EDCI (321 mg, 1.68 mmol, 5.0 equiv). Purification 
by column chromatography (20–40% EtOAc–petrol) gave (7S,Z)-7-methyl-3-tosyl-
3,4-dihydrooxepin-2(7H)-one (S)-354 (65 mg, 68%) as a colourless solid; mp 169–170 
°C; Rf 0.50 (50% EtOAc–petrol); νmax (film) 3054, 2986, 1742, 1422, 1327, 1265, 
1142, 1120, 1086, 738 cm–1; δH (400 MHz) 7.95 (2H, d, J 8.0 Hz, o-SO2Ar), 7.36 (2H, 
d, J 8.0 Hz, m-SO2Ar), 5.79 (1H, dddd, J 11.5, 5.5, 3.0, 2.5 Hz, CH2CH), 5.59 (1H, 
ddd, J 11.5, 5.0, 2.5 Hz, OCHCH), 5.21 (1H, dqd, J 9.5, 6.5, 3.5 Hz, CHCH3), 4.74 
(1H,  dd, J 13.5, 4.0 Hz, SCH), 3.10 (1H, m, CH2), 2.64 (1H, dddd, J 18.5, 13.5, 5.5, 
3.0 Hz, CH2), 2.44 (3H, s, ArCH3), 1.40 (3H, d, J 6.5 Hz, CHCH3); δC (100 MHz) 
166.3 (C=O), 145.6, 133.6 (4°), 130.5, 129.6, 128.5 (3°), 71.2 (CHCH3), 64.4 (SCH), 
27.1 (CH2), 21.7 (ArCH3), 21.6 (CHCH3); m/z (CI) 298 [M+NH4]+, 174, 144, 52 
(Found [M+NH4]+, 298.1119. C14H16O4S requires [M+NH4]+, 298.1113) (Found: C, 
59.98; H, 5.75. C14H16O4S requires C, 60.05; H, 5.80). 
 
 (1R,2S)-2-((E)-prop-1-enyl)-1-tosylcyclopropanecarboxylic acid 
 
According to procedure H lactone (S)-354 (50 mg, 0.18 mmol, 1.0 equiv) in CH2Cl2 
(1.0 mL) was treated with KOAc (1.77 mg, 0.018 mmol, 0.1 equiv) and BSA (44.1 µl, 
0.18 mmol, 1.0 equiv) to give (1R,2S)-2-((E)-prop-1-enyl)-1-
tosylcyclopropanecarboxylic acid (S)-355 (42 mg, 84%) as a colourless solid; [α]D20 –
21.4 (c. 0.0084 gdm–3, CHCl3); νmax (film) 3059, 2921, 1730, 1597, 1427, 1304, 1139, 
1085, 964, 814, 736, 663 cm-1; δH (400 MHz) 9.65 (1H, br s, OH), 7.79 (2H, d, J 8.0 
Hz, o- SO2Ar), 7.33 (2H, d, J 8.0 Hz, m- SO2Ar), 5.84 (1H, dq, J 13.0, 6.5 Hz, 
CHCH3), 5.24 (1H, ddd, J 15.5, 8.5, 1.5 Hz, CHCHCH3), 2.99 (1H, dd, J 9.0, 9.0 Hz, 
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SCCH), 2.44 (3H, s, ArCH3), 2.15 (1H, dd, J 10.0, 5.5 Hz, CH2), 1.91 (1H, dd, J 8.5, 
5.5 Hz, CH2), 1.66 (3H, dd, J 6.5, 1.0 Hz, CHCH3); δC (100 MHz) 168.0 (C=O), 145.2, 
136.1 (4°), 133.0, 129.8, 128.7, 123.2 (3°), 50.2 (SC), 33.0 (SCCH), 21.7 (ArCH3), 
20.4 (CH2), 18.1 (CHCH3); m/z (CI) 298 [M+NH4]+ (Found [M+NH4]+, 298.1109. 
C14H16O4S requires [M+NH4]+, 298.1113). 
 
1-Methyl-4-((1R,2S)-2-((E)-prop-1-enyl)cyclopropylsulfonyl)benzene 
 
According to general procedure I, lactone (S)-354 (20 mg, 0.07 mmol, 1.0 equiv) in 
DMF (0.35 mL) was treated with KOAc (0.7 mg, 7.0 µmol, 0.1 equiv) and BSA (17.6 
µL, 0.07 mmol, 1.0 equiv). Purification by column chromatography (20% EtOAc–
petrol) gave 1-methyl-4-((1R,2S)-2-((E)-prop-1-enyl)cyclopropylsulfonyl) benzene 
(S)-369 (16 mg, 95%) as a colourless gum; Rf 0.63 (50 % EtOAc–petrol); [α]D20 –50.0 
(c. 0.0016 gdm–3, CHCl3); νmax (film) 3055, 2986, 1598, 1422, 1311, 1265, 1147, 1088, 
963, 743, 705 cm-1; δH (400 MHz) 7.76 (2H, d, J 8.0 Hz, o- SO2Ar), 7.34 (2H, d, J 8.0 
Hz, m- SO2Ar), 5.61 (1H, dq, J 15.0, 6.5 Hz, CHCH3), 5.01 (1H, ddd, J 15.0, 7.5, 1.5 
Hz, CHCHCH3), 2.44 (3H, s, ArCH3), 2.37–2.29 (2H, m, SCH and SCHCH), 1.62 
(3H, dd, J 6.5, 1.5 Hz, CHCH3), 1.57 (1H, ddd, J 14.5, 5.5, 5.5 Hz, CH2), 1.05 (1H, m, 
CH2); δC (125 MHz) 144.2, 137.9 (4°), 129.9, 128.0, 127.8, 127.5 (3°), 40.0 (SCH), 
22.0 (SCHCH), 21.6 (ArCH3), 17.7 (CHCH3), 12.8 (CH2); m/z (CI) 254 [M+NH4]+, 
490 (Found [M+NH4]+, 254.1212. C13H16O2S requires [M+NH4]+, 254.1215). 
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3.3.3 Compounds Relevant to Section 2.4 
 
(±)-S-Methyl-S-phenyl-N-tosylsulfilimine 
 
Thioanisole 397 (5.87 mL, 50.0 mmol, 1.0 equiv) and tetrabutylammonium bromide 
(0.81 g, 2.50 mmol, 5.0 mol%) were dissolved in CH2Cl2 (100 mL). Solid chloramine-
T trihydrate (dried under vacuum over P2O5; 15.5 g, 55.0 mmol, 1.1 equiv) was slowly 
added with stirring and cooling in a water bath. After addition was complete the water 
bath was removed and stirring continued for 2 h. The reaction mixture was washed 
with cold 5% NaOH(aq) and H2O (×2), the organic layer dried (MgSO4) and 
concentrated under reduced pressure. The crude sulfilimine was recrystallised from 
methanol–water (9:1) to give  (±)-S-methyl-S-phenyl-N-tosylsulfilimine 398 (13.9 g, 
95%) as colourless needles; mp 130 °C; Rf 0.07 (20% EtOAc–petrol); νmax (nujol) 
1593, 1295, 1279, 1142, 1086, 1021, 989, 932, 826, 766, 746, 689, 652 cm-1; δH (270 
MHz) 7.68 (4H, m, o-Ph, o-SO2Ar), 7.49 (3H, m, m-/p-Ph), 7.14 (2H, d, J 8.0 Hz, m-
SO2Ar), 2.82 (3H, s, SCH3), 2.33 (3H, s, ArCH3); δC (100 MHz) 141.7, 141.2, 136.1 
(4°), 132.4, 129.9, 129.2, 126.2, 125.8 (3°), 39.1 (SCH3), 21.3 (ArCH3); m/z (CI) 294 
[M+H]+, 206, 189; data in accordance with those previously reported.117 
 
(±)-S-Methyl-S-phenyl-N-tosylsulfoximine 
 
To a solution of the sulfilimine 398 (13.5 g, 46.0 mmol, 1.0 equiv) in CCl4 (100 mL) 
and MeCN (100 mL) was added RuO2.xH2O (12.2 mg, 0.92 mmol, 2.0 mol%). A 
solution of NaIO4 (19.7 g, 92.0 mmol, 2.0 equiv) in H2O (200 mL) was then added 
slowly (~30 min) and the reaction stirred for 90 min. The phases were separated and 
the aqueous layer extracted with CH2Cl2. The organic layers were combined and 
iPrOH (4.5 mL) added and the reaction mixture stirred for a further 1 h, then filtered 
over celite, dried (MgSO4), and concentrated under reduced pressure. The 
yellow/green crystals were washed with EtOH to give the (±)-S-methyl-S-phenyl-N-
tosylsulfoximine 399 (11.8 g, 83%) as white crystals; mp 102 °C; νmax (nujol) 1597, 
1580, 1327, 1314, 1230, 1146, 1090, 1067, 982, 811, 754, 740, 689, 653 cm-1; δH (270 
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MHz) 8.00 (2H, d, J 7.5 Hz, o-Ph), 7.84 (2H, d, J 8.5 Hz, o-SO2Ar), 7.72–7.56 (3H, m, 
m-/p-Ph), 7.24 (2H, d, J 8.5 Hz, m-SO2Ar), 3.41 (3H, s, SCH3), 2.38 (3H, s, ArCH3); 
δC (67.5 MHz) 142.9, 140.7, 138.6 (4°), 134.5, 129.8, 129.4, 127.6, 126.7 (3°), 46.7 
(SCH3), 21.6 (ArCH3); m/z (CI) 327 [M+NH4]+, 294, 189, 52; data in accordance with 
those previously reported.118 
 
(±)-S-Methyl-S-phenylsulfoximine 
 
A solution of 399 (11.8 g, 38.1 mmol, 1.0 equiv) was heated in conc. H2SO4 (20 mL) 
for 25 min at 120 °C. The reaction was cooled to rt, then poured into ice and 
neutralised using 2 M NaOH(aq). The reaction was then extracted with CH2Cl2 (×2), the 
organic layer dried (MgSO4) and concentrated under reduced pressure to give (±)-S-
methyl-S-phenylsulfoximine 400 (5.83 g, 99%) as a colourless oil; νmax (film) 3268, 
3191, 3091, 3062, 3018, 1446, 1409, 1320, 1222, 1097, 1070, 1029, 1010, 950, 769, 
742, 690 cm-1; δH (270 MHz) 7.99 (2H, d, J 8.0 Hz, o-Ph), 7.64–7.50 (3H, m, m-/p-Ph), 
3.07 (3H, s, SCH3); δC (67.5 MHz) 143.4 (4°), 133.2, 129.4, 127.8 (3°), 46.2 (SCH3); 
m/z (CI) 156 [M+H]+; data in accordance with those previously reported.119 
 
(–)-(R)-S-Methyl-S-phenylsulfoximine-(–)-camphorsulfonic acid 
 
A solution of (–)-(R)-camphorsulfonic acid (4.28 g, 18.4 mmol, 0.5 equiv) in dry 
acetone (distilled over P2O5; 30 mL) was added to a solution of 400 (5.72 g, 36.9 
mmol, 1.0 equiv) in dry acetone (20 mL) at rt and stirred for 16 h. The precipitate was 
then filtered and washed with dry acetone (×3) to give (–)-(R)-S-methyl-S-
phenylsulfoximine-(–)-camphorsulfonic acid 401 (5.40 g, 40% from a possible 50%) 
as a colourless powder; mp 172–174 °C; νmax (nujol) 1728, 1580 1415, 1253, 1231, 
1190, 1140, 1038, 669, 748 cm-1; δH (270 MHz) 8.17 (2H, d, J 8.0 Hz, o-Ph), 7.82–
7.67 (3H, m, m-/p-Ph), 3.84 (3H, s, SCH3), [3.11 and 2.62] (2H, 2 × d, J 15.0 Hz, 
SCH2), [2.42, 2.24] (2H, 2 × m, SCH2CCH2), 1.96 (1H, dd, J 4.0, 4.0 Hz, CHCH2CO), 
1.89 (1H, dd, J 8.0, 4.0 Hz, CHCH2CO), 1.80 (1H, d, J 18.5 Hz, CHCH2CO), 1.48 
(1H, ddd, J 13.0, 9.5, 4.0 Hz, CHCH2CH2), 1.28 (1H, ddd, J 13.0, 9.5, 4.0 Hz, 
CHCH2CH2), [0.95, 0.73] (6H, 2 × s, CSA-CH3); δC (125 MHz, DMSO-d6) 215.9 
Experimental 
 
 143 
(C=O), 137.9 (4°), 130.2, 128.2, 125.5 (3°), 58.0 (SO2CH2C), 47.1 (CCH3)2), 46.9 
(SO2CH2), 43.5 (SCH3), 42.2 (CH2CO), 42.1 (CHCO), 26.3 (SO2CH2CCH2), 24.1 
(CH2CCO), 19.9, 19.5 (C(CH3)2); m/z (CI) 156; data in accordance with those 
previously reported.120  
 
(–)-(R)-S-Methyl-S-phenyl-N-tosylsulfoximine 
 
Sulfoximine 401 (8.2 g, 22.2 mmol, 1.0 equiv) was dissolved in dry pyridine (15 mL) 
and tosyl chloride (4.23 g, 22.2 mmol, 1.0 equiv) was added slowly and the reaction 
was stirred for 16 h. The reaction mixture was then poured onto H2O and extracted 
with CH2Cl2. The organic layers were combined, washed with 2 M  HCl(aq) (×2) and 
H2O, dried (MgSO4) and concentrated under reduced pressure to give (–)-(R)-S-
methyl-S-phenyl-N-tosylsulfoximine 402 (6.07 g, 88%) as a white crystalline solid; mp 
106–107 °C; [α]D22 −40.0 (c. 5.0 gdm-3, CH2Cl2); νmax (nujol) 2361, 1735, 1312, 1239, 
1061, 965, 805, 685, 651 cm-1; δH (270 MHz) 7.99 (2H, d, J 8.0 Hz, o-Ph), 7.82 (2H, d, 
J 8.0 Hz, o-SO2Ar), 7.72–7.55 (3H, m, m-/p-Ph), 7.23 (2H, d, J 8.0 Hz, m-SO2Ar), 
3.41 (3H, s, SCH3), 2.38 (3H, s, ArCH3); δC (67.5 MHz) 143.0, 140.7, 138.6 (4°), 
134.5, 129.8, 129.4, 127.6, 126.7 (3°), 46.7 (SCH3), 21.6 (ArCH3); data in accordance 
with those previously reported.121  
 
(–)-(R)-S-Carboxymethyl-S-phenyl-N-tosylsulfoximine 
 
A solution of sulfoximine 402 (3.71 g, 12.0 mmol, 1.0 equiv) in THF (45 mL) at –78 
°C under N2 was treated with nBuLi (2.83 M in hexanes; 4.66 mL, 13.2 mmol, 1.1 
equiv). After stirring for 1 h at this temperature, dry CO2(g) was bubbled through the 
solution for 2 h. The cooling bath was then removed, the solution diluted with CH2Cl2, 
hydrolysed with H2O and the layers separated. The aqueous layer was acidified with 2 
M HCl(aq) until a colourless precipitate appeared. The suspension was extracted with 
CH2Cl2 (×3), the organic layers combined, dried (MgSO4), and concentrated under 
reduced pressure. The initial organic layer gave back starting material (1.60 g, 43%) 
and the aqueous layer gave the desired product (–)-(R)-S-carboxymethyl-S-phenyl-N-
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tosylsulfoximine 403 (2.10 g, 49%) as a colourless foam; νmax (film) 3497, 2928, 2614, 
1735, 1630, 1598, 1448, 1303, 1248, 1151, 1087, 1018, 998, 909, 814, 737, 683 cm-1; 
δH (270 MHz) 7.99 (2H, d, J 8.0 Hz, o-Ph), 7.83 (2H, d, J 8.0 Hz, o-SO2Ar), 7.72–7.55 
(3H, m, m-/p-Ph), 7.24 (2H, d, J 8.0 Hz, m-SO2Ar), 5.62 (br s, COOH), 4.67 (2H, s, 
SCH2), 2.37 (3H, s, ArCH3); δC (67.5 MHz) 163.9 (C=O), 143.4, 140.1, 135.7 (4°), 
135.1, 129.6, 129.5, 128.8, 126.7 (3°), 61.3 (SCH2), 21.6 (ArCH3); data in accordance 
with those previously reported.92  
 
(R)-tert-Butyl 2-(N-tosylphenylsulfonimidoyl)acetate 
  
To t-butanol (0.53 mL, 5.66 mmol, 1.0 equiv) and (–)-(R)–S-carboxymethyl-S-phenyl-
N-(4-toluenesulfonyl)sulfoximine 403 (2.00 g, 5.66 mmol, 1.0 equiv) in CH2Cl2 (25 
mL) at 0 °C was added dropwise N, N’-diisopropylcarbodiimide (0.88 mL, 5.66 mmol, 
1.0 equiv). The reaction mixture was stirred at 0 °C for 10 min, at rt for 1 h, then was 
filtered, concentrated under reduced pressure and purified by column chromatography 
(20% EtOAc–petrol) to give (R)-tert-butyl 2-(N-tosylphenylsulfonimidoyl)acetate 404 
(1.15 g, 50%) as a white solid; mp 124–126 °C; Rf 0.51 (50% EtOAc–petrol); νmax 
(film) 3055, 2985, 1735, 1318, 1303, 1265, 1155, 1088, 1064, 738, 704 cm-1; δH (270 
MHz) 8.00 (2H, dt, J 7.5, 1.5 Hz, o-Ph), 7.86 (2H, d, J 8.0 Hz, o-SO2Ar), 7.70 (1H, tt, 
J 7.5, 1.5 Hz, p-Ph), 7.58 (2H, t, J 7.5 Hz, m-Ph), 7.25 (2H, d, J 8.0 Hz, m-SO2Ar), 
[4.63, 4.48] (2H, AB doublet, J 14.5 Hz, CH2), 2.38 (3H, s, ArCH3), 1.31 (9H, s, 
C(CH3)3); δC (125 MHz), 160.3 (C=O), 143.0, 140.6, 136.3 (4°), 134.7, 129.4, 129.3, 
128.7, 126.7 (3°), 84.4 (C(CH3)3), 62.5 (CH2), 27.6 ((CH3)3), 21.5 (ArCH3); m/z (CI) 
427 [M+NH4]+, 371, 327, 310, 294, 189 (Found [M+NH4]+, 427.1364. C19H23NO5S2 
requires [M+NH4]+, 427.1361).  
 
(S,Z)-tert-Butyl 6-(methoxymethoxy)-2-((R)-N-tosylphenyl sulfonimidoyl)hex-4-enoate 
 
According to general procedure D, sodium hydride (0.14 g, 3.49 mmol, 1.1 equiv) 
suspended in THF (5.0 mL) at 0 °C was treated with ester 404 (1.30 g, 3.17 mmol, 1.0 
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equiv) in THF (5.0 mL) and methane sulfonate 312 (0.67 g, 3.17 mmol, 1.0 equiv) in 
THF (5.0 mL). Purification by column chromatography (20% EtOAc–petrol) gave a 
diastereomeric mixture of (S,Z)-tert-butyl 6-(methoxymethoxy)-2-((S)-N-
tosylphenylsulfonimidoyl)hex-4-enoate 405 (1.00 g, 60%) as a sticky white solid; Rf 
0.36 (50% EtOAc–petrol); νmax (film) 3055, 2986, 1735, 1321, 1304, 1265, 1154, 
1089, 1062, 738, 704 cm-1; δH (400 MHz) 7.94 (2H, m, o-Ph), 7.81 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.74–7.69 (1H, m, p-Ph), 7.62–7.57 (2H, d, J 8.0 Hz, m-Ph), 7.23 (2H, d, J 8.0 
Hz, m-SO2Ar), [5.72–5.65, 5.43–5.34] (2H, 2 × m, CH=CH), 4.61–4.55 (1H, m, SCH), 
[4.57, 4.55] (2H, 2 × s, OCH2O), 4.09–3.94 (2H, m, CHCH2O), [3.32, 3.30] (3H, 2 × s, 
OCH3), 2.86–2.51 (2H, m, SCHCH2CH), 2.39 (3H, s, ArCH3), [1.39, 1.30] (9H, 2 × s, 
C(CH3)3); δC (100 MHz) 163.2, 163.1 (C=O), 142.9, 142.8, 140.8, 140.6, 134.9, 134.4 
(4o) 134.7, 134.6, 130.9, 130.9, 129.8, 129.7, 129.2, 129.2, 129.2, 129.1, 126.7, 126.6, 
125.0, 124.9 (3o), 95.8, 95.7 (OCH2O), 84.3, 84.2 (C(CH3)3), 71.3, 71.0 (SCH), 62.6, 
62.5 (OCH2CH), 55.2 (OCH3), 27.6, 27.4 (C(CH3)3), 26.3, 25.1 (SCHCH2CH), 21.5 
(ArCH3); m/z (CI) 541 [M+NH4]+, 417, 303, 271, 254, 230, 224, 206, 189, 159, 132 
(Found [M+NH4]+, 541.2019. C25H33NO7S2 requires [M+NH4]+, 541.2042) (Found: C, 
57.39; H, 6.07; N, 2.56. C25H33NO7S2 requires C, 57.34; H, 6.35; N, 2.67). 
 
(R)-Methyl 2-(N-tosylphenylsulfonimidoyl) acetate 
 
To a suspension of sodium hydride (60% dispersion in mineral oil, washed in hexane; 
430 mg, 10.7 mmol, 2.2 equiv) in THF (10 mL) was added dimethyl carbonate (8.50 
mL, >20 equiv) and the reaction mixture stirred at reflux whilst a solution of 
sulfoximine 402 (1.50 g, 4.85 mmol, 1.0 equiv) in THF (15 mL) was added dropwise. 
The stirred reaction mixture was heated at reflux overnight, cooled on ice and then 
quenched with MeOH:AcOH (2:1, 15 mL). The solution was poured onto H2O and the 
product extracted with Et2O (×5). The combined organic layers were washed with sat. 
NaHCO3(aq) and H2O, dried (MgSO4) and concentrated under reduced pressure. The 
yellow oil was then treated with EtOH to give (R)-methyl 2-(N-
tosylphenylsulfonimidoyl) acetate 408 (1.39 g, 78%) as a white solid; mp 76–77 °C; 
[α]D22 −32.2 (c. 5.0 gdm-3, CH2Cl2);  Rf 0.43 (50% EtOAc–petrol); νmax (film) 1742, 
1643, 1496, 1447, 1318, 1153, 814, 666 cm-1; δH (270 MHz) 7.99 (2H, d, J 7.5 Hz, o-
Ph), 7.86 (2H, d, J 8.5 Hz, o-SO2Ar), 7.70 (1H, m, p-Ph), 7.58 (2H, m, m-Ph), 7.25 
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(2H, d, J 8.5 Hz, m-SO2Ar), [4.79, 4.58] (2H, AB doublet, J 14.5 Hz, CH2), 3.64 (3H, 
s, OCH3), 2.38 (3H, s, ArCH3); δC (67.5 MHz) 162.2 (C=O), 143.3, 140.4, 135.9 (4°), 
135.0, 129.5, 129.4, 128.7, 126.8 (3°), 61.4 (CH2), 53.4 (OCH3), 21.6 (ArCH3); m/z 
(CI) 385 [M+NH4]+, 279, 208, 189; data in accordance with those previously 
reported.92 
 
(S,Z)-Methyl 6-(methoxymethoxy)-2-((R)-N-tosylphenylsulfonimidoyl)hex-4-enoate 
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According to procedure D, a suspension of sodium hydride (0.42 g, 10.5 mmol, 1.1 
equiv) in THF (10 mL) was treated with acetate 408 (3.49 g, 9.5 mmol, 1.0 equiv) in 
THF (25 mL), followed by mesylate 312 (2.00 g, 9.50 mmol, 1.0 equiv) in THF (15 
mL). Purification by column chromatography (20–40% EtOAc–petrol) gave a 
diastereomeric mixture (1:1) of (S,Z)-methyl 6-(methoxymethoxy)-2-((S)-N-
tosylphenylsulfonimidoyl)hex-4-enoate 409 (3.68 g, 80%) as a colourless gum; Rf 0.42 
(50% EtOAc–petrol); νmax (film) 2952, 1746, 1598, 1447, 1321, 1245, 1152, 1087, 
1061, 1018, 997, 815, 765, 685, 666 cm-1; δH (500 MHz) 7.96 (2H, m, o-Ph), 7.88 (2H, 
m, o-SO2Ar), 7.76 (1H, m, p-Ph), 7.63 (2H, m, m-Ph), 7.28 (2H, m, m-SO2Ar), 5.71 
(1H, dt, J 11.0, 6.5 Hz, OCH2CH), 5.40 (1H, m, SCHCH2CH), [4.89, 4.64] (1H, dd, J 
11.0, 3.5 Hz, SCH), [4.59, 4.57] (2H, 2 × s, OCH2O), 4.08–3.98 (2H, m, CHCH2O), 
[3.74, 3.69]  (3H, 2 × s, CO2CH3), [3.35, 3.33] (3H, 2 × s, CH2OCH3), [2.91–2.84, 
2.72–2.54] (2H, 2 × m, SCHCH2), 2.42 (3H, s, ArCH3); δC (125 MHz) 165.2, 164.0 
(C=O), 143.1, 143.0, 140.7, 140.5, 134.4, 133.8 (4°), 135.0, 135.0, 131.3, 131.2, 129.8, 
129.7, 129.3, 126.7, 126.7, 124.7 (3°), 95.8 (OCH2O), 71.1, 70.4 (SCH), 62.6 
(OCH2CH), 55.3 (CH2OCH3), 53.4, 53.3 (CO2CH3), 26.4, 25.1 (SCHCH2), 21.6 
(ArCH3); m/z (CI) 499 [M+NH4]+, 455, 450, 420, 385, 313, 189 (Found [M+NH4]+, 
499.1591. C22H27NO7S2 requires [M+NH4]+, 499.1573) (Found: C, 54.89; H, 5.63; N, 
2.92. C22H27NO7S2 requires C, 54.87; H, 5.65; N, 2.91). 
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(Z)-Methyl 6-hydroxy-2-((R)-N-tosylphenylsulfonimidoyl)hex-4-enoate 
 
According to procedure E, ester 409 (1.40 g, 2.90 mmol, 1.0 equiv) was heated under 
reflux in MeCN (30 mL) and 2 M HCl(aq) (6 mL) to give (Z)-methyl 6-hydroxy-2-((R)-
N-tosylphenylsulfonimidoyl) hex-4-enoate 410 (1.13 g, 89%) as a viscous white oil; Rf 
0.13 (50% EtOAc–petrol); νmax (film) 3525, 2954, 1744, 1598, 1447, 1318, 1242, 
1153, 1088, 1062, 998, 815, 754, 685. 665 cm-1; δH (400 MHz) 7.94 (2H, d, J 8.5 Hz, 
o-Ph), 7.87 (2H, m, o-SO2Ar), 7.76 (1H, m, p-Ph), 7.62 (2H, m, m-Ph), 7.28 (2H, m, 
m-SO2Ar), 5.77 (1H, m, CHCH2OH), 5.35 (1H, m, SCHCH2CH), [4.99, 4.67] (1H, dd, 
J 11.5, 3.5 Hz, SCH), 4.16–4.05 (2H, m, CH2OH), [3.76, 3.61] (3H, 2 × s, OCH3), 
2.96–2.84 (1H, m, SCHCH2), [2.77, 2.69] (1H, m, SCHCH2), 2.41 (3H, s, ArCH3); δC 
(100 MHz) 165.6, 165.3 (C=O), 143.2, 143.0, 140.6, 140.4, 134.4, 133.3 (4°), 135.2, 
135.0, 133.9, 133.8, 129.8, 129.6, 129.4, 129.3, 124.0, 123.8 (3°), 71.2, 70.5 (SCH), 
58.1, 58.0 (CH2OH), 53.5, 53.4 (OCH3), 26.4, 25.0 (SCHCH2), 21.6 (ArCH3); m/z (CI) 
455 [M+NH4]+, 300, 189, 160 (Found [M+NH4]+, 455.1295. C20H23NO6S2 requires 
[M+NH4]+, 455.1311) (Found: C, 55.02; H, 5.27; N, 3.09. C20H23NO6S2 requires C, 
54.90; H, 5.30; N, 3.20). 
 
(Z)-6-Hydroxy-2-((R)-N-tosylphenylsulfonimidoyl)hex-4-enoic acid 
 
According to procedure F, ester 410 (1.10 g, 2.51 mmol, 1.0 equiv) in THF (6.3 mL) 
was treated with 2 M LiOH(aq) (6.3 mL, 2.00 mmol, 5.0 equiv) to give (Z)-6-hydroxy-
2-((R)-N-tosylphenylsulfonimidoyl)hex-4-enoic acid 407 (860 mg, 81%) as a white 
solid without further purification; mp 149–151 °C; δH (400 MHz, DMSO-d6); 7.91–
7.88 (2H, m, o-Ph), 7.85–7.79 (1H, m, p-Ph), 7.72–7.63 (4H, m, o-SO2Ar and m-Ph), 
7.35–7.31 (2H, m, m-SO2Ar), 5.82–5.75 (1H, m, CHCH2OH), 5.48–5.41 (1H, m, 
SCHCH2CH), 4.90 (1H, dd, J 11.5, 3.0 Hz, SCH), 4.10 (2H, ddd, J 19.0, 13.0, 7.0 Hz, 
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CH2OH), [2.82–2.80, 2.69–2.61] (2H, 2 × m, SCHCH2), 2.41 (3H, s, ArCH3);  δC (100 
MHz, DMSO-d6) 165.6, 165.5 (C=O), 143.1, 143.0, 142.9, 141.1, 136.6, 135.1 (4°), 
135.4, 135.2, 134.9, 133.6, 130.1, 130.0, 129.8, 129.8, 129.8, 128.5, 126.4, 125.0, 
122.9, 122.4 (3°) 70.3, 70.1 (SCH), 57.1, 57.1 (CH2OH), 25.4, 24.7 (SCHCH2), 21.4 
(ArCH3); m/z (FAB+) 424 [M+H]+, 406, 392, 296, 167, 125, 89, 77 (Found [M+H]+, 
424.0887. C19H21NO6S2 requires [M+H]+, 424.0889) (Found: C, 53.91; H, 4.94; N, 
3.24. C19H21NO6S2 requires C, 53.88; H, 5.00; N, 3.31). 
 
(Z)-3-((R)-N-Tosylphenylsulfonimidoyl)-3,4-dihydrooxepin-2(7H)-one 
 
According to general procedure G, hydroxy acid 407 (0.84 g, 1.99 mmol, 1.0 equiv) in 
CH2Cl2 (5 mL) was added EDCI (0.42 g, 2.19 mmol, 1.1 equiv). The product was 
purified by column chromatography (20–50% EtOAc–petrol) to give (Z)-3-((R)-N-
tosylphenylsulfonimidoyl)-3,4-dihydrooxepin-2(7H)-one 412 (0.68 g, 84%) as a white 
crystalline solid; mp 74–76 °C; Rf 0.26 (50% EtOAc–petrol); νmax (film) 3441 (br), 
3056, 1748, 1598, 1448, 1386, 1316, 1265, 1151, 1087, 736 cm-1; δH (500 MHz) 8.14 
(2H, d, J 7.5 Hz, o-Ph), 7.87 (2H, d, J 8.5 Hz, o-SO2Ar), 7.70 (1H, m, p-Ph), 7.58 (2H, 
dt, J 7.5, 7.5 Hz, m-Ph), 7.28 (2H, m, m-SO2Ar), [6.03, 5.78] (1H, dd, J 13.0, 4.0 Hz, 
SCH), 5.88 (2H, d, J 4.0 Hz, HC=CH), [5.11, 4.51] (2H, m, OCH2), [3.31, 3.15] (1H, 
dd, J 17.5, 3.5 Hz, SCHCH2), 2.45–2.36 (1H, m, SCHCH2), 2.40 (3H, s, ArCH3); δC 
(125 MHz) 166.4 (C=O), 143.2, 143.2, 140.40, 140.2, 133.0, 132.8, (4°), 134.9, 131.1, 
131.0, 129.3, 129.0, 128.9, 128.6, 126.7, 126.7, 124.9, 124.5, (3°), 65.4, 65.3 (SCH), 
64.2, 64.1 (OCH2), 28.9, 27.5 (SCHCH2), 21.5 (ArCH3); m/z (CI) 423 [M+NH4]+, 379, 
189, 128 (Found [M+NH4]+, 423.1055. C19H19NO5S2 requires [M+NH4]+, 423.1048) 
(Found: C, 56.21; H, 4.80; N, 3.52. C19H19NO5S2 requires C, 56.28; H, 4.72; N, 3.45). 
 
1-((R)-N-Tosylphenylsulfonimidoyl)-2-vinylcyclopropane carboxylic acid 
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According to general procedure H, lactone 412 (50 mg, 120 µmol, 1.0 equiv) in 
CH2Cl2 (3 mL) was treated with KOAc (1.2 mg, 12.0 µmol, 0.1 equiv) and BSA (30.5 
µL, 120 µmol, 1.0 equiv) to give a diastereomeric mixture (3:2) of 1-((S)-N-
tosylphenylsulfonimidoyl)-2-vinylcyclopropanecarboxylic acid 413 (40.0 mg, 80%) as 
a colourless oil without further purification; νmax (film) 3063, 1731, 1702, 1681, 1597, 
1446, 1320, 1239, 1154, 1088, 1018, 997, 928, 816, 752, 729, 684, 660, 535cm-1; δH 
(400 MHz, Acetone-d6) 8.09 (2H, dd, J 8.5, 1.0 Hz, o-Ph major), 7.99 (2H, dd, J 8.5, 
1.0 Hz, o-Ph minor) 7.75 (2H, d, J 8.5 Hz, o-SO2Ar), 7.71 (1H, m, p-Ph), 7.60 (2H, t, J 
7.5 Hz, m-Ph), 7.30 (1H, d, J 8.5 Hz, m-SO2Ar major), 7.27 (1H, d, J 8.5 Hz, m-SO2Ar 
minor), 5.62 (2H, m, SCCHCH),  5.56 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis minor), 
5.39 (1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis major), 5.22 (1H, dd, J 10.0, 1.5 Hz, 
CH=CH2 trans minor), 5.13 (1H, dd, J 10.5, 1.5 Hz, CH=CH2 trans major), 3.19 (1H, 
m, SCCH minor), 2.97 (1H, m, SCCH major), 2.39 (1H, dd, J 10.0, 6.0 Hz, SCCH2 
major), 2.29 (1H, dd, J 10.0, 5.5 Hz, SCCH2 minor), [2.36, 2.35] (3H, 2 × s, ArCH3), 
2.16 (1H, dd, J 8.5, 6.0 Hz, SCCH2 major), 1.96 (1H, dd, J 8.5, 5.5 Hz, SCCH2 minor), 
δC (100 MHz, Acetone-d6) 164.1 (C=O), 142.7, 142.5, 141.8, 141.7, 138.6, 138.3 (4°), 
134.2, 134.1, 131.9, 131.2, 129.5, 129.3, 129.2, 129.1, 129.1, 128.9, 127.0, 126.4, 
126.4, 124.7 (3°), 120.6, 120.4 (CH=CH2), 51.7, 51.6 (SC), 33.2, 32.9 (SCCH), 20.6 
(CH3), 20.7, 20.0 (SCCH2); m/z (CI) 423 [M+NH4]+, 379, 362, 313, 189 (Found 
[M+NH4]+, 423.1051. C19H19NO5S2 requires [M+NH4]+, 423.1048) (Found: C, 56.36; 
H, 4.62; N, 3.50. C19H19NO5S2 requires C, 56.28; H, 4.72; N, 3.45). 
 
1-Methylbenzyl-4-((R)-(2-vinylcyclopropyl)sulfonimidoyl) benzenesulfonamide  
 
According to general procedure I, lactone 412 (50.0 mg, 120 µmol, 1.0 equiv), was 
treated with BSA (30.5 µl, 120 µmol, 1.0 equiv) and KOAc (1.2 mg, 12.0 µmol, 0.1 
equiv) in DMF (0.6 mL) to give a diastereomeric mixture (3:2) of 1-methyl-4-((S)-(2-
vinylcyclopropyl)sulfonimidoyl) benzenesulfonamide 414 without further purification 
(28.0 mg, 65%) as a colourless oil; Rf 0.50 (50% EtOAc–petrol); νmax (film) 3052, 
2985, 2923, 2852, 1640, 1598, 1447, 1421, 1316, 1264, 1151, 1070 cm-1; δH (400 
MHz) 7.96 (2H, m, o-Ph), 7.83 (2H, d, J 8.0 Hz, o-SO2Ar), 7.70 (1H, t, J 7.5 Hz, p-
Ph), 7.60 (2H, t, J 7.5 Hz, m-Ph), 7.26 (2H, d, J 8.0 Hz, m-SO2Ar), 5.55 (1H, ddd, J 
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17.5, 10.0, 7.5 Hz, CH=CH2 minor), 5.35 (1H, ddd, J 17.5, 10.0, 7.5 Hz, CH=CH2 
major), 5.28 (1H, d, J 17.5 Hz, CH=CH2 cis minor), 5.15 (1H, d, J 10.0 Hz, CH=CH2 
trans minor), 5.07 (1H, d, J 17.0 Hz, CH=CH2 cis major), 5.01 (1H, d, J 10.0 Hz, 
CH=CH2 trans major), 2.70 (1H, m, SCH major and minor), 2.63 (1H, m, SCHCH 
minor), 2.42 (3H, s, ArCH3), 2.23 (1H, m, SCHCH major), 1.95 (1H, dt, J 10.0, 5.5 
Hz, SCHCH2 major), 1.42 (1H, dt, J 8.0, 6.5 Hz, SCHCH2 major), 1.53 (1H, dt, J 10.0, 
5.5 Hz, SCHCH2 minor), 1.16 (1H, dt, J 8.0, 6.5 Hz, SCHCH2 minor); δC (100 MHz) 
142.8, 140.8, 138.7 (4°), 134.2, 134.1, 134.0, 129.6, 129.2, 127.7, 127.6, 126.6 (3°), 
117.7, 117.4 (CH=CH2), 41.7, 41.6 (SCH), 24.1, 23.3 (SCHCH), 21.5 (ArCH3), 14.4, 
12.7 (SCHCH2); m/z (CI) 362 [M+H]+, 379, 189, 52 (Found [M+H]+, 362.0888. 
C18H19NO3S2 requires [M+H]+, 362.0885) (Found: C, 59.81; H, 5.26; N, 3.89. 
C18H19NO3S2 requires C, 59.81; H, 5.30; N, 3.87). 
 
(+)-(S)-S-Methyl-N-(2,4,6-triisopropylphenylsulfonyl)sulfoximine 
 
To a solution of 401 (8.40 g, 54.0 mmol, 1.0 equiv) in pyridine (45 mL) at –5 °C, were 
added DMAP (30 mg) and 2,4,6-triisopropylbenzene sulfonyl chloride (16.4 g, 54.0 
mmol, 1.0 equiv) to give a yellow solution. The reaction was heated at 60 °C for 2 h. 
The reaction was cooled to rt, poured into cold H2O and 2 M HCl(aq) added. The 
organic layer was extracted with CH2Cl2, and then washed with 2 M HCl(aq) and H2O, 
until pH 8 was achieved. The organic layer was dried (MgSO4) and concentrated under 
reduced pressure. The orange oil was treated with EtOH to give (+)-(S)-S-methyl-N-
(2,4,6-triisopropylphenylsulfonyl)sulfoximine 415 (14.15 g, 59%) as a white solid; Rf 
0.60 (50% EtOAc–petrol); mp 139–141 °C; [α]D20 +20.0 (c. 5.0 gdm-3, CH2Cl2); νmax 
(film) 3055, 2963, 2870, 1599, 1463, 1448, 1423, 1312, 1294, 1265, 1238, 1148, 1100, 
1069, 741, 704 cm-1; δH (400 MHz) 8.02 (2H, d, J 8.0 Hz, o-Ph) 7.71 (1H, t, J 7.5 Hz, 
p-Ph) 7.61 (2H, t, J 8.0 Hz, m-Ph), 7.14 (2H, s, m-SO2Ar), 4.40 (2H, sept, J 6.5 Hz, o-
ArCH), 3.44 (3H, s, SCH3), 2.90 (1H, sept, J 7.0 Hz, p-ArCH), 1.29–1.24 (18H, m, 
CH(CH3)2); δC (100 MHz) 152.0, 149.0, 138.8, 137.2 (4°), 134.3, 129.6, 127.5, 123.4 
(3°), 47.0 (SCH3), 34.1 (p-ArCH), 29.3 (o-ArCH), 24.7, 24.6 (o-ArCH(CH3)2), 23.7 
(p-ArCH(CH3)2); m/z (CI) 439 [M+NH4]+, 422, 299, 208, 156, 141, 80; data in 
accordance with those previously reported.122  
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(+)-(S)-S-Methyl 2-(N-(2,4,6-triisopropylphenylsulfonyl) phenylsulfonimidoyl)acetate 
 
To sodium hydride (60% dispersion in mineral oil, washed with hexane; 68.0 mg, 2.82 
mmol, 2.5 equiv) suspended in THF (2 mL) was added dimethyl carbonate (2 mL) and 
the reaction mixture stirred at reflux whilst a solution of sulfoximine 415 (500 mg, 
1.13 mmol, 1.0 equiv) in THF (3 mL) was added dropwise. The stirred reaction was 
heated under reflux for 16 h, cooled on ice and quenched with MeOH:AcOH (2:1; 2 
mL). The solution was poured on to H2O and the product extracted with Et2O (×5). 
The combined organic layers were washed with sat. NaHCO3(aq) and H2O, dried 
(MgSO4) and concentrated under reduced pressure. The yellow oil was then 
crystallised from EtOH to give (+)-(S)-S-methyl 2-(N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)acetate 416 (0.29 g, 75%) as a white 
solid; mp 111–112 °C; Rf 0.40 (100% CH2Cl2); [α]D20 +11.0 (c. 5.0 gdm-3, CH2Cl2); 
νmax (film) 3055, 2960, 1749, 1599, 1265, 1149, 1095, 1065, 738, 704 cm-1; δH (400 
MHz) 8.04 (2H, d, J 7.5 Hz, o-Ph), 7.74 (1H, t, J 7.5 Hz, p-Ph) 7.62 (2H, t, J 8.0 Hz, 
m-Ph), 7.14 (2H, s, m-SO2Ar), [4.76, 4.62] (2H, AB doublet, J 14.5 Hz, CH2), 4.40 
(2H, sept, J 6.5 Hz, o-ArCH), 3.68 (3H, s, OCH3), 2.90 (1H, sept, J 7.0 Hz, p-ArCH), 
1.29–1.21 (18H, m, CH(CH3)2); δC (100 MHz) 162.2, (C=O), 152.2, 149.1, 137.0, 
136.5 (4°), 134.8, 129.4, 128.6, 123.5 (3°), 61.8 (OCH3), 53.2 (CH2), 34.1 (p-ArCH), 
29.3 (o-ArCH), 24.7, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 497 
[M+NH4]+, 301, 208 (Found [M+NH4]+, 497.2141. C24H33NO5S2 requires [M+NH4]+, 
497.2144). 
 
(Z)-Methyl 6-(methoxymethoxy)-2-((S)-N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-4-enoate 
 
To a suspension of sodium hydride (60% dispersion in mineral oil, washed with 
hexane; 1.19 g, 29.7 mmol, 2.5 equiv) in THF (30 mL) was added dimethyl carbonate 
(20 mL) and the reaction mixture was stirred at reflux whilst a solution of sulfoximine 
415 (5.00 g, 11.9 mmol, 1.0 equiv) in THF (30 mL) was added dropwise. The stirred 
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reaction was heated under reflux overnight, cooled in ice and quenched with mesylate 
312 (2.49 g, 11.9 mmol, 1.0 equiv), followed by MeOH:AcOH (2:1; 10 mL) The 
solution was poured on to water and the product extracted with Et2O (×5). The 
combined organic layers were washed with sat. NaHCO3(aq) and H2O, dried (MgSO4) 
and concentrated under reduced pressure. The yellow oil was purified by column 
chromatography (100% CH2Cl2) to give (+)-(S)-S-methyl 2-(N-(2,4,6-
triisopropylphenylsulfonyl) phenylsulfonimidoyl) acetate 416  (2.06 g, 36%) as a white 
solid (data as previously reported) and (Z)-methyl 6-(methoxymethoxy)-2-((S)-N-
(2,4,6-(triisopropylphenylsulfonyl) phenylsulfonimidoyl)hex-4-enoate 417 (3.01 g, 
47%) as a yellow oil; Rf  0.17 (100% CH2Cl2); νmax (film) 2958, 1747, 1600, 1448, 
1362, 1317, 1244, 1196, 1150, 1094, 1048, 998, 940, 922, 844, 768, 749, 685, 665 cm-
1; δH (400 MHz) 7.95 (2H, d, J 8.0 Hz, o-Ph), 7.73 (1H, tt, J 7.5, 1.0 Hz, p-Ph), 7.59 
(2H, td, J 8.0, 3.0 Hz, m-Ph), 7.13 (2H, s, m-SO2Ar), 5.70 (1H, dt, J 11.0, 6.5 Hz, 
OCH2CH), 5.39 (1H, dd, J 11.0, 7.0 Hz, SCHCH2CH), [4.57, 4.56] (2H, 2 × s, 
CH2OCH3), 4.06–3.95, (2H, m, o-ArCH), [3.72, 3.62] (3H, 2 × s, CO2CH3), [3.32, 
3.31] (3H, 2 × s, CH2OCH3), 2.88 (1H, sept, J 7.0 Hz, p-ArCH), 1.28–1.19 (18H, m, 
CH(CH3)2); δC (100 MHz) 165.3, 165.1 (C=O), 152.2, 152.1, 149.2, 149.1, 137.3, 
137.0, 134.2, 132.3, 131.1, 124.9 (4°), 134.9, 134.8, 132.6, 131.2, 129.8, 129.2, 124.9, 
123.5 (3°), 95.8 (OCH2O), 71.4, 70.7 (SCH), 62.6, 62.6 (OCH2OCH2), 55.4, 55.3 
(CH2OCH3), 53.3, 53.2 (CO2CH3), 34.1, (p-ArCH), 29.3, 29.3 (o-ArCH), 26.5, 25.2 
(SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 23.6, (p-ArCH(CH3)2); m/z (CI) 611 
[M+NH4]+, 567, 532, 497, 425, 301 (Found [M+NH4]+, 611.2388. C30H43NO7S2 
requires [M+NH4]+, 611.2825) (Found: C, 60.59; H, 7.18; N, 2.26. C30H43NO7S2 
requires C, 60.68; H, 7.30; N, 2.36). 
 
6-Hydroxy-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-
enoate 
 
According to general procedure E, a solution of ester 417 (2.50 mg, 4.20 mmol) in 
MeCN (42 mL) was treated with 2 M HCl(aq) (8.5 mL) to give  (Z)-methyl 6-hydroxy-
2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 418 
(2.14 g, 93%) as a yellow oil; Rf 0.24 (50% EtOAc–petrol); νmax (film) 3425, 2960, 
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1743, 1643, 1600, 1448, 1314, 1245, 1149, 1093, 1054 cm-1; δH (400 MHz) 7.95 (2H, 
d, J 8.0 Hz, o-Ph), 7.76 (1H, dt, J 7.5, 7.5 Hz, p-Ph), 7.62 (2H, dt, J 8.0, 7.5 Hz, m-Ph), 
7.14 (2H, s, m-SO2Ar), 5.79 (1H, dt, J 13.0, 6.5 Hz, CHCH2OH), 5.37 (1H, dt, J 18.0, 
8.0 Hz, SCHCH2CH), [4.99, 4.59] (1H, 2 × dd, J 11.5, 3.5 Hz, SCH), 4.37 (2H, 2 × 
sept, J 6.5 Hz, o-ArCH), 4.18–4.06 (2H, m, CH2OH), [3.77, 3.63] (3H, 2 × s, OCH3), 
3.00–2.87 (2H, m, p-ArCH and 1 × SCHCH2), [2.80–2.71, 2.59–2.51] (1H, 2 × m, 1 × 
SCHCH2), 1.30–1.18 (18H, m, CH(CH3)2); δC (100 MHz) 165.8, 165.5 (C=O), 152.3, 
152.1, 149.2, 149.1, 137.9, 137.2, 136.9, 134.9, 133.8, 128.2, 124.0 (4°), 135.0, 133.8, 
129.7, 129.7, 129.2, 129.1, 125.3, 124.7, 123.5, 123.5 (3°), 71.5, 70.8 (SCH), 58.1, 
58.0 (CH2OH), 53.4, 53.3 (CO2CH3), 34.1, (p-ArCH), 29.4, 29.3 (o-ArCH), 26.4, 25.1 
(SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 23.6, (p-ArCH(CH3)2); m/z (CI) 567 
[M+NH4]+, 425, 301, 284, 194 (Found [M+NH4]+, 567.2579. C28H39NO6S2 requires 
[M+NH4]+, 567.2563). 
 
6-Hydroxy-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-
enoic acid 
O
OH
HOHO
S
O
S
OMe
OO
Ph Ph
TrisN TrisN
418 419
 
According to general procedure F, a solution of ester 418 (2.14 g, 3.89 mmol, 1.0 
equiv) in THF (10 mL) was treated with 2 M LiOH(aq) (10.0 mL, 20.0 mmol, 5.0 
equiv) to give 6-hydroxy-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)hex-4-enoic acid 419 (1.84 g, 88%) as a white crystalline solid; 
mp 58–60 °C;  νmax (film) 3445 (br), 2963, 1645, 1600, 1448, 1265, 1147, 1094, 1063, 
738 cm-1; δH (400 MHz) 7.95, (2H, d, J 7.5 Hz, o-Ph), 7.73 (1H, m, p-Ph), 7.59 (2H, dt, 
J 7.5, 7.5 Hz, m-Ph), 7.13 (2H, s, m-SO2Ar), 5.76 (1H, dd, J 17.5, 7.0 Hz, CHCH2OH), 
5.58 (1H, br s, CO2H), 5.42 (1H, dd, J 16.0, 10.0 Hz, SCHCH2CH), [4.83, 4.58] (1H, 2 
× dd, J 11.5, 3.0 Hz, SCH), 4.32 (2H, sept, J 6.5 Hz, o-ArCH), [4.12, 4.01] (2H, 2 × d, 
J 6.5 Hz, CH2OH), 2.95–2.56 (3H, m, p-ArCH and SCHCH2), 1.29–1.20 (18H, m, 
CH(CH3)2); δC (100 MHz) 166.7, 166.2 (C=O), 152.4, 149.2, 136.8, 134.3, 133.9, 
124.2 (4°), 135.0, 133.0, 132.8, 129.7, 129.3, 124.9, 124.7, 123.5 (3°), 71.4, 70.9 
(SCH), 58.5, 57.8 (CH2OH), 34.2 (p-ArCH), 29.3 (o-ArCH), 26.2, 25.1 (SCHCH2), 
24.7, 24.7, 24.6, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (FAB) 536 
[M+NH4]+, 538, 518, 446, 282, 267, 203, 125, 93 (Found [M+NH4]+, 536.2122. 
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C27H37NO6S2 requires [M+NH4]+, 536.2141) (Found: C, 60.55; H, 6.91; N, 2.63. 
C27H37NO6S2 requires C, 60.53; H, 6.96; N, 2.61). 
 
(Z)- 3-((S)-N-(2,4,6-Triisopropylphenylsulfonyl)phenylsulfonimidoyl) -3,4-
dihydrooxepin-2(7H)-one 
O
S
OO
Ph
TrisN
S
O
Ph
TrisN
O
OH
HO
419 420
 
According to general procedure G, a solution of hydroxy acid 419 (1.00 g, 1.87 mmol, 
1.0 equiv) in CH2Cl2 (10 mL) was treated with EDCI (0.39 g, 2.05 mmol, 1.1 equiv) 
and purified by column chromatography (50% EtOAc–petrol) to give (Z)-3-((S)-N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-3,4-dihydrooxepin-2(7H)-one 
420 (0.87 g, 90%) as a white crystalline solid; mp 77–79 °C; Rf 0.63 (50% EtOAc–
petrol);  νmax (film) 3442 (br), 3055, 1752, 1638, 1600, 1422, 1265, 1148, 1093, 1054, 
895, 735 cm-1; δH (500 MHz) 8.14 (2H, 2 × dt, J 7.0, 1.5 Hz, o-Ph), 7.69 (1H, m, p-Ph), 
7.57 (2H, m, m-Ph), [7.11, 7.10] (2H, 2 × s, m-SO2Ar), [6.00, 5.73] (1H, dd, J 13.0, 
3.5Hz, SCH), 5.88 (2H, br d, J 3.5 Hz, HC=CH), [5.12, 4.51] (2H, m, OCH2), 4.37 
(2H, sept, o-ArCH), [3.40, 3.21] (1H, dd, J 17.5, 3.0 Hz, SCHCH2), 2.87 (1H, sept, p-
ArCH), 2.41 (1H, td, J 16.0, 2.5 Hz, SCHCH2), 1.27–1.14 (18H, m, CH(CH3)2); δC 
(125 MHz) 166.3 (C=O), 152.2, 149.2, 149.0, 137.0, 136.7, 133.5, 133.1 (4°), 134.8, 
134.8, 131.1, 130.9, 128.8, 128.7, 124.8, 124.4, 123.5, 123.4 (3°), 66.0, 65.8 (SCH), 
64.2, 64.0 (OCH2), 34.1 (p-ArCH), 29.3, 29.2 (o-ArCH), 28.9, 27.6 (SCHCH2), 24.7, 
24.7, 24.6, 24.5 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 535 [M+NH4]+, 491, 
425, 301 (Found [M+NH4]+, 535.2300. C27H35NO5S2 requires [M+NH4]+, 535.2300) 
(Found: C, 62.54; H, 6.71; N, 2.87. C27H35NO5S2 requires C, 62.64; H, 6.81; N, 2.71). 
 
1-((S)-N-(2,4,6-Triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-
vinylcyclopropanecarboxylic acid 
S
O
Ph
TrisN
COOHO
S
OO
Ph
TrisN
420 421
 
According to general procedure H, a solution of lactone 420 (100 mg, 190 µmol, 1.0 
equiv) in CH2Cl2 (1 mL) was treated with KOAc (1.9 mg, 19.0 µmol, 0.1 equiv) and 
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BSA (47.8 µL, 190 µmol, 1.0 equiv) to give a diastereomeric mixture (3:2) of 1-((S)-N-
(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-
vinylcyclopropanecarboxylic acid 421 (91 mg, 91%) as a colourless solid; mp 55–57 
°C; νmax (film) 3448 (br), 3055, 2986, 1638, 1422, 1265, 1148, 1098, 1051, 895, 738 
cm-1; δH (400 MHz, DMSO-d6) 8.07 (2H, d, J 7.5 Hz, o-Ph), 7.74–7.68 (1H, m, p-Ph), 
7.65–7.56 (2H, m, m-Ph), 7.17 (1H, s, m-SO2Ar minor), 7.13 (1H, s, m-SO2Ar major), 
5.63 (2H, m, SCCHCH), 5.51 (1H, d, J 17.0 Hz, CH=CH2 cis minor), 5.35 (1H, d, J 
10.5 Hz, CH=CH2 trans minor), 5.31 (1H, d, J 17.0 Hz, CH=CH2 cis major), 5.20 (1H, 
d, J 10.5 Hz, CH=CH2 trans major), 4.35 (2H, 2 × sept, J 6.5 Hz, o-ArCH), 3.32 (1H, 
m, SCCH minor), 2.91 (2H, m, p-ArCH and SCCH major), 2.53 (1H, dd, J 10.0, 6.0 
Hz, SCCH2 major), 2.27 (1H, dd, J 8.5, 6.0 Hz, SCCH2 major), 1.99 (2H, m, SCCH2 
minor), 1.29–1.20 (18H, m, CH(CH3)2 major and minor); δC (100 MHz, DMSO-d6) 
166.7 (C=O), 152.1, 149.4, 149.2, 138.0, 137.2, 137.0 (4°), 134.2, 130.5, 129.7, 129.3, 
129.0, 128.3, 123.6, 123.4 (3°), 122.0, 121.2 (CH=CH2), 52.2 (SCH), 34.1 (p-ArCH), 
32.9, 29.8 (SCCH), 29.3, 29.2 (o-ArCH), 24.7, 24.6 (o-ArCH(CH3)2), 24.7, 21.5 
(SCHCH2), 23.6 (p-ArCH(CH3)2); m/z (CI) 535 [M+NH4]+, 491, 425, 301, 52 (Found 
[M+NH4]+, 535.2303. C27H35NO5S2 requires [M+NH4]+, 535.2300) (Found: C, 62.58; 
H, 6.81; N, 2.69. C27H35NO5S2 requires C, 62.64; H, 6.81; N, 2.71). 
 
2,4,6-Triisopropylphenyl-1-((S)-(2-vinylcyclopropyl)sulfonimidoyl) 
benzenesulfonamide 
S
O
Ph
TrisN
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S
OO
Ph
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According to general procedure I, a solution of lactone 420 (50.0 mg, 97.0 µmol, 1.0 
equiv) was treated with BSA (23.9 µl, 97.0 µmol, 1.0 equiv) and KOAc (1.0 mg, 9.70 
µmol, 0.1 equiv) in DMF (1 mL) to give a diastereomeric mixture (3:2) of 2,4,6-
triisopropylphenyl-1-((S)-(2-vinylcyclopropyl)sulfonimidoyl)benzenesulfonamide 422 
(32 mg, 69%) as a brown oil; Rf 0.80 (50% EtOAc–petrol); νmax (film) 3449 (br), 3057, 
1639, 1421, 1264, 1148, 1100, 895, 737 cm-1; δH (500 MHz) 7.94 (2H, dt, J 8.0, 1.5 
Hz, o-Ph), 7.66 (1H, m, p-Ph), 7.56 (2H, td, J 8.0, 1.5 Hz, m-Ph), 7.11 (1H, s, m-
SO2Ar major), 7.10 (1H, s, m-SO2Ar minor), 5.50 (1H, ddd, J 17.0, 10.0, 7.5 Hz, 
CH=CH2 minor), 5.32 (1H, ddd, J 17.0, 10.0, 7.5 Hz, CH=CH2 major), 5.23 (1H, d, J 
17.0 Hz, CH=CH2 cis minor), 5.11 (1H, d, J 10.0 Hz, CH=CH2 trans minor), 5.04 (1H, 
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d, J 17.0 Hz, CH=CH2 cis major), 4.98 (1H, d, J 10.0 Hz, CH=CH2 trans major), 4.35 
(2H, 2 × sept, J 7.0 Hz, o-ArCH), 2.88 (1H, sept, J 7.0 Hz, p-ArCH), 2.67 (1H, m, 
SCH major), 2.65 (1H, m, SCH minor), 2.61 (1H, m, SCHCH minor), 2.23 (1H, m, 
SCHCH major), [1.92, 1.37] (2H, 2 × m, SCHCH2 major), [1.50, 1.10] (2H, 2 × m, 
SCHCH2 minor), 1.28–1.20 (18H, m, CH(CH3)2); δC (125 MHz) 151.9, 151.8, 149.1, 
139.2, 139.2, 137.3 (4°), 134.3, 133.9, 129.4, 127.7, 127.6, 123.3 (3°), 134.2, 133.8 
(CH=CH2), 117.5, 117.2 (CH=CH2), 42.0 (SCH), 34.1 (p-ArCH), 29.2, 29.2 (o-ArCH), 
24.7, 24.7, 24.6, 24.6 (o-ArCH(CH3)2), 23.7, 23.2 (SCHCH), 23.6 (p-ArCH(CH3)2), 
14.2, 12.4 (SCHCH2); m/z (CI) 491 [M+NH4]+, 474 [M+H]+, 301, 52 (Found [M+H]+, 
474.2157. C26H35NO3S2 requires [M+H]+, 474.2137) (Found: C, 66.00; H, 7.44; N, 
2.80. C26H35NO3S2 requires C, 65.92; H, 7.45; N, 2.96). 
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3.3.4 Compounds Relevant to Section 2.4 
 
(E)-2-(Tributylstannyl)but-2-en-1,4-diol 
 
To a solution of but-2-yn-1,4-diol 427 (2.58 g, 30 mmol, 1.0 equiv) and PdCl2(PPh3)2 
(420 mg, 0.6 mmol, 2 mol%) in THF (15 mL) was added dropwise a solution of 
SnBu3H (9.68 mL, 36 mmol, 1.2 equiv) in THF (20 mL) over a period of 1 h. After 
stirring for 2 h, the solution was concentrated under reduced pressure and the product 
purified by column chromatography (40–80% Et2O–petrol) to give (E)-2-
(tributylstannyl)but-2-en-1,4-diol 428 (8.80 g, 78%) as a brown oil. Rf 0.70 (50% 
EtOAc–petrol); νmax (film) 3329, 2952, 1613, 1463, 1416, 1375, 1356, 1291, 1071, 
1033, 960, 874 cm-1; δH (400 MHz) 5.82 (1H, ttt, J 34.5, 6.0, 2.0 Hz, CH), 4.40 (2H, 
td, J 18.5, 4.0 Hz, SnCCH2) 4.22 (2H, t, J 5.5 Hz, SnCCHCH2), 1.96 (2H, 2 × t, J 5.5 
Hz, OH), 1.62–1.42 (6H, m, Sn(CH2)3), 1.38–1.29 (6H, m, Sn(CH2CH2)3), 1.03–0.86 
(15H, m, (CH2CH3)3); δC (100 MHz) 149.3 (SnC), 138.0 (SnCCH), 63.6 (SnCCH2), 
59.8 (SnCCHCH2), 29.2 (Sn(CH2)3), 27.4 (Sn(CH2CH2)3), 13.7 (Sn(CH2CH2CH2)3), 
10.0 ((CH3)3); data in accordance with those previously reported.123  
 
(E)-4-(tert-Butyldimethylsiloxy)-2-(tributylstannyl)but-2-en-1-ol 
 
To a solution of alkene 428 (8.50 g, 22.5 mmol, 1.0 equiv) in DMF (220 mL) at 0 °C 
was added imidazole (1.52 g, 22.5 mmol, 1.0 equiv) and TBDMSCl (3.36 g, 22.5 
mmol, 1.0 equiv). The solution was stirred at 0 °C for 6 h, and then crushed ice (5.6 g) 
was added. The solution was diluted with Et2O, washed with sat. NH4Cl(aq), dried 
(MgSO4) and concentrated under reduced pressure. The product was purified by 
column chromatography (0–10% Et2O–petrol) to give (E)-4-(tert-
butyldimethylsiloxy)-2-(tributylstannyl)but-2-en-1-ol 429 (2.62 g, 23%) as a 
colourless oil; Rf 0.23 (10% Et2O–petrol); νmax (film) 3443, 2956, 2928, 2856, 1463, 
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1376, 1362, 1255, 1078, 1048, 837, 776, 666 cm-1; δH (400 MHz) 5.72 (1H, ttt, J 35.0, 
5.5, 2.0 Hz, CCH), 4.36 (2H, td, J 19.0, 5.5 Hz, CH2OH), 4.24 (2H, d, J 5.5 Hz, 
SnCCHCH2), 1.89 (1H, t, J 5.5 Hz, OH), 1.55–1.47 (6H, m, Sn(CH2)3), 1.38–1.29 (6H, 
m, Sn(CH2CH2)3), 0.95–0.89 (24H, m, (CH2CH3)3 and C(CH3)3), 0.10 (6H, s, SiCH3); 
δC (100 MHz) 149.0 (SnC), 138.8 (SnCCH), 63.8 (SnCCH2), 60.8 (SiOCH2), 29.2 
(Sn(CH2)3), 27.4 (Sn(CH2CH2)3), 25.9 (SiC(CH3)3),  20.1 (C(CH3)3), 13.7 
((CH2CH3)3), 10.5 ((CH2CH3)3), –5.1 (Si(CH3)2); data in accordance with those 
previously reported.124  
 
4-Bromofuran-2(5H)-one 
 
Oxalyl bromide (10.0 mL, 107 mmol, 1.2 equiv) was added dropwise to a suspension 
of tetronic acid 435 (8.89 g, 88.8 mmol, 1.0 equiv) in CH2Cl2 (178 mL) and DMF (8.9 
mL), whilst carefully maintaining the reaction temperature at 0 °C. The yellow 
solution was stirred successively at 0 °C for 1 h, then rt for 2 h. H2O was added, the 
layers separated, and the aqueous phase further extracted with Et2O (×4). The 
combined organic extracts were washed successively with H2O, sat. NaHCO3(aq) and 
sat. NaCl(aq), dried (MgSO4) and concentrated under reduced pressure to give 
bromofuranone 434 as a white solid (11.9 g, 83%); mp 74–75 °C; Rf 0.67 (1% AcOH–
EtOAc); νmax (film) 3448, 3056, 1781, 1746, 1607, 1448, 1421, 1343, 1265, 1146, 
1019, 827, 861, 852, 737, 704 cm-1; δH (400 MHz) 6.39 (1H, t, J 2.0 Hz, CH), 4.90 
(2H, d, J 2.0 Hz, CH2); δC (100 MHz) 170.8 (C=O), 146.3 (CBr), 121.9 (CH), 74.9 
(CH2); m/z (CI) 182, 180 [M+NH4]+; data in accordance with those previously 
reported.98 
 
(Z)-2-Bromo-but-2-ene-1,4-diol 
 
To a solution of furanone 434 (220 mg, 1.35 mmol, 1.0 equiv) in Et2O (6.75 mL) at –
20 °C was added LiAlH4 (76.8 mg, 2.02 mmol, 1.5 equiv) in small portions, with 
stirring. The solution was maintained at –20 °C for 30 min, then allowed to warm to rt 
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over 1 h. The reaction was quenched by dropwise addition of H2O (76.8 µL), 15% 
NaOH(aq)  (76.8 µL) and H2O (230 µL) and the mixture allowed to stir for a further 30 
min. The residue was filtered off, washed with Et2O and the eluent concentrated under 
reduced pressure.
 
Purification by column chromatography (50–70% EtOAc–petrol) 
gave (Z)-2-bromo-but-2-ene-1,4-diol 433 (175 mg, 78%) as a colourless oil; Rf 0.40 
(1% AcOH–EtOAc); νmax (film) 3356, 2935, 1644, 1420, 1367, 1231, 1103, 998 cm–1; 
δH (400 MHz, CD3OD) 6.17 (1H, t, J 7.0 Hz, CH), 4.29 (2H, s, CH2CBr), 4.14 (2H, d, 
J 7.0 Hz, CH2OH); δC (100 MHz, CD3OD) 137.6 (CH), 131.1 (CBr), 65.9 (CH2CBr), 
61.9 (CH2CH); m/z (CI) 186, 184 [M+NH4]+, 174, 157, 108, 106, 52; (Found 
[M+NH4]+, 183.9979. C4H779BrO2 requires [M+NH4]+, 183.9973) (Found: C, 28.83; H, 
4.15. C4H7BrO2 requires C, 28.77; H, 4.22). 
 
2-Methoxy-5-bromo-4,7-dihydro-[1,3]dioxepine 
 
According to general procedure A, a solution of diol 433 (1.42 g, 8.48 mmol, 1.0 
equiv) in CH2Cl2 (8.5 mL) was treated with CSA (98.4 mg, 0.42 mmol, 5 mol%) and 
trimethylorthoformate (3.71 mL, 33.9 mmol, 4.0 equiv). Purification by column 
chromatography (20–40% EtOAc–petrol) gave 2-methoxy-5-bromo-4,7-dihydro-
[1,3]dioxepine 436 (1.34 g, 76%) as a colourless oil; Rf 0.76 (50% EtOAc–petrol); νmax 
(film) 2957, 1653, 1447, 1383, 1343, 1273, 1212, 1135, 1104, 1080, 1022, 987, 940, 
786 cm–1; δH (400 MHz) 6.10 (1H, tt, J 4.0, 1.0 Hz, CHCH2), 5.42 (1H, s, OCH), 4.62 
(1H, ddd, J 16.0, 2.0, 2.0 Hz, CCH2), 4.41 (1H, dddd J 15.5, 4.0, 2.0, 2.0 Hz, CHCH2), 
4.28 (1H, ddd, J 16.0, 3.5, 1.5 Hz, CCH2), 4.08 (1H, dddd, J 15.5, 4.0, 2.0, 2.0 Hz, 
CHCH2), 3.43 (3H, s, CH3); δC (100 MHz) 130.2 (CHCBr), 121.5 (CBr), 113.4 (CHO), 
67.2 (CH2CH), 60.8 (CH2CBr), 53.8 (CH3); m/z (CI) 211, 209 [M+H]+, 179, 177, 129, 
114, 86, 75 (Found [M+H]+, 208.9811. C6H979BrO3 requires [M+H]+, 208.9813) 
(Found: C, 34.37; H, 4.26. C6H9BrO3 requires C, 34.47; H, 4.34). 
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(Z)-2-Bromo-4-methoxymethoxy-but-2-en-1-ol  
 
According to general procedure B, a solution of orthoester 436 (768 mg, 3.67 mmol, 
1.0 equiv) in PhMe (10.0 mL) was treated with DIBAL-H (1.7 M in PhMe; 2.81 mL, 
4.78 mmol, 1.3 equiv) Purification by column chromatography (25% EtOAc–petrol) 
gave (Z)-2-bromo-4-methoxymethoxy-but-2-en-1-ol 432 (700 mg, 90%) as a 
colourless oil; Rf 0.46 (50% EtOAc–petrol); νmax (film) 3422, 2939, 2888, 1725, 1645, 
1449, 1378, 1213, 1152, 1103, 1043, 921 cm-1; δH (400 MHz) 6.21 (1H, t, J 7.0 Hz, 
CH), 4.66 (2H, s, OCH2O), 4.38 (2H, s, CH2OH), 4.14 (2H, d, J 7.0 Hz, CHCH2), 3.40 
(3H, s, CH3), 2.37 (1H, t, J 6.5 Hz, OH); δC (100 MHz) 130.1 (CH), 129.7 (CBr), 95.2 
(OCH2O), 63.5 (CH2OH), 62.8 (CH2O), 55.5 (OCH3); m/z (CI) 230, 228 [M+NH4]+, 
195, 193, 186, 184, 101, 99 (Found [M+NH4]+, 228.0238. C6H1179BrO3 requires 
[M+NH4]+, 228.0235) (Found: C, 34.03; H, 5.18. C6H11BrO3 requires C, 34.14; H, 
5.25). 
 
Methane sulfonic acid (Z)-2-bromo-4-methoxymethoxy-but-2-enyl ester 
 
According to general procedure C, a solution of alcohol 432 (1.00 mg, 4.74 mmol, 1.0 
equiv) in CH2Cl2 (20 mL) was treated with NEt3 (1.98 mL, 14.2 mmol, 3.0 equiv) and 
MsCl (730 µL, 9.48 mmol, 2.0 equiv) to give methane sulfonic acid (Z)-2-bromo-4-
methoxymethoxy-but-2-enyl ester 450 as a colourless oil, used crude in the next step; 
Rf 0.44 (50% EtOAc–heptane). 
  
(E)-4-Bromo-6-methoxymethoxy-2-tosyl-hex-4-enoic acid tert-butyl ester 
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According to general procedure D, a suspension of sodium hydride (152 mg, 3.80 
mmol, 1.1 equiv) in THF (5.0 mL) at 0 °C was treated with tert-butyl 2-tosylacetate 
313 (935 mg, 3.46 mmol, 1.0 equiv) in THF (5.0 mL) and methane sulfonate 450 (1.00 
g, 3.46 mmol, 1.0 equiv) in THF (5.0 mL) to give (E)-4-bromo-6-methoxymethoxy-2-
tosyl-hex-4-enoic acid tert-butyl ester 453 which was used crude in the next step; Rf 
0.69 (50% EtOAc–heptane); νmax (film) 2979, 2935, 1731, 1596, 1370, 1324, 1140, 
1083, 1037, 813, 709, 672 cm-1; δH (300 MHz) 7.78 (2H, d, J 8.0 Hz, o-SO2Ar), 7.37 
(2H, d, J 8.0 Hz, m-SO2Ar), 6.14 (1H, t, J 6.5 Hz, CHCH2OH), 4.59 (2H, s, OCH2O), 
4.26 (1H, dd, J 11.0, 3.5 Hz, CHCH2O), 4.13 (1H, dd, J 12.5, 7.5 Hz, CHCH2O), 3.96 
(1H, ddd, J 12.5, 6.5, 1.0 Hz, SCH), 3.35 (1H, m, SCHCH2), 3.34 (3H, s, OCH3), 3.00 
(1H, ddd, J 14.5, 3.5, 1.0 Hz, SCHCH2), 2.45 (3H, s, ArCH3), 1.33 (9H, s, C(CH3)3); 
δC (75 MHz) 164.8 (C=O), 145.6, 122.5 (4°), 133.0 (CBr), 129.8, 129.2 (3°), 95.8 
(OCH2O), 83.6 (C(CH3)3), 69.2 (SCH), 63.7 (OCH2CH), 55.4 (OCH3), 33.2 
(SCHCH2), 27.6 (C(CH3)3), 21.8 (ArCH3); m/z (CI) 482, 480 [M+NH4]+, 409, 407, 
347, 345.  
 
(E)-4-Bromo-6-hydroxy-2-tosyl-hex-4-enoic acid 
 
According to general procedure E, a solution of ester 453 (1.27 g, 2.74 mmol, 1.0 
equiv) in MeCN (30.0 mL) was treated with 2 M HCl(aq) (6.0 mL) to give (E)-4-
bromo-6-hydroxy-2-tosyl-hex-4-enoic acid 454 used crude in the next step. 
 
5-Bromo-3-tosyl-4,7-dihydro-3H-oxepin-2-one 
 
According to general procedure G, a solution of acid 454 (1.08 g, 2.97 mmol, 1.0 
equiv) in CH2Cl2 (7.5 mL) was treated with EDCI (627 mg, 3.27 mmol, 1.1 equiv). 
Purification by column chromatography (30% EtOAc–petrol) gave 5-bromo-3-tosyl-
4,7-dihydro-3H-oxepin-2-one 455 (569 mg, 48% over 3 steps) as a colourless solid; Rf 
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0.44 (50% EtOAc–heptane); νmax (film) 1747, 1654, 1596, 1394, 1320, 1305, 1250, 
1139, 1082, 1018, 965, 813, 716, 704, 666 cm-1; δH (300 MHz) 7.95 (2H, d, J 8.5 Hz, 
o-SO2Ar), 7.39 (2H, d, J 8.0 Hz, m-SO2Ar), 6.29 (1H, dddd, J 5.5, 3.5, 3.5, 2.0 Hz, 
CHCH2O), [4.87, 4.81] (1H, 2 × dd, J 7.0, 3.5 Hz, SCH), [4.71, 4.67] (1H, 2 × d, J 8.0 
Hz, OCH2), [4.43, 4.37] (1H, 2 × d, J 8.0 Hz, OCH2), [3.53, 3.47] (1H, 2 × m, 
SCHCH2), 3.02 (1H, m, SCHCH2), 2.46 (3H, s, CH3); m/z (CI) 364, 362 [M+NH4]+ 
(Found [M+NH4]+, 362.0056. C13H1379BrO4S requires [M+NH4]+, 362.0056). 
 
 
4-Phenylfuran-2(5H)-one 
 
Phenylboronic acid (76 mg, 0.62 mmol, 1.0 equiv), bromofuranone 434 (100 mg, 0.62 
mmol, 1.0 equiv) and PdCl2(PPh3)2 (8.7 mg, 2.0 mol%) in 2 M KF(aq) (2 mL) and THF 
(2 mL) were heated at reflux for 5 hours. After cooling to rt the layers were separated 
and the aqueous layer further extracted with EtOAc (×3). The combined organic 
extracts were washed with sat. NaCl(aq), dried (MgSO4) and concentrated under 
reduced pressure to give 4-phenylfuran-2(5H)-one 458 as a colourless solid; Rf 0.57 
(1% AcOH–EtOAc); νmax (film) 3111, 2929, 1793, 1734, 1621, 1450, 1331, 1167, 
1048, 894, 862, 771, 684 cm-1; δH (400 MHz) 7.50 (5H, m, Ph), 6.38 (1H, t, J 1.5 Hz, 
CH), 5.23 (2H, d, J 1.5 Hz, CH2); δC (100 MHz) 173.9 (C=O), 163.9, 131.8 (4°), 129.7, 
129.3, 126.4 (3°), 113.1 (CH), 71.0 (CH2); m/z (CI) 178 [M+NH4]+; data in accordance 
with those previously reported.98  
 
(Z)-2-Phenyl-but-2-ene-1,4-diol 
O
O
Ph
Ph
HO
OH
458 459
 
According to general procedure J, a solution of furanone 458 (950 mg, 5.93 mmol, 1.0 
equiv) in PhMe (10 mL) was treated with DIBAL-H (1.7 M in PhMe; 7.68 mL, 13.0 
mmol, 2.2 equiv). Purification by column chromatography (50–70% EtOAc–petrol) 
gave (Z)-2-phenyl-but-2-ene-1,4-diol 459 (793 mg, 81%) as a colourless oil; Rf 0.08 
(50% EtOAc–petrol); νmax (film) 3298, 2885, 1685, 1598, 1493, 1445, 1000, 758, 697 
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cm–1; δH (300 MHz) 7.45 (2H, m, m-Ph), 7.35 (3H, m, o-/p–Ph), 6.12 (1H, t, J 7.0 Hz, 
CH), 4.59 (2H, s, CCH2OH), 4.42 (2H, d, J 7.0 Hz, CHCH2), 2.04 (2H, s, OH); δC (75 
MHz) 142.9, 140.4 (4°), 129.8, 128.6, 127.8, 126.4 (3°), 60.4 (CCH2OH), 59.0 
(CHCH2OH); m/z (CI) 182 [M+NH4]+, 164, 146, 118, 103, 91, 78; (Found [M+NH4]+, 
182.1175. C10H12O2 requires [M+NH4]+, 182.1176) (Found: C, 73.15; H, 7.37. 
C10H12O2 requires C, 73.21; H, 7.40). 
 
2-Methoxy-5-phenyl-4,7-dihydro-[1,3]dioxepine 
 
According to general procedure A, a solution of diol 459 (3.67 g, 22.6 mmol, 1.0 
equiv) in CH2Cl2 (60 mL) was treated with CSA (52.5 mg, 0.23 mmol, 1 mol%) and 
trimethylorthoformate (4.96 mL, 45.3 mmol, 2.0 equiv). Purification by column 
chromatography (20–40% EtOAc–petrol) gave 2-methoxy-5-phenyl-4,7-dihydro-
[1,3]dioxepine 460 (3.64 g, 78%) as a colourless oil; Rf 0.59 (50% EtOAc–petrol); νmax 
(film) 2940, 2869, 2842, 1599, 1494, 1446, 1344, 1279, 1209, 1133, 1102, 1088, 1034, 
753, 701 cm–1; δH (300 MHz) 7.29 (5H, m, Ph), 5.88 (1H, tt, J 4.0, 1.0 Hz, CHCH2), 
5.47 (1H, s, OCH), 4.88 (1H, dd, J 15.5, 2.0 Hz, CCH2), 4.61 (1H, dddd J 16.0, 4.0, 
2.0, 2.0 Hz, CHCH2), 4.50 (1H, ddd, J 16.0, 3.5, 1.5 Hz, CCH2), 4.28 (1H, dddd, J 
16.0, 4.0, 2.0, 2.0 Hz, CHCH2), 3.45 (3H, s, CH3); δC (75 MHz) 141.1, 139.5 (4°), 
128.5, 127.5, 126.3, 126.1 (3°), 113.8 (CHO), 64.0 (CCH2O), 61.3 (CHCH2O), 53.6 
(CH3); m/z (ESI) 229 [M+Na]+, 206, 147, 129, 115, 91, 78 (Found [M+Na]+, 229.0835. 
C12H14O3 requires [M+Na]+, 229.0835) (Found: C, 69.79; H, 6.90. C12H14O3 requires 
C, 69.88; H, 6.84). 
 
(Z)-2-Phenyl-4-methoxymethoxy-but-2-en-1-ol and (Z)-3-phenyl-4-methoxymethoxy-
but-2-en-1-ol 
 
According to general procedure B, a solution of orthoester 460 (4.64 g, 22.5 mmol, 1.0 
equiv) in PhMe (4.0 mL) was treated with DIBAL-H (1.2 M in PhMe; 41.2 mL, 49.5 
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mmol, 1.3 equiv) Purification by column chromatography (25% EtOAc–petrol) gave 
(Z)-2-phenyl-4-methoxymethoxy-but-2-en-1-ol 431 and (Z)-3-phenyl-4-
methoxymethoxy-but-2-en-1-ol 461 (3.73 g, 80; 69:31 431:461; separable by column 
chromatography) as colourless oils; 431: Rf 0.28 (50% EtOAc–heptane); νmax (film) 
3411, 2934, 2884, 1493, 1445, 1377, 1149, 1089, 1033, 1013, 945, 917, 766, 697 cm-1; 
δH (300 MHz) 7.49 (2H, m, m-Ph), 7.39–7.29 (3H, m, o-/p-Ph), 6.04 (1H, t, J 7.0 Hz, 
CH), 4.71 (2H, s, OCH2O), 4.55 (2H, d, J 6.5 Hz, CCH2OH), 4.35 (2H, d, J 7.0 Hz, 
CHCH2), 3.42 (3H, s, CH3), 2.37 (1H, t, J 6.5 Hz, OH); δC (75 MHz) 144.1, 140.5 (4°), 
128.5, 127.8, 126.5, 126.4 (3°), 95.3 (OCH2O), 63.2 (CH2OH), 60.2 (CHCH2), 55.4 
(OCH3); m/z (CI) 226 [M+NH4]+, 129 (Found [M+NH4]+, 226.1438. C12H16O3 requires 
[M+NH4]+, 226.1438) (Found: C, 69.29; H, 7.72. C12H16O3 requires C, 69.21; H, 
7.74); 
 
461: Rf 0.22 (50% EtOAc–heptane); νmax (film) 3388, 2932, 2883, 1494, 1446, 1384, 
1210, 1147, 1097, 1034, 945, 920, 757, 699 cm-1; δH (300 MHz) 7.48 (2H, m, m-Ph), 
7.32 (3H, m, o-/p-Ph), 6.27 (1H, t, J 7.0 Hz, CH), 4.66 (2H, s, OCH2O), 4.56 (2H, s, 
CCH2), 4.38 (2H, d, J 6.5 Hz, CH2OH), 3.38 (3H, s, CH3); δC (100 MHz) 140.5, 138.4 
(4°), 131.8, 128.5, 127.7, 126.3 (3°), 95.1 (OCH2O), 63.7 (CH2OH), 58.9 (CHCH2), 
55.5 (OCH3); m/z (CI) 226 [M+NH4]+, 191, 161, 159, 131, 129 (Found [M+NH4]+, 
226.1438. C12H16O3 requires [M+NH4]+, 226.1438) (Found: C, 69.27; H, 7.80. 
C12H16O3 requires C, 69.21; H, 7.74). 
 
Methane sulfonic acid (Z)-2-phenyl-4-methoxymethoxy-but-2-enyl ester 
 
According to general procedure C, a solution of alcohol 431 (122 mg, 0.59 mmol, 1.0 
equiv) in CH2Cl2 (2 mL) was treated with NEt3 (245 µL, 1.76 mmol, 3.0 equiv) and 
MsCl (90.7 µL, 1.17 mmol, 2.0 equiv) to give methane sulfonic acid (Z)-2-phenyl-4-
methoxymethoxy-but-2-enyl ester 464 (162 mg, 96%) as a colourless oil which was 
used crude in the next step; Rf 0.34 (50% EtOAc–heptane); νmax (film) 3025, 2937, 
2888, 1447, 1354, 1174, 1150, 1103, 1037, 929, 845, 772, 699 cm-1; δH (400 MHz) 
7.43 (2H, m, o-Ph), 7.35 (3H, m, m-/p-Ph), 6.26 (1H, t, J 6.5 Hz, CH), 5.21 (2H, s, 
CCH2), 4.70 (2H, s, OCH2O), 4.39 (2H, d, J 6.5 Hz, CHCH2), 3.41 (3H, s, OCH3), 
Experimental 
 
 165 
2.90 (3H, s, SCH3); δC (100 MHz) 138.6, 135.6 (4°), 132.0, 128.6, 128.3, 126.3 (3°), 
96.0 (OCH2O), 65.8 (CH2OS), 63.3 (CHCH2), 55.5 (OCH3), 38.2 (SO2CH3); m/z (CI) 
304 [M+NH4]+ (Found [M+NH4]+, 304.1226. C13H18O5S requires [M+NH4]+, 
304.1219). 
 
(E)-4-Phenyl-6-methoxymethoxy-2-tosyl-hex-4-enoic acid tert-butyl ester 
 
According to general procedure D, a suspension of sodium hydride (25 mg, 0.62 
mmol, 1.1 equiv) in THF (0.3 mL) at 0 °C was treated with tert-butyl 2-tosylacetate 
313 (153 mg, 0.57 mmol, 1.0 equiv) in THF (0.4 mL) and methane sulfonate 464 (162 
mg, 0.57 mmol, 1.0 equiv) in THF (0.3 mL) to give (E)-4-phenyl-6-methoxymethoxy-
2-tosyl-hex-4-enoic acid tert-butyl ester 465 which was used crude in the next step; Rf 
0.48 (50% EtOAc–heptane); νmax (film) 2980, 2933, 1732, 1597, 1493, 1446, 1370, 
1327, 1151, 1084, 1047, 919, 836, 816, 766, 714, 699, 566 cm-1; δH (400 MHz) 7.77 
(2H, d, J 8.0 Hz, o-SO2Ar), 7.37 (2H, d, J 8.0 Hz, m-SO2Ar), 7.29 (5H, m, Ph), 5.91 
(1H, t, J 6.5 Hz, CHCH2OH), 4.66 (2H, s, OCH2O), 4.32 (1H, dd, J 13.0, 7.0 Hz, 
CHCH2O), 4.18 (1H, dd, J 13.0, 6.0 Hz, CHCH2O), 3.82 (1H, dd, J 4.5, 1.0 Hz, SCH), 
3.39 (3H, s, OCH3), 3.25 (2H, m, CHCH2O), 2.48 (3H, s, ArCH3), 1.23 (9H, s, 
C(CH3)3); δC (100 MHz) 164.3 (C=O), 145.3, 139.9, 137.6, 134.3 (4°), 129.6, 129.4, 
128.7, 128.6, 127.9, 126.5 (3°), 95.9 (OCH2O), 83.1 (C(CH3)3), 69.4 (SCH), 64.0 
(OCH2CH), 55.3 (OCH3), 27.5 (C(CH3)3), 27.2 (SCHCH2), 21.7 (ArCH3); m/z (CI) 
478 [M+NH4]+ (Found [M+NH4]+, 478.2260. C25H32O6S requires [M+NH4]+, 
478.2263) (Found: C, 65.19; H, 7.00. C25H32O6S requires C, 65.17; H, 6.97). 
 
(E)-4-Phenyl-6-hydroxy-2-tosyl-hex-4-enoic acid 
 
According to general procedure E, a solution of ester 465 (218 mg, 0.47 mmol, 1.0 
equiv) in MeCN (4.5 mL) was treated with 2 M HCl(aq) (0.9 mL) to give (E)-4-phenyl-
6-hydroxy-2-tosyl-hex-4-enoic acid 466 used crude in the next step. 
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5-Phenyl-3-tosyl-4,7-dihydro-3H-oxepin-2-one 
 
According to general procedure G, a solution of acid 466 (109 mg, 0.30 mmol, 1.0 
equiv) in CH2Cl2 (0.75 mL) was treated with EDCI (63 mg, 0.33 mmol, 1.1 equiv). 
Purification by column chromatography (30% EtOAc–petrol) gave 5-phenyl-3-tosyl-
4,7-dihydro-3H-oxepin-2-one 467 (69 mg, 35% over 3 steps) as a colourless solid; Rf 
0.40 (50% EtOAc–petrol); νmax (film) 2925, 1739, 1596, 1324, 1269, 1158, 1143, 
1087, 1056, 1019, 815, 746, 692, 662 cm-1; δH (300 MHz) 7.99 (2H, d, J 8.5 Hz, o-
SO2Ar), 7.39–7.29 (7H, m, m-SO2Ar and Ph), 6.07 (1H, m, CHCH2O), [5.06, 5.00] 
(1H, 2 × dd, J 3.5, 3.5 Hz, SCH), [4.86, 4.82] (1H, 2 × d, J 4.0 Hz, OCH2), [4.68, 4.62] 
(1H, 2 × d, J 7.5 Hz, OCH2), [3.57, 3.51] (1H, 2 × m, SCHCH2), 3.03 (1H, m, 
SCHCH2), 2.45 (3H, s, CH3); δC (75 MHz) 166.6 (C=O), 145.8, 141.4, 140.2, 133.5 
(4°), 130.5, 129.7, 128.7, 125.9 (3°), 121.3 (CHCH2O), 64.3 (SCH), 64.0 (OCH2), 
29.7, 29.5 (SCHCH2), 21.8 (ArCH3); m/z (CI) 360 [M+NH4]+, 187 (Found [M+NH4]+, 
360.1263. C19H18O4S requires [M+NH4]+, 360.1264) (Found: C, 66.63; H, 5.30. 
C19H18O4S requires C, 66.65; H, 5.30). 
 
1-Methyl-4-(2-phenyl-2-vinyl-cyclopropanesulfonyl)-benzene 
 
According to general procedure I, a solution of lactone 467 (27 mg, 0.08 mmol, 1.0 
equiv) in DMF (0.4 mL) was treated with KOAc (0.8 mg, 0.008 mmol, 0.1 equiv) and 
BSA (19.1µL, 0.08 mmol, 1.0 equiv) to give a diastereomeric mixture (3:2) of 1-
methyl-4-(2-phenyl-2-vinyl-cyclopropanesulfonyl)-benzene separable by column 
chromatography (20% EtOAc–petrol) as colourless oils; 469: Rf 0.57 (50% EtOAc–
petrol); νmax (film) 2924, 1633, 1598, 1446, 1403, 1318, 1266, 1148, 1088, 738, 701 
cm-1; δH (400 Hz) 7.86 (2H, d, J 8.0 Hz, o-SO2Ar), 7.37 (2H, d, J 8.0 Hz, m-SO2Ar), 
7.24 (3H, m, o-/p-Ph), 7.04 (2H, dd, J 7.5, 1.5 Hz, m-Ph), 6.45 (1H, dd, J 17.0, 10.5 
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Hz, CH=CH2), 5.18 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans), 4.57 (1H, dd, J 17.0, 1.0 
Hz, CH=CH2 cis), 2.89 (1H, dd, J 9.0, 6.0 Hz, SCH), 2.47 (3H, s, ArCH3), 2.13 (1H, 
dd, J 6.0, 6.0 Hz, SCHCH2), 1.83 (1H, dd, J 9.0, 5.5 Hz, SCHCH2); δC (100 Hz) 144.4, 
140.0, 138.2, 137.2 (4°), 129.7, 129.5, 128.5, 127.6, 127.5 (3°), 118.3 (CH=CH2), 46.9 
(SCH), 38.6 (SCHC), 21.7 (ArCH3), 19.4 (SCHCH2); m/z (CI) 316 [M+NH4]+, 143 
(Found [M+NH4]+, 316.1382. C18H18O2S requires [M+NH4]+, 316.1371); 
 
468: Rf 0.50 (50% EtOAc–petrol); νmax (film) 3059, 2925, 1633, 1598, 1495, 1446, 
1323, 1298, 1266, 1149, 1087, 914, 737, 702 cm-1; δH (400 Hz) 7.56 (2H, d, J 8.0 Hz, 
o-SO2Ar), 7.33–7.26 (7H, m, m-SO2Ar and Ph), 5.64 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2), 5.02 (1H, dd, J 10.5, 0.5 Hz, CH=CH2 trans), 4.75 (1H, dd, J 17.0, 0.5 Hz, 
CH=CH2 cis), 2.84 (1H, dd, J 8.5, 6.0 Hz, SCH), 2.43 (3H, s, ArCH3), 2.25 (1H, dd, J 
6.0, 5.5 Hz, SCHCH2), 1.49 (1H, dd, J 8.5, 5.5 Hz, SCHCH2); δC (100 Hz) 144.1, 
141.7, 138.2, 134.8 (4°), 130.6, 129.6, 128.1, 127.7, 127.6 (3°), 115.3 (CH=CH2), 45.8 
(SCH), 38.3 (SCHC), 21.6 (ArCH3), 18.0 (SCHCH2); m/z (CI) 316 [M+NH4]+ (Found 
[M+NH4]+, 316.1380. C18H18O2S requires [M+NH4]+, 316.1371). 
 
4-(2,4-Difluorophenyl)-5H-furan-2-one  
 
To bromofuranone 434 (2.0 g, 12.3 mmol, 1.0 equiv) and PdCl2(PPh3)2 (172 mg, 0.25 
mmol, 2 mol%) in 2 M KF(aq) (40 mL) and THF (40 mL) was added 2,4-
difluorophenylboronic acid (1.94 g, 12.3 mmol, 1.0 equiv) and the mixture heated at 
reflux for 5 h. After cooling to rt the layers were separated and the aqueous layer 
extracted with EtOAc (×3). The combined organic phases were washed with sat. 
NaCl(aq), dried (Na2SO4) and concentrated under reduced pressure. Purification by 
column chromatography (20–40% EtOAc–petrol) gave 4-(2,4-difluorophenyl)-5H-
furan-2-one 471a (2.39 g, 99%) as a colourless solid; Rf 0.40 (50% EtOAc–petrol); 
νmax (film) 3118, 3059, 1799, 1735, 1618, 1609, 1585, 1508, 1490, 1456, 1425, 1333, 
1266, 1163, 1148, 1106, 1049, 996, 961, 897, 888, 872, 809, 734 cm-1; δH (300 MHz) 
7.48 (1H, m, o-ArF), 6.99 (2H, m, m-ArF), 6.49 (1H, t, J 2.0 Hz, CH), 5.24 (2H, d, J 
2.0 Hz, CH2); δC (75 MHz) 173.4 (C=O), 166.5, 166.4, 163.3, 163.2, 163.1, 162.9, 
159.9, 159.7, (CF), 157.3 (4°), 129.5, 129.4 (3°), 115.9, 115.9, 115.8, 115.8 
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(CFCHCH), 114.7, 114.6, 114.5 (CCF), 112.9, 112.8, 112.6, 112.6 (CFCHCH), 105.8, 
105.4, 105.1 (CFCHCF) 71.7 (CH2); m/z (EI) 214 [M+NH4]+, 197 (Found [M+H]+, 
197.0409. C10H6F2O2 requires [M+H]+, 197.0409) (Found: C, 61.29; H, 3.06. 
C10H6F2O2 requires C, 61.23; H, 3.08). 
 
(Z)-2-(2,4-Difluorophenyl)-but-2-ene-1,4-diol 
 
According to general procedure J, a solution of furanone 471a (602 mg, 3.07 mmol, 
1.0 equiv) in PhMe (5 mL) was treated with DIBAL-H (1.7 M in PhMe; 3.97 mL, 6.75 
mmol, 2.2 equiv). Purification by column chromatography (50–70% EtOAc–petrol) 
gave (Z)-2-(2,4-difluorophenyl)-but-2-ene-1,4-diol 472a (262 mg, 42%) as a 
colourless oil; Rf 0.10 (50% EtOAc–petrol); νmax (film) 3305, 2884, 1613, 1592, 1500, 
1421, 1265, 1138, 1095, 997, 965, 847, 811, 723 cm-1; δH (400 MHz) 7.28 (1H, m, o-
ArF), 6.84 (2H, m, m-ArF), 6.00 (1H, t, J 6.5 Hz, CH), 4.49 (2H, s, CCH2OH), 4.40 
(2H, d, J 6.5 Hz, CHCH2), 2.22 (2H, br s, OH); δC (100 MHz) 163.7, 163.6, 161.2, 
161.1, 160.9, 160.8, 158.7, 158.6 (CF), 138.2 (4°), 133.4 (3°), 131.1, 131.0 
(CFCHCH), 128.6, 128.5 (CCF), 111.6, 111.5, 111.4, 111.3 (CFCHCH), 104.3, 104.1, 
103.8 (CFCHCF), 61.1 (CCH2), 58.8 (CHCH2); m/z (CI) 218 [M+NH4]+, 182; (Found: 
C, 60.08; H, 5.00. C10H10F2O2 requires C, 60.00; H, 5.04). 
 
2-Methoxy-5-(2,4-difluorophenyl)-4,7-dihydro-[1,3]dioxepine 
 
According to general procedure A, a solution of diol 472a (250 mg, 1.24 mmol, 1.0 
equiv) in CH2Cl2 (5 mL) was treated with CSA (14.5 mg, 0.062 mmol, 5 mol%) and 
trimethylorthoformate (545 µL, 4.98 mmol, 4.0 equiv). Purification by column 
chromatography (20–50% EtOAc–petrol) gave 2-methoxy-5-(2,4-difluorophenyl)-4,7-
dihydro-[1,3]dioxepine 473a (300 mg, 100%) as a colourless solid; mp 39–41°C; Rf 
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0.54 (50% EtOAc–heptane); νmax (film) 2942, 2845, 1614, 1591, 1500, 1424, 1266, 
1134, 1097, 1068, 1023, 966, 847, 798, 733 cm-1; δH (300 MHz) 7.18 (1H, m, o-ArF), 
6.80 (2H, m, m-ArF), 5.80 (1H, t, J 4.0 Hz, CHCH2), 5.45 (1H, s, OCH), 4.74 (1H, 
ddd, J 15.5, 2.0, 2.0 Hz, CCH2), 4.59 (1H, dddd J 16.5, 4.0, 2.0, 2.0 Hz, CHCH2), 4.39 
(1H, dddd, J 15.5, 3.5, 2.0, 2.0 Hz, CCH2), 4.26 (1H, dddd, J 16.5, 4.0, 2.0, 2.0 Hz, 
CHCH2), 3.43 (CH3); δC (75 MHz) 164.1, 164.0, 161.5, 161.3, 160.8, 160.7, 158.2, 
158.0 (CF), 136.5, (4°), 130.5, 130.3 (CFCHCH), 129.5, (3°), 124.0, 123.9, 123.8, 
123.7 (CCF), 113.8 (CHO), 111.6, 111.5, 111.3, 111.2 (CFCHCH), 104.5, 104.1, 
103.8 (CFCHCF), 63.9, 63.8 (CCH2O), 61.1 (CHCH2O), 53.7 (CH3); m/z (ESI) 265 
[M+Na]+, 183, 165, 151, 127 (Found [M+Na]+, 265.0646. C12H12F2O3 requires 
[M+Na]+, 265.0647) (Found: C, 59.59; H, 4.89. C12H12F2O3 requires C, 59.50; H, 
4.99). 
 
(Z)-2-(2,4-Difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol and (Z)-3-(2,4-
difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 
 
According to general procedure B, to a solution of orthoester 473a (781 mg, 3.22 
mmol, 1.0 equiv) in PhMe (8.3 mL) was treated with DIBAL-H (1.7 M in PhMe; 2.47 
mL, 4.19 mmol, 1.3 equiv). Purification by column chromatography (20% EtOAc–
petrol) gave (Z)-2-(2,4-difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 445a and 
(Z)-3-(2,4-difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 474a (739 mg, 94%; 
68:32 445a:474a; separable by column chromatography) as colourless oils; 445a: Rf 
0.25 (50% EtOAc–petrol); νmax (film) 3394, 2939, 2886, 1616, 1592, 1501, 1422, 
1266, 1139, 1097, 967, 850, 815 cm-1; δH (300 MHz) 7.30 (1H, m, o-ArF), 6.83 (2H, 
m, m-ArF), 5.90 (1H, t, J 7.0 Hz, CH), 4.71 (2H, s, OCH2O), 4.47 (2H, d, J 5.5 Hz, 
CCH2OH), 4.34 (2H, d, J 7.0 Hz, CHCH2), 3.41 (3H, s, CH3), 2.22 (1H, t, J 6.0 Hz, 
OH); δC (100 MHz) 163.7, 163.5, 161.2, 161.1, 158.5, 158.6 (CF), 138.9 (4°), 131.1, 
131.0 (CFCHCH), 130.2 (3°), 125.1, 124.9 (CCF), 111.5, 111.4, 111.3, 111.2 
(CFCHCH), 104.3, 104.1, 103.8 (CFCHCF), 95.6 (OCH2O), 63.0 (CH2OH), 60.7, 60.6 
(CHCH2O), 55.4 (CH3); m/z (CI) 262 [M+NH4]+, 227, 183 (Found [M+NH4]+, 
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262.1249. C12H14F2O3 requires [M+NH4]+, 262.1249) (Found: C, 58.92; H, 5.69. 
C12H14F2O3 requires C, 59.01; H, 5.78). 
 
474a: Rf 0.19 (50% EtOAc–petrol); νmax (film) 3404, 2945, 2887, 1616, 1593, 1501, 
1422, 1266, 1140, 1097, 1039, 1007, 966, 919, 850, 815 cm-1; δH (300 MHz) 7.29 (1H, 
m, o-ArF), 6.83 (2H, m, m-ArF), 6.07 (1H, t, J 7.0 Hz, CH), 4.62 (2H, s, OCH2O), 
4.47 (2H, s, CCH2), 4.37 (2H, t, J 6.0 Hz, CH2OH), 3.34 (3H, s, CH3) 2.14 (1H, t, J 6.0 
Hz, OH); δC (75 MHz) 164.0, 163.9, 161.7, 161.5, 160.7, 160.6, 158.4, 158.3 (CF), 
134.9 (3°), 134.1(4°), 131.0, 130.9, 130.9, 130.8, (CFCHCH), 125.2, 125.1, 125.0, 
124.9 (CCF), 111.4, 111.4, 111.2, 111.1 (CFCHCH), 104.4, 104.0, 103.7 (CFCHCF), 
95.4 (OCH2O), 64.4 (CH2OH), 58.7 (CCH2) 55.5 (CH3); m/z (EI) 262 [M+NH4]+, 227, 
197, 167 (Found [M+NH4]+, 262.1249. C12H14F2O3 requires [M+NH4]+, 262.1249) 
(Found: C, 59.14; H, 5.67. C12H14F2O3 requires C, 59.01; H, 5.78). 
 
Methane sulfonic acid (Z)-2-(2,4-difluorophenyl)-4-methoxymethoxy-but-2-enyl ester 
 
According to general procedure C, to a solution of alcohol 445a (68 mg, 0.28 mmol, 
1.0 equiv) in CH2Cl2 (1 mL) was treated with NEt3 (116 µL, 0.84 mmol, 3.0 equiv) and 
MsCl (43.1 µL, 0.56 mmol, 2.0 equiv) to give methane sulfonic acid (Z)-2-(2,4-
difluorophenyl)-4-methoxymethoxy-but-2-enyl ester 426a (84 mg, 93%) as a 
colourless oil, without further purification; Rf 0.35 (50% EtOAc–petrol); νmax (film) 
2942, 1615, 1592, 1502, 1353, 1267, 1172, 1141, 1099, 1048, 1030, 920, 846, 807 cm-
1; δH (400 MHz) 7.28 (1H, m, o-ArF), 6.86 (2H, m, m-ArF), 6.07 (1H, t, J 6.5 Hz, CH), 
5.13 (2H, s, CCH2), 4.69 (2H, s, OCH2O), 4.36 (2H, d, J 6.5 Hz, CHCH2), 3.41 (3H, s, 
OCH3), 2.92 (3H, s, SCH3); δC (100 MHz) 164.0, 163.9, 161.5, 161.4, 161.2, 161.1, 
158.7, 158.6 (CF), 134.8 (4°), 134.8 (3°), 131.3, 131.3, 131.2, 131.2 (CFCHCH), 
123.1, 123.1, 123.0, 123.0 (CCF), 111.8, 111.8, 111.6, 111.5 (CFCHCH), 104.5, 
104.2, 104.0 (CFCHCF), 96.0 (OCH2O), 66.3, 66.3 (CHCH2), 63.0 (CCH2), 55.5 
(OCH3), 37.7 (SCH3); m/z (CI) 340 [M+NH4]+, 165 (Found [M+NH4]+, 340.1025. 
C11H16F2O5S requires [M+NH4]+, 340.1025). 
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(E)-4-(2,4-Difluorophenyl)-6-methoxymethoxy-2-tosyl-hex-4-enoic acid tert-butyl ester 
 
According to general procedure D, a suspension of sodium hydride (11.5 mg, 0.29 
mmol, 1.1 equiv) in THF (0.3 mL) was treated with tert-butyl 2-tosylacetate 313 (71 
mg, 0.26 mmol, 1.0 equiv) in THF (0.4 mL) followed by methane sulfonate 426a (84 
mg, 0.26 mmol, 1.0 equiv) in THF (0.3 mL) to give (E)-4-(2,4-difluorophenyl)-6-
methoxymethoxy-2-tosyl-hex-4-enoic acid tert-butyl ester 475a used crude in the next 
step; Rf 0.49 (50% EtOAc–heptane). 
 
(E)-4-(2,4-Difluorophenyl)-6-hydroxy-2-tosyl-hex-4-enoic acid  
 
According to general procedure E, a solution of ester 475a (85 mg, 0.17 mmol, 1.0 
equiv) in MeCN (1.5 mL) was treated with 2 M HCl(aq) (0.3 mL) to give (E)-4-(2,4-
difluorophenyl)-bromo-6-hydroxy-2-tosyl-hex-4-enoic acid 476a as a colourless gum, 
used crude in the next step. 
 
5-(2,4-Difluorophenyl)-3-tosyl-4,7-dihydro-3H-oxepin-2-one  
 
According to general procedure G, a solution of acid 476a (77 mg, 0.19 mmol, 1.0 
equiv) in CH2Cl2 (0.5 mL) was treated with EDCI (41 mg, 0.21 mmol, 1.1 equiv). 
Purification by column chromatography (40% EtOAc–petrol) gave 5-(2,4-
difluorophenyl)-3-tosyl-4,7-dihydro-3H-oxepin-2-one 477a (73 mg, 74% over 3 steps) 
as a colourless solid; Rf 0.36 (50% EtOAc–petrol); νmax (film) 1745, 1594, 1501, 1321, 
1305, 1291, 1265, 1139, 1084, 972, 850, 813, 670 cm-1; δH (400 MHz) 7.95 (2H, d, J 
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8.5 Hz, o-SO2Ar), 7.36 (2H, d J 8.0 Hz, m-SO2Ar), 7.17 (1H, td, J 8.5, 6.5 Hz, o-ArF), 
6.90–6.79 (2H, m, m-ArF), 5.95 (1H, m, CHCH2O), [5.04, 4.99] (1H, 2 × dd, J 6.5, 3.5 
Hz, SCH), [4.86, 4.81] (1H, 2 × d, J 4.0 Hz, OCH2), [4.67, 4.62] (1H, 2 × d, J 7.5 Hz, 
OCH2), [3.43, 3.37] (1H, 2 × m, SCHCH2), 3.01 (1H, m, SCHCH2), 2.45 (3H, s, CH3); 
δC (75 MHz) 166.3 (C=O), 164.6, 164.4, 161.3, 161.2, 161.2, 161.1, 158.1, 157.9 (CF), 
145.8, 136.8, 133.6 (4°), 130.4, 130.3, 130.3, 129.9 (CFCHCH), 130.5, 129.7, 125.1, 
(3°), 124.8, 124.7, 124.6, 124.5 (CCF), 111.9, 111.8, 111.6, 111.6 (CFCHCH), 104.9, 
104.5, 104.2 (CFCHCF), 64.4, 63.6 (OCH2), 63.7 (SCH), 30.0, 29.9 (SCHCH2), 21.7 
(CH3); m/z (CI) 396 [M+NH4]+ (Found [M+NH4]+, 396.1075. C19H16F2O4S requires 
[M+NH4]+, 396.1076). 
 
2,4-Difluoro-1-[2-tosyl-1-vinyl-cyclopropyl]-benzene 
 
According to general procedure I, lactone 477a (700 mg, 0.20 mmol, 1.0 equiv) in 
DMF (1.0 mL) was treated with KOAc (pinch) and BSA (46.0 µL, 0.20 mmol, 1.0 
equiv) to give a diastereomeric mixture (2:3) of 2,4-difluoro-1-[2-tosyl-1-vinyl-
cyclopropyl]-benzene (46 mg, 75%) as a colourless gum, separable by column 
chromatography (10–20% EtOAc–petrol); 479a: Rf 0.59 (50% EtOAc–petrol); νmax 
(film) 3923, 1598, 1505, 1425, 1321, 1290, 1148, 1088, 967, 851, 741, 659 cm-1; δH 
(400 MHz) 7.66 (2H, d, J 8.0 Hz, o-SO2Ar), 7.45 (1H, dd, J 15.0, 8.5 Hz, CFCHCH), 
7.32 (2H, d, J 8.0 Hz, m-SO2Ar), 6.90 (1H, dddd, J 9.0, 9.0, 2.5, 1.0 Hz, CFCHCH), 
6.80 (1H, ddd, J 10.5, 9.0, 2.5 Hz, CFCHCF), 5.55 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2), 5.04 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.74 (1H, d, J 17.0 Hz, CH=CH2 
cis), 2.82 (1H, dd, J 8.5, 6.5 Hz, SCH), 2.45 (3H, s, ArCH3), 2.17 (1H, dd, J 6.0, 6.0 
Hz, SCHCH2), 1.64 (1H, dd, J 8.5, 6.0 Hz, SCHCH2); δC (100 MHz) 163.8, 163.6, 
162.6, 162.4, 161.3, 161.2, 160.2, 160.0 (CF), 144.5, 137.7 (4°), 132.4, 132.3, 132.3, 
132.2 (CCF), 135.5, 129.7, 127.6 (3°), 123.1, 123.0 (CFCHCH), 117.6 (CH=CH2), 
111.6, 111.6, 111.4, 111.4 (CFCHCH), 104.5, 104.2, 104.0 (CFCHCF), 46.7 (SCH), 
29.7 (SCHCH), 21.7 (ArCH3), 19.4 (SCHCH2); δF (376 MHz) –108.8 (1F, ddd, J 16.5, 
8.5, 6.5 Hz, o-CF), –109.4 (1F, dd, J 17.5, 8.5 Hz, p-CF); m/z (CI) 352 [M+NH4]+, 
316, 298 (Found [M+NH4]+, 352.1198. C18H16F2O2S requires [M+NH4]+, 352.1183). 
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480a: Rf 0.55 νmax (film) 3056, 2926, 1618, 1508, 1426, 1266, 1148, 1090, 738 cm-1; 
δH (500 MHz) 7.84 (2H, d, J 8.0 Hz, o-SO2Ar), 7.36 (2H, d, J 8.0 Hz, m-SO2Ar), 7.01 
(1H, ddd, J 8.5, 8.5, 6.5 Hz, CFCHCH), 6.80 (1H, dddd, J 8.0, 8.0, 2.5, 1.0 Hz, 
CFCHCH), 6.72 (1H, ddd, J 10.0, 9.0, 2.5 Hz, CFCHCF), 6.39 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.18 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.56 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 2.84 (1H, dd, J 9.0, 6.5 Hz, SCH), 2.47 (3H, s, ArCH3), 2.19 (1H, dd, J 
6.0, 6.0 Hz, SCHCH2), 1.79 (1H, dd, J 9.0, 6.0 Hz, SCHCH2); δC (100 MHz) 163.7, 
163.6, 162.9, 162.8, 161.8, 161.7, 160.9, 160.8 (CF), 144.4, 138.0 (4°), 139.9 129.7, 
127.6 (3°), 133.5 (CCF), 118.7 (CFCHCH), 115.4 (CH=CH2), 111.2, 111.1, 111.0 
(CFCHCH), 104.3, 104.1, 103.9 (CFCHCF), 45.4 (SCH), 29.7 (SCHC), 21.6 (ArCH3), 
18.7 (SCHCH2); δF (376 MHz) –109.3 (1F, ddd, J 16.5, 8.0, 6.5 Hz, p-CF); m/z (CI) 
352 [M+NH4]+, 316 (Found [M+NH4]+, 352.1198. C18H16F2O2S requires [M+NH4]+, 
352.1183). 
 
4-(2,6-Difluorophenyl)-5H-furan-2-one 
 
To bromofuranone 434 (4.25 g, 26.1 mmol, 1.0 equiv) and PdCl2(PPh3)2 (366 mg, 0.52 
mmol, 2 mol%) in 2 M KF(aq) (87 mL) and THF (87 mL) was added 2,6-
difluorophenyl boronic acid (4.12 g, 26.1 mmol, 1.0 equiv) and the mixture heated at 
reflux for 5 h. After cooling to rt the layers were separated and the aqueous layer 
further extracted with EtOAc (×3). The combined organic phases were washed with 
sat. NaCl(aq), dried (MgSO4) and concentrated under reduced pressure. Purification by 
column chromatography (30–50% EtOAc–petrol) gave 4-(2,6-difluorophenyl)-5H-
furan-2-one 471b (4.40 g, 86%) as a colourless solid; Rf 0.52 (50% EtOAc–petrol); 
νmax (film) 3055, 2987, 1758, 1626, 1466, 1265, 1167, 1071, 1053, 1017, 896, 868, 
791, 741, 704 cm–1; δH (400 MHz) 7.45 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 7.04 (2H, dd, J 
9.5, 8.5 Hz, m-ArF), 6.68 (1H, s, CH), 5.29 (2H, s, CH2); δC (100 MHz) 173.3 (C=O), 
162.5, 162.4, 160.0, 159.9 (CF), 153.3 (CCH), 133.0, 132.9, 132.8 (CFCHCH), 119.4, 
119.3, 119.2 (CCH), 112.7, 112.4 (CHCF), 108.5, 108.4, 108.2 (CCF), 73.1, 73.0 
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(CH2); m/z (CI) 197 [M+H]+, 410, 214 (Found [M+H]+, 197.0421. C10H6F2O2 requires 
[M+H]+, 197.0414) (Found: C, 61.18; H, 2.99. C10H6F2O2 requires C, 61.23; H, 3.08). 
 
(Z)-2-(2,6-Difluorophenyl)-but-2-ene-1,4-diol 
 
According to general procedure J, furanone 471b (4.32 g, 22.0 mmol, 1.0 equiv) in 
PhMe (70 mL) was treated with DIBAL-H (1.2 M in PhMe; 40.4 mL, 48.5 mmol, 2.2 
equiv). Purification by column chromatography (50% EtOAc–petrol) gave (Z)-2-(2,6-
difluorophenyl)-but-2-ene-1,4-diol 472b (2.61 g, 60%) as a colourless oil; Rf 0.15 
(50% EtOAc–petrol); νmax (film) 3338, 2886, 1622, 1586, 1462, 1269, 1231, 1000, 788 
cm–1; δH (400 MHz) 7.22 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.90 (2H, t, J 8.0 Hz, m-ArF), 
6.00 (1H, t, J 6.5 Hz, CCH), 4.46 (2H, s, CCH2), 4.45 (2H, d, J 7.0 Hz, CHCH2), 2.14 
(2H, br s, OH); δC (100 MHz) 161.6, 161.5, 159.1, 159.1 (CF) 136.0 (CHCH2OH), 
131.3 (CCH2), 128.9, 128.8 (CFCHCH), 118.1 (CCF),  111.6, 111.5, 111.4, 111.3 
(CFCH), 61.3 (CCH2), 58.9 (CHCH2); m/z (CI) 218 [M+NH4]+, 200 (Found 
[M+NH4]+, 218.0999. C10H10F2O2 requires [M+NH4]+, 218.0993) (Found: C, 59.97; H, 
5.01. C10H10F2O2 requires C, 60.00; H, 5.04). 
 
2-Methoxy-5-(2,6-difluorophenyl)-4,7-dihydro-[1,3]dioxepine 
 
According to general procedure A, diol 472b (1.60 g, 7.99 mmol, 1.0 equiv) in CH2Cl2 
(20 mL) was treated with CSA (18.6 mg, 0.08 mmol, 1 mol%) and 
trimethylorthoformate (1.75 mL, 16.0 mmol, 2.0 equiv). Purification by column 
chromatography (20–50% EtOAc–petrol) gave 2-methoxy-5-(2,6-difluorophenyl)-4,7-
dihydro-[1,3]dioxepine 473b (1.77 mg, 91%) as a yellow liquid; Rf 0.67 (50% EtOAc–
petrol); νmax (film) 2945, 2874, 2846, 1621, 1583, 1567, 1463, 1388, 1344, 1270, 1230, 
1212, 1136, 1035, 998, 915, 814, 784, 722 cm–1; δH (400 MHz) 7.22 (1H, tt, J 8.5, 6.5 
Hz, p-ArF), 6.91 (2H, t, J 8.0 Hz, m-ArF), 5.92 (1H, t, J 3.5 Hz, CHCH2), 5.49 (1H, s, 
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OCH), 4.69 (2H, m, CCH2), 4.38 (2H, m, CHCH2), 3.47 (3H, s, CH3); δC (100 MHz) 
161.4, 161.3, 158.9, 158.8 (CF) 132.3 (CCH2), 129.7 (CHCH2), 128.9, 128.8, 128.7 
(CFCHCH), 116.7 (CCF), 113.7 (CHO), 111.7, 111.6, 111.5, 111.4 (CFCH), 63.9 
(CCH2), 61.3 (CHCH2), 53.7 (CH3); m/z (CI) 143 [M+H]+, 502, 260, 228, 211, 200, 
182 (Found [M+H]+, 243.0841. C12H12F2O3 requires [M+H]+, 243.0833) (Found: C, 
59.58; H, 5.05. C12H12F2O3 requires C, 59.50; H, 4.99). 
 
(Z)-2-(2,6–Difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol and (Z)-3-(2,6-
difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 
 
According to general procedure B, orthoester 473b (2.78 g, 11.48 mmol, 1.0 equiv) in 
PhMe (36.4 mL) was treated with DIBAL-H (1.2 M in PhMe; 21.0 mL, 25.3 mmol, 
2.2 equiv). Purification by column chromatography (5–10% Et2O–CH2Cl2) gave a (Z)-
2-(2,6-difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 445b and (Z)-3-(2,6-
difluorophenyl)-4-methoxymethoxy-but-2-en-1-ol 474b (2.32 g, 82%; 66:34 
445b:474b; separable by column chromatography) as colourless oils; 445b: Rf 0.39 
(20% Et2O–CH2Cl2); νmax (film) 3433, 2939, 1622, 1585, 1462, 1268, 1231, 1150, 
1101, 1043, 996, 788 cm-1; δH (400 MHz) 7.21 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.90 (2H, 
t, J 8.0 Hz, m-ArF), 5.87 (1H, t, J 7.0 Hz, CH), 4.73 (2H, s, OCH2O), 4.42 (2H, s, 
CCH2OH), 4.37 (2H, d, J 7.0 Hz, CHCH2), 3.42 (3H, s, CH3), 2.16 (1H, br s, OH); δC 
(100 MHz) 161.7, 161.6, 159.2, 159.1 (CF), 132.9 (CCH2), 132.4 (CHCH2), 129.0, 
128.9, 128.8 (CFCHCH), 118.3, 118.1, 117.9 (CCF), 111.5, 111.5, 111.4, 111.3 
(CFCH), 95.3 (OCH2O), 62.5 (CH2OH), 60.8 (CHCH2), 55.5 (CH3); m/z (CI) 262 
[M+NH4]+, 506, 230 (Found [M+NH4]+, 262.1265. C12H14F2O3 requires [M+NH4]+, 
262.1255) (Found: C, 59.01; H, 5.78. C12H14F2O3 requires C, 59.06; H, 5.78). 
 
474b: Rf 0.31 (20% Et2O–CH2Cl2); νmax (film) 3412, 2932, 1623, 1463, 1268, 1231, 
1150, 1101, 1053, 995, 790 cm–1; δH (400 MHz) 7.24 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 
6.92 (2H, t, J 8.0 Hz, m-ArF), 6.08 (1H, t, J 7.0 Hz, CH), 4.65 (2H, s, OCH2O), 4.46 
(2H, s, CCH2), 4.42 (2H, d, J 7.0 Hz, CH2OH), 3.35 (3H, s, CH3) 2.11 (1H, br s, OH); 
δC (100 MHz) 161.7, 161.6, 159.2, 159.2 (CF) 137.2 (CHCH2), 128.9, 128.8, 128.7 
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(CFCHCH), 127.8 (CCH2), 118.2, 118.0, 117.8 (CCF), 111.5, 111.4, 111.3 (CFCH), 
95.0 (OCH2O), 64.1 (CH2OH), 58.7 (CCH2) 55.4 (CH3); m/z (CI) 262 [M+NH4]+, 506, 
230 (Found [M+NH4]+, 262.1263. C12H14F2O3 requires [M+NH4]+, 262.1255) (Found: 
C, 59.12; H, 5.69. C12H14F2O3 requires C, 59.01; H, 5.78). 
 
Methane sulfonic acid (Z)-2-(2,6–difluorophenyl)-4-methoxymethoxy-but-2-enyl ester 
 
According to general procedure C, alcohol 445b (349 mg, 1.43 mmol, 1.0 equiv) in 
CH2Cl2 (7.2 mL) was treated with NEt3 (597 µL, 4.29 mmol, 3.0 equiv) and MsCl (221 
µL, 2.86 mmol, 2.0 equiv) to give methane sulfonic acid (Z)-2-(2,6-difluorophenyl)-4-
methoxymethoxy-but-2-enyl ester 426b as a colourless oil, used crude in the next step; 
Rf 0.64 (50% EtOAc–petrol); νmax (film) 3436, 3004, 2934, 2887, 1622, 1586, 1464, 
1360, 1329, 1271, 1254, 1196, 1151, 1104, 1047, 999, 789, 735 cm–1; δH (400 MHz) 
7.28 (1H, tt, J 8.5, 6.5 Hz, o-ArF), 6.93 (2H, t, J 8.0 Hz, m-ArF), 6.08 (1H, t, J 6.5 Hz, 
CH), 5.11 (2H, s, CCH2), 4.69 (2H, s, OCH2O), 4.38 (2H, d, J 6.5 Hz, CHCH2), 3.40 
(3H, s, OCH3), 2.93 (3H, s, SCH3); δC (100 MHz) 161.6, 161.5, 159.1, 159.1 (CF),  
137.3 (CCH2), 129.8, 129.7, 129.6 (CFCHCH), 125.1 (CHCH2), 116.2, 116.1, 115.9 
(CCF), 111.7, 111.7, 111.5, 111.5 (CFCHCH), 95.9 (OCH2O), 66.6 (CHCH2), 62.8 
(CCH2), 55.5 (OCH3), 37.9 (SCH3); m/z (CI) 340 [M+NH4]+, 102 (Found [M+NH4]+, 
340.1020. C11H16F2O5S requires [M+NH4]+, 340.1030). 
 
Methyl 2-tosylacetate 
 
To tosyl acetic acid 330 (9.53 g, 44.5 mmol, 1.0 equiv) in MeOH (90 mL) was added 
conc. H2SO4 (2 mL) and the solution heated at reflux for 16 h. The reaction mixture 
was then cooled to rt, concentrated under reduced pressure and partitioned between 
EtOAc and sat. NaHCO3(aq). The organic layer was dried (MgSO4) and concentrated 
under reduced pressure to give methyl 2-tosylacetate 365 (9.80 g, 96%) as a colourless 
oil without further purification; Rf 0.46 (50% EtOAc–petrol); νmax (film) 3005, 2954, 
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1744, 1710, 1597, 1437, 1401, 1326, 1289, 1150, 1085, 1006, 915, 814, 728, 644, 609 
cm-1; δH (400 MHz) 7.85 (2H, d, J 8.0 Hz, o-SO2Ar), 7.40 (2H, d, J 8.0 Hz, m-SO2Ar), 
4.13 (2H, s, CH2), 3.74 (3H, s, OCH3), 2.49 (3H, ArCH3); δC (100 MHz) 163.1 (C=O), 
145.6, 135.7 (4°), 130.0, 128.6 (3°), 61.0 (CH2), 53.2 (OCH3), 21.8 (ArCH3); m/z (CI) 
246 [M+NH4]+, 174; data in accordance with the literature.125 
 
(E)-4-(2,6-Difluorophenyl)-6-methoxymethoxy-2-tosyl-hex-4-enoate 
 
According to general procedure D, sodium hydride (40.2 mg, 1.00 mmol, 1.2 equiv) in 
DMF (1.5 mL) was treated with methyl 2-tosylacetate 365 (191 mg, 0.84 mmol, 1.0 
equiv) in DMF (1.5 mL) and methane sulfonate 426b (0.84 mmol, 1.0 equiv) in THF 
(1.2 mL) to give (E)-4-(2,6-difluorophenyl)-6-methoxymethoxy-2-tosyl-hex-4-enoate 
475b used crude in the next step; Rf 0.64 (50% EtOAc–petrol). 
 
(E)-Methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-tosyl-hex-4-enoate  
 
According to general procedure E, ester 475b (0.84 mmol, 1.0 equiv) in MeCN (8.4 
mL) was treated with 2 M HCl(aq) (1.68 mL). Purification by column chromatography 
(20–40% EtOAc–petrol) gave (E)-methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-tosyl-
hex-4-enoate 478b (277 mg, 80% over 3 steps) as a colourless gum; Rf 0.33 (50% 
EtOAc–petrol); νmax (film) 3055, 2986, 1741, 1620, 1463, 1423, 1265, 1149, 1085, 
895, 738 cm–1; δH (400 MHz) 7.70 (2H, d, J 8.0 Hz, o-SO2Ar), 7.35 (2H, d, J 8.0 Hz, 
m-SO2Ar), 7.23 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.87 (2H, t, J 8.0 Hz, m-ArF), 5.83 (1H, 
t, J 7.0 Hz, CHCH2OH), 4.36 (1H, dd, J 13.5, 7.5 Hz, CH2OH), 4.18 (1H, dd, J 13.5, 
6.5 Hz, CH2OH), 3.84 (1H, dd, J 12.0, 3.5 Hz, SCH), 3.59 (3H, s, OCH3), 3.29 (1H, 
dd, J 14.0, 12.0 Hz, SCHCH2), 3.02 (1H, dd, J 14.0, 2.5 Hz, SCHCH2), 2.47 (3H, s, 
ArCH3); δC (100 MHz) 166.3 (C=O), 161.5, 161.4, 159.0, 158.9 (CF), 145.7, 136.9, 
133.6 (4°), 129.8, 129.2 (3°), 129.6, 129.5, 129.4 (CFCHCH), 125.0 (CHCH2OH), 
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117.2 (CCF), 111.7, 111.6, 111.5, 111.4 (CFCH), 69.0 (SCH), 58.6 (CH2OH), 53.1 
(OCH3), 28.0 (SCHCH2), 21.7 (ArCH3); m/z (CI) 428 [M+NH4]+, 410, 393, 272, 174; 
(Found [M+NH4]+, 428.1325. C20H20F2O5S requires [M+NH4]+, 428.1343). 
 
(E)-4-(2,6-Difluorophenyl)-6-hydroxy-2-tosyl-hex-4-enoic acid  
 
According to general procedure F, ester 478b (270 mg, 0.66 mmol, 1.0 equiv) in THF 
(1.65 mL) was treated with 2 M LiOH(aq) (1.65 mL) to give (E)-4-(2,6-difluorophenyl)-
6-hydroxy-2-tosyl-hex-4-enoic acid 476b (214 mg, 82%) without further purification; 
νmax (film) 3416, 3055, 2986, 1731, 1622, 1464, 1324, 1265, 1232, 1149, 1084, 1001, 
815, 789, 738, 704 cm–1; δH (400 MHz) 7.71 (2H, d, J 8.5 Hz, o-SO2Ar), 7.33 (2H, d, J 
8.5, 0.5 Hz, m-SO2Ar), 7.23 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.83 (2H, dd, J 8.5, 7.5 Hz, 
m-ArF), 5.82 (1H, dd, J 7.5, 6.5 Hz, CHCH2OH), 4.42 (1H, dd, J 13.0, 8.5 Hz, 
CH2OH), 4.12 (1H, dd, J 13.0, 6.0 Hz, CH2OH), 3.81 (1H, dd, J 12.0, 3.0 Hz, SCH), 
3.30 (1H, dd, J 14.0, 12.0 Hz, SCHCH2), 2.96 (1H, dd, J 14.0, 2.0 Hz, SCHCH2), 2.44 
(3H, s, ArCH3); δC (100 MHz) 168.2 (C=O), 161.5, 161.4, 159.0, 159.0 (CF), 145.8, 
135.9, 133.5 (4°), 129.9, 129.3 (3°), 129.8, 129.6, 129.5 (CFCHCH), 125.9 
(CHCH2OH), 117.3, 117.1, 116.9 (CCF), 111.8, 111.7, 111.6, 111.5 (CFCH), 68.7 
(SCH), 58.4 (CH2OH), 28.2 (SCHCH2), 21.8 (ArCH3); m/z (CI) 370 [M–CO2+NH4]+, 
412, 396, 352, 335, 174 (Found [M+NH4]+, 414.1185. C19H18F2O5S requires 
[M+NH4]+, 414.1187) (Found: C, 57.62; H, 4.49. C19H18F2O5S requires C, 57.57; H, 
4.58). 
 
5-(2,6-Difluorophenyl)-3-tosyl-4,7-dihydro-3H-oxepin-2-one  
 
According to general procedure G, acid 476b (98 mg, 0.25 mmol, 1.0 equiv) in 
CH2Cl2 (1.25 mL) was treated with EDCI (52.7 mg, 0.28 mmol, 1.1 equiv). 
Purification by column chromatography (30% EtOAc–petrol) gave 5-(2,6-
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difluorophenyl)-3-tosyl-4,7-dihydro-3H-oxepin-2-one 477b (73 mg, 74% over 3 steps) 
as a colourless solid; Rf 0.60 (50% EtOAc–petrol); νmax (film) 3139, 1748, 1622, 1463, 
1398, 1321, 1267, 1231, 1144, 1084, 1002, 781, 735, 666 cm–1; δH (400 MHz) 7.95 
(2H, d, J 8.5 Hz, o-SO2Ar), 7.36 (2H, d J 8.0 Hz, m-SO2Ar), 7.28 (1H, td, J 8.5, 6.5 
Hz, o-ArF), 6.92 (2H, dd, J 8.0, 8.0 Hz, m-ArF), 5.96 (1H, m, CHCH2O), [5.06, 5.02] 
(1H, 2 × dd, J 3.5, 3.5 Hz, SCH), [4.87, 4.83] (1H, 2 × d, J 4.0 Hz, OCH2), [4.68, 4.64] 
(1H, 2 × d, J 7.5 Hz, OCH2), 3.29 (1H, d, J 17.5 Hz, SCHCH2), 3.02 (1H, m, 
SCHCH2), 2.45 (3H, s, CH3); δC (100 MHz) 166.2 (C=O), 161.0, 160.9, 158.5, 158.4 
(CF), 145.7, 133.6, 130.6 (4°), 130.4, 129.6, (3°), 130.0, 129.9, 129.8 (CFCHCH), 
127.5 (CHCH2OH), 117.6 (CCF), 111.9, 111.8, 111.7, 111.6 (CFCHCH), 64.4 
(OCH2), 63.6 (SCH), 29.8 (SCHCH2), 21.7 (CH3); m/z (CI) 396 [M+NH4]+, 254, 242, 
174 (Found [M+NH4]+, 396.1085. C19H16F2O4S requires [M+NH4]+, 396.1081) 
(Found: C, 60.38; H, 4.19. C19H16F2O4S requires C, 60.31; H, 4.26). 
 
2,6–Difluoro–1–[2–tosyl–1–vinyl–cyclopropyl]–benzene 
 
According to general procedure I, lactone 477b (63 mg, 0.17 mmol, 1.0 equiv) in 
DMF (0.85 mL) was treated with KOAc (0.85 mg, 0.017 mmol, 0.1 equiv) and BSA 
(41 µL, 0.17 mmol, 1.0 equiv) to give a diastereomeric mixture (2:3) of 2,6-difluoro-1-
[2-tosyl-1-vinyl-cyclopropyl]-benzene (47 mg, 82%) as a colourless oil, separable by 
column chromatography (10% Et2O–petrol); 479b: Rf 0.34 (50% Et2O–petrol); νmax 
(film) 3054, 1625, 1467, 1321, 1265, 1151, 1090, 1008, 790, 738, 704, 653 cm–1; δH 
(400 MHz) 7.84 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, d, J 8.0 Hz, m-SO2Ar), 7.21 
(1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.80 (2H, t, J 8.0 Hz, m-ArF), 6.35 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.17 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.62 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 2.91 (1H, dd, J 9.0, 6.5 Hz, SCHCH2), 2.46 (3H, s, ArCH3), 2.30 (1H, 
dd, J 6.5, 6.5 Hz, SCHCH2), 1.8 (1H, dd, J 9.0, 6.0 Hz, SCHCH2); δC (100 MHz) 
162.9, 162.8, 160.4, 160.3 (CF), 144.4, 137.5 (4°), 134.5 (CH=CH2), 129.9, 129.8, 
129.7 (CFCHCH), 129.5, 128.1 (3°), 117.2 (CH=CH2), 111.8, 111.5 (CFCH), 46.6 
(SCH), 27.9 (SCHC), 21.7 (ArCH3), 19.8 (CH2); m/z (CI) 352 [M+NH4]+ (Found 
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[M+NH4]+, 352.1183. C18H16F2O2S requires [M+NH4]+, 352.1183) (Found: C, 64.69; 
H, 4.75. C18H16F2O2S requires C, 64.65; H, 4.82). 
 
480b: Rf 0.27 (50% Et2O–petrol); νmax (film) 1628, 1466, 1325, 1298, 1234, 1150, 
1088, 1004, 910, 734 cm–1; δH (400 MHz) 7.68 (2H, d, J 8.0 Hz, o-SO2Ar), 7.32 (2H, 
d, J 8.0 Hz, m-SO2Ar), 7.30 (1H, tt, J 8.5, 6.5 Hz, p-ArF), 6.92 (2H, dd, J 17.0, 8.5 Hz, 
m-ArF), 5.56 (1H, dd, J 17.0, 10.5 Hz, CH=CH2), 5.06 (1H, d, J 10.5 Hz, CH=CH2 
trans), 4.82 (1H, d, J 17.0 Hz, CH=CH2 cis), 2.85 (1H, ddd, J 8.5, 6.5, 2.0 Hz, 
SCHCH2), 2.44 (3H, s, ArCH3), 2.23 (1H, ddd, J 6.5, 6.5, 2.5 Hz, SCHCH2), 1.71 (1H, 
dd, J 9.0, 6.0 Hz, SCHCH2); δC (125 MHz) 163.5, 163.5, 162.8, 162.7, 161.5, 161.5, 
160.8, 160.8 (CF), 144.3, 138.6, 138.1 (4°), 134.5 (CH=CH2), 129.5, 129.6, 129.7 
(CFCHCH), 129.7, 127.7 (3°), 115.2 (CH=CH2), 112.4, 112.2, 112.2, 112.1 
(CFCHCF), 111.8, 111.8, 111.7, 111.6, 111.4, 111.4, 111.3, 111.2 (CFCH), 44.9 
(SCH), 29.1 (SCHC), 21.6 (ArCH3), 18.9 (CH2); m/z (CI) 352 [M+NH4]+ (Found 
[M+NH4]+, 352.1197. C18H16F2O2S requires [M+NH4]+, 352.1183) (Found: C, 64.77; 
H, 4.73. C18H16F2O2S requires C, 64.65; H, 4.82). 
 
 (Z)-Methyl 4-phenyl-6-(methoxymethoxy)-2-((S)-N-(2,4,6-
(triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-4-enoate 
Ph
MOMO
OMs
S
OMe
O
+
S
OMe
O
Ph
MOMO
O
O
TrisN
TrisNPh
Ph
416 464 482c
 
According to general procedure D, a suspension of sodium hydride (13.7 mg, 0.57 
mmol, 1.2 equiv) in THF (0.75 mL) was treated with acetate 416 (228 mg, 0.48 mmol, 
1.0 equiv) in THF (1.0 mL) and methane sulfonate 464 (136 mg, 0.48 mmol, 1.0 
equiv) in THF (0.75 mL) to give (Z)-methyl 4-phenyl-6-(methoxymethoxy)-2-((S)-N-
(2,4,6-(triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-4-enoate 482c used crude 
in the next step; Rf 0.40 (50% EtOAc–petrol). 
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(Z)-Methyl 4-phenyl-6-hydroxy-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)hex-4-enoate 
 
According to general procedure E, a solution of ester 482c (276 mg, 0.41 mmol, 1.0 
equiv) in MeCN (4 mL) was treated with 2 M HCl(aq) (0.8 mL). Purification by column 
chromatography (20–50% EtOAc–petrol) gave (Z)-methyl 4-phenyl-6-hydroxy-2-((S)-
N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 483c as a 
colourless oil; Rf 0.16 (50% EtOAc–petrol); νmax (film) 2957, 2869, 1743, 1599, 1447, 
1313, 1296, 1243, 1195, 1147, 1091, 1048, 1021, 997, 764, 683 cm-1; δH (400 MHz) 
7.93 (2H, dd, J 8.0, 8.0 Hz, o-SPh), 7.74 (1H, m, p-SPh), 7.59 (2H, m, m-SPh), 7.32–
7.17 (5H, m, Ph), 7.10 (2H, s, m-SO2Ar), 5.97 (1H, 2 × t, J 6.5 Hz, CHCH2OH), [4.63, 
4.41] (1H, 2 × dd, J 11.5, 3.5 Hz, SCH), 4.30 (2H, sept, J 7.0 Hz, o-ArCH), 4.20 (2H, 
m, CH2OH), [3.48, 3.41] (3H, 2 × s, OCH3), 3.17 (2H, m, SCHCH2), 2.87 (1H, 2 × 
sept, J 7.0 Hz, p-ArCH), [2.04, 1.84] (1H, 2 × dd, J 7.0, 5.0 Hz, SCHCH2), 1.27–1.18 
(18H, m, CH(CH3)2); δC (100 MHz) 165.5, 165.4 (C=O), 152.2, 152.1, 149.2, 149.1, 
139.4, 139.3, 137.1, 137.0, 134.8, 134.6, (4°), 136.1, 135.8, 135.2, 134.9, 129.7, 129.6, 
129.2, 128.8, 128.6, 128.2, 128.1, 126.6, 126.4 (3°), 123.4, 123.4 (m-SO2Ar), 70.6, 
70.4 (SCH), 58.9, 58.8 (CH2OH), 53.1, 53.1 (OCH3), 34.1 (p-ArCH), 29.3 (o-ArCH), 
27.8, 26.7, (SCHCH2), 24.7, 24.6 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 
643 [M+NH4]+ (Found [M+NH4]+, 643.2873. C34H43NO6S2 requires [M+NH4]+, 
643.2870) (Found: C, 65.29; H, 6.93; N, 2.24. C34H43NO6S2 requires C, 65.25; H, 
6.93; N, 2.24.). 
 
6-Hydroxy-4-phenyl-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl) 
hex-4-enoic acid 
S
OMe
O
Ph
HO
O
TrisN
Ph S
OH
O
Ph
HO
O
TrisN
Ph
483c 484c
 
According to general procedure F, a solution of ester 483c (117 mg, 0.19 mmol, 1.0 
equiv) in THF (0.5 mL) was treated with 2 M LiOH(aq) (0.5 mL) to give 6-hydroxy-4-
phenyl-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) phenylsulfonimidoyl)hex-4-enoic 
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acid 484c as a colourless foam, without further purification; νmax (film) 3420, 2959, 
1738, 1599, 1447, 1311, 1295, 1244, 1147, 1092, 1049, 1021, 997, 764, 753, 743, 684 
cm-1; δH (300 MHz; CD3OD) 7.87 (2H, d, J 8.0 Hz, o-SPh), 7.79 (1H, 2 × t, J 7.5 Hz, 
p-SPh), 7.61 (2H, 2 × t, J 8.0 Hz, m-SPh), 7.31 (2H, s, m-SO2Ar), 7.25–7.09 (5H, m, 
Ph), [5.93, 5.87] (1H, 2 × t, J 6.5 Hz, CHCH2OH), 4.20 (2H, 2 × sept, J 6.5 Hz, o-
ArCH), 4.29–4.04 (3H, m, SCH and CH2OH), 3.40–3.06 (2H, m, SCHCH2), 2.90 (1H, 
2 × sept, J 6.5 Hz, p-ArCH), 1.26–1.12 (18H, m, CH(CH3)2); δC (75 MHz; CD3OD) 
166.7, 166.6 (C=O), 153.8, 153.8, 150.6, 150.6, 141.2, 141.0, 138.5, 138.5, 136.2, 
136.1, 133.4, 133.3 (4°),  136.5, 136.4, 130.9, 130.9, 130.6, 130.4, 129.8, 129.7 129.1, 
129.1, 127.7, 127.6, 124.6 (3°), 72.0, 71.5 (SCH), 59.7, 59.7 (CH2OH), 35.4 (p-ArCH), 
30.5, 30.5 (o-ArCH), 28.6, 28.0 (SCHCH2), 25.1, 25.1 (o-ArCH(CH3)2), 24.1 (p-
ArCH(CH3)2); m/z (CI) 629 [M+NH4]+, 594, 550 (Found [M+NH4]+, 629.2717. 
C33H41NO6S2 requires [M+NH4]+, 629.2714). 
 
(Z)-5-Phenyl 3-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-3,4-
dihydrooxepin-2(7H)-one 
S
OH
O
Ph
HO
O
TrisN
Ph
S
O
TrisN
Ph
O
O
Ph
484c 423c
 
According to general procedure G, a solution of acid 484c (109 mg, 0.18 mmol, 1.0 
equiv) in CH2Cl2 (1.0 mL) was treated with EDCI (41 mg, 0.21 mmol, 1.2 equiv). 
Purification by column chromatography (30% EtOAc–petrol) gave (Z)-5-phenyl 3-
((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-3,4-dihydrooxepin-
2(7H)-one 423c (103 mg, 36% over 4 steps) as a colourless solid; Rf 0.45 (50% 
EtOAc–petrol); νmax (film) 2958, 1753, 1599, 1446, 1311, 1246, 1148, 1093, 1057 cm-
1; δH (400 MHz) 8.17 (2H, m, o-SPh), 7.70 (1H, td, J 7.5, 1.5 Hz, p-SPh), 7.58 (2H, m, 
m-SPh), 7.37–7.31 (4H, m, o-/m-Ph), 7.27 (1H, m, p-Ph), [7.12, 7.11] (2H, 2 × s, m-
SO2Ar), [6.15, 5.91] (1H, dd, J 13.0, 3.5 Hz, SCH), 6.05 (1H, ddtd, J 9.5, 5.5, 3.5, 2.0 
Hz, OCH2CH), 5.26 (1H, ddd, J 16.0, 12.5, 3.5 Hz, OCH2), 4.67 (1H, dd, J 16.0, 7.5 
Hz, OCH2), 4.39 (2H, 2 × sept, J 7.0 Hz, o-ArCH), [3.82, 3.61] (1H, d, J 17.5 Hz, 
SCHCH2), 2.87 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 2.75 (1H, 2 × d, J 13.5 Hz, 
SCHCH2), 1.28–1.20 (18H, m, CH(CH3)2); δC (100 MHz) 166.3 (C=O), 152.3, 149.3, 
149.0, 141.0, 140.8, 140.4, 140.3, 137.0, 136.6, 133.6, 133.2 (4°), 134.9, 131.1, 131.0, 
128.9, 128.8, 128.7, 128.7, 126.3, 126.0, 123.5, 123.5, 121.9, 121.6 (3°), 66.0, 65.7 
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(SCH), 64.4, 64.2 (OCH2), 34.1 (p-ArCH), 31.9, 30.4 (SCHCH2), 29.4, 29.3 (o-ArCH), 
24.7, 24.7, 24.6, 24.5 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 611 [M+NH4]+, 
425, 301, 251, 206, 156, 132 (Found [M+NH4]+, 611.2623. C33H39NO5S2 requires 
[M+NH4]+, 611.2613) (Found: C, 66.66; H, 6.53; N, 2.27. C33H39NO5S2 requires C, 
66.75; H, 6.62; N, 2.36.). 
 
1-((S)-N-(2,4,6-Triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-phenyl-2-
vinylcyclopropane 
 
According to general procedure I, a solution of lactone 423c (50 mg, 0.08 mmol, 1.0 
equiv) was treated with KOAc (0.8 mg, 0.008 mmol, 0.1 equiv) and BSA (20.8 µL, 
0.08 mmol, 1.0 equiv) in DMF (0.4 mL) to give 1-((S)-N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-phenyl-2-vinylcyclopropane (34 
mg, 78%) as a mixture of diastereomers 486c:485c:488c:487c (9:6:6:4 separable by 
column chromatography; 10% EtOAc–petrol) as a colourless gum; 488c (isolated as a 
single diastereoisomer): Rf 0.44 (50% EtOAc–petrol); νmax (film) 2960, 1600, 1447, 
1423, 1311, 1265, 1148, 1099, 1068, 998, 737, 702 cm-1; δH (400 Hz) 8.03 (2H, d, J 
7.5 Hz, o-Ph), 7.70 (1H, tt, J 7.5, 1.5 Hz, p-Ph), 7.60 (2H, t, J 7.5 Hz, m-Ph), 7.21 (3H, 
m, Ph), 7.11 (2H, s, m-SO2Ar), 6.82 (2H, m, Ph), 6.12 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2), 5.04 (1H, dd, J 10.5, 1.0 Hz, CH=CH2 trans), 4.42 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 4.39 (2H, sept, J 7.0 Hz, o-ArCH), 3.33 (1H, dd, J 9.0, 6.0 Hz, SCH), 
2.88 (1H, sept, J 7.0 Hz, p-ArCH), 2.30 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 2.07 (1H, 
dd, J 9.0, 6.0 Hz, SCHCH2), 1.24 (18H, m, CH3); δC (100 MHz) 151.9, 149.1, 139.2, 
139.1, 137.3 (4°), 138.8 (CH=CH2), 134.0, 129.2, 128.6, 127.8, 127.7, 123.3 (3°), 
119.0 (CH=CH2), 48.4 (SCH), 39.4 (SCHC), 34.1 (p-ArCH), 29.2 (o-ArCH), 24.7, 
24.6, 23.7, 23.6 (CH(CH3)2), 20.0 (SCHCH2); m/z (CI) 550 [M+H]+, 567, 425, 301 
(Found [M+H]+, 550.2457. C32H39NO3S2 requires [M+H]+, 550.2450).  
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486c (isolated as a single diastereoisomer): Rf 0.41 (50% EtOAc–petrol); νmax (film) 
2961, 2929, 1600, 1463, 1447, 1423, 1311, 1265, 1149, 1097, 1051, 739, 703 cm-1; δH 
(400 Hz) 8.04 (2H, d, J 7.5 Hz, o-Ph), 7.68 (1H, t, J 7.5 Hz, p-Ph), 7.58 (2H, t, J 7.5 
Hz, m-Ph), 7.29 (5H, m, Ph), 7.12 (2H, s, m-SO2Ar), 6.43 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2), 5.12 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.65 (1H, dd, J 17.0, 0.5 Hz, 
CH=CH2 cis), 4.39 (2H, sept, J 7.0 Hz, o-ArCH), 3.03 (1H, dd, J 8.5, 6.5 Hz, SCH), 
2.90 (1H, sept, J 7.0 Hz, p-ArCH), 2.03 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.75 (1H, 
dd, J 8.5, 6.0 Hz, SCHCH2), 1.28 (18H, m, CH3);  δC (125 MHz) 151.8, 149.2, 140.3, 
139.7, 137.5 (4°), 136.1, 133.8, 129.5, 129.4, 128.6, 127.9, 127.7, 123.2 (3°), 118.8 
(CH=CH2), 49.0 (SCH), 41.1 (SCHC), 34.1 (p-ArCH), 29.3 (o-ArCH), 24.8, 24.7, 
23.7, 23.6 (CH(CH3)2), 19.1 (SCHCH2); m/z (CI) 550 [M+H]+, 567, 425, 301 (Found 
[M+H]+, 550.2465. C32H39NO3S2 requires [M+H]+, 550.2450). 
 
485c (isolated as a single diastereoisomer): Rf 0.38 (50% EtOAc–petrol); νmax (film) 
2960, 2928, 1600, 1463, 1448, 1311, 1295, 1265, 1244, 1148, 1098, 1068, 1030, 738, 
702 cm-1; δH (400 Hz) 7.61 (1H, m, Ph), 7.43 (4H, m, Ph), 7.21 (1H, m, Ph), 7.10 (2H, 
m, Ph), 7.08 (2H, s, m-SO2Ar), 6.79 (2H, d, J 7.5 Hz, Ph), 5.72 (1H, dd, J 17.0, 10.5 
Hz, CH=CH2), 5.05 (1H, d, J 10.5 Hz, CH=CH2 trans), 4.82 (1H, d, J 17.0 Hz, 
CH=CH2 cis), 4.33 (2H, sept, J 6.5 Hz, o-ArCH), 3.51 (1H, dd, J 9.0, 5.5 Hz, SCH), 
2.87 (1H, sept, J 7.0 Hz, p-ArCH), 2.63 (1H, dd, J 6.0, 6.0 Hz, SCHCH2), 1.89 (1H, 
dd, J 9.0, 6.0 Hz, SCHCH2), 1.25 (18H, m, CH3);  δC (100 MHz) 151.7, 149.0, 140.3, 
137.8, 137.2 (4°), 133.5, 132.4, 130.3, 129.4, 128.7, 128.0, 127.6, 123.2 (3°), 115.6 
(CHCH2), 46.8 (SCH), 38.2 (SCHC), 34.1 (p-ArCH), 29.1 (o-ArCH), 24.7, 24.6, 23.7, 
23.6 (CH(CH3)2), 17.4 (SCHCH2); m/z (CI) 550 [M+H]+, 567, 425, 301, 272, 254, 237 
(Found [M+H]+, 550.2435. C32H39NO3S2 requires [M+H]+, 550.2450).  
 
(Z)-Methyl 4-(2,4-difluorophenyl)-6-(methoxymethoxy)-2-((S)-N-(2,4,6-
(triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-4-enoate 
 
According to general procedure D, a suspension of sodium hydride (54 mg, 1.35 
mmol, 1.1 equiv) in THF (1.5 mL) was treated with acetate 416 (589 mg, 1.23 mmol, 
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1.0 equiv) in THF (2 mL) and methane sulfonate 426a (396 mg, 1.23 mmol, 1.0 equiv) 
in THF (1.5 mL) to give (Z)-methyl 4-(2,4-difluorophenyl)-6-(methoxymethoxy)-2-
((S)-N-(2,4,6-(triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 482a as a 
colourless gum, used without further purification; Rf 0.44 (50% EtOAc–petrol); νmax 
(film) 2955, 2925, 1744, 1599, 1501, 1315, 1243, 1148, 1091, 1039, 1022, 997, 961, 
845, 684 cm-1; δH (300 MHz) 7.92 (2H, d, J 7.5 Hz, o-Ph), 7.74 (1H, t, J 7.5 Hz, p-Ph), 
7.59 (2H, t, J 8.0 Hz, m-Ph), 7.08 (2H, m-SO2Ar), 7.13–7.03 (1H, m, ArF), 6.85–6.70 
(2H, m, ArF), 5.76 (1H, t, J 6.5 Hz, CHCH2O), 4.58 (2H, s, OCH2O), 4.47 (1H, dd, J 
12.0, 3.0 Hz, SCH), 4.27 (2H, sept, J 7.0 Hz, o-ArCH), 4.10 (2H, dd, J 6.5, 3.0 Hz, 
OCH2CH), 3.54 (3H, s, CO2CH3), 3.34 (3H, s, CH2OCH3), [3.21, 3.17] (1H, 2 × m, 
SCHCH2), 3.00 (1H, 2 × d, J 12.0 Hz, SCHCH2), 2.86 (1H, sept, J 7.0 Hz, p-ArCH), 
1.25–1.16 (18H, m, CH(CH3)2); δC (75 MHz) 164.8 (C=O), 164.3, 164.0, 161.6, 161.5, 
161.0, 160.8, 158.3, 158.2 (CF), 152.1, 149.2, 137.0, 133.0 (4°),134.8, 134.7, 129.7, 
129.2, 123.4 (3°), 131.3, 131.2, 131.2, 131.1 (CFCHCH), 124.0, 123.9, 123.8, 123.7 
(CCF), 111.5, 111.5 111.3, 111.2 (CFCHCH), 104.6, 104.2, 103.9 (CFCHCF), 95.9 
(OCH2O), 70.1 (SCH), 63.3 (CHCH2O), 55.4 (CH2OCH3), 53.1 (CO2CH3), 34.1 (p-
ArCH), 29.7, 29.0 (SCHCH2), 29.3 (o-ArCH), 24.7 (o-ArCH(CH3)2), 23.6 (p-
ArCH(CH3)2); m/z (EI) 723 [M+NH4]+ (Found [M+NH4]+, 723.2943. C36H45F2NO7S2 
requires [M+NH4]+, 723.2944) (Found: C, 61.23; H, 6.42; N, 1.95. C36H45F2NO7S2 
requires C, 61.26; H, 6.43; N, 1.98.). 
  
(Z)-Methyl 4-(2,4-difluorophenyl)-6-hydroxy-2-((S)-N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 
 
According to general procedure E, ester 482a (433 mg, 0.61 mmol, 1.0 equiv) in 
MeCN (6 mL) was treated with 2 M HCl(aq) (1.2 mL). Purification by column 
chromatography (20–40% EtOAc–petrol) gave (Z)-methyl 4-(2,4-difluorophenyl)-6-
hydroxy-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) phenylsulfonimidoyl)hex-4-
enoate 483a (331 mg, 41% over 2 steps) as a colourless gum; Rf 0.21 (50% EtOAc–
petrol); νmax (film) 2958, 1743, 1599, 1501, 1447, 1423, 1312, 1295, 1242, 1147, 1091, 
1048, 1021, 997, 966, 846, 769, 740, 684 cm-1; δH (500 MHz) 7.90 (2H, m, o-Ph), 7.73 
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(1H, m, p-Ph), 7.58 (2H, m, m-Ph), 7.09 (1H, m, o-ArF), 7.09 (2H, s, m-SO2Ar), 6.79 
(2H, m, m-ArF), 5.84 (1H, 2 × t, J 6.5 Hz, CHCH2OH), [4.69, 4.38] (1H, 2 × dd, J 
11.5, 3.5 Hz, CHCH2OH), 4.30 (2H, m, CH2OH), 4.24 (2H, m, o-ArCH), [3.53, 3.46] 
(3H, 2 × s, OCH3), [3.33, 3.25] (1H, 2 × dd, J 14.0, 3.5 Hz, SCHCH2), [3.16, 2.97] 
(1H, 2 × dd, J 14.0, 11.5 Hz, SCHCH2), 2.86 (1H, 2 × sept, J 7.0 Hz, p-ArCH), [2.14, 
1.85] (1H, t, J 6.0 Hz, OH), 1.21 (18H, m, CH(CH3)2); δC (125 MHz) 165.6, 165.4 
(C=O), 163.6, 163.5, 161.6, 161.5, 161.0, 160.9, 159.0, 158.9 (CF), 152.2, 152.2, 
149.2, 149.1, 137.1, 136.9, 134.0, 130.8, 130.7 (4°), 124.1, 124.0, 124.0, 123.9 (CCF), 
135.3, 135.1, 135.0, 134.9, 129.7, 129.6, 129.2, 123.5, 123.4 (3°), 131.3, 131.3, 131.2, 
131.2, 131.1, 131.1, 131.0, 131.0 (CFCHCH), 111.7, 111.5, 111.3 (CFCHCH), 104.6, 
104.4, 104.2, 104.0 (CFCHCF), 70.7, 70.3 (SCH), 58.7, 58.5 (CH2OH), 53.2, 53.2 
(OCH3), 34.1 (p-ArCH), 29.3, 29.3 (o-ArCH), 28.9, 27.8 (SCHCH2), 24.7, 24.6 (o-
ArCH(CH3)2), 23.6 (p-ArCH(CH3)2; δF (376 MHz) [–108.8, –109.0] (1F, 2 × qd, J 8.0, 
6.5 Hz, o-CF), –109.8 (1F, m, p-CF); m/z (EI) 679 [M+NH4]+, 644, 408 (Found 
[M+NH4]+, 679.2680. C34H41F2NO6S2 requires [M+NH4]+, 679.2682) (Found: C, 
61.80; H, 6.32; N, 2.18. C34H41F2NO6S2 requires C, 61.70; H, 6.24; N, 2.12). 
 
6-Hydroxy-4-(2,4-difluorophenyl)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)hex-4-enoic acid  
 
According to general procedure F, ester 483a (326 mg, 0.49 mmol, 1.0 equiv) in THF 
(1.25 mL) was treated with 2 M LiOH(aq) (1.25 mL) to give 6-hydroxy-4-(2,4-
difluorophenyl)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-
4-enoic acid 484a (290 mg, 91%) as a colourless foam, without further purification; 
νmax (film) 2958, 2556, 1731, 1599, 1501, 1448, 1423, 1293, 1244, 1141, 1091, 1049, 
1021, 997, 966, 848, 765, 741, 684 cm-1; δH (300 MHz; CD3OD) 7.86 (2H, d, J 8.0 Hz, 
o-Ph), 7.78 (1H, m, p-Ph), 7.60 (2H, m, m-Ph), 7.24–7.09 (1H, m, o-ArF), 7.15 (2H, s, 
m-SO2Ar), 6.96–6.81 (2H, m, m-ArF), 5.77 (1H, 2 × t, J 6.5 Hz, CHCH2OH), 4.29–
4.03 (3H, m, SCH and CH2OH), 4.17 (2H, 2 × sept, J 6.5 Hz, o-ArCH), 3.28–3.05 
(2H, m, SCHCH2), 2.90 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 1.26–1.12 (18H, m, 
CH(CH3)2); δC (75 MHz; CD3OD) 166.0 (C=O), 165.9, 165.7, 163.2, 163.0, 162.6, 
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162.4, 159.9, 159.7 (CF), 153.8, 150.6, 150.6, 138.5, 138.4, 137.2, 137.0, 136.3, 136.2 
(4°), 126.0, 126.0, 125.8, 125.6 (CCF), 133.2, 133.1, 133.0, 133.0, 131.5, 131.4, 124.5 
(3°), 130.9, 130.8, 130.6, 130.4 (CFCHCH), 112.7, 112.4, 112.3 (CFCHCH), 105.4, 
105.0, 104.7 (CFCHCF) 72.0, 71.4 (SCH), 59.3, 59.2 (CH2OH), 35.4 (p-ArCH), 30.5 
(o-ArCH), 29.7, 29.0 (SCHCH2) 25.1, 25.1, 25.0 (o-ArCH(CH3)2), 24.1 (p-
ArCH(CH3)2); m/z (EI) 665 [M+NH4]+, 630 (Found [M+NH4]+, 665.2524. 
C33H39F2NO6S2 requires [M+NH4]+, 665.2525) (Found: C, 61.06; H, 5.99; N, 2.09. 
C33H39F2NO6S2 requires C, 61.19; H, 6.07; N, 2.16). 
 
(Z)-5-(2,4-Difluorophenyl) 3-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)-3,4-dihydrooxepin-2(7H)-one 
 
According to general procedure G, acid 484a (260 mg, 0.40 mmol, 1.0 equiv) in 
CH2Cl2 (1.0 mL) at 0 °C was treated with EDCI (85 mg, 0.44 mmol, 1.1 equiv). 
Purification by column chromatography (40% EtOAc–petrol) gave (Z)-5-(2,4-
difluorophenyl) 3-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-3,4-
dihydrooxepin-2(7H)-one 423a (89 mg, 35%) as a colourless solid; mp 86–87 °C; Rf 
0.48 (50% EtOAc–petrol); νmax (film) 2959, 1754, 1502, 1231, 1141, 1090, 1048, 
1022, 998, 972, 847, 733, 682 cm-1; δH (400 MHz) 8.13 (2H, 2 × d, J 7.0 Hz, o-Ph), 
7.70 (1H, t, J 7.5 Hz, p-Ph), 7.57 (2H, t, J 7.5 Hz, m-Ph), 7.30–7.12 (1H, m, o-ArF), 
[7.12, 7.10] (2H, 2 × s, m-SO2Ar), 6.92–6.79 (2H, m, m-ArF), [6.08, 5.89] (1H, 2 × dd, 
J 13.0, 3.5 Hz, SCH), 5.96 (1H, m, CHCH2O), 5.23 (1H, ddd, J 16.0, 13.0, 3.5 Hz, 
OCH2), 4.68 (1H, ddd, J 16.0, 7.5, 4.0 Hz, OCH2), 4.37 (2H, sept, J 6.5 Hz, o-ArCH), 
[3.66, 3.47] (1H, 2 × d, J 17.5 Hz, SCHCH2), 2.88 (1H, sept, J 6.5 Hz, p-ArCH), 2.78 
(1H, m, SCHCH2) 1.27–1.12 (18H, m, CH(CH3)2); δC (125 MHz) 166.1, 166.0 (C=O), 
163.8, 163.8, 161.9, 161.8, 160.6, 160.5, 158.6, 158.5 (CF), 152.3, 152.2, 149.2, 149.0, 
136.9, 136.5, 135.9, 135.7, 134.9, 134.9, 133.5, 133.2 (4°), 131.0, 130.9, 128.9, 128.8, 
125.5, 125.1, 123.5, 123.4 (3°), 130.6, 130.6, 130.5, 130.5, 130.4, 130.4, 130.3, 130.3 
(CFCHCH), 124.7, 124.7, 124.6, 124.5 (CCF), 111.9, 111.8, 111.8, 111.8 111.7, 
111.7, 111.6, 111.6 (CFCHCH), 104.7, 104.5, 104.3 (CFCHCF), 65.8, 65.4 (SCH), 
64.0, 63.8 (OCH2), 34.1, 34.1 (p-ArCH), 32.0, 30.6 (SCHCH2), 29.3, 29.3 (o-ArCH), 
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24.7, 24.6, 24.4 (o-ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (EI) 647 [M+NH4]+, 630 
[M+H]+ (Found [M+H]+, 630.2156. C33H37F2NO5S2 requires [M+H]+, 630.2154) 
(Found: C, 63.07; H, 5.97; N, 2.18. C33H37F2NO5S2 requires C, 62.94; H, 5.92; N, 
2.22). 
 
1-((S)-N-(2,4,6-Triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-(2,4-
difluorophenyl)-2-vinylcyclopropane 
 
 
According to general procedure I, lactone 423a (7.0 mg, 0.02 mmol, 1.0 equiv) in 
DMF (0.1 mL) was treated with KOAc (pinch) and BSA (4.6 µL, 0.02 mmol, 1.0 
equiv) to give gave 1-((S)-N-(2,4,6-triisopropylphenylsulfonyl) phenylsulfonimidoyl)-
2-(2,4-difluorophenyl)-2-vinylcyclopropane (5 mg, 70%) as a mixture of 
diastereoisomers 486a:485a:488a:487a (9:6:6:4) as a colourless gum. Purification by 
column chromatography (10–40% EtOAc–petrol) allowed partial separation of the 
diastereoisomeric mixture; 485a (isolated as a single diastereoisomer): Rf 0.60 (50% 
EtOAc–petrol); νmax (film) 2985, 1740, 1447, 1374, 1240, 1047, 938, 847, 737, 634, 
608 cm–1; δH (500 MHz) 8.00 (2H, dd, J 8.5, 1.0 Hz, o-Ph), 7.69 (1H, tt, J 7.5, 1.5 Hz, 
p-Ph), 7.57 (2H, t, J 8.0 Hz, m-Ph), 7.12 (2H, s, m-SO2Ar), 6.89 (1H, dt, J 8.5, 6.5 Hz, 
CFCHCH) 6.78 (1H, t, J 8.0, Hz, CFCHCH) 6.67 (1H, ddd, J 10.0, 9.0, 2.5 Hz, 
CFCHCF) 6.11 (1H, dd, J 17.0, 10.5 Hz, CH=CH2), 5.06 (1H, dd, J 10.5, 1.0 Hz, 
CH=CH2 trans) 4.44 (1H, d, J 17.0 Hz, CH=CH2 cis) 4.40 (2H, sept, J 7.0 Hz, o-
ArCH) 3.29 (1H, dd, J 9.0, 6.0 Hz, SCH) 2.88 (1H, sept, J 7.0 Hz, p-ArCH) 2.39 (1H, 
dd, J 6.5, 6.5 Hz, SCHCH2) 2.06 (1H, dd, J 9.0, 6.5 Hz, SCHCH2), 1.22–1.25 (18H, m, 
CH(CH3)2); δC (125 MHz) 163.6, 163.5, 162.3, 162.2, 160.2, 160.1 (CF), 152.0, 149.1, 
138.2, 137.1 (4°), 134.2 (CH=CH2), 134.1 (p-Ph), 132.0, 131.9, 131.9 (CFCHCH), 
129.0 (m-Ph), 128.1 (o-Ph), 123.3 (m-SO2Ar), 122.3, 122.2 (CCF), 118.4 (CH=CH2), 
111.7, 111.6 (CFCHCH), 104.5, 104.3, 104.1 (CFCHCF), 48.0 (SCH), 34.1 (SCHC), 
34.1 (p-ArCH), 29.2 (o-ArCH), 24.7, 24.6, 23.7, 23.6 (CH(CH3)2), 20.3 (SCHCH2); 
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m/z (CI) 603 [M+NH4]+, 586, 301 (Found [M+H]+, 586.2257. requires [M+H]+, 
586.2261). 
 
488a and 486a (isolated as a mixture of the two diastereoisomers): Rf 0.67 (50% 
EtOAc–petrol); νmax (film) 2985, 1740, 1447, 1374, 1240, 1094, 1047, 938, 847, 737, 
634, 608 cm–1; δH (500 MHz) 8.03 (2H, dd, J 8.5, 1.0 Hz, o-Ph major) 7.66 (2H, m, 
Ph) 7.57 (3H, m, Ph) 7.47 (2H, dd, J 8.5, 7.5 Hz, m-Ph minor) 7.32 (1H, dt, J 8.5, 6.5 
Hz, p-Ph major), 7.11 (2H, s, m-SO2Ar major), 7.06 (2H, s, m-SO2Ar minor), 6.85 
(1H, m, ArF), 6.74 (1H, m, ArF), 6.50 (1H, m, ArF), 6.36 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2 major), 5.60 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 minor), 5.11 (1H, dd, J 10.5, 
1.0 Hz, CH=CH2 trans major), 5.02 (1H, d, J 10.5Hz, CH=CH2 trans minor), 4.74 
(1H, dd, J 17.0, 1.5 Hz, CH=CH2 cis minor), 4.64 (1H, d, J 17.0Hz, CH=CH2 cis 
major), 4.35 (2H, sept, J 6.5 Hz, o-ArCH major), 4.27 (2H, sept, J 6.5 Hz, o-ArCH 
minor), 3.43 (1H, dd, J 9.0, 5.5 Hz, SCH minor), 2.98 (1H, dd, J 9.0, 6.5 Hz, SCH 
major), 2.88 (1H, sept, J 6.5 Hz, p-ArCH major), 2.85 (1H, sept, J 6.5 Hz, p-ArCH 
minor), 2.61 (1H, dd, J 6.0, 6.0 Hz, SCHCH2 minor), 2.13 (1H, dd, J 6.5 Hz, SCHCH2 
major), 1.96 (1H, dd, J 9.0, 6.5 Hz, SCHCH2 minor), 1.71 (1H, dd, J 9.0, 6.0 Hz, 
SCHCH2 major), 1.30–1.17 (18H, m, CH(CH3)2); δC (125 MHz) 163.7, 163.6, 163.5, 
162.8, 162.1, 162.1, 161.7, 161.6, 161.5, 160.8, 160.7, 160.1, 160.0 (CF), 151.9, 149.2, 
149.0, 137.6, 137.4, 137.0 (4°), 138.5, 134.5 (CH=CH2), 134.0, 133.9, 129.4, 129.0, 
128.0, 127.6 (3°), 132.9, 132.9, 132.8, 132.8 (CFCHCH), 123.3, 122.8, 122.8, 122.7, 
122.6 (CCF), 118.3, 115.6 (CH=CH2), 117.0, 117.0, 111.7, 111.7, 111.5, 111.5, 111.2, 
111.0 (CFCHCH), 104.4, 104.2, 104.1, 104.0, 103.9, 103.7 (CFCHCF), 48.9, 46.7 
(SCH), 35.5, 34.1, 33.9 (p-ArCH), 29.7, 29.3, 29.1 (o-ArCH), 24.8, 24.8, 24.6, 24.6, 
23.7, 23.6, 23.6 (CH(CH3)2), 19.7, 17.7 (SCHCH2); m/z (CI) 603 [M+NH4]+, 586, 425 
(Found [M+H]+, 586.2258. requires [M+H]+, 586.2261) 
 
 (Z)-Methyl 4-(2,6-difluorophenyl)-6-(methoxymethoxy)-2-((S)-N-(2,4,6-
(triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-4-enoate 
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According to general procedure D, sodium hydride (102 mg, 2.55 mmol, 1.2 equiv) in 
DMF (3.5 mL) was treated with acetate 416 (1.02 mg, 2.13 mmol, 1.0 equiv) in DMF 
(3.5 mL) and methane sulfonate 426b (2.13 mmol, 1.0 equiv) in DMF (3.5 mL) to give 
(Z)-methyl 4-(2,6-difluorophenyl)-6-(methoxymethoxy)-2-((S)-N-(2,4,6-
(triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 482b as a colourless 
gum, used crude in the next step; Rf 0.71 (50% EtOAc–heptane). 
 
(Z)-Methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-((S)-N-(2,4,6-
triisopropylphenylsulfonyl)phenylsulfonimidoyl)hex-4-enoate 
 
According to general procedure E, ester 482b (2.13 mmol, 1.0 equiv) in MeCN (22 
mL) was treated with 2 M HCl(aq) (4.5 mL). Purification by column chromatography 
(20–40% EtOAc–petrol) gave (Z)-methyl 4-(2,6-difluorophenyl)-6-hydroxy-2-((S)-N-
(2,4,6-triisopropylphenylsulfonyl) phenylsulfonimidoyl)hex-4-enoate 483b (491 mg, 
33% over 3 steps) as a colourless gum; Rf 0.36 (50% EtOAc–heptane); νmax (film) 
2958, 1744, 1621, 1462, 1316, 1237, 1150, 1095, 1057 cm-1; δH (400 MHz) 7.90 (2H, 
d, J 8.0 Hz, o-Ph), 7.72 (1H, m, p-Ph), 7.58 (2H, m, m-Ph), 7.22 (1H, m, o-ArF), 7.09 
(2H, s, m-SO2Ar), 6.86 (2H, 2 × t, J 8.0 Hz, m-ArF), 5.84 (1H, 2 × t, J 6.5 Hz, 
CHCH2OH), 4.64 (1H, dd, J 12.0, 3.0 Hz, SCH), 4.37 (1H, dd, J 11.0, 4.5 Hz, SCH),  
4.29 (2H, m, CH2OH), 4.25 (2H, m, o-ArCH), [3.58, 3.47] (3H, 2 × s, OCH3), [3.25, 
3.18] (1H, 2 × dd, J 13.5, 2.0 Hz, SCHCH2), [3.15, 3.00] (1H, 2 × d, J 12.0 Hz, 
SCHCH2), 2.86 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 2.05 (1H, br s, OH), 1.20 (18H, m, 
CH(CH3)2); δC (100 MHz) 165.5, 165.3 (C=O), 161.4, 158.9 (CF), 152.2, 152.1, 149.2, 
149.1, 137.7, 137.5, 134.1, 129.4 (4°), 137.1, 136.9 (CHCH2OH), 134.9, 134.8, 129.6, 
129.5, 129.3, 129.2, 123.4 (3°), 124.1, 124.0 (CFCHCH), 117.1 (CCF), 111.7, 111.6, 
111.5, 111.3 (CFCHCH), 70.4, 70.1 (SCH), 58.6, 58.5 (CH2OH), 53.2, 53.1 (OCH3), 
34.1 (p-ArCH), 29.3 (o-ArCH), 29.0, 27.8 (SCHCH2), 24.6, 24.6 (o-ArCH(CH3)2), 
23.6 (p-ArCH(CH3)2); m/z (CI) 679 [M+NH4]+, 586, 425, 301, 272 (Found [M+H]+, 
662.2416. C34H41F2NO6S2 requires [M+H]+, 662.2422) (Found: C, 61.77; H, 6.18; N, 
2.11. C34H41F2NO6S2 requires C, 61.70; H, 6.24; N, 2.12). 
 
Experimental 
 
 191 
6-Hydroxy-4-(2,6-difluorophenyl)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)hex-4-enoic acid  
S OMe
O
HO
F
TrisN
O
Ph
F
S OH
O
HO
F
TrisN
O
Ph
F
483b 484b
 
According to general procedure F, ester 483b (491 mg, 0.74 mmol, 1.0 equiv) in THF 
(1.85 mL) was treated with 2 M LiOH(aq) (1.85 mL) to give 6-hydroxy-4-(2,6-
difluorophenyl)-2-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl) hex-
4-enoic acid 484b (402 mg, 84%) as a colourless foam, without further purification; 
νmax (film) 3427, 2961, 2929, 2870, 1707, 1622, 1599, 1463, 1398, 1265, 1232, 1146, 
1095, 1064, 1021, 998, 738 cm-1; δH (400 MHz; CD3OD) 7.80 (2H, d, J 7.5 Hz, o-Ph), 
7.71 (1H, 2 × t, J 7.5 Hz, p-Ph), 7.53 (2H, 2 × t, J 7.5 Hz, m-Ph), 7.31 (1H, m, o-ArF), 
[7.14, 7.13] (2H, 2 × s, m-SO2Ar), 6.92 (2H, 2 × t, J 8.0 Hz, m-ArF), [5.80, 5.74] (1H, 
2 × t, J 6.5 Hz, CHCH2OH), [4.39, 4.29] (2H, 2 × dd, J 13.5, 7.0 Hz, CH2OH), 4.17 
(2H, 2 × sept, J 6.5 Hz, o-ArCH), 3.96 (1H, d, J 11.5 Hz, SCH), [3.44, 3.22, 2.85] (2H, 
3 × m, SCHCH2), 2.91 (1H, 2 × sept, J 7.0 Hz, p-ArCH), 1.18–1.10 (18H, m, 
CH(CH3)2); δC (100 MHz; CD3OD) 169.0, 168.7 (C=O), 162.9, 160.5 (CF), 153.7, 
153.5, 150.5, 150.4, 138.7, 138.1, 135.8, 129.4 (4°), 137.9, 137.4, 136.9, 135.4, 135.3, 
130.8, 130.6, 130.4, 130.2, 130.1, 126.8, 126.6 (3°), 124.4 (CFCHCH), 119.2, 119.0, 
118.8 (CCF), 112.8, 112.7, 112.7, 112.5, 112.5 (CFCHCH), 74.6 (SCH), 59.2, 59.1 
(CH2OH), 35.4 (p-ArCH), 30.3 (o-ArCH), 25.1, 25.0, 24.9 (o-ArCH(CH3)2), 24.1 (p-
ArCH(CH3)2); m/z (CI) 621 [M-CO2+NH4]+, 370, 301 (Found [M-CO2+NH4]+, 
621.2609. C33H39F2NO6S2 requires [M+NH4]+, 621.2632) (Found: C, 61.18; H, 6.14; 
N, 2.16. C33H39F2NO6S2 requires C, 61.19; H, 6.07; N, 2.16). 
 
(Z)-5-(2,6-Difluorophenyl) 3-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)-3,4-dihydrooxepin-2(7H)-one 
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According to general procedure G, acid 484b (360 mg, 0.56 mmol, 1.0 equiv) in 
CH2Cl2 (2.8 mL) at 0 °C was treated with EDCI (118 mg, 0.62 mmol, 1.1 equiv). 
Purification by column chromatography (30% EtOAc–petrol) gave (Z)-5-(2,6-
difluorophenyl) 3-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-3,4-
dihydrooxepin-2(7H)-one 423b (289 mg, 82%) as a colourless solid; mp 86–87 °C; Rf 
0.69 (50% EtOAc–petrol); νmax (film) 2959, 1756, 1623, 1599, 1464, 1401, 1267, 
1234, 1148, 1092, 1064, 1023, 998, 738 cm-1; δH (400 MHz) 8.12 (2H, 2 × d, J 8.5 Hz, 
o-Ph), 7.69 (1H,  2 × t, J 8.5 Hz, p-Ph), 7.56 (2H, 2 × t, J 8.0 Hz, m-Ph), 7.27 (1H, m, 
o-ArF), [7.12, 7.10] (2H, 2 × s, m-SO2Ar), 6.91 (2H, m, m-ArF), 5.98 (1H, m, 
CHCH2O), [5.96, 5.90] (1H, 2 × dd, J 13.0, 3.5 Hz, SCH), [5.27, 5.21] (1H, 2 × ddd, 
16.0, 13.0, 3.5 Hz, OCH2), 4.68 (1H, ddd, J 16.0, 7.5, 4.5 Hz, OCH2), 4.3 (2H, sept, J 
6.5 Hz, o-ArCH), [3.54, 3.36] (1H, 2 × d, J 17.5 Hz, SCHCH2), 2.88 (1H, sept, J 6.5 
Hz, p-ArCH), 2.78 (1H, m, SCHCH2) 1.27–1.12 (18H, m, CH(CH3)2); δC (100 MHz) 
166.0, 165.9 (C=O), 161.0, 161.0, 160.9, 158.6, 158.5, 158.4 (CF), 152.3, 152.2, 
149.3, 149.0, 137.1, 136.6, 134.9, 133.7, 133.6, (4°), 131.0, 130.9, 130.1, 130.0, 129.9 
(CFCHCH), 128.9, 128.8, 127.9, 127.7, 123.5 (3°), 117.7, 117.6, 117.5, 117.4, 117.3, 
117.2 (CCF), 112.0, 111.9, 111.7, 111.7 (CFCHCH), 66.0, 65.4 (SCH), 63.8, 63.7 
(OCH2), 34.1 (p-ArCH), 31.7, 30.5 (SCHCH2), 29.3 (o-ArCH), 24.7, 24.5 (o-
ArCH(CH3)2), 23.6 (p-ArCH(CH3)2); m/z (CI) 647 [M+NH4]+, 603, 586, 425, 370, 
352, 335, 301, 240 (Found [M+NH4]+, 647.2405. C33H37F2NO5S2 requires [M+NH4]+, 
647.2425) (Found: C, 62.83; H, 5.85; N, 2.15. C33H37F2NO5S2 requires C, 62.94; H, 
5.92; N, 2.22). 
 
1-((S)-N-(2,4,6-Triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-(2,6-
difluorophenyl)-2-vinylcyclopropane 
 
According to general procedure I, lactone 423b (74 mg, 0.12 mmol, 1.0 equiv) in 
DMF (0.6 mL) was treated with KOAc (1.2 mg, 0.012 mmol, 0.1 equiv) and BSA (29 
µL, 0.12 mmol, 1.0 equiv). Purification by column chromatography (10–20% Et2O–
petrol) gave 1-((S)-N-(2,4,6-triisopropylphenylsulfonyl)phenylsulfonimidoyl)-2-(2,6-
Experimental 
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difluorophenyl)-2-vinylcyclopropane (56 mg, 78%) as an inseparable mixture of 
diastereoisomers 486b:485b:488b:487b (9:6:6:4) as a colourless gum;  
 
Rf 0.75 (50% EtOAc–petrol); νmax (film) 2960, 2869, 1625, 1599, 1585, 1467, 1448, 
1312, 1296, 1236, 1148, 1100, 1052, 1006, 910, 788, 772, 735, 684 cm–1; δH (500 
MHz) [8.09, 8.02] (2H, 2 × d, J 7.5 Hz, o-Ph), 7.71–7.47 (m, Ph), 7.24 (m, Ph), [7.14, 
7.08] (2H, 2 × s, SO2Ar), 6.84 (2H, t, J 8.0 Hz, m-ArF), 6.56 (1H, t, J 8.0 Hz, p-ArF), 
6.42 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 486b), 6.11 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 
488b), 5.62 (1H, dd, J 17.0, 10.5 Hz, CH=CH2 487b), 5.59 (1H, dd, J 17.0, 10.5 Hz, 
CH=CH2 485b), 5.18 (1H, d, J 10.5 Hz, CH=CH2 cis 486b), 5.10 (1H, d, J 10.5 Hz, 
CH=CH2 cis 487b), 5.09 (1H, d, J 10.5 Hz, CH=CH2 cis 488b), 5.06 (1H, d, J 10.5 Hz, 
CH=CH2 cis 485b), 4.87 (1H, d, J 17.0 Hz, CH=CH2 trans 487b), 4.80 (1H, d, J 17.0 
Hz, CH=CH2 trans 485b), 4.70 (1H, d, J 17.0 Hz, CH=CH2 trans 486b), 4.55 (1H, d, J 
17.0 Hz, CH=CH2 trans 488b), [4.44, 4.39, 4.30] (2H, 3 × sept, J 6.5 Hz, o-ArCH), 
[3.40, 2.94, 2.82] (1H, 3 × m, SCH), 2.91 (1H, sept, J 6.5 Hz, p-ArCH), [2.51, 2.38] 
(1H, 4 × dd, J 6.5, 6.5 Hz, SCHCH2), [2.11, 1.82] (1H, 2 × dd, J 9.0, 7.0 Hz, 
SCHCH2), 1.30–1.19 (18H, m, CH(CH3)2); δC (125 MHz) 162.4, 162.4, 160.4, 160.4 
(CF), 151.8, 149.3, 149.0, 139.8, 137.8, 137.7, 137.6, 137.1 (4°), 133.8, 133.3 
(CH=CH2), 129.2, 128.9, 128.4, 127.7, 123.3, 123.2, 123.2 (3°), 130.2, 130.1, 130.0, 
129.9, 129.8, 129.7 (CFCHCH), 118.3, 115.5 (CH=CH2), 112.2, 112.0, 111.8, 111.6, 
111.2, 111.0 (CFCHCH), 49.2, 46.0 (SCH), 34.1 (p-ArCH), 29.8, 29.7, 29.5 29.3, 
29.2, 29.1 (o-ArCH), 24.9, 24.7, 24.7, 24.6, 24.6 23.8, 23.8, 23.7, 23.6 (CH(CH3)2), 
20.2, 18.5, 18.4 (SCHCH2); m/z (CI) 603 [M+NH4]+, 586, 425 (Found [M+H]+, 
586.2255. requires [M+H]+, 586.2261). 
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3.3.5 Compounds Relevant to Section 2.6 
 
2-(But-3-ynyloxy)-tetrahydro-2H-pyran 
 
To a mixture of 3-butyn-1-ol 492 (5.0 g, 71.3 mmol, 1.0 equiv) and dihydropyran (6.51 
mL, 71.3 mmol, 1.0 equiv) was added a few drops of 2 M HCl(aq) and the mixture 
allowed to stir for 16 h. Et2O was then added and the solution was shaken vigorously 
with 2 M NaOH(aq) to remove the acid, and the aqueous layer re-extracted with Et2O. 
The organic layers were combined, dried (MgSO4), concentrated under reduced 
pressure and purified by vacuum distillation (62–64 °C) to give 2-(but-3-ynyloxy)-
tetrahydro-2H-pyran 493 (6.78 g, 62%) as a colourless oil; Rf 0.70 (50% EtOAc–
petrol); νmax (film) 3294, 2943, 2874, 1443, 1352, 1263, 1202, 1129, 1072, 1034, 980, 
907, 871, 814, 639 cm-1; δH (400 MHz) 4.67 (1H, t, J 3.5 Hz, OCHO), [3.89, 3.57] 
(4H, 2 × m, OCH2CH2C and OCH2CH2CH2), 2.52 (2H, td, J 7.0, 2.5 Hz, CH2CCH), 
1.99 (1H, t, J 2.5 Hz, CCH), 1.89–1.53 (6H, m, OCH2CH2CH2CH2);  δC (100 MHz) 
98.8 (OCHO), 81.5 (CCH), 69.2 (CCH), 65.5 (OCH2CH2C), 62.3 (OCH2CH2CH2), 
30.5 (OCHCH2), 25.4 (OCH2CH2CH2), 20.0 (CCH2), 19.4 (OCH2CH2CH2); m/z (CI) 
172 [M+NH4]+, 102, 85; data in accordance with the literature.126 
 
5-(Tetrahydro-2H-pyran-2-yloxy)pent-2-yn-1-ol 
 
To alkyne 493 (6.78 g, 44.0 mmol, 1.0 equiv) in THF (70 mL) was added nBuLi (2.60 
M; 16.9 mL, 44.0 mmol, 1.0 equiv) dropwise at –78 °C. The mixture was stirred at –78 
°C for 10 min, then paraformaldehyde (1.58 g, 52.8 mmol, 1.2 equiv) was added 
portionwise. The mixture was warmed to rt and stirred for 3 h before being quenched 
with sat. NH4Cl(aq). The reaction mixture was poured onto Et2O and the aqueous layer 
further extracted with Et2O (×2), dried (MgSO4), concentrated under reduced pressure 
and purified by column chromatography (30% EtOAc–petrol) to give 5-(tetrahydro-
2H-pyran-2-yloxy)pent-2-yn-1-ol 494 (7.87 g, 97%) as a colourless oil; Rf 0.34 (50% 
EtOAc–petrol); νmax (film) 3415, 2941, 2871, 2227, 1441, 1353, 1200, 1136, 1120, 
1070, 1034, 970, 906, 868 cm-1; δH (400 MHz) 4.66 (1H, dd, J 4.0, 3.0 Hz, OCHO), 
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4.26 (2H, m, CH2OH), [3.87, 3.56] (4H, 2 × m, OCH2CH2C and OCH2CH2CH2), 2.55 
(2H, tt, J 7.0, 2.0 Hz, OCH2CH2C), 1.89–1.52 (6H, m, OCH2CH2CH2CH2); δC (100 
MHz) 98.9 (OCHO), 83.3 (CCH2OH), 79.4 (CCCH2OH), 65.7 (OCH2CH2C), 62.4 
(OCH2CH2CH2), 51.4 (CH2OH), 30.6 (OCHCH2CH2), 25.4 (OCH2CH2CH2), 20.3 
(OCH2CH2C), 19.5 (OCH2CH2CH2); m/z (CI) 202 [M+NH4]+, 102, 85 (Found 
[M+NH4]+, 202.1443. C10H16O3 requires [M+NH4]+, 202.1443) (microanalysis not 
possible, unstable compound). 
 
Methyl 5-(tetrahydro-5H-pyran-2-yloxy)pent-2-ynyl carbonate 
 
To alcohol 494 (7.86 g, 42.6 mmol, 1.0 equiv) and pyridine (13.7 mL, 171 mmol, 4.0 
equiv) in CH2Cl2 (85 mL) at 0 °C was added methyl chloroformate (4.28 mL, 55.4 
mmol, 1.3 equiv) dropwise and the reaction stirred at 0 °C for 1 h. The reaction 
mixture was then diluted with H2O, extracted with EtOAc and the organic layers 
washed with sat. NH4Cl(aq) and sat. NaCl(aq). The combined organic layers were dried 
(MgSO4), concentrated under reduced pressure and purified by column 
chromatography (30% EtOAc–petrol) to give methyl 5-(tetrahydro-5H-pyran-2-
yloxy)pent-2-ynyl carbonate 495 (9.93 g, 96%) as a colourless oil; Rf 0.63 (50% 
EtOAc–petrol); νmax (film) 2944, 1754, 1444, 1376, 1263, 1122, 1070, 1033, 951 cm-1; 
δH (400 MHz) 4.74 (2H, t, J 2.0 Hz, OCH2C), 4.65 (1H, t, J 3.5 Hz, OCHO), 3.92–3.80 
(2H, m, 1 × OCH2CH2C and 1 × OCH2CH2CH2), 3.82 (3H, s, CH3), 3.60–3.50 (2H, m, 
1 × OCH2CH2C and 1 × OCH2CH2CH2), 2.55 (2H, tt, J 7.0, 2.0 Hz, OCH2CH2C), 
1.88–1.53 (6H, m, OCH2CH2CH2CH2); δC (100 MHz) 155.4 (C=O), 98.8 (OCHO), 
85.3 (CCH2O), 74.4 (CCH2CH2O), 65.3 (OCH2CH2C), 62.2 (OCH2CH2CH2), 56.1 
(OCH2C), 55.0 (OCH3), 30.5 (OCHCH2CH2), 25.4 (OCH2CH2CH2), 20.3 
(OCH2CH2C), 19.4 (OCH2CH2CH2); m/z (CI) 260 [M+NH4]+, 102, 85 (Found 
[M+NH4]+, 260.1504. C12H18O5 requires [M+NH4]+, 260.1498) (Found: C, 59.53; H, 
7.41. C12H18O5 requires C, 59.49; H, 7.49). 
 
5-Hydroxypent-2-ynyl methyl carbonate 
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A solution of carbonate 495 (1.77 g, 7.3 mmol, 1.0 equiv) and pyridinium p-
toluenesulfonate (184 mg, 0.73 mmol, 10 mol%) in EtOH (35 mL) was stirred at 55 °C 
for 2 h. The reaction mixture was allowed to cool, concentrated under reduced pressure 
and purified by column chromatography (40% EtOAc–petrol) to give 5-hydroxypent-
2-ynyl methyl carbonate 496 (9.72 g, 93%) as a colourless oil; Rf 0.35 (50% EtOAc–
petrol); νmax (film) 3400, 2958, 2888, 2236, 1752, 1447, 1377, 1266, 1149, 1046, 956, 
902, 791 cm-1; δH (400 MHz) 4.76 (2H, t, J 2.0 Hz, OCH2C), 3.83 (3H, s, CH3), 3.75 
(2H, q, J 6.0 Hz, CH2OH), 2.53 (2H, tt, J 6.0, 2.0 Hz, CH2CH2OH), 1.96 (1H, t, J 6.0 
Hz, OH); δC (100 MHz) 155.4 (C=O), 85.1 (CCH2O), 75.6 (CCH2CH2), 60.9 
(CH2OH), 56.1 (CCH2O), 55.2 (OCH3), 23.2 (CCH2CH2); m/z (CI) 176 [M+NH4]+, 
102 (Found [M+NH4]+, 176.0922. C7H10O4 requires [M+NH4]+, 176.0923) (Found: C, 
53.22; H, 6.35. C7H10O4 requires C, 53.16; H, 6.37). 
(Z)-5-Hydroxypent-2-enyl methyl carbonate 
 
To alkyne 496 (3.12 g, 19.8 mmol, 1.0 equiv) in THF (120 mL) was added Lindlar’s 
catalyst (156 mg, 5% wt.). With vigorous stirring the reaction vessel was flushed with 
a balloon of H2(g) then allowed to stir for 1 h under a slight positive pressure of H2(g). 
The reaction mixture was then filtered through celite, concentrated under reduced 
pressure and purified by column chromatography (20–30% EtOAc–petrol) to give (Z)-
5-hydroxypent-2-enyl methyl carbonate 497 (2.81 g, 89%) as a colourless oil; Rf 0.31 
(50% EtOAc–petrol); νmax (film) 3400, 2958, 1749, 1444, 1363, 1265, 1050, 948, 792 
cm-1; δH (400 MHz) 5.74 (2H, m, CH=CH), 4.73 (2H, d, J 5.5 Hz, OCH2CH), 3.80 
(3H, s, CH3), 3.71 (2H, q, J 6.0 Hz, CH2OH), 2.44 (2H, q, J 6.0 Hz, CH2CH2OH), 1.74 
(1H, t, J 5.5 Hz, OH); δC (100 MHz) 155.9 (C=O), 132.0, 125.7 (CH=CH), 63.6 
(CH2OH), 61.7 (CHCH2O), 54.9 (OCH3), 31.1 (CH2CH2OH); m/z (CI) 178 [M+NH4]+ 
(Found [M+NH4]+, 178.1082. C7H12O4 requires [M+NH4]+, 178.1079) (Found: C, 
52.59; H, 7.57. C7H12O4 requires C, 52.49; H, 7.55).  
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(Z)-5-(Methoxycarbonyloxy)pent-3-enyl methane sulfonate  
 
According to general procedure C, alcohol 497 (1.00 g, 6.24 mmol, 1.0 equiv) in 
CH2Cl2 (30 mL) was treated with NEt3 (2.61 mL, 18.7 mmol, 3.0 equiv) and MsCl 
(0.97 mL, 12.5 mmol, 2.0 equiv) to give (Z)-5-(methoxycarbonyloxy)pent-3-enyl 
methane sulfonate 498 as an orange oil, used crude in the next step; Rf 0.51 (50% 
EtOAc–petrol); νmax (film) 3027, 2960, 1749, 1444, 1353, 1268, 1174, 956, 915, 794, 
734 cm-1; δH (400 Hz) 5.72 (2H, m, CH=CH), 4.69 (2H, d, J 6.5 Hz, OCH2CH), 4.26 
(2H, t, J 6.5 Hz, CH2OS), 3.79 (3H, s, OCH3), 3.02 (3H, s, SCH3), 2.61 (2H, q, J 6.5 
Hz, CH2CH2O); δC (100 MHz) 155.9 (C=O), 129.4, 127.0 (CH=CH), 68.6 (CH2OS), 
63.4 (CHCH2O), 55.1 (OCH3), 37.7 (SCH3), 27.8 (CH2CH2OH); m/z (CI) 256 
[M+NH4]+, 178, 52 (Found [M+NH4]+, 256.0858. C8H14O6S requires [M+NH4]+, 
256.0855). 
 
(Z)-5-Iodopent-2-enyl methyl carbonate 
 
To mesylate 498 (1.41 g, 5.93 mmol, 1.0 equiv) in MeCN (20 mL) was added sodium 
iodide (1.78 g, 11.9 mmol, 2.0 equiv) and the mixture stirred at 70 °C for 16 h. The 
reaction was then cooled and divided between Et2O and H2O. The combined organic 
layers were washed with sat. Na2S2O3(aq), dried (MgSO4) and concentrated under 
reduced pressure to give (Z)-5-iodopent-2-enyl methyl carbonate 499 as a colourless 
oil, used crude in the next step; Rf 0.79 (50% EtOAc–petrol); νmax (film) 2956, 1748, 
1443, 1362, 1263, 1175, 965, 903, 791 cm–1; δH (400 MHz) 5.72 (1H, m, CHCH2O), 
5.63 (1H, m, CHCH2CH2I), 4.67 (2H, d, J 7.0 Hz, OCH2), 3.78 (3H, s, CH3), 3.17 (2H, 
t, J 7.0 Hz, CH2I), 2.72 (2H, dt, J 7.0, 6.5 Hz, CH2CH2I); δC (100 MHz) 155.7 (C=O), 
133.6, 125.2 (3°), 63.4 (OCH2), 54.8 (OCH3), 31.4 (CH2CH2I), 4.2 (CH2I); m/z (CI) 
288 [M+NH4]+, 256, 212, 195, 143 (Found [M+NH4]+, 288.0091. C7H11IO3 requires 
[M+NH4]+, 288.0097). 
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(Z) Methyl 7-(methoxycarbonyloxy)-2-tosylhept-5-enoate 
 
According to general procedure D, sodium hydride (300 mg, 7.49 mmol, 1.2 equiv) 
suspended in THF (10 mL) was treated with methyl p-toluenesulfonyl acetate 365 
(1.42 g, 6.24 mmol, 1.0 equiv) in THF (7.5 mL) followed by a solution of (Z)-5-
iodopent-2-enyl methyl carbonate 499 (1.49 g, 6.24 mmol, 1.0 equiv) in THF (7.5 mL) 
to give (Z) methyl 7-(methoxycarbonyloxy)-2-tosylhept-5-enoate 500 as a colourless 
oil used crude in the next step; Rf 0.55 (50% EtOAc– petrol).  
 
(Z)-Methyl 7-hydroxy-2-tosylhept-5-enoate 
 
To a solution of carbonate 500 (1.0 g, 2.79 mmol, 1.0 equiv) in dry MeOH (14 mL) at 
0 °C was added K2CO3 (1.93 g, 13.95 mmol, 5.0 equiv) and the reaction stirred at 0 °C 
for 2 h. The solvent was removed under reduced pressure and the residue partitioned 
between 2 M HCl(aq) and EtOAc. The aqueous layer was further washed with EtOAc 
and the combined organic layers dried (MgSO4), concentrated under reduced pressure 
and purified by column chromatography (50–75% EtOAc–petrol) to give (Z)-methyl 7-
hydroxy-2-tosylhept-5-enoate 501 (382 mg, 43% over 4 steps) as a colourless oil;  Rf 
0.20 (50% EtOAc–petrol); νmax (film) 3539, 2952, 1740, 1597, 1436, 1321, 1198, 
1147, 1084, 1036, 816, 729, 667, 570 cm–1; δH (400 MHz) 7.73 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.36 (2H, d, J 8.0 Hz, m-SO2Ar), 5.68 (1H, dt, J 11.0 7.0 Hz, CHCH2OH), 
5.38 (1H, dt, J 11.0, 7.0 Hz, SCH2CH2CH), 4.01 (2H, d, J 6.5 Hz, CH2OH), 3.94 (1H, 
dd, J 10.5, 3.5 Hz, SCH), 3.68 (3H, s, OCH3), 2.46 (3H, s, ArCH3), 2.24–1.99 (4H, m, 
SCHCH2CH2); δC (100 MHz) 166.6 (C=O), 145.6, 134.0 (4°), 131.1, 129.8, 129.5, 
129.3 (3°), 70.1 (SCH), 58.2 (CH2OH), 53.0 (OCH3), 26.5 (SCHCH2CH2), 24.6 
(SCHCH2), 21.7 (ArCH3); m/z (CI) 330 [M+NH4]+, 174 (Found [M+NH4]+, 330.1389. 
C15H20O5S requires [M+NH4]+, 330.1375) (Found: C, 57.72; H, 6.51. C15H20O5S 
requires C, 57.67; H, 6.45).  
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(Z)-7-Hydroxy-2-tosylhept-5-enoic acid 
 
According to general procedure F, a solution of ester 501 (1.45 g, 4.63 mmol, 1.0 
equiv) in THF (11.6 mL) was treated with 2 M LiOH(aq) (11.6 mL) to give (Z)-7-
hydroxy-2-tosylhept-5-enoic acid 502 (1.45 g, 90%) as a colourless solid without 
further purification; νmax (film) 3367, 974, 2894, 1725, 1451, 1381, 1319, 1148, 1086, 
1049, 880 cm–1; δH (400 MHz) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.35 (2H, d, J 8.0 Hz, 
m-SO2Ar), 7.05 (1H, br s, OH), 5.67 (1H, dt, J 11.0, 7.0 Hz, CHCH2OH), 5.41 (1H, dt, 
J 10.5, 7.5 Hz, SCHCH2CH2CH), 4.10 (2H, m, CH2OH), 3.94 (1H, dd, J 9.5, 5.0 Hz, 
SCH), 2.44 (3H, s, ArCH3), 2.18 (2H, m, SCHCH2 and SCHCH2CH2), 2.04 (2H, m, 
SCHCH2 and SCHCH2CH2); δC (100 MHz) 168.8 (C=O), 145.7, 133.8 (4°), 130.2, 
129.8, 129.4 (3°), 70.0 (SCH), 57.9 (CH2OH), 26.3 (SCHCH2CH2), 24.4 (SCHCH2), 
21.7 (ArCH3); m/z (-ve CI) 297 [M–H]-, 253, 155 (Found [M–H]-, 297.0790. 
C14H18O5S requires [M–H]-, 297.0797). 
 
(Z)-3-Tosyl-3,4,5,6-tetrahydrooxocin-2-one 
 
To a solution of HATU (637 mg, 1.68 mmol, 5.0 equiv) and DIPEA (598 µL, 3.35 
mmol, 10.0 equiv) in DMF (10 mL) was added hydroxy acid 502 (100 mg, 0.34 mmol, 
1.0 equiv) in DMF
 
(7 mL) via syringe pump over a period of 12 h. The reaction 
mixture was allowed to stir for a further 8 h then extracted with EtOAc (× 3). The 
combined organic phases were washed sequentially with 2 M HCl(aq), 2 M NaOH(aq), 
sat. NaHCO3(aq) and sat. NaCl(aq), dried (MgSO4) and concentrated under reduced 
pressure. Purification by column chromatography (30–80% EtOAc–petrol) gave (Z)-3-
tosyl-3,4,5,6-tetrahydrooxocin-2-one 489 (63 mg, 66%) as a colourless solid; Rf 0.42 
(50% EtOAc–petrol); mp 133–134 °C; νmax (film) 3056, 2940, 1754, 1596, 1449, 1316, 
1265, 1148, 1086, 1035, 813, 738, 663 cm-1; δH (400 MHz) 7.89 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.37 (2H, d, J 8.0 Hz, m-SO2Ar), 5.60–5.50 (2H, m, CH=CH), 4.95 (1H, dd, J 
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15.5, 3.0 Hz, OCH2), 4.60 (1H, d, J 15.5 Hz, OCH2), 4.06 (1H, dd, J 10.0, 6.0 Hz, 
SCH), 2.46 (3H, s, ArCH3), 2.55–2.35 (3H, m, SCHCH2CH2 and 1 × SCHCH2), 1.91 
(1H, m, SCHCH2); δC (100 MHz) 168.4 (C=O), 145.4, 134.2 (4°), 129.8, 129.7, 128.6, 
128.2 (3°), 67.4 (SCH), 66.1 (OCH2), 25.2 (SCHCH2CH2), 24.7 (SCHCH2), 21.7 
(ArCH3); m/z (CI) 298 [M+NH4]+ (Found [M+NH4]+, 298.1114. C14H16O4S requires 
[M+NH4]+, 298.1113) (Found: C, 60.05; H, 5.74. C14H16O4S requires C, 59.98; H, 
5.75). 
 
(1R,2S)-1-Tosyl-2-vinylcyclobutanecarboxylic acid  
 
According to general procedure H, lactone 489 (98 mg, 0.35 mmol, 1.0 equiv) in 
CH2Cl2 (1.75 mL) was treated with KOAc (3.4 mg, 0.035 mmol, 0.1 equiv) and BSA 
(87 µL, 0.35 mmol, 1.0 equiv) to give (1R,2S)-1-tosyl-2-vinylcyclobutanecarboxylic 
acid 490 (97 mg, 99%) as a colourless solid; mp 135–136 °C; νmax (film) 2985, 1728, 
1376, 1267, 1046, 737 cm-1; δH (400 MHz) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.37 (2H, 
d, J 8.0 Hz, m-SO2Ar), 5.79 (1H, ddd, J 17.5, 10.5, 7.5 Hz, CH=CH2), 5.22 (1H, d, J 
17.5 Hz, CH=CH2 cis), 5.21 (1H, d, J 10.0 Hz, CH=CH2 trans), 4.05 (1H, dd, J 17.0, 
9.0 Hz, SCCH), 2.68 (1H, ddd, J 11.5, 9.5, 9.5 Hz, SCCH2), 2.52 (1H, m, SCCH2), 
2.47 (3H, s, ArCH3), 2.25 (1H, m, SCCH2CH2), 2.14 (1H, m, SCCH2CH2); δC (100 
MHz) 166.9 (C=O), 145.9, 133.0 (4°), 135.0 (CH=CH2), 130.1, 129.3 (3°), 119.0 
(CH=CH2), 74.1 (SC), 42.9 (SCCH), 23.3 (SCCH2), 21.7 (ArCH3), 21.2 (SCCH2CH2); 
m/z (CI) 298 [M+NH4]+, 254 (Found [M+NH4]+, 298.1107. C14H16O4S requires 
[M+NH4]+, 298.1113) (Found: C, 60.07; H, 5.80. C14H16O4S requires C, 59.98; H, 
5.75). 
 
1-Methyl-4-((1R,2S)-2-vinylcyclobutylsulfonyl)benzene 
 
According to general procedure I, lactone 489 (42 mg, 0.15 mmol, 1.0 equiv) in DMF 
(0.75 mL) was treated with KOAc (1.5 mg, 0.015 mmol, 0.1 equiv) and BSA (37 µL, 
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0.15 mmol, 1.0 equiv). Purification by column chromatography (20% EtOAc–petrol) 
gave 1-methyl-4-((1R,2S)-2-vinylcyclobutylsulfonyl) benzene 491 (30 mg, 85%) as a 
colourless gum; Rf 0.67 (50% EtOAc–petrol); νmax (film) 2926, 1600, 1493, 1452, 
1265, 1146, 740, 702 cm-1; δH (400 MHz) 7.76 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, 
d, J 8.0 Hz, m-SO2Ar), 5.66 (1H, ddd, J 17.0, 10.0, 6.0 Hz, CH=CH2), 4.90 (1H, dd, J 
16.0, 1.5 Hz, CH=CH2 cis), 4.90 (1H, dd, J 11.5, 1.5 Hz, CH=CH2 trans), 3.57 (1H, 
ddd, J 9.0, 9.0, 9.0 Hz, SCHCH), 3.40 (1H, ddd, J 9.0, 8.5, 7.5 Hz, SCH), 2.43 (3H, s, 
ArCH3), 2.43 (1H, ddd, J 11.5, 9.5, 9.5 Hz, SCHCH2), 2.14 (1H, ddd, J 20.5, 9.0, 2.5 
Hz, SCHCH2CH2), 2.03 (1H, ddd, J 20.0, 8.5, 2.5 Hz, SCHCH2), 1.84 (1H, ddd, J 
20.0, 9.5, 9.5 Hz, SCHCH2CH2); δC (100 MHz) 144.6, 135.5 (4°), 138.2 (CH=CH2), 
129.8, 128.4 (3°), 115.2 (CH=CH2), 62.0 (SCH), 39.8 (SCHCH), 22.9 (SCHCH2), 21.6 
(ArCH3), 19.6 (SCHCH2CH2); m/z (CI) 254 [M+NH4]+, 490 (Found [M+NH4]+, 
254.1212. C13H16O2S requires [M+NH4]+, 254.1215) (Found: C, 66.09; H, 6.76. 
C13H16O2S requires C, 66.07; H, 6.82). 
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3.3.6 Compounds Relevant to Section 2.7 
 
Ethyl 2-(diphenoxyphosphoryl)propanoate 
 
To a solution of phosphonate 375 (2.0 g, 6.20 mmol, 1.0 equiv) in DMSO (7.5 mL) 
was added sodium hydride (60% dispersion in mineral oil; 273 mg, 6.82 mmol, 1.1 
equiv) at 15 °C. The solution was stirred for 20 min at rt, then methyl iodide (430 µL, 
6.82 mmol, 1.1 equiv) was added and the mixture stirred for a further 1 h. The reaction 
was quenched with sat. NH4Cl(aq) and extracted with EtOAc (×2). The combined 
extracts were washed with H2O and sat. NH4Cl(aq), dried (MgSO4) and concentrated 
under reduced pressure. Purification by column chromatography (10–20% EtOAc–
petrol) gave ethyl 2-(diphenoxyphosphoryl)propanoate 537 (970 mg, 49%) as a 
colourless oil; Rf 0.30 (50% EtOAc–petrol); νmax (film) 1737, 1591, 1489, 1311, 1279, 
1213, 1187, 1162, 1025, 937, 765, 689 cm–1; δH (400 MHz) 7.35 (4H, m, m-Ph), 7.21 
(6H, m, o-/p-Ph), 4.27 (2H, m, OCH2), 3.40 (1H, dq J 23.5, 7.5 Hz, CHCH3), 1.67 (3H, 
dd, J 19.0, 7.5 Hz, CHCH3), 1.30 (3H, t, J 7.0 Hz, CH2CH3); δC (100 MHz) 168.8, 
168.7 (C=O), 150.4, 150.3, 150.3, 150.2 (4°), 129.8, 125.3, 120.6, 120.6, 120.5, 120.5 
(3°), 61.9 (OCH2), 40.3, 39.0 (PCH), 14.1 (CH2CH3), 11.8, 11.7 (CHCH3); m/z (CI) 
352 [M+NH4]+, 335; data in accordance with the literature.107 
 
3-(tert-Butyldiphenylsilyloxy)propan-1-ol 
 
To sodium hydride (800 mg, 20 mmol, 1.0 equiv) in THF (40 mL) was added 1,3-
propanediol 538 (1.45 mL, 20 mmol, 1.0 equiv) and the mixture stirred at rt for 45 
min. TBDPSCl (5.20 mL, 20 mmol, 1.0 equiv) was then added and vigorous stirring 
continued for a further 1 h. The mixture was poured into Et2O, then washed with 10% 
K2CO3(aq) and sat. NaCl(aq), dried (MgSO4) and concentrated under reduced pressure. 
Purification by column chromatography (30–50% EtOAc–petrol) gave 3-(tert-
butyldiphenylsilyloxy) propan-1-ol 539 (3.23 g, 51%) as a colourless solid; Rf 0.63 
(50% EtOAc–petrol); mp 36–37 °C; νmax (film) 3445, 2931, 2858, 1472, 1428, 1391, 
1265, 1112, 967, 823, 737, 703 cm–1; δH (400 MHz) 7.71 (4H, m, m-Ph), 7.45 (6H, m, 
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o-/p-Ph), 3.94 (4H, t, J 5.5 Hz, OCH2), 1.84 (2H, m, OCH2CH2), 1.09 (9H, s, 
C(CH3)3); δC (100 MHz) 133.3 (4°), 135.6, 129.8, 127.8 (3°), 63.3 (CH2OH), 62.0 
(CH2OSi), 34.3 (CH2CH2OH), 26.9 (C(CH3)3), 19.1 (C(CH3)3); m/z (CI) 332 
[M+NH4]+, 315; data in accordance with the literature.127 
 
3-(tert-Butyldiphenylsilyloxy)propanal 
 
To a solution of alcohol 539 (4.54 g, 14.4 mmol, 1.0 equiv) in DMSO (72 mL) was 
added IBX (4.24 g, 15.1 mmol, 1.05 equiv). The reaction mixture was allowed to stir 
at rt overnight, then was diluted with Et2O and H2O and the layers separated. The 
organic layer was then washed with sat. NaCl(aq), dried (MgSO4), concentrated under 
reduced pressure and purified by column chromatography (20–30% EtOAc–petrol) to 
give 3-(tert-butyldiphenylsilyloxy)propanal 540 (4.21 g, 94%) as a colourless oil; Rf 
0.73 (50% EtOAc–petrol); νmax (film) 2930, 2857, 1728, 1472, 1428, 1390, 1111, 823, 
740, 702, 614 cm–1; δH (400 MHz) 9.85 (1H, t, J 2.0 Hz, CHO), 7.69 (4H, m, m-Ph), 
7.45 (6H, m, o-/p-Ph), 4.06 (2H, t, J 6.0 Hz, OCH2), 2.64 (2H, td, J 6.0, 2.0 Hz, 
OCH2CH2), 1.07 (9H, s, C(CH3)3); δC (100 MHz) 201.9 (C=O), 133.3 (4°), 135.6, 
129.8, 127.8 (3°), 58.3 (OCH2), 46.4 (OCH2CH2), 26.8 (C(CH3)3), 19.1 (C(CH3); m/z 
(CI) 330 [M+NH4]+; data in accordance with the literature.127 
 
(Z)-Ethyl 5-(tert-butyldiphenylsilyloxy)-2-methylpent-2-enoate 
 
To a solution of phosphate 537 (2.39 g, 7.42 mmol, 1.0 equiv) in THF (74.2 mL) was 
added sodium iodide (1.33 g, 8.90 mmol, 1.2 equiv) and DBU (1.22 mL, 8.16 mmol, 
1.1 equiv) at 0 °C and stirred for 10 min. The mixture was cooled to –78 °C and 
aldehyde 540 (2.32 g, 7.42 mmol, 1.0 equiv) added. After 10 min the mixture was 
warmed to 0 °C over 2 h. The reaction was quenched with sat. NH4Cl(aq), extracted 
with EtOAc and the organic layer washed with H2O and sat. NaCl(aq), dried (MgSO4) 
and concentrated under reduced pressure. Purification by column chromatography (10–
50% CH2Cl2–petrol) gave a mixture of geometric isomers (87:13 cis:trans) of ethyl 5-
(tert-butyldiphenylsilyloxy)-2-methylpent-2-enoate 541 (2.64 g, 90%) as a colourless 
oil; cis: Rf 0.27 (50% CH2Cl2–petrol); νmax (film) 2958, 2936, 2857, 1714, 1428, 1211, 
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1143, 1111, 1053, 822, 701 cm–1; δH (400 MHz) 7.68 (4H, m, m-Ph), 7.42 (6H, m, o-
/p-Ph), 6.05 (1H, td, J 7.0, 1.5 Hz, CH), 4.20 (2H, q, J 7.0 Hz, CH2CH3), 3.76 (2H, t, J 
6.5 Hz, OCH2CH2), 2.77 (2H, td, J 7.5, 1.5 Hz, CHCH2), 1.93 (3H, d, J 1.5 Hz, CCH3), 
1.30 (3H, t, J 7.0 Hz, CH2CH3), 1.07 (9H, s, C(CH3)3); δC (100 MHz) 168.0 (C=O), 
139.4 (CHCH2), 133.9, 128.5 (4°), 135.6, 129.6, 127.6 (3°), 63.3 (OCH2CH2), 60.1 
(OCH2CH3), 33.0 (OCH2CH2), 26.8 (C(CH3)3), 20.7 (CCH3), 19.2 (C(CH3), 14.3 
(CH2CH3); m/z (CI) 397 [M+H]+, 414, 330, 170, 125 (Found [M+H]+, 397.2202. 
C24H32O3Si requires [M+H]+, 397.2199) (Found: C, 72.63; H, 8.09. C24H32O3Si 
requires C, 72.68; H, 8.13). 
 
trans: Rf 0.20 (50% CH2Cl2–petrol); νmax (film) 3073, 2932, 2859, 1713, 1472, 1428, 
1391, 1279, 1212, 1111, 823, 740, 702cm–1; δH (400 MHz) 7.68 (4H, m, m-Ph), 7.42 
(6H, m, o-/p-Ph), 6.83 (1H, td, J 7.5, 1.0 Hz, CH), 4.21 (2H, q, J 7.0 Hz, CH2CH3), 
3.76 (2H, t, J 6.5 Hz, OCH2CH2), 2.45 (2H, q, J 7.0 Hz, CHCH2), 1.82 (3H, s, CCH3), 
1.31 (3H, t, J 7.0 Hz, CH2CH3), 1.07 (9H, s, C(CH3)3); δC (100 MHz) 168.1 (C=O), 
138.5 (CHCH2), 133.7, 129.3 (4°), 135.6, 129.7, 127.7 (3°), 62.5 (OCH2CH2), 60.4 
(OCH2CH3), 32.1 (OCH2CH2), 26.8 (C(CH3)3), 19.2 (C(CH3)3), 14.3 (CH2CH3), 12.5 
(CCH3); m/z (CI) 397 [M+H]+, 414, 330, 170, 125 (Found [M+H]+, 397.2202. 
C24H32O3Si requires [M+H]+, 397.2199) (Found: C, 72.74; H, 8.15. C24H32O3Si 
requires C, 72.68; H, 8.13). 
 
(Z)-5-(tert-Butyldiphenylsilyloxy)-2-methylpent-2-en-1-ol 
EtO
O OTBDPS
HO
OTBDPS
541 542
 
To ester 541 (2.13 g, 5.36 mmol, 1.0 equiv) in PhMe (17 mL) at –78 °C was added 
DIBAL-H (1.2 M in PhMe; 9.83 mL, 11.8 mmol, 2.2 equiv) dropwise. The reaction 
mixture was allowed to warm to rt and stirred for 2 h. The reaction mixture was again 
cooled to 0 °C, carefully quenched with sat. Na/K tartrate soln. and the mixture 
allowed to stir for a further 2 h. The aqueous layer was then extracted with EtOAc and 
the combined organic layers washed with sat. NaCl(aq) (×2) and H2O, dried (MgSO4) 
and concentrated under reduced pressure. Purification by column chromatography 
(30% EtOAc–petrol) gave (Z)-5-(tert-butyldiphenylsilyloxy)-2-methylpent-2-en-1-ol 
542 (1.82 g, 96%) as a colourless oil; Rf 0.66 (50% EtOAc–petrol); νmax (film) 3347, 
2930, 2857, 1472, 1427, 1389, 1111, 1007, 938, 823, 736, 701, 614 cm–1; δH (400 
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MHz) 7.70 (4H, m, m-Ph), 7.44 (6H, m, o-/p-Ph), 5.33 (1H, t, J 7.5 Hz, CH), 4.09 (2H, 
s, CH2OH), 3.66 (2H, t, J 6.5 Hz, OCH2CH2), 2.37 (2H, dt, J 6.5, 6.5 Hz, CHCH2), 
1.85 (3H, s, CCH3), 1.79 (1H, br s, OH), 1.08 (9H, s, C(CH3)3); δC (100 MHz) 137.3 
(CHCH2), 133.6, 124.7 (4°), 135.6, 129.7, 127.7 (3°), 63.6 (OCH2CH2), 61.7 
(CH2OH), 31.0 (CHCH2), 26.8 (C(CH3)3), 21.8 (CCH3), 19.1 (C(CH3)3); m/z (CI) 372 
[M+NH4]+, 355, 337, 277; data in accordance with the literature.128 
 
(Z)-5-(tert-Butyldiphenylsilyloxy)-2-methylpent-2-enyl methyl carbonate 
 
To alcohol 542 (1.82 g, 5.14 mmol, 1.0 equiv) and pyridine (1.65 mL, 20.6 mmol, 4.0 
equiv) in CH2Cl2 (25 mL) at 0 °C was added methyl chloroformate (516 µL, 6.68 
mmol, 1.3 equiv) dropwise and the reaction stirred at 0 °C for 1 h. The reaction 
mixture was then diluted with H2O and extracted with EtOAc. The organic layer was 
washed with sat. NH4Cl(aq) and sat. NaCl(aq), dried (MgSO4), concentrated under 
reduced pressure and purified by column chromatography (50–80% CH2Cl2–petrol) to 
give (Z)-5-(tert-butyldiphenylsilyloxy)-2-methylpent-2-enyl methyl carbonate 543 
(1.73 g, 82%) as a colourless oil; Rf 0.38 (50% CH2Cl2–petrol); νmax (film) 2954, 2856, 
1749, 1442, 1427, 1384, 1261, 1111, 947, 822, 792, 738, 702 cm–1; δH (400 MHz) 7.66 
(4H, m, m-Ph), 7.40 (6H, m, o-/p-Ph), 5.45 (1H, t, J 7.5 Hz, CH), 4.62 (2H, s, 
CCH2O), 3.78 (3H, s, OCH3), 3.65 (2H, t, J 6.5 Hz, OCH2CH2), 2.36 (2H, dt, J 7.0, 7.0 
Hz, CHCH2), 1.77 (3H, s, CCH3), 1.05 (9H, s, C(CH3)3); δC (100 MHz) 155.9 (C=O), 
135.6 (CHCH2), 133.9, 131.1 (4°), 129.6, 127.7, 127.6 (3°), 66.7 (OCH3), 63.4 
(OCH2CH2), 54.7 (OCH2CCH3), 31.2 (CHCH2), 26.8 (C(CH3)3), 21.3 (CCH3), 19.2 
(C(CH3)3); m/z (CI) 430 [M+NH4]+, 337, 81 (Found [M+NH4]+, 430.2408. C24H32O4Si 
requires [M+H]+, 430.2414) (Found: C, 69.93; H, 7.81. C24H32O4Si  requires C, 69.86; 
H, 7.82). 
 
(Z)-5-Hydroxy-2-methylpent-2-enyl methyl carbonate 
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To a stirred solution of alkene 543 (1.73 g, 4.19 mmol, 1.0 equiv) in MeOH (14 mL) at 
rt was added conc. HCl (280 µL). The mixture was stirred at rt for 16 h, then 
NaHCO3(s) was added until effervescence ceased, and the solids removed by filtration. 
The reaction mixture was concentrated under reduced pressure and the residue purified 
by column chromatography (30–60% EtOAc–petrol) to give (Z)-5-hydroxy-2-
methylpent-2-enyl methyl carbonate 544 (673 mg, 92%) as a colourless oil; Rf 0.28 
(50% EtOAc–petrol); νmax (film) 3394, 2958, 1748, 1444, 1385, 1351, 1264, 1049, 948 
cm–1; δH (400 MHz) 5.48 (1H, t, J 7.5 Hz, CH), 4.69 (2H, s, OCH2C), 3.79 (3H, s, 
OCH3), 3.67 (2H, t, J 6.5 Hz, CH2OH), 2.40 (2H, dt, J 6.5, 6.5 Hz, CHCH2), 1.89 (1H, 
s, OH), 1.82 (3H, d, J 0.5 Hz, CCH3); δC (100 MHz) 156.0 (C=O), 132.3 (CCH3), 
127.6 (CH), 66.6 (OCH3), 62.0 (OCH2CH2), 54.9 (OCH2CCH3), 31.3 (CHCH2), 21.4 
(CCH3); m/z (CI) 192 [M+NH4]+ (Found [M+NH4]+, 192.1228. C8H14O4 requires 
[M+NH4]+, 192.1236) (Found: C, 55.19; H, 8.20. C8H14O4  requires C, 55.16; H, 8.10). 
 
(Z)-5-(Methoxycarbonyloxy)-4-methylpent-3-enyl methanesulfonate 
 
According to general procedure C, alcohol 544 (650 mg, 3.73 mmol, 1.0 equiv) in 
CH2Cl2 (20 mL) was treated with NEt3 (1.56 mL, 11.2 mmol, 3.0 equiv) and MsCl 
(577 µL, 7.46 mmol, 2.0 equiv) to give (Z)-5-(methoxycarbonyloxy)-4-methylpent-3-
enyl methanesulfonate 545 as a yellow oil, used crude in the next step; Rf 0.38 (50% 
EtOAc–petrol); νmax (film) 2960, 1747, 1445, 1351, 1265, 1173, 956, 792 cm–1; δH 
(400 MHz) 5.38 (1H, t, J 8.0 Hz, CH), 4.60 (2H, s, OCH2CCH3), 4.17 (2H, t, J 6.5 Hz, 
CH2OS), 3.73 (3H, s, OCH3), 2.96 (3H, s, SCH3), 2.53 (2H, dt, J 6.5, 6.5 Hz, CHCH2), 
1.76 (3H, dd, J 2.5, 1.0 Hz, CCH3); δC (100 MHz) 155.6 (C=O), 133.4 (CCH3), 124.4 
(CH), 68.9 (SOCH2), 66.0 (OCH3), 54.7 (OCH2CCH3), 37.2 (SCH3), 27.7 (CHCH2), 
21.2 (CCH3); m/z (CI) 270 [M+NH4]+ (Found [M+NH4]+, 270.1012. C9H16O6S 
requires [M+NH4]+, 270.1011). 
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(Z)-5-Iodo-2-methylpent-2-enyl methyl carbonate 
 
To mesylate 545 (3.73 mmol, 1.0 equiv) in MeCN (12.5 mL) was added sodium iodide 
(1.12 g, 7.46 mmol, 2.0 equiv) and the mixture heated at 70 °C for 16 h. After cooling 
to rt, the mixture was partitioned between Et2O and H2O. The organic layer was 
washed with sat. Na2S2O3(aq) (×2), dried (MgSO4) and concentrated under reduced 
pressure to give (Z)-5-iodo-2-methylpent-2-enyl methyl carbonate 546 as a colourless 
oil used crude in the next step; Rf 0.76 (50% EtOAc–petrol); νmax (film) 2955, 1747, 
1443, 1383, 1352, 1263, 1170, 954 cm–1; δH (400 MHz) 5.37 (1H, t, J 7.0 Hz, CH), 
4.61 (2H, s, OCH2CCH3), 3.77 (3H, s, OCH3), 3.12 (2H, t, J 7.0 Hz, CH2I), 2.67 (2H, 
dtd, J 7.0, 7.0, 1.0 Hz, CHCH2), 1.77 (3H, dd, J 2.5, 1.0 Hz, CCH3); δC (100 MHz) 
155.7 (C=O), 132.0 (CCH3), 129.3 (CH), 66.3 (OCH3), 54.8 (OCH2CCH3), 31.7 
(CH2I), 21.3 (CCH3), 5.2 (CH2CH2I); m/z (CI) 302 [M+NH4]+ (Found [M+NH4]+, 
302.0255. C8H13O3I requires [M+NH4]+, 302.0253). 
 
(Z)-Methyl 7-(methoxycarbonyloxy)-6-methyl-2-tosylhept-5-enoate 
O
I
OMe
O
Ts
OMe
O
Ts
OMe
O
O OMe
O
+
547546365
 
According to general procedure D, sodium hydride (179 mg, 4.48 mmol, 1.2 equiv) 
suspended in DMF (7 mL) was treated with a solution of methyl p-toluenesulfonyl 
acetate 365 (851 mg, 3.73 mmol, 1.0 equiv) in DMF (7 mL) followed by a solution of 
iodide 546 (3.73 mmol, 1.0 equiv) in DMF (6 mL) to give (Z)-methyl 7-
(methoxycarbonyloxy)-6-methyl-2-tosylhept-5-enoate 547 used crude in the next step; 
Rf 0.60 (50% EtOAc–petrol). 
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(Z)-Methyl 7-hydroxy-6-methyl-2-tosylhept-5-enoate 
 
To a solution of ester 547 (905 mg, 2.35 mmol, 1.0 equiv) in dry MeOH (11.75 mL) 
was added K2CO3 (1.63 g, 11.8 mmol, 5.0 equiv) at 0 °C and the reaction stirred at 0 
°C for 2 h. The reaction was concentrated under reduced pressure and the residue 
partitioned between 2 M HCl(aq) and EtOAc and the aqueous layer further extracted 
with EtOAc (×2). The combined organic phase was dried (MgSO4), concentrated 
under reduced pressure and purified by column chromatography (50–70% EtOAc–
petrol) to give (Z)-methyl 7-hydroxy-6-methyl-2-tosylhept-5-enoate 548 (416 mg, 42% 
over 4 steps) as a colourless oil; Rf 0.16 (50% EtOAc–petrol); νmax (film) 3056, 2954, 
1740, 1597, 1440, 1322, 1266, 1147, 1085, 1004, 815, 734 cm–1; δH (400 MHz) 7.75 
(2H, d, J 8.0 Hz, o-SO2Ar), 7.39 (2H, d, J 8.0 Hz, m-SO2Ar), 5.16 (1H, t, J 6.5 Hz, 
CH), 4.04 (2H, s, CH2OH), 3.96 (1H, dd, J 10.5, 3.5 Hz, SCH), 3.71 (3H, s, OCH3), 
2.49 (3H, s, ArCH3), 2.20–2.00 (4H, m, SCHCH2 and SCHCH2CH2), 1.80 (3H, s, 
CCH3); δC (100 MHz) 166.7 (C=O), 145.5, 137.5, 133.9 (4°), 129.7, 129.3, 125.0 (3°), 
70.2 (SCH), 61.2 (CH2OH), 53.1 (OCH3), 26.9 (SCHCH2CH2), 24.8 (SCHCH2), 21.7 
(ArCH3), 21.4 (CCH3); m/z (CI) 344 [M+NH4]+, 326, 188, 174 (Found [M+NH4]+, 
344.1530. C16H22O5S requires [M+NH4]+, 344.1532) (Found: C, 58.94; H, 6.83. 
C16H22O5S  requires C, 58.87; H, 6.79). 
 
(Z)-7-Hydroxy-6-methyl-2-tosylhept-5-enoic acid 
 
According to procedure F, ester 548 (391 mg, 1.20 mmol, 1.0 equiv) in THF (3.0 mL) 
was treated with 2 M LiOH(aq) (3.0 mL, 2.00 mmol, 5.0 equiv) to give (Z)-7-hydroxy-
6-methyl-2-tosylhept-5-enoic acid 549 (360 mg, 92%) as a white solid, without further 
purification; νmax (film) 3487, 2939, 2587, 1726, 1597, 1447, 1317, 1193, 1147, 1084, 
1001, 816, 712, 665 cm–1; δH (400 MHz; CD3OD) 7.79 (2H, d, J 8.5 Hz, o-SO2Ar), 
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7.46 (2H, d, J 8.0 Hz, m-SO2Ar), 5.20 (1H, t, J 7.5 Hz, CH), 4.03 (2H, s, CH2OH), 
4.02 (1H, dd, J 9.0, 5.5 Hz, SCH), 2.48 (3H, s, ArCH3), 2.16 (2H, m, SCHCH2 and 
SCHCH2CH2), 1.99 (2H, m, SCHCH2 and SCHCH2CH2), 1.78 (3H, d, J 0.5 Hz, 
CCH3); δC (100 MHz; CD3OD) 167.4 (C=O), 145.6, 136.9, 134.4 (4°), 129.4, 129.1, 
124.7 (3°), 70.0 (SCH), 59.8 (CH2OH), 26.9 (SCHCH2CH2), 24.4 (SCHCH2), 20.3 
(ArCH3), 20.1 (CCH3); m/z (CI) 330 [M+NH4]+, 286, 268, 251, 95 (Found [M+NH4]+, 
330.1387. C15H20O5S requires [M+NH4]+, 330.1375) (Found: C, 57.79; H, 6.38. 
C15H20O5S requires C, 57.67; H, 6.45). 
 
(Z)-7-Methyl-3-tosyl-3,4,5,8-tetrahydro-2H-oxocin-2-one 
 
To a solution of HATU (362 mg, 0.95 mmol, 3.0 equiv) and DIPEA (283 µL, 1.58 
mmol, 5.0 equiv) in DMF (9.5 mL) was added acid 549 (99 mg, 0.32 mmol, 1.0 equiv) 
in DMF
 
(6.5 mL) via syringe pump over a period of 12 h. The reaction mixture was 
allowed to stir for a further 8 h then extracted with EtOAC (× 3). The combined 
organic phases were washed sequentially with 2 M HCl(aq), 2 M NaOH(aq), sat. 
NaHCO3(aq) and sat. NaCl(aq), dried (MgSO4) and concentrated under reduced pressure. 
Purification by column chromatography (30–50% EtOAc–petrol) gave (Z)-7-methyl-3-
tosyl-3,4,5,8-tetrahydro-2H-oxocin-2-one 534 (80 mg, 85%) as a colourless gum; Rf 
0.55 (50% EtOAc–petrol); νmax (film) 3055, 2983, 2937, 1758, 1597, 1449, 1318, 
1265, 1152, 1085, 737, 705 cm–1; δH (400 MHz) 7.85 (2H, d, J 8.0 Hz, o-SO2Ar), 7.34 
(2H, d, J 8.0 Hz, m-SO2Ar), 5.27 (1H, t, J 8.5 Hz, CH), [4.74, 4.47] (2H, 2 × d, J 15.0 
Hz, OCH2), 4.00 (1H, dd, J 10.0, 6.0 Hz, SCH), 2.44 (3H, s, ArCH3), 2.44–2.28 (3H, 
m, SCHCH2 and SCHCH2CH2), 1.90 (2H, m, SCHCH2), 1.59 (3H, s, CCH3); δC (100 
MHz) 168.5 (C=O), 145.3, 136.0, 134.5 (4°), 129.7, 122.8 (3°), 68.6 (OCH2), 67.4 
(SCH), 25.4 (SCHCH2CH2), 24.6 (SCHCH2), 21.7 (ArCH3), 21.3 (CCH3); m/z (CI) 
312 [M+NH4]+ (Found [M+NH4]+, 312.1279. C15H18O4S requires [M+NH4]+, 
312.1270) (Found: C, 61.19; H, 6.20. C15H18O4S requires C, 61.20; H, 6.16). 
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(1R,2S)-2-(Prop-1-en-2-yl)-1-tosylcyclobutanecarboxylic acid 
 
According to general procedure H, lactone 534 (140 mg, 0.48 mmol, 1.0 equiv) in 
CH2Cl2 (2.4 mL) was treated with KOAc (4.7 mg, 0.048 mmol, 0.1 equiv) and BSA 
(235 µL, 0.95 mmol, 2.0 equiv) to give (1R,2S)-2-(prop-1-en-2-yl)-1-
tosylcyclobutanecarboxylic acid 533 (132 mg, 94%) as a colourless gum, without 
further purification; νmax (film) 3195, 2962, 1702, 1596, 1402, 1301, 1154, 1086, 899, 
812, 710, 661 cm–1; δH (400 MHz) 10.20 (1H, br s, OH), 7.75 (2H, d, J 8.0 Hz, o-
SO2Ar), 7.32 (2H, d, J 8.0 Hz, m-SO2Ar), [4.97, 4.84] (2H, 2 × s, C=CH2), 3.92 (1H, 
dd, J 9.5, 9.5 Hz, SCCH), 2.69 (1H, ddd, J 11.5, 9.5, 9.5 Hz, SCCH2), 2.43 (3H, s, 
ArCH3), 2.37 (1H, m, SCCH2), 2.25 (1H, m, SCCH2CH2), 2.08 (1H, m, SCCH2CH2), 
1.78 (3H, s, CCH3); δC (100 MHz) 170.1 (C=O), 145.6, 142.1, 133.0 (4°), 129.8, 129.6 
(3°), 114.2 (CH=CH2), 75.3 (SC), 46.0 (SCCH), 23.6 (SCCH2), 22.1 (SCCH2CH2), 
21.7 (ArCH3), 19.7 (CCH3); m/z (CI) 312 [M+NH4]+, 268 (Found [M+NH4]+, 
312.1277. C15H18O4S requires [M+NH4]+, 312.1270) (Found: C, 61.29; H, 6.12. 
C15H18O4S  requires C, 61.20; H, 6.16). 
 
 (1R,2S)-Methyl 2-(prop-1-en-2-yl)-1-tosylcyclobutanecarboxylate 
 
To acid 533 (27 mg, 0.09 mmol, 1.0 equiv) in CH2Cl2 (0.9 ml) and MeOH (0.54 mL) 
was added TMSCHN2 (2.0 M in Et2O; 115 µl, 0.23 mmol, 2.5 equiv) at 0 °C. The 
reaction mixture was warmed to rt over 3 h, then concentrated under reduced pressure 
to give (1R,2S)-methyl 2-(prop-1-en-2-yl)-1-tosylcyclobutanecarboxylate 
 550 (26 mg, 92%) as a colourless gum, without further purification; Rf 0.65 (50% 
EtOAc–petrol); νmax (film) 2954, 1731, 1644, 1597, 1433, 1402, 1303, 1215, 1150, 
1123, 1087, 738, 705, 661 cm–1; δH (400 MHz) 7.75 (2H, d, J 8.0 Hz, o-SO2Ar), 7.31 
(2H, d, J 8.0 Hz, m-SO2Ar), [4.92, 4.76] (2H, 2 × s, C=CH2), 3.83 (1H, dd, J 9.5, 9.5 
Hz, SCCH), 3.61 (3H, s, OCH3), 2.80 (1H, ddd, J 11.5, 9.5, 9.5 Hz, SCCH2), 2.47 (1H, 
m, SCCH2),  2.43 (3H, s, ArCH3), 2.21 (1H, m, SCCH2CH2), 2.10 (1H, ddd, J 14.5, 
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9.5, 3.5 Hz, SCCH2CH2), 1.74 (3H, s, CCH3); δC (100 MHz) 166.9 (C=O), 145.1, 
143.2, 134.3 (4°), 129.6 (3°), 113.0 (CH=CH2), 75.9 (SC), 52.5 (OCH3), 45.6 (SCCH), 
24.1 (SCCH2), 22.2 (SCCH2CH2), 21.7 (ArCH3), 19.7 (CCH3); m/z (CI) 326 
[M+NH4]+, 309, 52 (Found [M+H]+, 309.1166. C16H20O4S requires [M+H]+, 
309.1161) (Found: C, 62.36; H, 6.53. C15H18O4S  requires C, 62.31; H, 6.54). 
 
1-Methyl-4-((1R,2S)-2-(prop-1-en-2-yl)cyclobutylsulfonyl)benzene 
 
According to general procedure I, lactone 534 (34 mg, 0.12 mmol, 1.0 equiv) in DMF 
(0.6 mL) was treated with KOAc (1.2 mg, 0.012 mmol, 0.1 equiv) and BSA (29 µL, 
0.12 mmol, 1.0 equiv). Purification by column chromatography (20% EtOAc–petrol) 
gave 1-methyl-4-((1R,2S)-2-(prop-1-en-2-yl)cyclobutylsulfonyl) benzene 551 (26 mg, 
90%) as a colourless gum; Rf 0.65 (50% EtOAc–petrol); νmax (film) 2950, 1649, 1597, 
1450, 1402, 1312, 1268, 1145, 1087, 893, 816, 665, 591, 564 cm–1; δH (400 MHz) 7.76 
(2H, d, J 8.0 Hz, o-SO2Ar), 7.34 (2H, d, J 8.0 Hz, m-SO2Ar), 4.72 (1H, d, J 1.0 Hz, 
C=CH2), 4.62 (1H, s, C=CH2), 3.73 (1H, ddd, J 9.0, 9.0, 9.0 Hz, SCH), 3.41 (1H, ddd, 
J 9.0, 9.0, 9.0 Hz, SCHCH), 2.45 (3H, s, ArCH3), 2.40 (1H, ddd, J 11.5, 9.5, 7.5 Hz, 
SCHCH2), 2.17 (1H, ddd, J 11.5, 9.0, 2.5 Hz, SCHCH2CH2), 2.00 (1H, ddd, J 8.5, 8.5, 
2.5 Hz, SCHCH2), 1.85 (1H, ddd, J 20.0, 9.5, 9.5 Hz, SCHCH2CH2); δC (100 MHz) 
144.5, 144.3, 135.5 (4°), 129.8, 128.4 (3°), 110.4 (CH=CH2), 60.9 (SCH), 42.6 
(SCHCH), 22.7 (SCHCH2), 21.6 (ArCH3), 20.0 (CCH3), 19.5 (SCHCH2CH2); m/z (CI) 
268 [M+NH4]+ (Found [M+NH4]+, 268.1379. C14H18O2S requires [M+NH4]+, 
268.1371) (Found: C, 67.09; H, 7.30. C14H18O2S requires C, 67.16; H, 7.25). 
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4.1 Crystallographic Data for 488a 
 
Crystallographic data for (RS*,1R*,2R*)-1-((S)-N-(2,4,6-triisopropylphenylsulfonyl) 
phenylsulfonimidoyl)-2-(2,4-difluorophenyl)-2-vinylcyclopropane 488a 
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Table 1. Crystal data and structure refinement for DC0807. 
 
Identification code DC0807 
Empirical formula C32 H37 F2 N O3 S2 
Formula weight 585.75 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Orthorhombic, Pca2(1) 
Unit cell dimensions a = 11.4277(3) Å α = 90° 
 b = 11.7915(3) Å β = 90° 
 c = 22.8410(5) Å γ = 90° 
Volume, Z 3077.82(13) Å3, 4 
Density (calculated) 1.264 Mg/m3 
Absorption coefficient 0.218 mm-1 
F(000) 1240 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.28 x 0.09 x 0.04 mm3 
θ range for data collection 3.89 to 30.44° 
Index ranges -16<=h<=15, -16<=k<=15, -31<=l<=30 
Reflns collected / unique 15743 / 6964 [R(int) = 0.0560] 
Reflns observed [F>4σ(F)] 4734 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.46127 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6964 / 7 / 366 
Goodness-of-fit on F2 0.928 
Final R indices [F>4σ(F)] R1 = 0.0472, wR2 = 0.0826 
 R1+ = 0.0472, wR2+ = 0.0826 
 R1- = 0.0479, wR2- = 0.0847 
R indices (all data) R1 = 0.0790, wR2 = 0.0918 
Absolute structure parameter x+ = 0.00(6), x- = 1.00(6) 
Largest diff. peak, hole 0.389, -0.341 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
Appendix 
 
 215 
Table 2. Bond lengths [Å] and angles [°] for DC0807. 
 
C(1)-C(2) 1.284(4) 
C(2)-C(3) 1.492(4) 
C(3)-C(4) 1.504(4) 
C(3)-C(9) 1.527(4) 
C(3)-C(5) 1.528(4) 
C(4)-C(5) 1.504(4) 
C(5)-S(6) 1.755(3) 
S(6)-O(15) 1.4473(18) 
S(6)-N(7) 1.548(2) 
S(6)-C(16) 1.758(3) 
N(7)-S(8) 1.631(2) 
S(8)-O(23) 1.4324(19) 
S(8)-O(22) 1.4340(19) 
S(8)-C(24) 1.794(2) 
C(9)-C(10) 1.367(4) 
C(9)-C(14) 1.389(4) 
C(10)-F(10) 1.323(3) 
C(10)-C(11) 1.384(4) 
C(11)-C(12) 1.368(4) 
C(12)-C(13) 1.344(4) 
C(12)-F(12) 1.362(3) 
C(13)-C(14) 1.389(4) 
C(14)-F(14) 1.292(9) 
C(16)-C(17) 1.381(4) 
C(16)-C(21) 1.391(4) 
C(17)-C(18) 1.373(4) 
C(18)-C(19) 1.391(5) 
C(19)-C(20) 1.378(4) 
C(20)-C(21) 1.367(4) 
C(24)-C(29) 1.404(3) 
C(24)-C(25) 1.411(3) 
C(25)-C(26) 1.398(4) 
C(25)-C(30) 1.520(4) 
C(26)-C(27) 1.380(4) 
C(27)-C(28) 1.384(4) 
C(27)-C(33) 1.515(4) 
C(28)-C(29) 1.399(4) 
C(29)-C(36) 1.523(4) 
C(30)-C(31) 1.523(4) 
C(30)-C(32) 1.532(4) 
C(33)-C(35) 1.523(4) 
C(33)-C(34) 1.525(4) 
C(36)-C(38) 1.509(4) 
C(36)-C(37) 1.532(4) 
 
C(1)-C(2)-C(3) 125.6(3) 
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C(2)-C(3)-C(4) 118.3(3) 
C(2)-C(3)-C(9) 115.0(2) 
C(4)-C(3)-C(9) 117.9(2) 
C(2)-C(3)-C(5) 122.8(2) 
C(4)-C(3)-C(5) 59.48(18) 
C(9)-C(3)-C(5) 112.3(2) 
C(3)-C(4)-C(5) 61.06(18) 
C(4)-C(5)-C(3) 59.46(19) 
C(4)-C(5)-S(6) 119.4(2) 
C(3)-C(5)-S(6) 123.0(2) 
O(15)-S(6)-N(7) 119.46(12) 
O(15)-S(6)-C(5) 111.97(13) 
N(7)-S(6)-C(5) 101.06(12) 
O(15)-S(6)-C(16) 108.24(13) 
N(7)-S(6)-C(16) 111.64(12) 
C(5)-S(6)-C(16) 103.17(12) 
S(6)-N(7)-S(8) 119.57(13) 
O(23)-S(8)-O(22) 115.87(11) 
O(23)-S(8)-N(7) 109.40(12) 
O(22)-S(8)-N(7) 110.75(11) 
O(23)-S(8)-C(24) 106.69(11) 
O(22)-S(8)-C(24) 111.34(12) 
N(7)-S(8)-C(24) 101.80(11) 
C(10)-C(9)-C(14) 117.7(3) 
C(10)-C(9)-C(3) 120.9(3) 
C(14)-C(9)-C(3) 121.4(2) 
F(10)-C(10)-C(9) 120.3(3) 
F(10)-C(10)-C(11) 116.9(3) 
C(9)-C(10)-C(11) 122.7(3) 
C(12)-C(11)-C(10) 116.9(3) 
C(13)-C(12)-F(12) 119.5(3) 
C(13)-C(12)-C(11) 123.3(3) 
F(12)-C(12)-C(11) 117.2(3) 
C(12)-C(13)-C(14) 118.6(3) 
F(14)-C(14)-C(13) 124.3(5) 
F(14)-C(14)-C(9) 113.5(5) 
C(13)-C(14)-C(9) 120.7(3) 
C(17)-C(16)-C(21) 120.9(3) 
C(17)-C(16)-S(6) 119.3(2) 
C(21)-C(16)-S(6) 119.7(2) 
C(18)-C(17)-C(16) 119.4(3) 
C(17)-C(18)-C(19) 119.9(3) 
C(20)-C(19)-C(18) 120.1(3) 
C(21)-C(20)-C(19) 120.5(3) 
C(20)-C(21)-C(16) 119.1(3) 
C(29)-C(24)-C(25) 121.8(2) 
C(29)-C(24)-S(8) 117.31(18) 
C(25)-C(24)-S(8) 120.4(2) 
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C(26)-C(25)-C(24) 116.0(2) 
C(26)-C(25)-C(30) 117.9(2) 
C(24)-C(25)-C(30) 126.1(2) 
C(27)-C(26)-C(25) 124.0(2) 
C(26)-C(27)-C(28) 117.2(2) 
C(26)-C(27)-C(33) 122.2(2) 
C(28)-C(27)-C(33) 120.6(2) 
C(27)-C(28)-C(29) 122.7(3) 
C(28)-C(29)-C(24) 117.4(2) 
C(28)-C(29)-C(36) 117.4(2) 
C(24)-C(29)-C(36) 125.2(2) 
C(25)-C(30)-C(31) 111.2(2) 
C(25)-C(30)-C(32) 111.9(2) 
C(31)-C(30)-C(32) 110.7(3) 
C(27)-C(33)-C(35) 112.6(2) 
C(27)-C(33)-C(34) 110.9(2) 
C(35)-C(33)-C(34) 109.8(2) 
C(38)-C(36)-C(29) 112.6(2) 
C(38)-C(36)-C(37) 110.8(3) 
C(29)-C(36)-C(37) 110.0(2) 
 218 
 
 
 
 
 
 
 
References 
References 
 
 219 
 
                                                 
1
 Maehr, H. J. Chem. Ed. 1985, 62, 114. 
2
 Sankararaman, S. Pericyclic reactions: a textbook; reactions, applications and theory; 
Wiley: Chichester, 2005. 
3
 (a) Deslongchamps, P. Aldrichimica Acta 1991, 24, 43–56; (b) Deslongchamps, P. 
Pure Appl. Chem. 1992, 64, 1831–1847;  
4
 For a review of IMDA reactions, see: Roush, W. R. Intramolecular Diels–Alder 
Reactions; Paquette, L. A., Ed.; Comprehensive Organic Synthesis; Pergamon: New 
York, 1991, 513–550 and references cited therein. 
5
 (a) Roberge, J. Y.; Giguere, P.; Soucy, P.; Dory, Y. L.; Deslongchamps, P. Can. J. 
Chem. 1994, 72, 1820–1829; (b) Bérubé, G; Deslongchamps, P. Can. J. Chem. 1990, 
68, 404–411. 
6
 Xu, Y.-C.; Cantin, M.; Deslongchamps, P. Can. J. Chem. 1990, 68, 2137–2143. 
7
 (a) Xu, Y.-C.; Roughton, A. L.; Plante, R.; Goldstein, S.; Deslongchamps, P. Can. J. 
Chem. 1993, 71, 1152–1168; (b) Xu, Y.-C.; Roughton, A. L.; Soucy, P.; Goldstein, S.; 
Deslongchamps, P. Can. J. Chem. 1993, 71, 1169–1183. 
8
 Lamothe, S.; Ndibwami, A.; Deslongchamps, P. Tetrahedron Lett. 1988, 29, 1641–
1644. 
9
 Ndibwami, A.; Lamothe, S.; Soucy, P.; Goldstein, S.; Deslongchamps, P. Can. J. 
Chem. 1993, 71, 714–725. 
10
 Dory, Y. L.; Soucy, P.; Drouin, M.; Deslongchamps, P. J. Am. Chem. Soc. 1995, 
117, 518–529. 
11
 Takahashi, T.; Simizu, K.; Doi, T.; Tsuji, J. J. Am. Chem. Soc. 1988, 110, 2674–
2676. 
12
 Couturier, M.; Dory, Y. L.; Fortin, D.; Rouillard, A.; Deslongchamps, P. 
Tetrahedron 1998, 54, 10089–10110. 
13
 (a) Baettig, K.; Marinier, A.; Pitteloud, R.; Deslongchamps, P. Tetrahedron Lett. 
1987, 28, 5249–5252; (b) Baettig, K.; Dallaire, C.; Pitteloud, R.; Deslongchamps, P. 
Tetrahedron Lett. 1987, 28, 5253–5254; (c) Marinier, A.; Baettig, K.; Dallaire, C.; 
Pitteloud, R.; Deslongchamps, P. Can. J. Chem. 1989, 67, 1609–1617. 
14
 Langlois, P.; Soucy, P.; Dory, Y. L.; Deslongchamps, P. Can. J. Chem. 1996, 67, 
129–143.  
References 
 
 220 
                                                                                                                                             
15
 (a) Marsault, E.; Toró, A.; Nowak, P.; Deslongchamps, P. Tetrahedron 2001, 57, 
4243–4260; (b) Takao, K.; Munakata, R.; Tadano, K. Chem. Rev. 2005, 105, 4779–
4807; (c) Clarke, P. A.; Reeder, A. T.; Winn, J. Synthesis 2009, 5, 691–709. 
16
 (a) Phoenix, S.; Reddy, M. S.; Deslongchamps, P. J. Am. Chem. Soc. 2008, 130, 
13989–13995; (b) Phoenix, S.; Bourque, E.; Deslongchamps, P. Org. Lett. 2000, 2, 
4149–4125; (c) Dory, Y. L.; Soucy, P.; Deslongchamps, P. Bull. Chim. Soc. Fr. 1994, 
131, 142–151; (d) Dory, Y. L.; Soucy, P.; Deslongchamps, P. Bull. Chim. Soc. Fr. 
1994, 131, 271–278. 
17
 (a) Vanderwal, C. D.; Vosburg, D. A.; Weiler, S.; Sorenson, E. J. Org. Lett. 1999, 1, 
645–648; (b) Vanderwal, C. D.; Vosburg, D. A.; Sorenson, E. J. Org. Lett. 2001, 3, 
4307–4310; (c) Vosburg, D. A.; Vanderwal, C. D.; Sorenson, E. J. J. Am. Chem. Soc. 
2002, 124, 4552–4553. 
18
 (a) Vanderwal, C. D.; Vosburg, D. A.; Weiler, S.; Sorenson, E. J. J. Am. Chem. Soc. 
2003, 125, 5393–5407; (b) Evans, D. A.; Starr, J. T. Angew. Chem. Int. Ed. 2002, 41, 
1787–1790; (c) Evans, D. A.; Starr, J. T. J. Am. Chem. Soc. 2003, 125, 13531–13540. 
19
 Tortosa, M.; Yakelis, N. A.; Roush, W. R. J. Am. Chem. Soc. 2008, 130, 2722–2723. 
20
 (a) Frank, S. A.; Works, A. B.; Roush, W. R. Can. J. Chem. 2000, 78, 757–771; (b) 
Roush, W. R.; Works, A. B. Tetrahedron Lett. 1996, 37, 8065–8068; (c) Winbush, S. 
M.; Mergott, D. J.; Roush, W. R. J. Org. Chem. 2008, 73, 1818–1829. 
21
 (a) Toró, A.; Nowak, P.; Deslongchamps, P. J. Am. Chem. Soc. 2000, 122, 4526–
4527; (b) Toró, A.; Lemelin, C.-A.; Préville, P.; Bélanger, G.; Deslongchamps, P. 
Tetrahedron 1999, 55, 4655–4684. 
22
 (a) Layton, M. E.; Morales, C. A.; Shair, M. D. J. Am. Chem. Soc. 2002, 124, 773–
775; (b) Morales, C. A.; Layton, M. E.; Shair, M. D. Proc. Natl. Acad. Sci. U.S.A. 
2004, 101, 12036–12041. 
23
 Rawal, V. H.; Isawa, S. J. Org. Chem. 1994, 59, 2685–2686. 
24
 Bodwell, G. J.; Li, J. Org. Lett. 2002, 4, 127–130. 
25
 Balskus, E. P.; Jacobsen, E. N. Science 2007, 317, 1736–1740. 
26
 (a) Corey, E. J.; Shibata, T.; Lee, T. W. J. Am. Chem. Soc. 2002, 124, 3808–3809; 
(b) Ryu, G.; Hu, Q.-Y.; Corey, E. J. J. Am. Chem. Soc. 2003, 125, 6388–6390; (c) 
Zhou, G.; Hu, Q.-Y.; Corey, E. J. Org. Lett. 2003, 5, 3979–3982. 
27
 For a review of cycloreversion chemistry, see: (a) Schaumann, E.; Ketcham, R. 
Angew. Chem. Int. Ed. 1982, 21, 225–314; (b) Griffin, G. W. Angew. Chem. Int. Ed. 
References 
 
 221 
                                                                                                                                             
1971, 10, 537–547; (c) Bianchi, G.; De Micheli, C.; Gandolfi, R. Angew. Chem. Int. 
Ed. 1979, 18, 721–738; (d) Hoffmann, R. Angew. Chem. Int. Ed. 1971, 10, 529–537. 
28
 (a) Mehta, G.; Reddy, A. V.; Srikrishna, A. Tetrahedron Lett. 1979, 20, 4863–4866; 
(b) Mehta, G.; Reddy, A. V. J. Chem. Soc. Chem. Commun. 1981, 15, 756–757. 
29
 Mehta, G.; Murthy, A. N.; Reddy, D. S. K.; Reddy, A. V. J. Am. Chem. Soc. 1986, 
108, 3443–3452. 
30
 Mehta, G.; Murthy, A. N.; Reddy, D. S. K. Tetrahedron Lett. 1987, 28, 1467–1468. 
31
 (a) White, J. D.; Dillon, M. P.; Butlin, R. J. J. Am. Chem. Soc. 1992, 114, 9673–
9674; (b) White, J. D.; Kim, J.; Drapela, N. E. J. Am. Chem. Soc. 2000, 122, 8665–
8671. 
32
 Griesbaum, K.; Ball, V. Tetrahedron Lett. 1994, 35, 1163–1164. 
33
 White, J. D.; Blakemore, P. R.; Korf, E. A.; Yokochi, A. F. T. Org. Lett. 2001, 3, 
413–415. 
34
 Craft, D. T.; Gung, B. W. Tetrahedron Lett. 2008, 49, 5931–5934. 
35
 Tang, B.; Bray, C. D.; Pattenden, G. Tetrahedron Lett. 2006, 47, 6401–6404. 
36
 For a review of biosynthetic and biomimetic electrocyclisations, see: Beaudry, C. 
M.; Malerich, J. P.; Trauner, D. Chem. Rev. 2005, 105, 4757–4778. 
37
 Woodward, R. B.; Hoffman, R. Angew. Chem. Int. Ed. 1969, 8, 781–853. 
38
 Schröder, G.; Martin, W.; Oth, J. F. M. Angew. Chem. Int. Ed. 1967, 10, 870–871. 
39
 For a review of ‘The Norcaradiene Problem’, see: Maier, G. Angew. Chem. Int. Ed. 
1967, 6, 402–413 and references cited therein. 
40
 Neuss, N.; Nagaraja, R.; Molloy, B. B.; Huckstep, L. L. Tetrahedron Lett. 1968, 9, 
4467–4471. 
41
 (a) Nicolaou, K. C.; Petasis, N. A.; Zipkin, R. E.; Uenishi, J. J. Am. Chem. Soc. 
1982, 104, 5555–5557; (b) Nicolaou, K. C.; Petasis, N. A.; Uenishi, J.; Zipkin, R. E. J. 
Am. Chem. Soc. 1982, 104, 5557–5558; (c) Nicolaou, K. C.; Zipkin, R. E.; Petasis, N. 
A. J. Am. Chem. Soc. 1982, 104, 5558–5560; (d) Nicolaou, K. C.; Petasis, N. A.; 
Zipkin, R. E. J. Am. Chem. Soc. 1982, 104, 5560–5562; 
42
 Banadarnayake, W. M.; Banfield, D. E.; Black, D. St. C. J. Chem. Soc. Chem. 
Commun. 1980, 19, 902–903. 
43
 (a) Beaudry, C. M.; Trauner, D. Org. Lett. 2002, 4, 2221–2224; (b) Moses, J. E.; 
Baldwin, J. E.; Marquez, R.; Adlington, R. M.; Cowley, A. R. Org. Lett. 2002, 4, 
3731–3734; (c) Parker, K. A.; Lim, Y.-H. Org. Lett. 2004, 6, 161–164; (d) Parker, K. 
A.; Lim, Y.-H. J. Am. Chem. Soc. 2004, 126, 15968–15969; (e) Jacobsen, M. F.; 
References 
 
 222 
                                                                                                                                             
Moses, J. E.; Adlington, R. M.; Baldwin, J. E. Org. Lett. 2005, 7, 2473–2476; (f) 
Beaudry, C. M.; Trauner, D. Org. Lett. 2005, 7, 4475–4477; (g) Jacobsen, M. F.; 
Moses, J. E.; Adlington, R. M.; Baldwin, J. E. Tetrahedron 2006, 62, 1675–1689. 
44
 Moses, J. E.; Baldwin, J. E.; Bruckner, S.; Eade, S. J. Adlington, R. M. Org. Biomol. 
Chem. 2003, 1, 3670–3684. 
45
 Moses, J. E.; Baldwin, J. E.; Marquez, R.; Adlington, R. M.; Claridge, T. D. W.; 
Odell, B. Org. Lett. 2003, 5, 661–663.  
46
 Cope, A. C.; Hardy, E. M. J. Am. Chem. Soc. 1940, 62, 441–444. 
47
 Claisen, L. Chem. Ber. 1912, 45, 3157–3166. 
48
 Doering, W. Von E.; Roth, W. R. Tetrahedron 1963, 19, 715–737. 
49
 Doering, W. Von E.; Roth, W. R. Angew. Chem. Int. Ed. 1963, 2, 115–122. 
50
 Lambert, J. B. Tetrahedron Lett. 1963, 27, 1901–1906. 
51
 Schröder, G. Angew. Chem. Int. Ed. 1963, 2, 481–482. 
52
 Tomooka, K.; Akiyama, T.; Man, P.; Suzuki, M. Tetrahedron Lett. 2008, 49, 6327–
6329. 
53
 Cameron, A. G.; Knight, D. W. Tetrahedron Lett. 1982, 23, 5455–5458. 
54
 (a) Abelman, M. M.; Funk, R. L.; Munger, J. D. J. Am. Chem. Soc. 1982, 104, 4030–
4032; (b) Abelman, M. M.; Funk, R. L.; Munger, J. D. Tetrahedron 1986, 42, 2831–
2846. 
55
 (a) Funk, R. L.; Munger, J. D. J. Org. Chem. 1985, 50, 707–709; (b) Cameron, A. 
G.; Knight, D. W. Tetrahedron Lett. 1985, 26, 3503–3506. 
56
 Funk, R. L.; Stallman, J. B.; Wos, J. A. J. Am. Chem. Soc. 1993, 115, 8847–8848. 
57
 Funk, R. L.; Munger, J. D. J. Org. Chem. 1984, 49, 4320–4322. 
58
 Stork, G.; Krafft, M. E.; Biller, S. A. Tetrahedron Lett. 1987, 28, 1035–1038. 
59
 (a) Wender, P. A.; Hubbs, J. C. J. Org. Chem. 1980, 45, 365–367; (b) Lange, G. L.; 
McCarthy, F. C. Tetrahedron Lett. 1978, 48, 4749–4750; (c) Williams, J. R.; Callahan, 
J. F. J. Org. Chem. 1980, 45, 4479–4483; (d) Williams, J. R.; Cleary, T. P. J. Chem. 
Soc. Chem. Commun. 1982, 11, 626–627; (e) Wender, P. A.; Eck, S. L. Tetrahedron 
Lett. 1982, 23, 187–1874. 
60
 Wender, P. A.; Letendre, L. J. J. Org. Chem. 1980, 45, 367–368. 
61
 (a) Paquette, L. A.; Yang, J.; Long, Y. O. J. Am. Chem. Soc. 2002, 124, 6542–6543; 
(b) Yang, J.; Long, Y. O.; Paquette, L. A. J. Am. Chem. Soc. 2003, 125, 1567–1574. 
62
 Barriault, L.; Arns, S. Chem. Commun. 2007, 22, 2211–2221. 
63
 Warrington, J. M.; Yap, G. P. A.; Barriault, L. Org. Lett. 2000, 2, 663–665. 
References 
 
 223 
                                                                                                                                             
64
 Barriault, L.; Doon, D. H. Org. Lett. 2001, 3, 1925–1927. 
65
 Barriault, L.; Denissova, I. Org. Lett. 2002, 4, 1371–1374. 
66
 Warrington, J. M.; Barriault, L. Org. Lett. 2005, 7, 4589–4592. 
67
 Sauer, E. L. O.; Barriault, L. J. Am. Chem. Soc. 2004, 126, 8569–5875. 
68
 For a recent review of the Claisen rearrangement, see: (a) Hiersemann, M.; 
Nubbemeyer, U., Ed.; The Claisen Rearrangement; Wiley: Weinheim, 2007; (b) 
Castro, A. M. M. Chem. Rev. 2004, 104, 2939–3002. 
69
 (a) Ireland, R. E.; Mueller, R. H. J. Am. Chem. Soc. 1972, 94, 5897–5898; (b) For a 
recent review of the Ireland–Claisen rearrangement, see: Chai, Y.; Hong, S. P.; 
Lindsay, H. A.; McFarland, C.; McIntosh, M. C. Tetrahedron 2002, 58, 2905–2928. 
70
 Ireland, R. E.; Wipf, P.; Armstrong, J. A. J. Org. Chem. 1991, 56, 650–657. 
71
 Uchiyama, H.; Kawano, M.; Katsuki, T.; Yamaguchi. M. Chem. Lett. 1987, 351–
354. 
72
 Bourgeois, D.; Craig, D.; King, N. P.; Mountford, D. M. Angew. Chem. Int. Ed. 
2005, 44, 618–621. 
73
 Bourgeois, D.; Craig, D.; Grellepois, F.; Mountford, D. M.; Stewart, A. J. W. 
Tetrahedron 2006, 62, 483–495. 
74
 Craig, D.; King, N. P.; Kley, J. T.; Mountford, D. M. Synthesis 2005, 19, 3279–
3282. 
75
 Craig, D.; Grellepois, F. Org. Lett. 2005, 7, 463–465. 
76
 Craig, D.; Lansdell, M. I.; Lewis, S. E. Tetrahedron Lett. 2007, 48, 7861–7864. 
77
 Craig, D.; Paina, F.; Smith, S. C. Chem. Commun. 2008, 3408–3410. 
78
 Lewis, S. E. Ph.D Thesis, University of London 2006. 
79
 Donaldson, W. A. Tetrahedron 2001, 57, 8589–8627. 
80
 (a) Zuo, G.; Louie, J. Angew. Chem. Int. Ed. 2004, 43, 2277–2279; (b) Davies, H. 
M. L.; Hu, B. J. Org. Chem. 1992, 57, 4309–4312. 
81
 Suzuki, M.; Sawada, S.; Yoshida, S.; Eberhardt, A.; Saegusa, T. Macromolecules 
1993, 26, 4748–4750. 
82
 (a) Trost, B. M.; Toste, F. D.; Shen, H. J. Am. Chem. Soc. 2000, 122, 2379–2380; 
(b) Wender, P. A.; Gamber, G. G.; Hubbard, R. D.; Zhang, L. J. Am. Chem. Soc. 2002, 
124, 2876–2877; (c) Wender. P. A.; Haustedt, L. O.; Lim, J.; Love, J. A.; Williams, T. 
J.; Yoon, J.-Y. J. Am. Chem. Soc. 2006, 128, 6302–6303. 
83
 Deng, L.; Giessert, A. J.; Gerlitz, O. O.; Dai, X.; Diver, S. T.; Davies, H. M. L. J. 
Am. Chem. Soc. 2005, 127, 1342–1343. 
References 
 
 224 
                                                                                                                                             
84
 Barrett, A. G. M.; Tam. W. J. Org. Chem. 1997, 62, 7673–7678. 
85
 Tsuji, T.; Nishida, S. Preparation of Cyclopropyl Derivatives; Rappoport, Z., Ed.; 
The Chemistry of the Cyclopropyl Group; Wiley: New York, 1987, 308–373. 
86
 Fürstner, A.; Langemann, K. J. Am. Chem. Soc. 1997, 119, 9130–9136. 
87
 Pentzer, E. B.; Gadzikwa, T.; Nguyen, S. T. Org. Lett. 2008, 10, 5613–5615. 
88
 Nubbemeyer, U. Synthesis 2003, 7, 961–1008. 
89
 Ireland, R. E.; Mueller, R. H.; Willard, A. K. J. Am. Chem. Soc. 1976, 98, 2868–
2877. 
90
 Kobayashi, M.; Masumoto, K.; Nakai, E; Nakai, T. Tetrahedron Lett. 1996, 37, 
3005–3008. 
91
 (a) Ando, K. J. Org. Chem. 1997, 62, 1934–1939; (b) Ando, K. J. Org. Chem. 2000, 
65, 4745–4749; (c) Ando, K. J. Org. Chem. 1999, 64, 8406–8408. 
92
 Craig, D.; Grellepois, F.; White, A. J. P. J. Org. Chem. 2005, 70, 6827–6832. 
93
 For a review of sulfoximines, see: Reggelin, M.; Zur, C. Synthesis 2000, 1–64. 
94
 Commeiras, L.; Bourdron, J.; Doulliard, S.; Barbier, P.; Vanthuyne, N.; Peyrot, V.; 
Parrain, J.-L. Synthesis 2006, 1, 166–181. 
95
 Cai, M.; Ye, H.; Zhao, H.; Song, C. J. Chem. Res. (S) 2003, 465–467. 
96
 Fieser, L. F.; Fieser, M. Reagents for Organic Synthesis 1967, 581–595. 
97
 Yamamoto, H.; Naruse, Y.; Takasu, M. Tetrahedron 1988, 29, 1947–1950. 
98
 Vézouët, R. L.; White, A. J. P.; Burrows, J. M.; Barrett, A. G. M. Tetrahedron 2006, 
62, 12252–2263. 
99
 Pilli, R. A.; Robello, L. G. J. Braz. Chem. Soc. 2004, 15, 938–944. 
100
 (a) Ishiyama, T.; Murata, M.; Miyaura, N. J. Org. Chem. 1995, 60, 7508–7508; (b) 
Heuser, S.; Barrett, D. G.; Berg, M.; Bonnier, B.; Kahl, A.; Luz De La Puente, M.; 
Oram, N.; Reidl, R.; Roettig, U.; Gil G. S.; Seger, E.; Steggles, D. J.; Wanner, J.; 
Weichert, A. G. Tetrahedron Lett. 2006, 47, 2675–2678. 
101
 a) Tumlinson, J. H.; Hardee, D. D.; Gueldner, R. C.; Thomson, A. C.; Hedin, P. A. 
Science 1969, 166, 1010–1012; b) Tumlinson, J. H.; Gueldner, R. C.; Hardee, D. D.; 
Thomson, A. C.; Hedin, P. A.; Minyard, J. P. J. Org. Chem. 1971, 36, 2616–2621. 
102
 Dickens, J. C.; Mori, K. J. Chem. Ecol. 1989, 15, 517–528. 
103
 Zurflüh, R.; Dunham, L. L.; Spain, V. L.; Siddall, J. B. J. Am. Chem. Soc. 1970, 92, 
425–427. 
104
 Billups, W. E.; Cross, J. H.; Smith, C. V. J. Am. Chem. Soc. 1973, 95, 3438–3439. 
105
 Clark, R. D. Synth. Comm. 1979, 9, 325–331. 
References 
 
 225 
                                                                                                                                             
106
 Mori, K.; Fukamatsu, K. Liebigs. Ann. Chem. 1992, 489–493. 
107
 Ando, K. J. Org. Chem. 1998, 63, 8411–8416. 
108
 Yu, J.; Cho, H.-S.; Chandrasekhar, S.; Falck, J. R.; Mioskowski, C. Tetrahedron 
Lett. 1994, 35, 5437–5440. 
109
 Cambie, R. C.; Clark, G. R.; Jones, T. C.; Rutledge, P. S.; Strange, G. A.; 
Woodgate, P. D. Aust. J. Chem. 1985, 38, 745–764. 
110
 Pawloski, C. E. U.S. Patent 1973, 3738997. 
111
 Shibuya, H.; Kawashima, K.; Narita, N.; Ikeda, M.; Kitigawa, I. Chem. Pharm. 
Bull. 1992, 40, 1154–1165. 
112
 Paina, F. Ph.D Thesis, Imperial College London 2008. 
113
 Larock, R. C.; Lui, C. L. J. Org. Chem. 1983, 48, 2151–2158. 
114
 Kimura, M.; Tanaka, S.; Tamaru, Y. Bull. Chem. Soc. Jpn. 1995, 68, 1689–1709. 
115
 Reader, J. C. Ph.D Thesis, University of London 1992. 
116
 Robles, O.; McDonald, F. E. Org. Lett. 2008, 10, 1811–1814. 
117
 Johnson, C. R.; Mori, K.; Nakanishi, A. J. Org. Chem. 1979, 44, 2065–2067. 
118
 Veale, H. S.; Levin, J.; Swern, D. Tetrahedron. Lett. 1978, 503–506. 
119
 Cram, D. J.; Day, J.; Rayner, D. R.; Von Schriltz, D. M.; Duchamp, D. J.; 
Garwood, D. C. J. Am. Chem. Soc. 1970, 92, 7369–7384. 
120
 Brandt, J.; Gaïs, H.-J. Tetrahedron: Asymmetry 1997, 8, 909–912. 
121
 Johnson, C. R.; Kirchoff, R. A.; Reischer, R. J.; Katekar, G. F. J. Am. Chem. Soc. 
1973, 95, 4287–4291. 
122
 Craig, D.; Geach, N. J.; Pearson, C. J.; Slawin, A. M. Z.; White, A. J. P.; Williams, 
D. J. Tetrahedron 1995, 51, 6071–6098. 
123
 Commeiras, L.; Bourdron, J.; Doulliard, S.; Barbier, P.; Vanthuyne, N.; Peyrot, V.; 
Parrain, J.-L. Synthesis, 2006, 1, 166–181. 
124
 Cai, M.; Ye, H.; Zhao, H.; Song, C. J. Chem. Res. (S), 2003, 465–467. 
125
 Back, T. G.; Bethell, R. J.; Parvez, M.; Wehrli, D. J. Org. Chem. 1998, 63, 7908–
7919. 
126
 Miura, K.; Hondo, T.; Okajima, S.; Nakagawa, T.; Takahashi, T.; Hosomi, A. J. 
Org. Chem. 2002, 67, 6082–6090. 
127
 Nacro, K.; Baltas, M.; Gorrichon, L. Tetrahedron 1999, 55, 14013–14030. 
128
 Chen, Y. K.; Walsh, P. J. J. Am. Chem. Soc. 2004, 126, 3702–3703. 
